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Abstract 
Available analgesics do not always provide adequate pain relief and are often 
associated with a significant side-effect profile. Following reports of a loss of 
inhibitory signalling in the spinal dorsal horn (DH) network in persistent pain 
conditions, γ-amino butyric acid type A (GABAA) and glycine receptors have been 
identified as promising targets. The present study assesses two in vitro models for 
their suitability for screening novel analgesics targeting GABAA and glycine 
receptors. Firstly, the embryonic cultured spinal DH cell model and secondly an 
acute rat spinal cord slice model.  
Immunofluorescence characterisation of the spinal DH culture illustrated that this 
model displays many similarities with the in vivo spinal DH. Immunofluorescence 
and RT-PCR demonstrated the presence of GABAA and glycine receptor subunits in 
the spinal DH culture. Calcium imaging and extracellular multi-electrode array 
(MEA) recording techniques were utilised to study the effect of GABAA, GABAB and 
glycine receptor drugs on the spinal DH culture network activity. All drugs tested 
significantly modulated the culture’s spontaneous firing. A further study assessed 
whether lentivirus and Accell siRNA mediated glycine receptor α subunit gene 
silencing modulates calcium responses in the DH culture model. The lentiviruses 
had low transfection efficiencies and caused cell death, however Accell siRNA 
transfection was successful and significantly decreased baseline spontaneous 
activity compared to untreated cultures.  
Single electrode and MEA extracellular recordings were performed with the acute 
spinal cord slice model. GABAA, GABAB and glycine receptor drugs modulated 4-
aminopyridine-induced hyperexcitability in the substantia gelatinosa lamina of the 
slices. The MEA recordings illustrated that 4-aminopyridine-induced activity 
manifested more prominently in the DH than the ventral horn (VH) and that the DH 
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network activity was highly synchronous. Taken together, these findings 
demonstrate that these in vitro models provide suitable platforms to test novel 
analgesics targeting GABAA and glycine receptors in the spinal DH network.  
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1 Introduction 
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1.1 Pain and Nociception 
The primary afferents which innervate the skin and deeper tissues of the body 
detect and respond to specific types of noxious and innocuous stimuli. There are 
defined classes of sensory primary afferents, which include the Aβ, Aδ and C fibres 
(Baron, 2006). The Aβ afferents respond to innocuous stimuli such as touch or hair 
movement, while Aδ and C fibres are nociceptors, responding to noxious 
mechanical, chemical and thermal stimuli. These primary afferents terminate in 
specific laminae of the spinal dorsal horn (DH), determined by their functional class 
(Figure 1.1) (Light and Perl, 1979). The spinal cord grey matter has been divided 
into ten lamina; the Aδ and C fibres innervate lamina I and II (Rexed, 1952). Lamina 
II is also known as the substantia gelatinosa. The neurons of the superficial spinal 
DH modulate the sensory information from the periphery before it is propagated to 
several brain regions (Ruscheweyh and Sandkuhler, 2005, Zheng et al., 2010, 
Smith et al., 2015). In periaqueductal grey matter (PAG) of the brainstem the 
second order neuron synapses, and via other brainstem regions, including the 
rostral ventromedial medulla, there is a descending pathway back to the spinal DH 
(Antal et al., 1996, Lau and Vaughan, 2014). This descending pathway is known to 
further modulate the spinal DH network activity (Koutsikou et al., 2007). The second 
order neurons terminate in the thalamus, from where neurons project to the 
somatosensory cortex which is involved with the discrimination of the sensory 
stimuli (Todd, 2010). Projections to other brains regions result in the emotional, 
cardiovascular and autonomic responses to pain stimuli (Treede et al., 1999).   
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Figure 1.1 The anatomy of the pain pathway. The classes of primary afferents are indicated 
with the locations of their termination within the spinal dorsal horn laminae. The second 
order neurons first cross the midline and then ascend to the thalamus where they terminate. 
Third order neurons subsequently project from the thalamus to the somatosensory cortex, 
and other brain regions to process the stimuli. There is also a feedback loop from the 
brainstem where a branch of the second order neurons synapse with neurons of the 
descending pathway which project back to the spinal dorsal horn to regulate output. Adapted 
from www.studyblue.com.   
 
4 
 
1.2 Loss of Inhibition in the Superficial Spinal Dorsal Horn in Chronic 
Pain Conditions 
Since the Gate Control Theory was proposed by Melzack and Wall (1965) there 
have been countless examples of the significance of inhibitory transmission in the 
development of pathological pain and the loss of inhibitory signalling in the spinal 
DH in pain conditions. For example, in vivo studies utilising antagonists of the γ-
aminobutyric acid (GABA) and glycine receptors induce hyperalgesia and allodynia 
(Yaksh, 1989, Sherman and Loomis, 1994, Sivilotti and Woolf, 1994). Conversely, 
GABAA agonists and positive allosteric modulators (PAMs) have an analgesic effect 
(Clavier et al., 1992, Eaton et al., 1999, Knabl et al., 2008). A number of potential 
causes of the changes in inhibitory neurotransmission in the spinal DH in chronic 
pain have been investigated, and discussed in detail below, including: (i) inhibitory 
interneuron cell death, (ii) a decrease in the synthesis of GABA and glycine, (iii) 
modulation of GABA and glycine release from presynaptic terminals, (iv) modulation 
of GABA and glycine receptor activity and (v) altered chloride ion homeostasis in the 
spinal DH. 
 
1.2.1 Spinal Dorsal Horn Inhibitory Interneuron Cell Death in Pain 
Conditions 
Several studies have investigated GABAergic cell death in models of neuropathic 
pain. There have been reports of a reduction in the number of GABAergic cells in 
the spinal DH following sciatic nerve transection (Castro-Lopes et al., 1993). Castro-
Lopes et al. (1993) suggested this resulted from a loss of sensory input to the DH 
GABAergic neurons. In addition, there is a selective loss of GABAA receptor-
mediated inhibitory postsynaptic currents (IPSCs) in lamina II of the spinal DH in 
peripheral nerve lesion rodent models of chronic pain (Ibuki et al., 1996, Moore et 
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al., 2002). Caspase-3, a protease playing a key role in apoptosis, has also been 
identified in the ipsilateral spinal DH neurons of rats with peripheral nerve lesions 
being expressed in glutamatergic and GABAergic interneurons (Scholz et al., 2005). 
In this study, the onset of apoptosis coincided with the observed decrease in IPSCs 
in DH lamina II. The loss of IPSCs and interneurons in the spinal DH was prevented 
with the local application of a caspase-3 inhibitor, which also reduced peripheral 
nerve injury-induced hypersensitivity (Scholz et al., 2005). However, other studies 
have not identified a loss of GABA or GABAergic neurons in the spinal DH in 
chronic constriction injury (CCI) or spared nerve injury models (Polgar et al., 2003, 
Polgar et al., 2005). These conflicting results may be due to the staining of GABA 
being associated with the cell bodies as shown by Scholz and co-workers (2005) 
and Moore and collaborators (2002) which may have a lower retention of GABA, as 
opposed to the axon terminals which were analysed by Polgar and co-wokers 
(Polgar et al., 2003, Polgar et al., 2005).  
 
1.2.2 Decrease in GABA and Glycine Synthesis and Release in Pain 
Conditions 
 A decrease in the synthesis of GABA has been identified as another potential 
aspect of the loss of inhibition observed in pain conditions. A lower level of GABA 
was detected in the spinal DH in the CCI model (Somers and Clemente, 2002). A 
decrease in the GABA synthesising enzyme glutamic acid decarboxylase (GAD) 65 
has also been shown in the ipsilateral spinal DH following peripheral nerve injury 
(Eaton et al., 1998, Moore et al., 2002). The release of inhibitory neurotransmitters 
GABA and glycine can be regulated by pre-synaptic GABAB receptor signalling on 
Aδ or C fibre terminals (Chéry and De Koninck, 2000, Choi et al., 2008). Activation 
of the GABAB receptor causes inhibition of the presynaptic terminal through 
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coupling with potassium and calcium ion channels (Hinckley et al., 2005). Increasing 
cell membrane permeability to potassium ions causes hyperpolarisation, and 
decreasing permeability to calcium ions prevents further release of 
neurotransmitters (Chen and Johnston, 2005). Therefore, presynaptic GABAB 
receptors are involved in the negative feedback for the release of GABA and glycine 
from the presynaptic terminals (Yang et al., 2015). Consequently this modulation of 
GABA release by GABAB receptors could contribute to the inhibitory regulation of 
glutamatergic signalling within the spinal DH, which is relevant to nociception. 
 
1.2.3 Modulation of GABA and Glycine Receptor Activity  
Naturally occurring neurosteroids can modulate GABAA receptor kinetics, prolonging 
synaptic inhibition (Cooper et al., 1999, Keller et al., 2004). The production of 
neurosteroids is upregulated in the spinal DH in peripheral inflammation, therefore 
slowing the GABAA receptor kinetics resulting in an anti-nociceptive action 
(Poisbeau et al., 2005). Therefore, these neurosteroids can work as endogenous 
analgesics (Belelli and Lambert, 2005, Kibaly et al., 2008). The production of 
prostaglandin E2 is also upregulated in inflammatory pain (Samad et al., 2001). 
Prostaglandin E2 phosphorylates α3-containing glycine receptors in the spinal DH 
through prostaglandin E2 receptor 2 (EP2) -mediated activation of protein kinase A 
(PKA) (Ahmadi et al., 2002, Harvey et al., 2004). Phosphorylation of the α3-
containing glycine receptors results in a conformational change in the glycine 
binding site on the receptor which prevents activity of the glycine receptor and thus 
glycinergic inhibition (Han et al., 2013). Consequently, this loss of glycinergic 
inhibition would result in increased excitability in the spinal DH and thus increase 
nociceptive signals. 
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1.2.4 Altered Chloride Homeostasis in the Spinal Dorsal Horn  
GABAA and glycine receptor ion channels are both permeable to chloride ions (Cl
-) 
and bicarbonate ions (HCO3
-) (Lynch, 2004, Hubner and Holthoff, 2013). Cl- ions are 
fourfold more permeable then HCO3
- and are more readily available, therefore the 
reversal potential for GABA (EGABA) and glycine (Eglycine) are dependent on the 
intracellular concentration of Cl- ions. In the adult central nervous system (CNS), 
neurons have a low intracellular Cl- ion concentration, therefore EGABA and Eglycine are 
more negative than the resting membrane potential. Consequently the opening of 
the GABAA or glycine receptor ion channels results in an influx of Cl
- ions which 
hyperpolarises the cell membrane preventing the generation of action potentials. 
The Cl- ion electrochemical gradient is therefore fundamental in maintaining 
inhibition in the spinal DH. A shift in the reversal potential for anions (Cl- and HCO3
-) 
to a more positive potential is known as shunting inhibition (Mitchell and Silver, 
2003). Shunting inhibition arises as a result of a small cell membrane 
depolarisation, which can activate some voltage-dependent ion channels. This can 
cause the resting membrane potential to become more positive, which can 
decrease or completely prevent hyperpolarisation induced by GABAA and glycine 
receptor channel opening resulting in disinhibition (Prescott et al., 2006). 
Consequently, shunting inhibition is believed to contribute to the development of 
central sensitisation as a consequence of the lack of inhibitory signalling in the 
spinal DH (Prescott et al., 2006).  
The potassium-chloride co-transporter 2 (KCC2) is required to maintain a low 
intracellular Cl- ion concentration, while the sodium-potassium-chloride 
cotransporter 1 (NKCC1) accumulates Cl- ions inside the cells (Watanabe and 
Fukuda, 2015). During early development there is a high expression of NKCC1 and 
a low expression of KCC2 causing GABA to be depolarising in immature neurons 
(Lee et al., 2005). However, during development NKCC1 expression decreases and 
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the KCC2 expression increases, which changes the electrochemical gradient of Cl- 
ions. Thus GABA switches from being depolarising to hyperpolarising in mature 
neurons (Rivera et al., 1999). In animal models of peripheral nerve injury, EGABA is 
more positive in spinal lamina I neurons, which leads to a reduction in GABA-
induced hyperpolarisation. The shift in EGABA was demonstrated to be the result of a 
downregulation of KCC2 (Coull et al., 2003, Rivera et al., 2004). Furthermore, rat 
models of peripheral inflammatory pain have a reduced KCC2 expression in the 
spinal DH and develop hypersensitivity (Zhang et al., 2008c). There is evidence that 
pharmacologically increasing KCC2 extrusion of Cl- ions in models of neuropathic 
pain restores spinal inhibition (Kahle et al., 2014). Therefore, the KCC2 transporter 
is a key target for the development of novel analgesics (Kahle et al., 2014). 
 
1.3 Classification of Spinal Dorsal Horn Cell Types 
The spinal DH is comprised of 90% interneurons, which synapse locally and are 
believed to be involved in the processing of sensory inputs, including pain 
(Basbaum et al., 2009, Sandkühler, 2009, Zeilhofer et al., 2012). The spinal DH 
physiology has been intensively investigated in order to understand how the circuitry 
controls the propagation of nociceptive inputs to higher brain centres. 
Understanding this circuitry could lead to the development of novel analgesics and 
improve treatment for a multitude of pain conditions. While progress has been made 
in this field, the circuitry of the DH remains elusive due to difficulty in defining 
functional interneuron populations (Graham et al., 2007, Todd, 2010). Inhibitory 
interneurons make up 25-40% of the neurons in laminae I-III of the rat spinal DH 
(Polgar et al., 2003). The remaining 60-75% is believed to be comprised of 
glutamatergic interneurons (Todd and Spike, 1993, Todd et al., 2003). 
Immunocytochemical studies have indicated that all the inhibitory interneurons in 
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the spinal DH are GABAergic, with 96 to 99% of these also being glycinergic in 
laminae I-II and III, respectively (Polgar et al., 2003, Todd, 2010, Polgar et al., 
2013). Many research investigations have suggested that the loss of function of 
inhibitory interneurons in the spinal DH leads to the development of central 
sensitisation and neuropathic pain conditions (Moore et al., 2002, Coull et al., 2003, 
Coull et al., 2005, Scholz et al., 2005). Blockade of GABAA and glycine receptors in 
the spinal DH in vivo induces symptoms of neuropathic and inflammatory pain 
illustrated by behavioural tests (Yaksh, 1989, Sherman and Loomis, 1994, Sivilotti 
and Woolf, 1994). These findings illustrate that DH inhibitory interneurons are 
involved in the processing of nociceptive signals. 
 
1.3.1 Spinal Dorsal Horn Cell Classification 
Classification of interneurons in the spinal DH has been based on cell morphology, 
electrophysiological properties and neurochemistry. Grudt and Perl (2002) provided 
one of the most comprehensive studies, where they identified at least nine 
categories of neurons in the spinal DH based on a combination of location, cellular 
geometry, distribution of neurites, connectivity and excitability. In lamina I two types 
of neurons were identified; projection neurons with axons that project ventromedially 
to the contralateral ventrolateral column and those which are non-projecting and 
have numerous neurites branching within the superficial DH (Grudt and Perl, 2002). 
Evidence suggests that the larger projection neurons all express the substance P 
receptor neurokinin 1 receptor (NK1r) while the smaller non-projecting neurons are 
interneurons (Al Ghamdi et al., 2009).  
In lamina II of the hamster spinal DH five distinct classes of interneurons were 
identified by Grudt and Perl (2002): islet, radial (stellate), vertical, central and 
medial-lateral cells (Figure 1.2). These have since been confirmed in rat and mouse 
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studies (Heinke et al., 2004, Maxwell et al., 2007, Yasaka et al., 2010). Islet cells 
have been identified as GABAergic and/or glycinergic (Todd and McKenzie, 1989, 
Todd and Sullivan, 1990). Electrophysiological recordings from islet cells have 
revealed that these cells display a tonic firing pattern throughout the duration of 
depolarisation (Grudt and Perl, 2002). Excitatory and inhibitory synaptic inputs to 
lamina II islet cells have been detected from cells also located within lamina II (Kato 
et al., 2007). Furthermore, C fibres were found to synapse with virtually all islet cells 
(Grudt and Perl, 2002), which demonstrates these inhibitory interneurons receive 
direct nociceptive input from the periphery.  
Vesicular glutamate transporters (vGluT) 1, 2 and 3 are glutamatergic neuronal 
makers. The majority of spinal glutamatergic neurons express vGluT2 (Oliveira et 
al., 2003, Todd et al., 2003, Malet et al., 2013, Punnakkal et al., 2014). vGluT2-
positive cells have a morphology similar to that described for vertical cells 
(Punnakkal et al., 2014). Vertical cells are non-GABAergic (Todd and McKenzie, 
1989) and account for a third of all the excitatory neurons found in the DH lamina II 
(Yasaka et al., 2010). There is evidence that vertical cells synapse with projection 
neurons in lamina I of the DH and therefore potentially provide a major output 
pathway from lamina II (Lu and Perl, 2005, Maxwell et al., 2007).  
Vertical cells are almost exclusively glutamatergic, while islet cells are exclusively 
GABAergic and/or glycinergic interneurons. The other cell types identified in the 
spinal DH have been more difficult to classify in terms of being excitatory or 
inhibitory. Central neurons were named based on their location in the ‘mid-zone’ of 
lamina II by Ramon y Cajal (1909) and they represent approximately a quarter of 
the cells in the DH. Grudt and Perl (2002) reported that central cells can be split into 
two groups: those displaying a tonic firing response to a step depolarisation and 
those only producing action potentials during the initial phase of the depolarisation 
(Hantman et al., 2004). Many of the tonically firing central cells are GABAergic and 
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receive monosynaptic input from C-fibres (Grudt and Perl, 2002). The group of the 
transiently firing central cells were identified as glutamatergic and receive input from 
Aδ-fibres. Radial cells identified by Grudt and Perl (2002) were located at the border 
between inner lamina II and outer lamina II, and had dendrites which extended in all 
directions, with some extending as far as lamina I in a dorsal-lateral direction but 
many projecting in the rostro-caudal axis. These are considered the same as 
“stellate” cells previously identified in the human spinal DH (Schoenen, 1982). Most 
radial cells have been labelled as glutamatergic, however, some GABAergic radial 
cells have also been identified (Maxwell et al., 2007, Yasaka et al., 2010). Medial-
lateral cells were identified as the only interneurons of lamina II which has dendrites 
which do not extend in a rostral-caudal direction, and therefore have been 
suggested to play a role in connecting the other interneurons of lamina II (Grudt and 
Perl, 2002). 
 
Figure 1.2 A figure of a transverse spinal cord section with the laminae defined, and a list of 
some of the classified neurons and interneurons present in laminae I and II. The significant 
properties of each of the classes of neurons and interneurons in these laminae are included. 
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A high density of parvalbumin (PV) positive interneurons in lamina II of the spinal 
DH have been identified from immunohistochemical studies, with some also found 
in lamina III but almost none in lamina I (Hughes et al., 2012). PV is a calcium-
binding protein, which can transiently bind calcium and transport it to intracellular 
calcium stores (Celio and Heizmann, 1982, Celio, 1990). Therefore, there is 
evidence that PV is involved in regulating neurotransmitter release in the 
presynaptic terminal, which is dependent on a calcium trigger for synaptic vesicle 
exocytosis (Augustine, 2001, Neher and Sakaba, 2008). Consequently PV affects 
the firing properties (Albéri et al., 2013) and short-term synaptic plasticity at 
inhibitory synapses in the brain (Caillard et al., 2000). GABAergic interneurons in 
the brain and spinal cord have been identified as PV-immunoreactive (Celio, 1990, 
Baimbridge et al., 1992), however a population of glutamatergic interneurons in the 
spinal DH are also PV-positive (Grudt and Perl, 2002).  
Neurochemically defining populations of cells within the spinal DH has indicated a 
significant expression of neuronal nitric oxide synthase (nNOS) (Sardella et al., 
2011, Polgár et al., 2013). DH lamina II was found to have a higher expression of 
nNOS-positive cells compared to laminae I and III (Sardella et al., 2011). Excitatory 
and inhibitory interneurons of the spinal DH express nNOS, although the majority 
(90%) of nNOS-positive cells are GABAergic (Valtschanoff et al., 1992, Sardella et 
al., 2011). Nitric oxide (NO) is produced by nNOS which subsequently produces 
cyclic guanosine monophosphate (cGMP) (Garthwaite, 2008, Schmidtko et al., 
2009). An NO-cGMP signalling pathway in the spinal DH has been linked with 
development of spinal hyperalgesia in the formalin inflammatory pain model (Tao et 
al., 1999). Inhibition of NO synthesis in the spinal cord and nNOS knockout mice 
have been used to illustrate that NOS is involved in the development and 
maintenance of inflammatory and neuropathic pain (Chu et al., 2005, Guan et al., 
2007). Furthermore, nNOS-positive cells respond to formalin injection and noxious 
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heat stimulation by an up-regulation of Fos (Polgár et al., 2013). Fos is currently 
used as a marker for demonstrating the occurrence of central sensitisation in pain 
conditions (Ahmad and Ismail, 2002, Gao and Ji, 2009, Hsieh et al., 2015).  
 
1.3.2 GABAA Receptor Expression in the Spinal Dorsal Horn 
The GABAA receptors are members of the Cys-loop pentameric ligand gated ion 
channel (LGIC) receptor family (Schofield et al., 1987). There is at least 30% 
homology between all members of the Cyc-loop LGIC family (Collingridge et al., 
2009), and they all form from five subunits with each subunit consisting of four 
transmembrane-spanning domains (Nayeem et al., 1994) (Figure 1.3). Together 
these subunits form a central pore, which for GABAA receptors is permeable to 
anions; particularly Cl- and HCO3
-. The binding of an agonist to the GABAA receptor 
causes a conformational change that leads to the opening of the ion channel pore. 
Depending on the electrochemical gradient of Cl- ions, when the channel pore is 
open there is either a net influx or efflux of Cl- ions across which can cause 
hyperpolarisation or depolarisation, respectively. 
There have been nineteen different human GABAA receptor subunits identified: six 
α, three β, three γ, one δ, one ε, one π, one θ, and three ρ, with splice variants 
identified for a number of these subunits (Simon et al., 2004, Olsen and Sieghart, 
2008). Not all combinations of subunits are thought to occur partly due to 
restrictions of subunit assembly, the most common combination in the brain contain 
two α, two β and one γ subunit (Chang et al., 1996, Tretter et al., 1997, Farrar et al., 
1999). However, multiple GABAA receptor subtypes have been found in a single 
neuron (Mangan et al., 2005). Synaptic GABAA receptors are predominantly 
composed of α1, α2 and/or α3 with β2/3 and γ2 subunits (Olsen and Sieghart, 
2008). These GABAA receptors have fast synaptic GABA transient current (Olsen 
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and Sieghart, 2009). Extrasynaptic GABAA receptors often contain the δ subunit 
(Mortensen and Smart, 2006). For example, the subtypes α4βδ, α6βδ and α5βγ2 
have all been detected extrasynaptically (Mortensen and Smart, 2006). These 
subtypes are more sensitive to low concentrations of GABA with some also having a 
higher affinity for GABA, and furthermore they are less likely to desensitise (Rossi 
and Hamann, 1998, Brickley et al., 1999, Mangan et al., 2005). Extrasynaptic 
GABAA receptors produce a tonic Cl
- current, which is believed to be involved in 
shunting inhibition (Mitchell and Silver, 2003). The synaptic GABAA receptors 
produce a phasic current which allows for these receptors to function at high 
frequency for efficient information transfer (Brickley et al., 1996, Wisden et al., 
2002).  
In the brain the GABAA receptor α1 subunit is the most abundant subunit, 
particularly in the cerebral and cerebellar cortex (Fritschy and Mohler, 1995, Korpi et 
al., 1999). The α2 subunit is most prominently expressed in the amygdala, 
hippocampus and striatum (Fritschy and Mohler, 1995). The GABAA receptor α3 
subunit is found primarily in the thalamus, basal forebrain and brainstem neurons 
(Fritschy and Mohler, 1995). The most prominent expression of the α4 subunit is in 
the thalamus and dentate gyrus of the hippocampus, with moderate expression in 
the cortex (Jia et al., 2007). The α5 subunit is most highly expressed in the 
hippocampus, and finally the α6 subunit is exclusively expressed in cerebellar 
granule cells (Fritschy and Mohler, 1995, Korpi et al., 1999). The expression of the 
γ1, γ3, ε, θ and π subunits is scarce throughout the CNS, which has limited their 
characterisation (Olsen and Sieghart, 2008). However, there is evidence for their 
expression in non-neuronal cells, including the pancreas, lung, breast and uterus 
(Jin et al., 2005, Zafrakas et al., 2006, Takehara et al., 2007). There are GABA 
receptors which are formed entirely from ρ subunits, which are termed GABAA-rho 
receptors (also known as GABAC receptors) (Barnard et al., 1998, Bormann, 2000, 
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Olsen and Sieghart, 2009). Additionally, ρ subunits have been found to assemble 
with the GABAA receptor γ2 subunit to form functional GABAA receptors (Pan et al., 
2000). The GABAA-rho receptors are primarily expressed in the retina (Cutting et al., 
1991), although have also been detected in the brainstem, hippocampus and other 
brain regions at lower levels of expression (Sieghart and Sperk, 2002, Milligan et al., 
2004). It has been shown that there is a laminar distribution of specific GABAA 
receptor α subunits in the spinal DH (Paul et al., 2012). In the superficial spinal DH 
the GABAA receptor α1, α2, α3, α5, β2/3 and γ2 subunits have all been detected in 
the superficial spinal DH (Bohlhalter et al., 1996, Zeilhofer et al., 2009). The α2 and 
α3 GABAA receptor subunits have been shown in rats to have a higher expression 
in lamina II of the spinal DH, while α1 and α5 subunits are more prominent in lamina 
III (Bohlhalter et al., 1996).  
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Figure 1.3 The structure of the GABAA receptor. (A) The GABAA receptor is formed from five 
subunits, with the most typical stoichiometry of two α, two β and a γ subunit. (B) Each 
subunit is composed of four transmembrane spanning domains (M1-M4), with a long 
extracellular N-terminal domain and a shorter extracellular C-terminal domain. (C) The M2 
domains of each subunit line the GABAA receptor channel pore. The GABA binding site is 
located at the interface between the α and β subunits. The benzodiazepine and barbiturate 
binding sites are located at the interface between the α and γ subunits. 
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1.3.3 Glycine Receptor Expression in the Spinal Dorsal Horn 
Glycine receptors, like the GABAA receptors, are pentameric LGICs. There are five 
glycine receptor subunits which have been identified, α1-4 and β and typically 
glycine receptors have a 2α:3β stoichiometry (Grudzinska et al., 2005) (Figure 1.4). 
Homomeric receptors consisting of only one α subtype can form functional glycine 
receptors in vitro (Griffon et al., 1999), but the β subunit alone does not form 
receptors (Bormann et al., 1993). Splice variants of each of the α subunits have 
been identified, the α1ins splice variant has an eight amino acid insert in the large 
intracellular loop (Malosio et al., 1991a). The α2 subunit has three splice variants: 
α2A and α2B, which have two amino acid substitutions, while the α2* splice variant 
has a single amino acid substitution which makes glycine receptors with this splice 
variant insensitive to strychnine (Kuhse et al., 1990). The glycine receptor α3 
subunit has two splice variants: α3L and α3K (Nikolic et al., 1998). The α3K variant 
is lacking 15 amino acids in the cytoplasmic loop between transmembrane spanning 
regions 3 and 4 compared to the other α subunits. The α3K-containing glycine 
receptors display faster desensitisation kinetics compared to those receptors 
containing the α3L subunit. The glycine receptor α4 subunit was first identified in the 
mouse, but is not found in humans (Matzenbach et al., 1994).  
The glycine receptor α1 subunit is expressed most prominently in the spinal cord 
and retina, but is also detected in the brainstem, thalamus and hypothalamus 
(Malosio et al., 1991b, Sato et al., 1991, Harvey et al., 2004). The α2 subunit is 
highly expressed during early development but decreases postnatally to very low 
levels in the mature CNS while the opposite is true for α1 and α3 subunits (Akagi et 
al., 1991, Watanabe and Akagi, 1995). The α3 subunit is strongly expressed in 
lamina II of the spinal DH, while the α1 subunit in the spinal DH is predominantly 
expressed in lamina III and deeper DH laminae (Harvey et al., 2004). A low 
expression of the α3 subunit has also been detected in the hippocampus and 
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hypothalamus (Malosio et al., 1991b). While the α4 subunit is a pseudo gene in 
humans, it is found as a protein in the sympathetic ganglia, spinal cord, dorsal root 
ganglia (DRG) and genital ridge of mice, chick, zebrafish and rat (Harvey et al., 
2000). The β subunit is expressed throughout the CNS, from early development 
through to the mature adult CNS (Grenningloh et al., 1990, Fujita et al., 1991, 
Malosio et al., 1991b). The β subunit in heteromeric glycine receptors anchors the 
receptor to the post-synaptic cytoskeleton through binding gephyrin (Meyer et al., 
1995b, Kneussel and Betz, 2000). Gephyrin has also been shown to cluster GABAA 
receptors at the post-synaptic membrane (Maric et al., 2011). Additionally, there is 
evidence that the glycine receptor β subunit is involved in ligand binding 
(Grudzinska et al., 2005). 
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Figure 1.4 The glycine receptor structure. (A) The glycine receptor is comprised of five 
subunits, which can composed of only α subunits, or of α and β subunits. (B) Each subunit 
has four transmembrane spanning domains (M1-M4), with extracellular N- and C-terminal 
domains. (C) The M2 transmembrane spanning domains of each subunit line the receptor 
channel pore. The agonist binding site is located at the interface between either two α 
subunits or an α and a β subunit.  
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1.4 GABAA Receptor Pharmacology 
The α subunits of the GABAA receptors are involved in ligand binding and the gating 
kinetics of the receptor (Gingrich et al., 1995, Labrakakis et al., 2014). The different 
subtypes of the GABAA receptor have different receptor gating kinetics and 
pharmacological profile. For example GABAA receptors containing the α2 subunit 
have slower deactivation kinetics, and a higher affinity for GABA compared to α1-
containing GABAA receptors (Dixon et al., 2014). The agonist GABA binding site is 
believed to be at the interface between the α and β subunits of the GABAA receptor 
(Galzi and Changeux, 1994, Smith and Olsen, 1995, Boileau et al., 1999). Only a 
small number of compounds bind to the ligand binding site of the GABAA receptor 
besides GABA itself. These include muscimol, 4,5,6,7-tetrahydroisoxazolo[5,4-
c]pyridine-3-ol (THIP or gaboxadol), taurine, isonipecotic acid and isoguvacine 
(Krogsgaard-Larsen et al., 2004). THIP has been suggested to bind and have a high 
potency at extrasynaptic GABAA receptors, including the α4β3δ subtype, while 
acting as a partial agonist at other GABAA receptor subtypes (Ebert et al., 2002, 
Stórustovu and Ebert, 2003, Voss et al., 2003, Drasbek and Jensen, 2006). THIP 
and morphine have almost equal potency as analgesics (Grognet et al., 1983). THIP 
also has anxiolytic effects and unlike morphine does not cause respiratory 
depression, but there are reports of THIP causing sedation and nausea similar to 
other GABA-mimetics (Hoehn-Saric, 1983, Drasbek and Jensen, 2006).  
Benzodiazepines are PAMs enhancing the actions of GABA at GABAA receptors, 
and are believed to bind at the interface between the α and γ subunits within a 
receptor (Duncalfe et al., 1996, Amin et al., 1997). Benzodiazepines have anxiolytic, 
anticonvulsant, sedative-hypnotic, analgesic and muscle relaxant properties. The 
sedative effect of benzodiazepines has been demonstrated to be the result of their 
binding to GABAA receptors containing the α1 subunit (McKernan et al., 2000). The 
analgesic properties of benzodiazepines may be mediated by α2- and α3-containing 
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GABAA receptors (Knabl et al., 2008). L-838,417 is a compound which binds to the 
benzodiazepine-site on α1-, α2-, α3- and α5-containing GABAA receptors, but 
selectively exerts its actions through α2-, α3- and α5-containing GABAA receptors 
(McKernan et al., 2000). It was shown to exhibit analgesic effects in CCI and spinal 
nerve ligation (SNL) models primarily through its action at α2- and α3-containing 
GABAA receptors (Nickolls et al., 2011). GABAA receptors can also be potentiated 
by barbiturates, which similarly have sedative-hypnotic effects. Barbiturates bind at 
another allosteric site separate from the benzodiazepine site (Chiara et al., 2013). 
Furthermore, a number of anaesthetics also exert their effects through GABAA 
receptors including isoflurane, halothane, chloroform and propofol (Jenkins et al., 
2001, Richardson et al., 2007).  
GABAA receptor antagonist bicuculline has long been utilised for the 
characterisation of the GABAA receptor (Curtis et al., 1970). The poor stability and 
solubility of bicuculline lead to the development of other GABAA receptor 
antagonists. For example, gabazine (SR99531) is a GABAA receptor antagonist 
derived from GABA (Heaulme et al., 1986). Gabazine and bicuculline are both 
selective for GABAA receptors over GABAA-rho receptors (Zhang et al., 2008a). In  
vivo and in vitro studies have shown that administration of bicuculline or gabazine 
increases excitability in the spinal DH (Green and Dickenson, 1997, Baba et al., 
2003, Bremner et al., 2006, Czarnecki et al., 2008, Chapman et al., 2009). 
Picrotoxin is a non-competitive inhibitor of the GABAA receptors (Barker et al., 
1983), and at higher concentrations also inhibits glycine (Schmieden et al., 1989) 
and 5-hydroxytryptamine receptor 3 (5-HT3) receptors (Das et al., 2003). Picrotoxin 
exerts its inhibitory action on the GABAA receptor by blocking its channel pore 
(Gurley et al., 1995). Similarly to the GABAA receptor antagonists, picrotoxin also 
increases excitability in the spinal DH (Vikman et al., 2003).  
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1.5 Glycine Receptor Pharmacology 
Glycine receptors can be activated by endogenous amino acids glycine, β-alanine 
and taurine; glycine is the most potent and β-alanine and taurine are partial agonists 
(Bormann et al., 1993, Schmieden and Betz, 1995). The ligand binding site on the 
glycine receptor is at the interface between two subunits, either two α subunits or an 
α and a β subunit (Brejc et al., 2002). When three glycine molecules are bound to 
the receptor it is maximally activated (Lewis et al., 2003). The homomeric and 
heteromeric glycine receptor subtypes have generally similar glycine sensitivities 
(Yang et al., 2007). Strychnine is a highly selective, potent competitive antagonist of 
the glycine receptor, frequently used to discriminate GABAA receptor inhibition from 
glycine receptor inhibition (Young and Snyder, 1973). There are a limited number of 
compounds which display some selectivity for the different glycine receptor 
subtypes. Picrotoxin is an equimolar mixture of picrotin and picrotoxinin, and inhibits 
both GABAA and glycine receptors. Picrotoxinin is selective for homomeric α2 and 
α3 glycine receptors over α1 subtype, and highly selective for homomeric glycine 
receptors compared to heteromeric glycine receptors containing the β subunit 
(Pribilla et al., 1992, Yang et al., 2007). Gelsemine is a plant alkaloid that acts 
primarily at α3-containing glycine receptors (Zhang et al., 2013, Zhang and Wang, 
2015). Gelsemine has displayed analgesic properties in models of neuropathic pain 
by binding to glycine receptors in the spinal cord (Zhang et al., 2013, Wu et al., 
2015b).  
 
1.6 Rhythmic Oscillations in Central Nervous System Networks 
Oscillatory activity exists throughout the CNS with a wide range of frequencies, from 
the slowest delta oscillations of 0.5-3 Hz, to theta oscillations of 3-8 Hz, gamma 
oscillations at 30-90 Hz and ultrafast 90-200 Hz frequencies (Buzsaki and Draguhn, 
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2004). These rhythmic oscillations have been linked with a number of functions, 
including learning and memory, locomotion, behaviour and nociception (Sandkuhler 
and Eblen-Zajjur, 1994, Bragin et al., 1995, Sejnowski and Destexhe, 2000, Buzsaki 
et al., 2003, Taccola and Nistri, 2006). Furthermore, during sleep, thalamocortical 
oscillations can also be observed, where both slow wave sleep (SWS) with a 
frequency of 1-4 Hz and rapid eye movement (REM) sleep with a frequency 
between 4 and 9 Hz can be recorded  (Sejnowski and Destexhe, 2000). A human 
study with patients with severe neurogenic pain demonstrated significant differences 
in their EEG power spectra compared to a healthy control group (Sarnthein et al., 
2006). This illustrates that chronic pain is linked to brain oscillations. Furthermore, in 
a human study brief painful stimuli were applied to the right hand of the subjects 
while the oscillatory activity and excitability in the sensorimotor cortex were 
measured (Ploner et al., 2006). A negative linear correlation was found between 
pain-induced modulations of brain oscillatory activity and pain-induced modulations 
of cortical excitability in the somatosensory system. This provides evidence for an 
association between pain and network oscillatory activity and demonstrates that 
oscillations are related to the functional state of cortical excitability.  
The rhythmic oscillations in the brain can be modulated through pharmacologically 
targeting GABAA receptors (Sohal et al., 2003, Wafford and Ebert, 2006). There is 
significant evidence that PV-containing GABAergic interneurons are involved in 
gamma rhythms in the brain (Lodge et al., 2009, Volman et al., 2011, Kim et al., 
2015, Kuki et al., 2015). Furthermore, during an epileptic seizure high frequency 
oscillations occur in the brain, which can be treated with anticonvulsants that target 
GABAA receptors including benzodiazepines and barbiturates (Fisher et al., 1992, 
Spencer and Lee, 2000, Grenier et al., 2003). Additionally, glycine receptor activity 
has been implicated in regulating brain oscillations, illustrated through application of 
glycine receptor agonists and antagonists to an intact corticohippocampal 
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preparation using field potential recordings (Chen et al., 2014). Many interneurons 
have been identified as being both GABAergic and glycinergic (Todd and Sullivan, 
1990), therefore it is unsurprising they are both involved in the generation of 
rhythmic oscillations.  
GABAA and glycine receptor neurotransmitters are involved in neuronal network 
oscillations of the spinal cord ventral horn (VH) (Hinckley et al., 2005, Taccola and 
Nistri, 2005, 2006) and the spinal DH (Sandkuhler and Eblen-Zajjur, 1994, Eblen-
Zajjur and Sandkuhler, 1997, Ruscheweyh and Sandkuhler, 2003, Chapman et al., 
2009). The spinal VH network generates locomotion independently of central and 
peripheral input (Guertin, 2012). It is generally accepted that the left-right alternating 
motor outputs are synchronised by reciprocal inhibition between the left and right 
VH networks, which can generate their own rhythmic activity (Butt et al., 2002). 
There is evidence that GABAergic and glycinergic signalling have distinct roles in 
the VH network. The GABAergic inhibition modulates the onset and duration of the 
VH rhythmic activity, while glycinergic inhibition regulates the pattern of the left-right 
rhythmic alternation (Hinckley et al., 2005).  
In vivo and in vitro spinal DH recordings have illustrated that the network can 
generate and sustain rhythmic oscillatory activity (Sandkuhler and Eblen-Zajjur, 
1994, Eblen-Zajjur and Sandkuhler, 1997, Ruscheweyh and Sandkuhler, 2003, 
Watanabe and Fukuda, 2015), (Loeser and Ward, 1967, Lombard et al., 1979). In 
vitro recordings from spinal cord slices have been used to illustrate that the rhythmic 
activity in the DH is generated and sustained in isolation by separating one DH 
quadrant from the remainder of the slice (Asghar et al., 2005, Chapman et al., 
2009). In addition, oscillations in the DH interfere with the locomotor activity of the 
VH (Taccola and Nistri, 2005). The rhythmic oscillations in the spinal DH could be a 
mechanism by which the afferent input is regulated by permitting signal propagation 
only at specific time intervals. The spinal DH rhythmic oscillations have been 
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suggested to be involved in synaptic plasticity, causing long-term potentiation (LTP) 
at synapses which could result in amplification of nociceptive signals before they are 
propagated to the brain (Ruscheweyh et al., 2011).  
The generation of network oscillations requires rhythmic, synchronised activity 
(Soltesz and Deschenes, 1993). There have been two mechanisms proposed for 
the generation of brain oscillations that are both dependent on inhibitory 
interneurons within the network. Firstly, the interneuron gamma (ING) oscillation 
mechanism could increase synchrony in a network if there is a large number of 
randomly firing excitatory neurons that synapse with inhibitory interneurons 
(Tiesinga and Sejnowski, 2009). The convergent inhibitory interneurons generate a 
summated IPSP from mutually inhibiting each other, and preventing postsynaptic 
excitatory interneuron activity until the IPSP diminishes. This consequently 
synchronises action potential firing of all the postsynaptic interneurons across the 
network (Whittington et al., 2000). Secondly the mechanism of pyramidal 
interneuron network gamma (PING) oscillations involves excitatory and inhibitory 
interneurons reciprocally innervating each other (Tiesinga and Sejnowski, 2009). In 
this case the input to an excitatory interneuron is restrained to the rhythm based on 
the recovery of the excitatory interneuron from the IPSP (Whittington et al., 2000, 
Tiesinga and Sejnowski, 2009). A continuous stimulation of an excitatory 
interneuron stimulates its reciprocal inhibitory interneuron and subsequently is 
inhibited and unable to stimulate the next postsynaptic excitatory neuron until the 
IPSP diminishes. Therefore the unsynchronised input to this circuit would become 
synchronised via the reciprocally inhibiting interneuron. Figure 1.5 illustrates these 
two proposed mechanisms for the generation of network oscillations. These theories 
can be extended to spinal DH rhythms where inhibitory to inhibitory interneuron 
synapses have been identified (Zheng et al., 2010). Furthermore, in the spinal DH 
PV-containing GABAergic interneurons have also been identified, and have been 
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linked to modulating DH excitability in a neuropathic pain model (Heinke et al., 
2004, Hughes et al., 2012, Polgár et al., 2013).  
An additional mechanism for the generation of rhythmic oscillations in neuronal 
networks involves pacemaker neurons, which are defined by their ability to generate 
rhythmic bursting activity in the absence of any input (Legendre et al., 1985). Such 
neurons have been found in the cortex and spinal DH and VH (Silva et al., 1991, 
Cunningham et al., 2004, Tohidi and Nadim, 2009, Li et al., 2013, Li et al., 2014). In 
the spinal VH the frequency of pacemaker neuron membrane resonance has been 
strongly linked with the central pattern generator oscillation frequency (Tohidi and 
Nadim, 2009). Pacemaker neurons in the superficial spinal DH have been shown to 
be dependent on inward-rectifying potassium channels (Kir) (Li et al., 2013). Li et al. 
(2014) demonstrated that there are pacemaker neurons in the spinal DH using 
patch-clamp recordings from an intact spinal cord preparation. 
Immunohistochemistry experiments revealed that these pacemaker neurons 
connect with projection neurons (Li et al., 2014a). This suggests these rhythmically 
active neurons could be involved in processing and modifying pain signals. 
However, previous in vitro studies using spinal cord slices have shown that the DH 
rhythm is not dependent on the DH cell holding potential, suggesting that it was not 
generated from intrinsically active neurons (Ruscheweyh and Sandkuhler, 2003). 
Ruscheweyh and Sandkuhler (2003) also demonstrated that the rhythmic activity 
was absent in the presence of the GABAA receptor antagonist bicuculline. 
Therefore, given the evidence for the significant role of GABAA and glycine 
receptors in rhythmic activity in the brain and spinal cord, these receptors are crucial 
targets in the development of novel analgesics. 
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Figure 1.5 Two proposed mechanisms for the generation of neuronal network oscillations. 
(A) The ING mechanism involves interconnected inhibitory interneurons which mutually 
inhibit each other and generate a summated IPSP. This synchronises the activity of the 
postsynaptic excitatory interneurons and subsequently the network. (B) The PING oscillation 
mechanism requires an excitatory interneuron with a reciprocally inhibiting inhibitory 
interneuron. This generates rhythmic oscillations from an asynchronous input by restraining 
the output of the excitatory interneuron to the time in which the excitatory interneuron is 
recovered from the IPSP generated from the stimulation of the inhibitory interneuron. 
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1.7 Investigating the Spinal Dorsal Horn Neuronal Network: In Vitro 
Models 
1.7.1 In Vivo Spinal Cord Recordings 
In vivo electrophysiological recordings from the spinal DH allow direct measurement 
of the activity of individual neurons to the whole network and are useful to 
investigate the neuronal response to stimulation of the peripheral receptive field. 
Many early investigations into the spinal cord and pain employed extracellular in 
vivo recordings (Christensen and Perl, 1970, Kumazawa and Perl, 1978). 
Extracellular recordings from the spinal DH have also been used to measure the 
oscillatory activity of the network population (Sandkuhler and Eblen-Zajjur, 1994). 
Extracellular recordings detect the changes in the extracellular field potential caused 
by the surrounding nearby cell ionic processes; they cannot provide information on 
individual neurons or ion channel activity (Buzsáki et al., 2012). However, 
extracellular recordings are ideal for recording the activity of a localised population 
of cells (Buzsáki et al., 2012). The in vivo intracellular recording technique was 
developed to allow for single cell and ion channel studies where there is control of 
the cell membrane potential. It is technically difficult to perform intracellular 
recording from superficial spinal DH neurons in vivo. This is due to the poor stability 
of the recordings and the impalement of the cells with sharp electrodes frequently 
causing destruction of the cells (Urch and Dickenson, 2003). Furthermore, the 
neurons of the superficial DH are small and therefore it is more difficult to obtain 
intracellular recordings. Some additionally issues with in vivo recordings include 
maintaining anaesthesia throughout the surgery and recordings, and also the 
movement of the animal that can affect the recording (Fee, 2000, Cuellar et al., 
2004). The surgery and the inaccessibility of the spinal DH have led to the 
development of in vitro models of the spinal DH to further study the network and 
properties of DH neurons.   
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1.7.2 In Vitro Spinal Cord Slices 
Brain and spinal cord slice preparations have been utilized over many decades to 
study the CNS neurophysiology (Li and Mc, 1957, Yamamoto and McIlwain, 1966). 
The techniques of both acute and organotypic spinal cord slices have been 
developed to establish in vitro models of the spinal cord network systems. 
Extracellular and intracellular recording techniques can be more easily performed 
with in vitro slices than in vivo preparations. There are a number of advantages of 
recording from in vitro slices compared to in vivo preparations (Collingridge, 1995). 
The preparation of acute spinal cord slices retains the synaptic circuits and 
cytoarchitecture of the intact spinal cord (Lossi et al., 2009). Preparations with and 
without dorsal roots attached have been developed (Murase et al., 1982, Marvizon 
et al., 1997). The absence of any afferent input can be advantageous in allowing the 
activity of the spinal DH to be studied in isolation. The slices are readily accessible 
for electrophysiological recordings where the external environment can be 
controlled and compounds of desired concentrations can be perfused without the 
influence of anaesthetics and in the absence of a blood-brain barrier or blood-nerve 
barrier. To study the network of tissue sections the multi-electrode array (MEA) 
technique has been developed to enable extracellular recordings to be made 
simultaneously from multiple sites across a tissue slice (Obien et al., 2015). 
Furthermore, the MEA technique provides information on the synchrony of neurons 
across a network (Obien et al., 2015). 
Organotypic slice cultures are usually obtained from neonatal animals, and cultured 
in vitro for weeks or months (Galimberti et al., 2006, Marksteiner and Humpel, 2007, 
Humpel, 2015). Therefore they provide a model of the spinal cord that has features 
of both acute in vitro slices and spinal cord cell culture (Pandamooz et al., 2015). 
Organotypic cultures are frequently used in molecular biology, 
immunohistochemistry and electrophysiology experiments to investigate molecular 
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and cellular processes of the spinal cord, its development and cell death (Czarnecki 
et al., 2008, Ravikumar et al., 2012). Acute spinal cord slices are also typically 
obtained from neonatal animals and used for electrophysiological experiments 
where the electrical activity of individual neurons or the network as a whole can be 
investigated with intracellular or extracellular recordings. The advantages of acute 
slice experiments are that the slice preparation is relatively quick and therefore the 
synaptic connections within the slice network is largely unchanged compared to in 
vivo conditions (Lossi et al., 2009). The endogenously released chemicals from the 
dissecting and slicing procedures are washed out before experimentation begins so 
as not to affect the activity of the spinal DH networks. Organotypic slices have to be 
cultured for 10-14 days before it can be ensured the chemicals released from slicing 
are no longer present (De Simoni and Yu, 2006). In the period of culturing 
organotypic slices the disruption to the neuronal network that occurred during the 
slicing procedure is believed to cause re-organization of the synapses between the 
neurons within the slice, which does not occur in acute slices (Coltman et al., 1995). 
Furthermore, a major factor to consider with slice cultures is how well the culture 
conditions enable the survival of the neuronal cells within the slice. Non-neuronal 
cells typically survive better in culture compared to neuronal cells, which are 
affected more severely by the preparation speed, culture medium, age of the tissue 
and sterility (Lossi et al., 2009). Therefore, the proportions of the different cell types 
within the slice are likely to be altered in the in vitro spinal cord slice culture model 
which could affect the network structure and functionality. This is not an issue with 
in vitro acute slices, which are used for experimentation on the day of dissection 
(Buskila et al., 2014). 
A drawback of utilising acute and organotypic slice models is that the viability of the 
slices diminishes with increasing age of the animal employed in the study. 
Consequently, neonatal animals are frequently used (Miletic and Randic, 1981, 
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Magnuson et al., 1987). However, there can be significant differences in the 
neurophysiology of neonatal compared to adult animals. An example of age-
dependent changes in rodent neurophysiology is the switch of GABA signalling from 
excitatory in early development to inhibitory in adult animals (Lee et al., 2005). 
GABAA receptors switch to become inhibitory as the expression of the KCC2 
increases during development (Lee et al., 2005). In this thesis the acute spinal cord 
slice preparation has been utilised to investigate the activity of the spinal DH 
network due to its advantages over the slice culture model and its comparability to 
in vivo conditions.  
 
1.7.3 Primary Cell Culture of the Spinal Dorsal Horn 
Primary cell culture provides a model system which lends itself to very reproducible 
and consistent high-throughput screening of compounds. These properties of 
primary cell culture models have resulted in their extensive use by pharmaceutical 
companies to screen novel compounds. However, primary cell culture models also 
provide a highly accessible tool for investigating cell physiology and biochemistry. 
Neuronal cultures simplify the complex intact CNS, and make it accessible for use in 
a multitude of assays including electrophysiology, calcium imaging and molecular 
biology techniques. Recent development of MEA technology has enabled primary 
cell cultures to be grown on MEAs (Ito et al., 2014). Therefore, the activity across a 
cultured network can be recorded simultaneously, providing an indication of the 
synchrony of network’s cells.   
In neuronal primary cell culture models both individual cells or the whole network of 
neurons can both be investigated to study the physiology of the system in more 
detail than is possible with in vitro slice or in vivo spinal cord recordings. However, 
the simplification of such a complex system means that caution should be taken 
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when interpreting results from cell culture models. Typically the tissue dissected for 
cell culture is completely disrupted dissociating all the cells, therefore in culture the 
cells re-organise and form synapses, which is largely dependent on the conditions 
of the culture (Streit et al., 2001, Malin et al., 2007). As previously mentioned in 
regard to slice cultures, different cell types survive the culture process better than 
others, which could impact on the reformation of the network of the remaining cells.  
Primary cell culture of spinal cord neurons has been widely developed and utilised 
(Ransom et al., 1977), however, there are far fewer reports using spinal DH culture. 
Selecting the dorsal region of the spinal cord for primary cell culture isolates those 
cells specifically involved in processing nociceptive signals. The spinal cord cell 
culture model exhibits a number of similarities with in vitro slice and spinal DH in 
vivo recording data, including rhythmic activity (Keefer et al., 2001, Streit et al., 
2001) and the development of central sensitisation (Vikman et al., 2003). However, 
there is minimal information on the characterisation of spinal cord or spinal DH 
cultures in terms of the classes of neuronal and non-neuronal cells they contain. In 
this study a spinal DH primary cell culture model has been established, 
characterised and utilised to explore the activity of the DH, its responses to 
pharmacological manipulation and its potential in drug discovery assays.  
 
1.8 Objectives 
The overall aim of this project is to investigate the role of GABAA and glycine 
receptors in the spinal DH using in vitro models as translational platforms for drug 
discovery. Specific aims of my thesis are as follows: 
1) Development and characterisation of the rat embryonic spinal DH primary 
cell culture 
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2) Investigate how targeting GABAA and glycine receptors modulates calcium 
release in the rat embryonic spinal DH primary cell culture model.  
3) Investigate the effect of glycine receptor α subunit short interference RNA 
(siRNA) gene silencing on calcium response using the rat embryonic spinal 
DH primary cell culture. 
4) Investigate how targeting GABAA and glycine receptors modulates network 
activity in the rat substantia gelatinosa (SG) of the spinal DH using 
extracellular recordings in the in vitro acute spinal cord slice model.  
5) Investigate how targeting GABAA and glycine receptors modulates network 
activity in the rat SG of the spinal DH using MEA methodology in acute 
spinal cord slices and rat embryonic spinal DH primary cell culture. 
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2 Characterisation of the Embryonic Spinal Dorsal Horn Cell 
Culture Model 
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2.1 Introduction 
Primary cell cultures present several advantages for neuronal cell network studies 
due to their greater similarity with neuronal cells in vivo compared to secondary cell 
lines. However, primary cell cultures are more challenging as the tissue dissection 
and processing of the cells has to be completed prior to commencing the culturing 
process (Gordon et al., 2013). Furthermore, primary cultures are not immortal like 
cell lines, which limits the volume of experimentation with each primary culture 
(Gordon et al., 2013). Cell culture models provide very versatile platforms, as they 
can be used with a multitude of techniques including molecular cell biology, 
immunofluorescence (IF), electrophysiology and calcium imaging. For these 
reasons pharmaceutical companies have been making use of primary cell cultures 
to screen novel compounds in various diseases (Eglen and Reisine, 2010, Nickolls 
et al., 2011, Lovitt et al., 2014).  
Typically, for neuronal primary cell cultures the cells of the dissected tissue are 
completely dissociated before they are cultured (Streit et al., 2001, Malin et al., 
2007, Gordon et al., 2013). The primary cell culture models of the spinal cord lack in 
vivo afferent input, which could affect the re-formation of the network in culture and 
the subsequent activity of the network. However, the more simplistic primary cell 
culture network makes it easier to decipher the circuitry. Therefore, it is essential to 
determine and classify the cell types present in the culture and compare to in vivo 
network populations to be able to draw stronger conclusions from the primary cell 
culture data and determine how transferrable the cell culture data is to the in vivo 
network.  
Primary cell culture of spinal cord cells has been developed and utilised to study 
network activity (Ransom et al., 1977, Keefer et al., 2001, Streit et al., 2001). 
However, this model system includes both motor neurons of the VH and sensory 
neurons of the DH mixed together. Therefore, following dissociation these spinal 
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cord cells are likely to form a very different network in culture compared to what 
exists in vivo. There are fewer reports of spinal DH cultures, which provide a model 
system to study the spinal DH network without the influence of VH cells (Vikman et 
al., 2001, Hendrich et al., 2012b). 
2.1.1 Aims 
In this chapter the techniques of primary cell culture, calcium imaging, IF and 
quantitative real-time polymerase chain reaction (RT-PCR) have been utilised to 
develop and characterise the embryonic spinal DH cell culture model. This in vitro 
model has been investigated with the final aim of utilizing it for the screening of 
novel analgesics and studying the spinal DH network. The aims of this investigation 
are: 
1. To develop the embryonic spinal DH cell culture model 
2. To determine the proportion of neuronal and non-neuronal cells in the DH 
culture. 
3. To determine the proportion of inhibitory and excitatory cells in the culture. 
4. To define the neurochemical and co-localization profile of cells within the 
culture 
5. To determine which of the GABAA receptor α subunits are expressed in the 
DH culture 
6. To determine which of the glycine receptor α subunits are expressed in the 
DH culture. 
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2.2 Methods 
2.2.1 Embryonic Dorsal Horn Primary Cell Culture  
The Schedule 1 procedure performed on pregnant female Wistar rats at embryonic 
day 14 (E14) was either by isoflurane followed by cervical dislocation at the 
University of Leeds or concussion followed by cervical dislocation when performed 
at Pfizer Neusentis, Cambridge. This was carried out in accordance with current 
EU/UK Home Office legislation and University of Leeds or Pfizer Neusentis local 
legislation. The embryos were removed from the dam and collected in ice-cold 
Hibernate E medium (Life Technologies, UK). Each embryo was subsequently 
removed from its embryonic sack and decapitated, then kept in ice-cold Hibernate E 
medium on ice. The embryonic fluid was collected from each embryonic sac when 
the sac was opened and added to the Hibernate E medium in which the decapitated 
embryos were collected in to improve viability of the tissue. The spinal cord was 
dissected from each embryo and the two thirds of DH of the spinal cords was 
separated and collected in fresh ice-cold Hibernate E medium immediately post-
decapitation. There were typically 11-14 embryos per dam, therefore in each spinal 
DH cell culture preparation there was tissue from 11-14 embryos which was 
combined before processing for culturing. Once all the DH tissue had been collected 
and pooled together the tissue was spun at 1000 rpm for 3 minutes. The 
supernatant was removed and the tissue was re-suspended in 2 ml of Hibernate E 
containing trypsin (12.5%) in at 37oC. The tissue was incubated at 37oC for 18-20 
minutes, with the tissue being manually mixed by shaking to improve trypsin 
digestion by separating the tissue sections. Deoxyribonuclease I (DNase I) (0.1%) 
(Sigma-Aldrich, UK) in 2 ml of culture medium 1 (Table 2.1) was then added to the 
sample and spun for 3 minutes at 1000 rpm. DNase I treatment is required for the 
breakdown of extracellular DNA that can arise in the processing of the tissue and 
cause damage to the cells. The supernatant was removed and 1 ml of culture 
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medium 1 containing 1% cytosine β-D-arabinofuranoside (Ara-C) (Sigma-Aldrich, 
UK) at 37oC was added to the tissue. The tissue was manually triturated then pulse 
centrifuged to 1000 rpm and the supernatant containing the cells was collected. This 
trituration step was repeated once more, and then a cell count was performed, 
either using a Countess cell counter (Invitrogen, UK) or manually on a 
haemocytometer. The cells were plated at 1.7 x 106 cells/100 μl and then the plates 
were pulse centrifuged to 1000 rpm to evenly spread the cells across each well. 
Typically, from a preparation from a single dam with 11-14 embryos, there were 
180-220 wells of the spinal DH cells plated normally plated as 36 wells per plate. A 
flow diagram of the DH tissue processing protocol can be found in Figure 2.1. The 
BD Falcon cell culture plates (BD Biosciences, UK) were pre-coated with poly-D-
lysine (molecular weight: 70,000-150,000; Sigma-Aldrich, UK) and natural mouse 
laminin protein (Life Technologies, UK) to aid cell attachment to the base of the 
plate. The poly-D-lysine was dissolved in distilled water and 50 μl/well was added 
the day before the cell culture preparation, kept at 4oC overnight. On the day of the 
cell culture preparation the poly-D-lysine was removed from the plates and 50 
μl/well of laminin diluted in PBS was added. The plates were then kept at 37oC in 
the incubator until required for plating the cells. After the cells were incubated for 24 
hours at 37oC the media was changed to culture medium 2 (Table 2.2), subsequent 
media changes were done every 2-3 days with culture medium 2. After 12-14 days 
in culture, the cells were used for experimentation. Spontaneous, synchronous firing 
of the network was observed in calcium imaging and electrophysiological 
experimentation after 12-14 days in culture. 
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 Table 2.1 Culture medium 1 components 
 
 
Table 2.2 Culture medium 2 components 
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Figure 2.1 A flow diagram of the protocol procedures for the processing and the culturing of 
the embryonic spinal DH tissue following the removal of the embryos from the dam. 
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2.2.2 Fluorescent Calcium Imaging with Cultured Dorsal Horn Cells 
The culture media was removed from the wells of the plate and replaced with 80 μl 
of FLIPR Calcium 5 Dye (Molecular Devices, USA) diluted in Hanks’ Balanced Salt 
Solution (HBSS) (-/-) with calcium chloride (1.8 mM) and 1% HEPES (Sigma-
Aldrich, UK), and adjusted to pH 7.4 with sodium hydroxide (Sigma-Aldrich, UK). No 
magnesium was added to the buffer solution to remove the N-methyl-D-aspartate 
(NMDA) receptor magnesium block as signalling through this receptor is known to 
be required for spontaneous activity (Smith et al., 1989, Kilic et al., 1991, Streit et 
al., 2001). The plate was incubated at 37˚C for 30-40 minutes to allow for the cells 
to take up the dye before calcium imaging was performed. The advantage of the 
Calcium 5 Dye over other calcium dyes such as Fura 2, is that the cells do not need 
pre-washing and the Calcium 5 Dye does not need to be washed off prior to running 
calcium imaging assays. Therefore, there is reduced disruption to the cells before 
they are used for the assay and there are fewer cells are lost. The fluorescent 
calcium imaging was done using the live-cell he bioimaging system BD Pathway 
855 (BD Biosciences, USA), in combination with the BD Attovision software (BD 
Biosciences, USA; version 1.6). This system allows for the measurement and 
recording of fluorescence intensity of live cells in culture. A video is captured of 
each well as the fluorescence intensity of individual regions of interest (ROI) was 
recorded. The ROIs were determined using the software with manual adjustment so 
that only the fluorescence of the cells was captured and any background noise was 
eliminated. The video recording of the culture enabled visualisation of the culture 
network within a well, which was vital in the optimisation process of the culture. 
Identifying which preparation of the cells worked best according to the appearance 
of the network formation and network firing behaviour enabled the development of 
the optimal DH cell culture protocol. The baseline activity was recorded for 4 
minutes, which was followed by manual addition of a compound diluted to the 
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required concentration using the HBSS (-/-) buffer. The activity in the presence of 
the compound was subsequently recorded for another 4 minutes. This data was not 
quantified or analysed, but used to optimise the spinal DH cell culture protocol 
through visualising the culture’s spontaneous activity and response to compound 
addition.  
 
2.2.3 Culture Dorsal Horn Cell Immunofluorescence 
The cultured DH cells were fixed at 12-14 days in vitro (DIV) by removing the media, 
washing the wells of the plates twice with PBS (0.1 M) and adding 100 µl 
paraformaldehyde (4%) per well. After 15-20 minutes the paraformaldehyde was 
removed and the wells washed three times with PBS (0.1 M). For each wash of the 
wells 200 µl of PBS was added to each well and left for 5 minutes before being 
removed, and the process repeated. After the washes 200 µl of PBS was added to 
each well and the cells stored at 4oC until ready to be used for staining. The 
required volume of blocking buffer was made, which contained PBS (0.1 M) with 3% 
normal donkey serum and 0.3% triton-X100. When ready to perform the staining the 
PBS was removed from the wells and 100 µl of blocking buffer was added per well 
and incubated at room temperature for 2 hours. The blocking buffer was then 
removed and replaced with 100 µl of the required primary antibodies diluted in the 
same blocking buffer (Table 2.3). A minimum of six wells were tested for each 
antibody combination. The plates of cells were incubated with the primary 
antibodies overnight on a rocking platform at 4oC. The primary antibodies were 
removed and the wells washed with PBS (0.1 M) three times. The secondary 
antibodies were diluted in the same blocking buffer and 100 µl of secondary 
antibody solution was added per well as required (Table 2.4). The plates were 
wrapped in aluminium foil to protect the antibodies from light damage, and the 
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samples incubated for 2 hours at room temperature on a rocking platform. The wells 
were washed 3 times with PBS (0.1 M) and then 200 µl of PBS was added to each 
well. The plates were kept wrapped in aluminium foil at 4oC until they were imaged. 
In parallel negative control experiments were performed for each primary antibody 
tested omitting the addition of the secondary antibodies. The negative controls 
demonstrated a lack of positive staining. Examples of some of these negative 
controls are illustrated in Figure 2.2. 
 
2.2.4 Imaging and Analysis 
The cultured cells were imaged using an inverted LSM 700 confocal microscope 
(Carl Zeiss Microscopy, USA) in conjunction with Zen 2.1 (Black) software (Carl 
Zeiss Microscopy, USA). The Alexa 488 and Alexa 555 laser filters were selected to 
image cells. For the cultured DH cells, a minimum of six wells were stained for each 
antibody combination, and between four and six of the wells were imaged and the 
cells counted. These six wells utilised for each staining consisted of three wells on 
one plate and three wells from another plate. The two different plates were from 
different cell culture preparations, therefore arising from separate sets of embryos. 
The number of independent culture preparations for each experiment is indicated as 
N, while the number of individual wells tested is given as n. The number of 
positively-stained cells in the four to six wells for each antibody staining was 
counted and the mean calculated. The number of co-localised cells in each staining 
was also counted and the mean calculated. The percentage of co-localised cells out 
of the total number of neuronal nuclei (NeuN)-positive cells or the total number of 
positive cells of that antibody was calculated where required. These values are 
given with the standard error of the mean (S.E.M). 
  
44 
 
 
 
Figure 2.2 IF control experiments in the absence of secondary antibodies, for the primary 
antibodies for (A) the GABAA receptor α1 subunit, (B) GAD65+67, (C) the glycine receptor 
α1 subunit and (D) GlyT2. The left panel for each is taken with Alexa Fluor 488 filter, the 
middle panel with Alexa Fluor 555 filter and the right panel is the merge.  
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Primary 
Antibody 
Function Species Dilution Source Reference 
NeuN Neuronal cell 
nuclei 
Mouse 1:500 Millipore (MAB377) Seelke et al. 
(2013) 
NeuN Neuronal cell 
nuclei 
Rabbit 1:500 Cell Signalling 
(D3S31) 
Cell Signalling 
GFAP Astrocytes Glial 
Cells 
Mouse 1:500 Millipore (MAB360) Kern et al. (2011) 
Iba1 Microglia Rabbit 1:500 Wako Pure Chemical 
Industries (019-
19741) 
Le Blon et al. 
(2014) 
GAD 65/67 GABAergic cells Rabbit 1:500 Abcam (AB1511) Krosnowski et al. 
(2012) 
GlyT2 Glycinergic cells Rabbit 1:500 Abcam (AB156022) Abcam 
VGlut2 Glutamatergic 
cells 
Guinea-
Pig 
1:500 Abcam (AB2251) Zelano et al. 
(2009) 
Glycine α1 Receptor 
subunit 
Goat 1:250 Santa Cruz  
(SC-17278) 
Ge et al. (2007) 
Glycine α2 Receptor 
subunit 
Goat 1:200 Santa Cruz  
(SC-17279) 
Majumdar et al. 
(2008) 
Glycine α3 Receptor 
subunit 
Goat 1:500 Santa Cruz  
(SC-17282) 
Majumdar et al. 
(2008) 
GABA α1 Receptor 
subunit 
Rabbit 1:150 Abcam (AB33299) Lindstrom et al. 
(2010) 
GABA α2 Receptor 
subunit 
Rabbit 1:200 Alomone Labs  
(AGA-002) 
Quadrato et al. 
(2014) 
GABA α3 Receptor 
subunit 
Rabbit 1:500 Alomone Labs 
(AGA-003) 
Zhou et al. 
(2013) 
GABA α4 Receptor 
subunit 
Rabbit 1:200 Abcam (AB73874) Quadrato et al. 
(2014) 
GABA α5 Receptor 
subunit 
Rabbit 1:200 Abcam (AB10098) Wu et al. (2014) 
GABA α6 Receptor 
subunit 
Rabbit 1:250 Sigma (G5544) Sigma-Aldrich 
Parvalbumin Calcium-binding 
protein 
Mouse 1:1000 Sigma (P3088) Contini and 
Raviola (2003) 
KCC2 Transporter Rabbit 1:100 Millipore (07-432) Wang and Sun 
(2012) 
nNOS Neuronal NOS  Rabbit 1:2000 Abcam (AB5380) Russo et al. 
(2013) 
Gephyrin Inhibitory cells Goat 1:250 Santa Cruz (SC-
6411) 
Waldvogel et al. 
(2003) 
Table 2.3 List of the primary antibodies used for IF 
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Secondary 
Antigen 
Species Flurophore Dilution Source 
Mouse Donkey Alexa 488 1:500 Invitrogen 
Mouse Donkey Alexa 555 1:500 Invitrogen 
Rabbit Donkey Alexa 488 1:500 Invitrogen 
Rabbit Donkey Alexa 555 1:500 Invitrogen 
Rabbit Goat Alexa 555 1:500 Invitrogen 
Guinea-Pig Donkey Alexa  488 1:500 Invitrogen 
Table 2.4 List of the secondary antibodies used for IF 
 
2.2.5 Quantitative Real-Time PCR  
The total RNA was isolated from the cultured DH cells at 12-14 DIV using RNeasy 
Mini Kit (Qiagen). Cells cultured from one independent preparation were utilised, 
with RNA extracted from 30 individual wells. Before commencing all RNA work, 
surfaces and pipettes were disinfected with RNase Away Reagent (Ambion, Life 
Technologies) to minimise RNA contamination. The cells were harvested by 
disrupting the cells with RLT buffer containing β-mercaptoethanol (1%) and 
triturating with a pipette. The pellet was vortexed and then added to a QIAshredder 
spin column and centrifuged for 2 minutes at maximum speed. The same volume as 
lysate of 70% ethanol was added to the homogenised lysate and mixed by pipetting. 
This sample was then transferred to an RNeasy spin column and centrifuged for 15 
seconds at 13,000 rpm. The flow-through was discarded and 700 μl of RW1 buffer 
was added to the spin column and spun again for 15 seconds at 13,000 rpm. Again 
the flow-through was discarded and the step repeated but with RPE buffer. This was 
repeated with RPE buffer, but spinning for 2 minutes. This ensures no ethanol 
remains in the spin column as this can effect subsequent reactions in the process. 
Finally the RNA was eluted by adding 30 μl of RNase-free water to the spin column 
and centrifuging for 1 minute at 13,000 rpm. The concentration of RNA was 
calculated with a NanoDrop 2000c (Thermo Scientific Inc, USA). The human spinal 
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cord mRNA used in this study was obtained from BioChain (AMS Biotechnology Ltd, 
UK). The spinal cord mRNA was extracted from the tissue of a healthy male, 59 
years old. The RNA was then converted to cDNA with an Omniscript Reverse 
Transcription Kit (Qiagen, USA). All the reagents for this protocol were thawed and 
stored on ice throughout the preparation. Two mastermixes were prepared as 
outlined in Table 2.5, one is the normal mastermix the other was a negative control 
with no reverse transcriptase added. Once all the reagents were mixed together to 
make mastermix reactions for each of the RNAs, the samples were incubated for 60 
minutes at 37oC. The concentration of cDNA was then determined using the 
NanoDrop 2000c. The cDNA was stored at -20oC until used for TaqMan PCR 
experiments.  
For the TaqMan relative quantitative RT-PCR the housekeeping gene β-actin 
(ACTB) was used as a positive control (Thermo Fisher Scientific Inc., USA), either 
human or rat as required. Including a reference gene in the same well as each of 
the samples allows for normalisation of each of the target genes. RT-PCR was 
performed for each of the GABAA receptor α subunits 1-6, with assay probes 
GABRA1-6 for human and rat (Applied Biosystems, Thermoscientific), for both the 
human spinal cord and the rat spinal DH cDNA samples. Similarly, human and rat 
assay probes for the glycine receptor α subunits 1-4 (Glra1-4) and the β subunit 
(Glrab) (Applied Biosystems, Thermoscientific) were utilised for RT-PCR with both 
human spinal cord and rat spinal DH cDNA samples. RT-PCR with the rat spinal DH 
sample was also performed with the assay probes for the rat glycine transporters 1 
and 2 (GlyT1 and GlyT2) (Applied Biosystems, Thermoscientific). All these primers 
were proprietary of Applied Biosystems, who have not disclosed the sequences but 
state that all these primers have been verified by the company for their high level of 
specificity and efficiency. A list of all the assay probes utilised can be found in Table 
2.6 and Table 2.7. The Taqman mastermix used for each 20 μl reaction per well of 
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the PCR plates is outlined in Table 2.8. A stock mastermix for each assay was 
made without adding cDNA to minimise pipetting error. The cDNA was added to the 
plate for the PCR reaction and the mastermix added to it to make 20 μl total reaction 
volume per well. Each reaction was done in triplicate, and each of the RT negative 
cDNA samples for negative controls were done in triplicate. The RNase-free water 
was also used as a negative control to confirm there was no contamination of the 
water used in the reactions. The TaqMan RT-PCR amplification reaction and 
detection was done using a LightCycler 480 II (Roche Diagnostics, Switzerland). 
This was linked to a computer with the LightCycler 480 II Software (version 1.5.1), 
where the programme for relative quantification was used with the detection format 
of dual colour hydrolysis probe. This programme begins with a pre-incubation of 10 
minutes at 4.4oC followed by 45 amplification cycles of 10 s at 95oC, 30 s at 60oC 
then 1 s at 72oC, with an end cooling phase of 30 s at 40oC. 
 
 
Table 2.5 The contents for 20 µl of mastermix for cDNA production used for all the samples 
required for the RT-PCR experiments. A negative control mastermix was also prepared for 
each RNA sample which did not contain reverse transcriptase (Omniscript RT).  
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Gene Assay ID 
GABRA1 Rn00788315_m1 
GABRA2 Rn01413643_m1 
GABRA3 Rn00567055_m1 
GABRA4 Rn00589846_m1 
GABRA5 Rn00568803_m1 
GABRA6 Rn00573029_m1 
Glra1 Rn00565582_m1 
Glra2 Rn00561280_m1 
Glra3 Rn00586890_m1 
Glra4 Rn01410530_m1 
Glrb Rn00583966_m1 
GlyT1 Rn01416529_m1 
GlyT2 Rn01475607_m1 
 
Table 2.6 A list of the RT-PCR rat assay probes used, with their assay ID number from 
Applied Biosystems (Thermoscientific, UK). 
Gene Assay ID 
GABRA1 Hs00971228_m1 
GABRA2 Hs00168069_m1 
GABRA3 Hs00968132_m1 
GABRA4 Hs00608034_m1 
GABRA5 Hs00181291_m1 
GABRA6 Hs00181301_m1 
Glra1 Hs00609267_m1 
Glra2 Hs01033736_m1 
Glra3 Hs00197920_m1 
Glra4 Hs01595852_m1 
Glrb Hs00923871_m1 
 
Table 2.7 A list of the RT-PCR human assay probes used, with their assay ID number from 
Applied Biosystems (Thermoscientific, UK). 
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Table 2.8 The TaqMan mastermix reagents for each well of the RT-PCR experiment. The 
same mastermix was utilised for the negative control sample (RT negative). The Taqman 
Mastermix, assay probes and ACTB were all sourced from Applied Biosystems. 
 
2.2.6 Analysis of Relative Quantification RT-PCR 
After the CT values were obtained from the RT-PCR experiments an arbitrary copy 
number was calculated from the CT values obtained for each repeat performed for 
all the assay probes. The average of the three housekeeping gene CT values 
obtained in the triplicate of repeats for each assay probe was calculated and the 
arbitrary copy numbers for these average values were then determined. The 
arbitrary copy number calculation used was 10(12−(0.3×𝐶𝑇)) (Cox et al., 2008). The 
scaling factor was determined for each assay probe using the housekeeping gene 
arbitrary copy number values. The GABAA receptor subunit arbitrary copy number 
values were scaled relative to GABRA1 and the glycine receptor subunits and 
glycine transporters were scaled relative to Glra1. For example, the averaged ACTB 
arbitrary copy number values for each of the GABAA receptor subunits was divided 
by the ACTB arbitrary copy number of GABRA1. The three arbitrary copy number 
repeats for the GABRA1 were each multiplied by the scaling factor for that receptor 
subunit. This was repeated for the other GABAA receptor subunits, each multiplied 
by their corresponding scaling factor value. Similarly this was done with the glycine 
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receptor subunit values. The average scaled arbitrary copy number was calculated 
from the repeats for each receptor subunit and plotted with the S.E.M. The RT-PCR 
data for the human spinal cord and rat spinal DH samples were analysed 
separately. 
 
2.2.7 Absolute Quantification of Glycine Receptor Subunits 
Plasmid DNA constructs containing the human or rat glycine receptor α subunits 
were obtained from OriGene Technologies Ltd (USA). Each of the plasmid 
constructs were transformed into One Shot TOP10 competent E.coli cells 
(Invitrogen, UK). The One Shot TOP10 cells were thawed on ice, and 5 µl of the 
plasmid DNA was added to the vial of cells (50 µl cells/vial) and the solution mixed 
by swirling or tapping the tube. The cells are then incubated on ice for 30 minutes, 
then they were heat-shocked for 30 seconds at 42oC. The cells were then returned 
to ice for 2 minutes then 250 µl of S.O.C medium was added to each vial. The vials 
were then incubated on a horizontal shaker at 37oC for one hour. 20 µl of each of 
the cell transformations were spread onto pre-warmed LB agar plates, and a repeat 
of each plate with 100 µl of each transformation. Two different volumes of cells were 
plated to ensure maximise the chances of one of them growing colonies. The plates 
were incubated at 37oC overnight. The colonies were selected from each plate and 
the DNA purified using a Qiagen Plasmid Plus Maxi Kit (Qiagen, USA), with the 
concentration of final purified DNA determined using a NanoDrop 2000c. For the 
absolute quantification RT-PCR experiments 10-fold serial dilutions of the DNA 
were made in PCR-grade water. These were used in conjunction with the same 
mastermix described previously with the appropriate TaqMan probe. On the same 
PCR plate three repeats of the required cDNA of the rat spinal DH culture or human 
spinal cord were also run. As previously negative control reverse transcription 
52 
 
negative samples and water only samples were also run on the same plate. 
Similarly the β-actin housekeeping gene was also used in the wells with the rat DH 
culture cDNA or human spinal cord cDNA. The RT-PCR reaction was done using 
the LightCycler 480 II as described for the relative quantification RT-PCR 
experiments.  
 
2.2.8 Analysis of the Absolute Quantification RT-PCR Data 
Using the calculated concentrations of each of the serial dilutions of each plasmid 
DNA and the CT values, standard curves were plotted for each of the plasmid DNA 
samples, which were all run as triplicates in the RT-PCR experiment. The mean CT 
value of the sample of the human spinal cord or spinal DH culture was calculated 
from the triplicate repeats of each of these samples. The standard curve was then 
used to determine the concentration of the cDNA of the sample. From this 
concentration the number of molecules was calculated for each of the glycine 
receptor subunits in the two samples using the provided molecular weights of the 
molecules from Qiagen.  
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2.3 Results 
2.3.1 Optimisation of the Embryonic Rat Spinal Dorsal Horn Culture 
There was extensive optimisation of the embryonic rat spinal DH cell culture with 
alterations made to numerous steps of the protocol from the collection of the 
embryos to the loading of the calcium dye. Initially the viability of the cells harvested 
from the embryonic spinal cords was low, at around 60%. This was thought to be 
due to the embryos being kept in Hibernate E media for an extended length of time 
before their spinal cords were removed and the DH isolated. It was considered that 
the Hibernate E did not contain sufficient ingredients to prevent degradation of the 
embryonic tissues. To counteract this amniotic fluid from each embryo’s amniotic 
sac was collected and added to the Hibernate E media in which the decapitated 
embryos were kept. Furthermore, the length of time for each DH dissection was 
reduced and consequently the viability of the cells when counted increased to 91.7 
± 0.38% (S.E.M) (n=17, N=8). 
The cells were found to form large clusters with very few projections between cells 
when cultured at a density of 1 x 106 cells/100 μl (Figure 2.3 A). When imaged on 
the BD Pathway system most of these cells did not display any spontaneous 
activity. The cell density was increased to 1.5 x 106 cells/100 μl, which improved the 
culture with fewer clusters forming. However, it was noted that the majority of the 
cells congregated to the edges of the wells leaving the centre with a much lower 
density. To resolve this issue the plates of cells were spun in a centrifuge 
immediately after the cells were plated. This dramatically improved the culture with 
the cells evenly distributed across the plate, and much less clustering of cells. 
These cells did spontaneously fire, with a much improved reliability. A further 
increase in cell density to 1.75 x 106 cells/100 μl was attempted which further 
reduced the formation of clusters of cells and thus was the final chosen plating 
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density (Figure 2.3 B). The progression of the culture through the 12-14 days spent 
in culture with all optimisation steps in place is depicted in Figure 2.4. The cells 
were run each day on the BD Pathway from 7 DIV to determine which days 
displayed the best spontaneous activity. From day 9 the occasional single cell could 
be seen to fire on their own and by day 10-11 the whole network was observed to 
display highly synchronously calcium spikes but not rhythmically. Between 12-14 
DIV the spinal DH culture had highly synchronous, repetitive calcium spikes with a 
rhythmic firing pattern. The frequency of this rhythmic calcium activity was 0.082 ± 
0.02 Hz (Figure 2.5 and supplementary CD). Beyond 14 DIV the calcium spikes 
began to diminish, and consequently for subsequent experimentation the spinal DH 
cultures were used when they reached 12-14 DIV.  
 
        
Figure 2.3 Embryonic rat DH cell culture at 14 DIV. In A and B the cells have been dye 
loaded with Calcium 5 dye. All images were taken using a digital inverted microscope 
(EVOS, AMG, Life Technologies, UK). (A) An example of the culture when the cell density 
was 1.5x10
6
 cells/100 μl and without centrifuging the plate. The cells can be seen clustered 
together, and there were fewer projections between cells. (B) The DH cell culture after 
application of all optimisation processes at 1.75x10
6
 cells/100 μl. The cells are evenly 
distributed across the surface with many projections forming the network.  
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Figure 2.4 Progression of a rat embryonic spinal DH cell culture from day 0, immediately 
after plating the cells, to 1 DIV, 8 DIV and 14 DIV. At day 0 the cells are completely 
dissociated and densely packed. After 24 hours in culture, neurite outgrowth from many of 
the cells can already be seen, and by 8 DIV extensive network connections can be 
observed. At 14 DIV there is no significant visible change in the network, however, by this 
stage, the cells are synchronously firing. 
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Figure 2.5 An example of the spontaneous, synchronous activity of the embryonic spinal DH 
cell culture after 13 DIV imaged using the BD Pathway system. (A) A still image of the video 
recorded using the BD Attovision software of the embryonic DH cell culture. See the 
supplementary CD for the real-time video. (B) The relative fluorescence intensity plot over 
time of the spontaneous activity of the culture shown in (A). Each coloured line represents 
the intensity of a single ROI within the frame of the image. The black line is the average of 
all the ROI intensities over time. The culture displays highly synchronous, rhythmic activity at 
all ROIs.  
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2.3.2 Characterisation of the Spinal Dorsal Horn Cell Culture Model: 
Neuronal and Non-Neuronal Cells 
To address the second aim of this study the primary embryonic DH cell cultures 
were stained with NeuN, glial fibrillary acidic protein (GFAP) and ionized calcium-
binding adapter molecule 1 (Iba1) to determine the presence of neuronal, glial and 
microglial cells, respectively. Positive staining was detected for all three cell types in 
the DH culture (Figure 2.6). In the NeuN and GFAP double-labelled cultured there 
were 71.8 ± 5.0 NeuN-positive cells and 19.0 ± 4.2 cells positive for GFAP. 
Therefore, from the total number of NeuN-positive and GFAP-positive cells in the 
cultures, there was an average of 79.1 ± 4.3% of NeuN-positive cells and 20.9 ± 
4.6% GFAP-positive cells (N=2, n=6). In the cultures labelled with NeuN and Iba1, 
74 ± 2.7 cells were NeuN-positive and 25.8 ± 3.5 were Iba1-positive. This is an 
average of 74.2 ± 1.7% NeuN-positive cells and 25.8 ± 1.7% Iba1-positive cells 
(N=2, n=4).  
 
2.3.3 Excitatory and Inhibitory Interneurons in the Spinal Dorsal Horn Cell 
Culture Model 
The second aim of the study was to determine the proportion of excitatory and 
inhibitory interneurons in the spinal DH cell culture. To investigate this, the 
excitatory marker vGluT2 was co-stained with NeuN (Figure 2.7). This staining 
illustrated the presence of glutamatergic interneurons in the DH culture. There were 
76 ± 3.7 NeuN-positive cells and 53 ± 4.6 vGluT2-positive cells. An average of 69.8 
± 5.6% of the NeuN-positive cells were co-localised with the vGluT2-positive cells 
(N=2, n=4). The inhibitory markers GAD 65 and 67 (Figure 2.8) and glycine 
transporter 2 (GlyT2) (Figure 2.9), for GABAergic and glycinergic cells, respectively, 
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were also co-stained with NeuN. In the cultures co-labelled with NeuN and GAD 65 
and 67, 97 ± 3.3 cells were NeuN-positive and 53 ± 4.2 cells were GAD 65 and 67-
positive. An average of 53.8 ± 4.9% of the NeuN-positive cells co-stained with 
GAD65-67-positive cells (N=2, n=4). From the NeuN and GlyT2 co-stained DH 
cultures 84 ± 5.1 NeuN-positive cells were counted and 24 ± 2.6 GlyT2-positive 
cells. All the GlyT2-positive cells co-localised with NeuN positive cells. There was 
an average of 29.0 ± 8.0% of the NeuN-positive cells which co-localised with GlyT2 
(N=2, n=4).  
A
 
B
 
Figure 2.6 NeuN, GFAP and Iba1 staining in the rat embryonic DH cell culture. (A) NeuN 
(green) and GFAP (red) with the merge image in the right panel. (B) NeuN (green) and Iba1 
(red), with the merge on the right. There is no co-localisation of these cell types, and there is 
a significantly higher proportion of NeuN-positive cells compared to either GFAP- or Iba1-
positive cells. 
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Figure 2.7 Embryonic DH culture stained with NeuN (green) and vGluT2 (red), and the 
merge image of the two images in the right panel.  Examples of those cells co-localised with 
vGluT2 and NeuN are indicated by arrows. 
 
 
Figure 2.8 The embryonic DH culture stained for NeuN (green) and GAD 65 and 67 (red). 
The merge image in the right panel shows the co-localisation of GAD 65 and 67 with 
neuronal cells confirming that there are GABAergic interneurons in the DH culture.  
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Figure 2.9 Double immunolabelling of the spinal DH culture with NeuN (green) and GlyT2 
(red). The white boxes in (A) are the section of the image which is illustrated in (B) in an 
enlarged view. The enlarged image allows visualisation of the GlyT2 staining surrounding 
the cell bodies of the neurons. The arrows indicate some of the co-stained cells in the 
culture for NeuN and GlyT2.  
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2.3.4 Neurochemically Defining Neuronal Cell Populations in the Dorsal 
Horn Culture 
Neurochemically defined classes of interneurons known to exist in vivo in the spinal 
DH were investigated in the spinal DH culture. PV and nNOS-positive cells were 
found to exist in the DH culture. PV was co-stained with GlyT2 and GAD65-67 to 
determine if PV-expressing interneurons are also inhibitory interneurons (Figure 
2.10). In the spinal DH cultures co-labelled with PV and GAD 65 and 67, 101 ± 2.2 
PV-positive cells and 71 ± 2.7 GAD 65 and 67-positive cells were counted (N=2, 
n=5). All the GAD 65 and 67 positive cells co-localised with PV-positive cells. Out of 
the total count of PV-positive cells, 70.7 ± 3.4% co-localised with GAD65-67-positive 
cells. In the DH cultures co-labelled for PV and GlyT2 there were 103 ± 2.0 PV-
positive cells and 21 ± 3.8 GlyT2 cells. The co-staining of PV with GlyT2 revealed 
that only 20.9 ± 4.7% of the PV-positive cells co-localised with the GlyT2-positive 
cells (N=2, n=5). The nNOS antibody could not be co-stained with the GAD65-67 
and GlyT2 antibodies due to the same host species. Therefore nNOS was co-
stained with gephyrin which is also a marker for inhibitory interneurons (Figure 
2.11). In these cultures 59 ± 5.6 nNOS-positive cells were counted with 23 ± 7.7 
gephyrin-positive cells (N=2, n=4). The co-staining of the antibody for the potassium 
chloride cotransporter 2 (KCC2) with gephyrin was also investigated to indicate if 
KCC2 is likely to be regulating the chloride ion electrochemical gradient in the DH 
culture. 75.0 ± 10.1 KCC2-positive cells and 62.8 ± 14.9 gephyrin-positive cells 
were counted in the DH cultures co-labelled with these antibodies (N=2, n=4). An 
average of 78.0 ± 12.0% of the KCC2-positive cells co-localised with gephyrin 
(Figure 2.12). Out of the total number of gephyrin-positive cells, 95.7 ± 2.2% co-
localised with the KCC2-positive cells. 
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B
 
Figure 2.10 The cultured rat embryonic spinal DH cells co-stained with (A) GAD65-67 
(green) and PV (red), and (B) GlyT2 (green) and PV (red). The merge of the images are 
shown on the right. The arrows indicate some of the cells which are positively labelled for 
both antibodies.   
 
 
Figure 2.11 The embryonic rat spinal DH culture stained with nNOS (green) and gephyrin 
(red) with the merge of the images on the right. The arrows indicate some of the cells which 
co-localized with nNOS and gephyrin. 
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Figure 2.12 The rat embryonic spinal DH culture stained for KCC2 (green) and gephyrin 
(red) and the merge of the images on the right. The arrows indicate some of the co-stained 
cells.  
 
2.3.5 GABAA Receptor α Subunit Expression in the Embryonic Dorsal Horn 
Culture 
The GABAA receptor α subunits 1-6 were each co-stained with NeuN to determine 
which of the subunits are expressed in the DH culture and whether they co-localise 
with neurons. The GABAA receptor α1 subunit was expressed in 53 ± 6.9 of the 85 ± 
4.5 NeuN-positive cells counted, and an average of 97.6 ± 1.6% of the α1 subunit-
positive cells co-stained with NeuN (N=2, n=6) (Figure 2.13). The GABAA receptor 
α2 subunit was expressed in 55 ± 3.8 of 75 ± 5.2 NeuN-positive cells (N=2, n=6). 
Out of the α2 subunit-positive cells, 99.4 ± 0.6% of them co-stained with NeuN-
positive cells (Figure 2.14). The GABAA receptor α3 subunit was also detected in 
the rat embryonic DH cells (Figure 2.15). There were 52 ± 5.7 GABAA receptor α3 
subunit-positive cells counted, and of the 75 ± 7.9 NeuN-positive cells, 94.2 ± 1.1% 
of these co-localised with NeuN (N=2, n=4). In the DH cultures stained with NeuN 
and the GABAA receptor α4 subunit 74 ± 3.6 GABAA α4 subunit-positive cells were 
counted, of these 64 ± 6.1 co-localised with the 108 ± 8.4 NeuN-positive cells (N=2, 
n=4) (Figure 2.16). The GABAA receptor α5 subunit was detected in 102 ± 2.3 of the 
110 ± 6.1 NeuN-positive cells, which was the highest proportion of all the GABAA 
receptor α subunits (N=2, n=4) (Figure 2.17). There was a mean of 93.0 ± 6.0% of 
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the total GABAA receptor α5 subunit-positive cells which co-localised with NeuN-
positive cells. Finally the GABAA receptor α6 subunit was also present in the DH 
culture, where 97 ± 7.1 cells were positive for this antibody and 88 ± 4.2 of those co-
localised with the 114 ± 3.6 NeuN-positive cells (N=2, n=5) (Figure 2.18). 
 
 
Figure 2.13 The embryonic DH cell culture with double immune-labelling of NeuN (green) 
and GABAA receptor α1 subunit (red), with the merge of the images on the right. The arrows 
indicate some of the cells which were positively stained for both NeuN and the GABAA 
receptor α1 subunit. 
 
 
Figure 2.14 The rat embryonic spinal DH cell culture stained with GABAA receptor α2 
subunit antibody (green) and NeuN (red), with the merge image on the right. The arrows 
indicate some of the cells which were positively stained for both NeuN and the GABAA 
receptor α2 subunit. 
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Figure 2.15 Staining of the embryonic DH culture for GABAA receptor α3 subunit (green) 
and NeuN (red) with the merge of the images in the right panel. The arrows indicate some of 
the cells which were positively stained for both NeuN and the GABAA receptor α3 subunit. 
 
 
Figure 2.16 The embryonic rat DH culture stained with the antibody for GABAA receptor α4 
subunit (green) and NeuN (red), and the merge of the two images in the right panel. The 
arrows indicate some of the cells which were positively stained for both NeuN and the 
GABAA receptor α4 subunit.  
 
 
Figure 2.17 Staining of the spinal DH culture for the GABAA
 
receptor α5 subunit (green) and 
NeuN (red), and the merge image in the right panel. The arrows indicate some of the cells 
which were positively stained for both NeuN and the GABAA receptor α5 subunit.  
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Figure 2.18 The rat embryonic DH culture stained with the GABAA receptor α6 subunit 
antibody (green) and NeuN (red), with the merge image in the right panel. The arrows 
indicate some of the cells which were positively stained for both NeuN and the GABAA 
receptor α6 subunit.  
 
2.3.6 Glycine Receptor α Subunit Expression in the Dorsal Horn Culture 
The expression of the glycine receptor α subunits 1-3 in the spinal DH culture were 
each stained separately with NeuN to determine which of the subunits is expressed 
in the spinal DH culture. In the spinal DH cultures co-stained with the glycine 
receptor α1 subunit and NeuN there were 126 ± 1.3 NeuN-positive cells and 117 ± 
2.4 glycine receptor α1 subunit-positive cells. There was an average of 50.1 ± 4.5% 
of the glycine receptor α1 subunit-positive cells that co-stained with NeuN (N=2, 
n=6) (Figure 2.19). There were only 2 ± 4.6 glycine receptor α2 subunit-positive 
cells counted in the DH cultures stained with the glycine receptor α2 subunit 
antibody, of which 71.4 ± 11.3% co-stained with NeuN. This accounts for only 1.6 ± 
3.4% of the 102 ± 8.5 NeuN-positive cells (N=2, n=3) (Figure 2.20). Finally, the 
glycine receptor α3 subunit antibody was detected in 29 ± 12.1 cells, in DH cultures 
co-stained with NeuN which had a total NeuN-positive cell count of 81 ± 6.7 cells in 
these cultures (N=2, n=4). This is an average of 36.0 ± 15.4% of the NeuN-positive 
cells. However, the number of glycine receptor α3 subunit-positive cells varied 
considerably between the wells (Figure 2.21).  
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Figure 2.19 The embryonic DH culture stained with NeuN (green) and the glycine receptor 
α1 subunit (Glra1) (red) with the merge image in the right panel. The arrows indicate some 
of the cells in the culture which are co-stained with NeuN and the glycine receptor α1 
subunit.  
 
 
Figure 2.20 The DH culture stained with NeuN (green) and the glycine receptor α2 subunit 
(red), with the merge image. In this image one of the glycine receptor α2 subunit-positive 
cells can be seen (indicated by the arrow), which co-localised with NeuN. The neurites of the 
glycine receptor α2 subunit-positive cells can clearly be observed, furthermore the cell body 
of these cells is larger than the other.   
 
68 
 
 
Figure 2.21 The spinal DH culture stained with NeuN (green) and glycine receptor α3 
subunit (red), with the merge image on the right. The arrows indicate some of the NeuN- and 
glycine receptor α3 subunit-positive cells which have co-localised. 
 
2.3.7 Quantitative Real-Time PCR with Human Spinal Cord and Culture 
Dorsal Horn Cells 
The expression of the GABAA and glycine receptor subunits in the spinal DH culture 
were also investigated using RT-PCR. The expression in the adult human spinal 
cord tissue of these receptor subunits was also determined to verify if there are any 
differences in the expression of the subunits compared to the rat DH culture. The 
RT-PCR results show that both the rat spinal DH culture and the adult human spinal 
cord express all six GABAA receptor α subunits (Figure 2.22). The glycine receptor 
subunits were all present except the α4 subunit in both the rat spinal DH culture and 
in the adult human spinal cord (Figure 2.23). The glycine receptor α4 subunit was 
not expressed in the human spinal cord, and only detected at a very low level in the 
rat embryonic spinal DH culture.  
Absolute quantification of the human glycine receptor α1 and 3 subunits was 
performed to determine which of the subunits is more highly expressed in the 
human spinal cord. The glycine receptor α2 subunit was not investigated as it is 
known to not be highly expressed in the spinal cord postnatally (Akagi et al., 1991, 
Watanabe and Akagi, 1995). Plasmid DNA containing the human glycine α1 gene 
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was used to generate a standard curve (Figure 2.24). Then using the CT value from 
the RT-PCR reaction with the glycine α1 subunit assay in the human spinal cord the 
concentration of RNA could be determined. Subsequently the number of molecules 
of this subunit in the human spinal cord was calculated. This was repeated for the 
glycine receptor α3 subunit variants K and L. There were 2.51 x 1011 molecules of 
the glycine receptor α1 subunit in the human spinal cord. There were 1.02 x 1017 
molecules of the α3 subunit K variant, and 1.53 x 1014 molecules of the L variant. 
These results are listed in Table 2.9. Similarly the number of molecules for each of 
the glycine receptor α subunits was investigated in the rat spinal DH culture. Here 
the two variants of the α3 subunit could not be determined due to no TaqMan probe 
being available for the two variants separately. The standard curves generated for 
each subunit in the rat DH culture are also shown in Figure 2.24. The number of 
molecules of the α1 subunit in the DH culture was 1.88 x 1017 molecules. There 
were 8.39 x 1016 molecules of the glycine receptor α2 subunit, and 1.09 x 1016 
molecules of the glycine receptor α3 subunit. These results are listed in Table 2.10. 
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B 
 
Figure 2.22 The relative expression of each of the GABAA receptor α subunits (GABRA1-6) 
in the rat spinal DH culture (A) and in the adult human spinal cord (B) determined by relative 
quantification RT-PCR. The data was scaled relative to the expression of GABRA1 for each 
species. 
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Figure 2.23 The relative expression of each of the glycine receptor α subunits (Glra1-4) and 
β subunit (Glrb) in the rat spinal DH culture (A) and in the human spinal cord (B) determined 
by relative quantification RT-PCR. In the rat spinal DH culture the expression of the two 
glycine transporters (GlyT1 and GlyT2) was also investigated. The arbitrary copy numbers 
were scaled relative to Glra1 for each species. 
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 Figure 2.24 The standard curves from each of the absolute quantification RT-PCR 
experiments to determine the number of molecules of the glycine receptor α subunits in the 
human spinal cord and in the rat embryonic spinal DH culture.  
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Table 2.9 A summary of the number of molecules of the glycine receptor α1 subunit and α3 
subunit variants K and L in the adult human spinal cord as found from absolute quantification 
RT-PCR. 
 
 
Table 2.10 A list of the results from the absolute quantification RT-PCR experiment to show 
the number of molecules of each of the glycine receptor α subunits in the spinal DH culture.  
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2.4 Discussion 
2.4.1 The Spinal Dorsal Horn Culture has a High Proportion of Neuronal 
Cells  
The aim of this study was to develop and characterise the rat embryonic spinal DH 
cell culture model and to assess its potential to be an assay for screening novel 
analgesics. Once the DH culture was optimised, the culture was characterised with 
IF and RT-PCR. Firstly, the presence of neurons, glia and microglia was 
determined. Secondly, the proportion of neuronal cells to glial cells within the culture 
was calculated. The dissection and processing of the spinal DH tissue and the cell 
culture conditions can result in cell death of neuronal cells, leaving primarily non-
neuronal populations (Gordon et al., 2013). This study is focused on the neuronal 
network of the spinal DH, and therefore it is important to determine a high proportion 
of neuronal cells in the culture. There were almost four times as many neurons as 
glia found in the culture, and three times as many neuronal cells as microglia. The 
higher proportion of neuronal cells supports this model for study of the spinal DH 
neuronal network.   
 
2.4.2 Excitatory and Inhibitory Interneurons in the Spinal Dorsal Horn 
Culture  
The classic excitatory cell marker for the spinal cord, vGluT2, was co-stained with 
NeuN to determine the proportion of excitatory interneurons in the spinal DH culture 
to address the second aim of this study. Approximately 70% of the labelled neuronal 
cells in the culture were excitatory. This is consistent with rat spinal cord slice IF 
studies which identify between 60 and 70% of interneurons in the superficial DH 
being excitatory (Todd et al., 2003, Maxwell et al., 2007, Yasaka et al., 2010, Polgar 
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et al., 2013). Labelling the GABAergic interneurons with GAD65-67 and glycinergic 
interneurons with GlyT2 revealed a larger population of inhibitory interneurons than 
anticipated based on the theory that the proportion of non-excitatory interneurons 
are inhibitory and vice versa. Just over 50% of the neuronal cell population detected 
were co-labelled with GAD65-67. This is a slightly larger proportion of inhibitory 
interneurons than has been reported in superficial spinal DH of spinal cord slices. In 
rats, 28% of neurons in lamina I up to 46% in lamina III of the superficial spinal DH 
have been reported to be GABAergic (Todd and Spike, 1993, Polgar et al., 2003, 
Polgar et al., 2013). The glycinergic labelled cells co-localised with just less than 
30% of the neuronal cell population. Similarly this is fairly consistent with previous 
reports of glycinergic interneurons ranging from 9% of lamina I neurons to 30% in 
lamina III (Todd and Spike, 1993). The proportions of excitatory and inhibitory cells 
in the DH culture therefore do correlate well with published spinal cord slice IF 
studies focusing on the superficial laminae. This could imply that this ratio of 
inhibitory to excitatory interneuron populations is a requirement of the rhythmic 
activity which has been recorded in the spinal DH in vivo and in in vitro studies, and 
was reported in this spinal DH culture with calcium imaging recordings. The 
generation of rhythmic activity in neuronal networks has been suggested to involve 
a cycling interaction between inhibitory and excitatory interneurons (Tiesinga and 
Sejnowski, 2009). 
 
2.4.3 The Spinal Dorsal Horn Culture Contains Parvalbumin and nNOS 
Neuronal Cells 
Neuropeptides PV and nNOS were both detected in the spinal DH culture, and were 
identified to co-localise with inhibitory interneurons. nNOS is expressed primarily in 
lamina II of the spinal DH, with very few nNOS-positive cells also found in lamina I 
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and III (Sardella et al., 2011). In the rat spinal cord it has also been shown that a 
small population of 2-6% of nNOS-expressing interneurons in the superficial DH is 
GABAergic (Sardella et al., 2011, Polgar et al., 2013, Polgár et al., 2013). In this 
study around 2% of the nNOS-positive cells co-stained with gephyrin, which 
therefore concurs with the reports in the superficial DH of spinal cord slices. It has 
been implied that the remaining nNOS-expressing cells in the spinal DH which don’t 
co-express gephyrin must therefore be glutamatergic interneurons. The NO 
produced by nNOS in the spinal cord has been demonstrated to have a role in 
developing and maintaining hyperalgesia in inflammatory and neuropathic pain 
(Guan et al., 2007, Schmidtko et al., 2009). Furthermore, there is evidence of NO 
causing prolonged changes in synaptic strength and the development of LTP in the 
superficial DH (Zhang et al., 2005, Ikeda et al., 2006). It has been demonstrated 
that the activation of NMDA receptors in the spinal DH is linked to increased 
production of nNOS, which consequently increases synthesis of NO (Lange et al., 
2012). Intracellular signalling of NO can lead to modulation of neurotransmitter 
release at the pre-synaptic terminal, which has been associated with the 
development of LTP (Infante et al., 2007, Lange et al., 2012). Moreover, antagonists 
of the NMDA receptor have an analgesic effect (Tong and MacDermott, 2014). This 
could result from a decrease in nNOS expression, NO synthesis and LTD which 
therefore would decrease spinal DH network excitability and prevent development of 
central sensitisation and the manifestation of pain.  
PV-expressing interneurons are present in the superficial spinal DH (Polgár et al., 
2013), and a number of GABAergic interneurons express PV in the spinal DH 
(Labrakakis et al., 2009, Hughes et al., 2012). The results of this study show that 
the spinal DH culture does express a large proportion of GABAergic interneurons 
which are PV-positive, and furthermore a number of glycinergic interneurons are 
also PV-positive. Since not all of the PV-expressing interneurons in the culture or in 
77 
 
spinal cord slices are GABAergic interneurons, it has been suggested that a 
population of these PV-positive neurons are glutamatergic (Grudt and Perl, 2002). 
PV is a calcium binding protein and transports intracellular calcium to the calcium 
stores in the cell. Through controlling the calcium ion concentration in the 
presynaptic terminal, PV impacts on the release of neurotransmitter from the cell 
and consequently the activity of the network of interneurons. Stimulation of PV-
expressing neurons in the brain has been illustrated to affect the cortical gamma 
rhythm (Kim et al., 2015). It is therefore possible that PV-positive interneurons in the 
spinal DH are required for the generation and maintenance of the rhythmic activity 
of the spinal DH network. 
 
2.4.4 Inhibitory Interneurons in the Spinal Dorsal Horn Culture Express 
KCC2 
The results of this IF study have identified that almost all of the inhibitory 
interneurons in the spinal DH culture express KCC2. However, not all the KCC2-
positive cells co-localised with gephyrin, suggesting that some glutamatergic 
interneurons also express KCC2. This resembles the spinal cord slices, where 
KCC2 is expressed throughout the grey matter, with much stronger expression in 
the superficial laminae (Javdani et al., 2015). KCC2 exports chloride ions from the 
cell to maintain a low intracellular chloride ion concentration (Rivera et al., 1999). 
Confirming the expression of KCC2-positive interneurons in the DH culture 
demonstrates that the action of GABA and glycine at their respective receptors will 
likely produce an inhibitory effect due to an influx of chloride ions. Furthermore, 
KCC2 expression increases quickly in early postnatal days (Ben-Ari et al., 2007). 
Therefore, as this culture was from embryonic rat spinal DH this finding suggests 
that the culture has reached a more mature state following 12-14 DIV.  
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2.4.5 All GABAA Receptor α Subunits are Expressed in the Spinal Dorsal 
Horn Culture 
The IF performed in this study shows that each of the GABAA receptor α subunits is 
expressed in the spinal DH culture. This was confirmed with the relative 
quantification RT-PCR results showing mRNA expression. This largely concurs with 
IF studies for these subunits in spinal cord slices. In adult rat spinal cord, GABAA 
receptor α1 and α5 subunits are expressed throughout the grey matter of the spinal 
cord, with particularly high expression in lamina III (Bohlhalter et al., 1996). The α2 
and α3 subunits also have a much stronger expression in laminae I and II, with α3 
strongly detected in lamina III (Bohlhalter et al., 1996). However, the GABAA 
receptor α6 subunit has not been detected in the adult rat spinal cord, but low levels 
have been detected in embryonic spinal cord (Poulter et al., 1992). Additionally, 
Poulter et al. (1992) did not detect the GABAA receptor α1 or 2 subunits in the 
embryonic spinal cord. The RT-PCR results show that the adult human spinal cord 
expresses all the GABAA receptor α subunits as found in the culture. These results 
demonstrate strong similarities between the cultured spinal DH cells, rat spinal cord 
and the adult human spinal cord in terms of the expression of the GABAA receptor α 
subunits. This is beneficial for drug screening, as it could provide an early indication 
of the clinical potential of a drug. Therefore, this data supports the use of this spinal 
DH culture as a model to investigate the roles of the GABAA receptor subtypes in 
this network, and furthermore to screen for compounds acting at GABAA receptors. 
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2.4.6 Differences in Glycine Receptor α Subunit Expression in the Spinal 
Dorsal Horn Culture Compared to Human Spinal Cord 
The IF staining for the glycine receptor α1-3 subunits demonstrated the expression 
of each of these subunits in the spinal DH culture. The glycine receptor α2 subunit 
expression was very low, and although the α1 and α3 subunit staining was not of 
good quality there was a higher expression of each of these subunits compared to 
the α2 subunit. The relative quantification RT-PCR results also demonstrated 
expression of each of the α subunits 1-3 in both the spinal DH culture and in adult 
human spinal cord. Expression of the α4 subunit was very low or absent in the DH 
culture and human spinal cord, which agrees with this subunit being found in mice 
but not human or rat (Matzenbach et al., 1994). The expression of the glycine 
receptor β subunit was confirmed with the RT-PCR results in both the DH culture 
and human spinal cord, which is known to be expressed throughout the CNS  
(Jonsson et al., 2012). The expression of the α1 and α3 glycine receptor subunits 
has previously been shown to increase postnatally, while the expression of the α2 
subunit is higher during development and decreases postnatally (Watanabe and 
Akagi, 1995, Jonsson et al., 2012). As the relative quantification RT-PCR data does 
not provide an indication of the levels of expression of the subunits, the actual 
number of molecules of the each of the glycine receptor α subunits was determined 
from absolute quantification RT-PCR. These results revealed that there is more 
glycine receptor α3 subunit than α1 in the human spinal cord, and more of the α3 K 
variant than the L variant. However, in the spinal DH culture the expression of these 
subunits was not comparable. In the DH culture the expression of the glycine 
receptor α1 subunit was far greater than the α3 subunit expression, which is 
consistent with the IF cell count data for the α1 and α3 subunits in the spinal DH 
culture. The absolute RT-PCR quantification also demonstrated there was a higher 
expression of the α2 subunit than the α3 subunit in the spinal DH culture, which was 
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not found in the IF experiments where the expression of the glycine receptor α2 
subunit was much lower than α1 and α3 subunit expression. This could result from 
differences in the PCR assay probe for the glycine receptor α2 subunit compared to 
the antibody for this protein. As the expression of these glycine receptor subunits 
does not correlate between the culture and the human spinal cord, it is likely that the 
glycine receptor pharmacology will be different. It is known that the different glycine 
receptor subunits display slightly different pharmacology and receptor kinetics, 
which could affect the network activity (Kuhse et al., 1993, Maksay et al., 2001).  
 
2.4.7 Conclusions 
The first aim of this chapter was to develop an in vitro rat embryonic spinal DH cell 
culture model, which was successfully achieved following extensive optimisation 
including the use of calcium imaging. The characterisation of this spinal DH culture 
suggests there is a strong uniformity between the types of cell classes that have 
been described in the ex vivo spinal cord to those found in the spinal DH culture. 
This includes the proportions of inhibitory to excitatory interneurons and the 
expression of PV, nNOS and KCC2 positive cells. A summary of these comparisons 
can be found in Table 2.11. The expression of the GABAA receptor α subunits 
detected by IF and RT-PCR, at the protein and mRNA, respectively, correlate well 
with the human adult spinal cord and also the rat spinal DH slices. However, there 
were some discrepancies discovered between the expression of the glycine 
receptor α subunits in the spinal DH culture compared with the human spinal cord. 
However, this is only concerning the different proportions of expression of the 
subunits. Overall the characterisation of the spinal DH culture illustrates that this 
model could be a useful platform for development of drug discovery assays.  
Caution should be taken when interpreting the results of drug testing using this 
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model, due to the absence of afferent input and the potential differences in the 
network due to the complete tissue dissociation and culturing processes. However, 
the versatility of cell culture models makes them ideal for the initial screening 
process of novel compounds prior to in vivo studies in animal models.  
Antibodies Spinal DH Culture (%) Ex vivo Spinal Cord (%) 
vGlut2/NeuN 70 60-70  
(Polgár et al., 2013) 
GAD65-67/NeuN 50 ≤46  
(Polgár et al., 2013) 
GlyT2/NeuN 30 9-30  
(Todd and Spike, 1993) 
nNOS/Gephyrin 2 2-6  
(Sardella et al., 2011) 
GAD65-67/PV 70 25  
(Labrakakis et al., 2009) 
GAD65-67/KCC2 78 n.d 
Table 2.11 A summary of the comparisons in expression of the antibodies utilised for 
characterisation of the spinal DH culture, between the spinal DH culture and the ex vivo 
spinal cord from published sources. The percentage values indicate the expression of the 
first antibody staining out of the total number of positive cells counted for the second 
antibody. Quantification of the expression of KCC2 and GAD65-67 has not been defined in 
the ex vivo spinal cord. 
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3 Calcium Response as a Measure of the Embryonic Spinal 
Dorsal Horn Network  
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3.1 Introduction 
3.1.1 Neuronal Primary Cell Culture 
In this chapter a calcium imaging assay has been used with the embryonic spinal 
DH cell culture developed and characterised in Chapter 2 to investigate the activity 
of the DH network. Primary cell culture provides the format by which the cells can 
be studied under controlled conditions and are versatile due to their adaptability and 
easy access for use with different assays and techniques. For example, primary cell 
cultures can be used for electrophysiological techniques (Massobrio et al., 2015), 
calcium imaging (Tibau et al., 2013) and molecular biology techniques 
(Emamghoreishi et al., 2015). Cultured cells can be used to investigate normal 
physiology of cells of a particular tissue and their biochemistry. Furthermore, drug 
efficacy and toxicity can also be assessed (Pratten et al., 2012). A major advantage 
of using cultured cells is the reproducibility of the results given the ability to maintain 
consistent conditions. In primary cell culture models, the advantages of high-
throughput assays mean that the number of animals required for an assay is 
reduced. There are a number of limitations of primary cultures; firstly it is likely that 
the different populations of cells in the spinal DH require different culture conditions 
therefore some populations of cells might not survive in the culture (Gordon et al., 
2013). This could affect the growth and activity of the remaining populations 
(Mergenthaler et al., 2014). Furthermore, neuronal cultures are typically from 
embryonic or early post-natal animals. Therefore, the developmental stage of 
maturation of the cells in the culture is unknown. Finally the presence of non-
neuronal cells within the culture should be considered in terms of their contribution 
to the responses observed in assays (Gordon et al., 2013).  
The primary cultures of embryonic DH cells were demonstrated in Chapter 2 to be 
spontaneously active after 12-14 days in culture using calcium imaging. 
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Spontaneous activity has been recorded in vitro in dissociated spinal cord cultures 
previously (Streit, 1993, Li and Baccei, 2011, Hendrich et al., 2012a). Li and Baccei 
(2011) demonstrated the existence of ‘pacemaker’ neurons within the superficial 
spinal DH which drive the spontaneous firing. These pacemaker neurons were later 
shown to be glutamatergic cells, which connect with ascending projection neurons 
transmitting their signals to supraspinal areas involved in nociception including the 
parabrachial nucleus (Li et al., 2014). Therefore, the inhibitory and excitatory 
interneurons within the DH network could be involved in generating and/or 
modifying this rhythmic activity and provide a mechanism for regulating nociceptive 
signals. Consequently, pharmacologically targeting the receptors whose signalling 
influences the spinal DH network rhythmic activity could have an analgesic effect.  
 
3.1.2 Calcium Imaging Techniques to Measure Neuronal Network Activity 
Calcium ions have a variety of intracellular functions in virtually all types of 
mammalian cells, including muscle contraction, cell proliferation and cell death 
(Berridge et al., 2000). In neurons, intracellular calcium release initiates exocytosis 
of synaptic vesicles in the pre-synaptic terminals which contain neurotransmitter 
molecules (Neher and Sakaba, 2008). Postsynaptically, the influx of calcium ions 
through NMDA receptors produces activity-dependent synaptic plasticity (Lu et al., 
2001). Calcium dyes, can be used to detect changes in the intracellular calcium ion 
concentration, which occur in neuronal cells during neurotransmitter release 
(Grienberger and Konnerth, 2012). Typically neurons at rest have an intracellular 
calcium ion concentration of 50-100 nM, which can increase by over ten-fold during 
action potential stimulation (Berridge et al., 2000). Therefore, the detection of a 
large transient increase in intracellular calcium ion concentration is an indicator of 
neuronal excitability.  
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Calcium ions enter neuronal cells via a number of mechanisms including voltage-
gated calcium channels, NMDA receptors and nicotinic acetylcholine receptors 
(Kovalchuk et al., 2000, Fucile, 2004). Release of calcium ions from intracellular 
stores also contributes to the signalling for the release of neurotransmitters from 
presynaptic terminals (Neher and Sakaba, 2008). Voltage-gate calcium channels 
are expressed in the spinal DH, where they influence DH neuron excitability (Diaz 
and Dickenson, 1997, Matthews and Dickenson, 2001a, Matthews and Dickenson, 
2001b, Zhang et al., 2008b, Youn et al., 2013, Xia et al., 2014). Calcium imaging 
techniques have been used with developing neuronal cell cultures to investigate 
network activity (Albantakis and Lohmann, 2009, Grienberger and Konnerth, 2012). 
Therefore, this technique has been employed in this study to investigate the 
embryonic spinal DH culture network activity.  
 
3.1.3 Aims 
In this chapter a calcium imaging assay is used to investigate the embryonic spinal 
DH culture network activity. The aims of this investigation are to use calcium 
imaging techniques: 
1. To determine whether GABAA receptor pharmacological tools can modulate the 
spontaneous activity of the spinal DH cell culture model  
2. To determine whether glycine receptor pharmacological tools can modulate the 
spontaneous activity of the spinal DH culture model  
3. To determine the effects of blocking the KCC2 co-transporter on the spinal DH 
culture activity 
4. To determine if activating or inhibiting the NMDA receptors in the spinal DH 
culture effects the network activity  
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3.2 Methods 
3.2.1 Embryonic Dorsal Horn Primary Cell Culture  
The spinal DH cell culture was performed as described in Chapter 2 (section 2.2.1). 
The cultures were used for the calcium imaging experiments between 12-14 DIV. 
 
3.2.2 Flexstation Calcium Imaging with Cultured Dorsal Horn Cells 
As described in Chapter 2 (section 2.2.2), the media was removed from the cultured 
DH cells and replaced with 80 μl of FLIPR Calcium 5 Dye (Molecular Devices, USA) 
diluted 1 ml of Calcium 5 Dye in 9 ml HBSS (-/-), with calcium chloride (1.8 mM) and 
1% HEPES (Sigma-Aldrich, UK), and adjusted to pH 7.4 with sodium hydroxide 
(Sigma-Aldrich, UK). After 30 minutes incubation at 37˚C the DH cell cultures were 
transferred to the Flexstation II 384 (Molecular Devices, USA). The Flexstation is a 
scanning fluorometer with an integrated fluid transfer system to allow for addition of 
compounds to a multi-well plate. SoftMax Pro software (version 5.4) (Molecular 
devices, USA) was used in conjunction with the Flexstation for data acquisition and 
analysis. The Flexstation is able to simultaneously measure the fluorescence 
intensity from a column of wells of a 96-well plate, and is therefore higher-
throughput than the previously utilised BD Pathway system which can only measure 
one well at a time. However, unlike the BD Pathway the Flexstation does not 
capture a video of each well so there is no record of which cells display 
spontaneous activity and/or respond to compound addition. An image of each well 
was captured separately after dye loading using an AMG digital inverted microscope 
(EVOS Thermofisher Scientific, UK). Those wells where the cells were seen not to 
form networks or did not display spontaneous firing were not included in the 
analysed data. 
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The Flexstation assay involved measuring the baseline activity of each well for 4 
minutes, at which point the compound was applied. The response of the cultured 
cells to the compound was recorded for the following 4 minutes. Depending on the 
experiment, a second compound could be added and the response to the second 
addition was recorded for a further 4 minutes. A recording duration of 4 minutes for 
each section of the assay was determined to be sufficiently long enough to capture 
the change in fluorescence of the culture in response to a compound without 
sacrificing the health of the dye loaded cells. The cells stop firing and start to die 
when they are exposed to the dye for over 90 minutes. The compounds could not 
be washed off; therefore it cannot be shown if the firing frequency would return to 
normal baseline firing after removal the compounds. Consequently, each well of the 
plate could only be used for one concentration of one compound. A list of the 
compounds and their concentrations investigated in this assay with the spinal DH 
culture model can be found in Table 3.1. The response to the vehicle DMSO was 
tested on the spinal DH culture to determine the maximum final percentage of 
DMSO that can be utilised if required as a solvent for a compound. The SoftMax Pro 
software was used to control the excitation and emission wavelengths of the 
Flexstation, the excitation wavelength was set to 485 nm and the emission 
wavelength was 525 nm. The sensitivity reading was set to 12 with a high 
photomultiplier tube (PMT) sensitivity, and the fluorescence intensity was set to be 
measured every 2 seconds. Compound addition of 20 µl was set to be added at a 
rate of 75 µl/second. The Flexstation II has a temperature control system, which 
maintained the plate at 37°C throughout the experiments.  
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3.2.3 Flexstation Data Analysis 
From the graph of relative fluorescence against time for each well, the area under 
the curve was determined for each section of the recording. The area under the 
curve was calculated from the baseline value for each well using the SoftMax Pro 
software. Due to the occurrence of artefacts with the addition of many compounds, 
the area under the curve for the section with compound present was calculated with 
the area under curve of the artefact duration subtracted. The same time period was 
compared for each section, therefore if 10 seconds of the area under the curve of 
the section where compound was present was removed for the artefact then 10 
seconds was also removed from the baseline section when calculating the area 
under the curve. The percentage change in the fluorescence was calculated as the 
difference between the area under the curve of the section of the trace with 
compound present minus that of the baseline section divided by the area under the 
curve of the baseline section. Concentration-response curves were generated with 
normalised percentage change values. GraphPad Prism 6 (GraphPad Software, La 
Jolla California USA; version 6.00) was used to obtain a concentration-response 
curve for the data using a non-linear fit model. Data points are plotted with error 
bars of S.E.M. The n values stated are the number of wells tested with each 
concentration of the compound. Each compound concentration was tested on a 
minimum of 6 different wells denoted as n, which were from at least two different 
cell culture preparations, denoted as N.  
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Table 3.1 A list of the compounds and their range of concentrations applied to the spinal DH 
culture in the Flexstation calcium imaging assay. Supplier information and solvent utilised for 
each compound is also provided.  
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3.3 Results 
3.3.1 Optimisation of the Flexstation Calcium Imaging with the Cultured 
Embryonic Spinal Dorsal Horn Cells  
The BD Pathway system was utilized to optimise the culture and its spontaneous 
activity in Chapter 2. During the initial optimisation of the calcium imaging assay it 
was found that the spinal DH culture is highly sensitive to dimethyl sulfoxide 
(DMSO). When DMSO is applied at a concentration as low as 0.006%, the baseline 
fluorescence increases to a level where the spontaneous rhythmic peaks of the cell 
network can only just be deciphered from the background level of fluorescence 
(Figure 3.1). Consequently any compounds which were required to be dissolved in 
DMSO were diluted so that the final concentration of DMSO was 0.001% or less to 
prevent a significant effect on the baseline calcium fluorescence. Due to the higher 
throughput of the Flexstation fluorometer, all pharmacological studies with the DH 
culture were performed using the Flexstation. The spontaneous firing of the DH 
culture was the same when observed with both systems (Figure 3.2). Therefore 
once the culture protocol had been optimised, the same DH cell culture protocol 
could be performed for the Flexstation assays. The Flexstation does not provide a 
video of each well on the DH culture plate and thus the synchrony of the individual 
cells could not be visualised. However, the high similarity between the two calcium 
imaging system traces with the DH culture suggested that the cultures could be 
considered to be synchronously firing when run on the Flexstation from the 
fluorescence intensity graph.  
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Figure 3.1 The effect of DMSO on the embryonic spinal DH culture baseline spontaneous 
activity. (A) DMSO at a concentration of 0.06% was applied to the DH culture at 180 s and 
caused a long-lasting increase in the baseline fluorescence. (B) 0.006% DMSO was applied 
to the spinal DH culture at 260 s into the recording. At this concentration, DMSO also 
increased the baseline fluorescence of the DH culture. (C) 0.001% DMSO was applied to the 
DH culture at 180 s, which did not have any effect on the baseline spontaneous activity of 
the culture.  
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Figure 3.2 Spontaneous firing of the DH culture observed by calcium imaging using two 
different fluorometer systems. (A) A recording from the BD Pathway system with the cultured 
DH cells. The first section shows the baseline spontaneous activity followed by addition of 
taurine to the well as shown, which completely removed all firing. (B) A recording from the 
Flexstation, demonstrating similar spontaneous activity followed by addition of taurine which 
also prevented any subsequent firing of the DH culture.  
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3.3.2 The Role of GABAA Receptor Signalling in Dorsal Horn Activity 
Agonists of the GABAA receptor, GABA and muscimol, both dose-dependently 
decreased the spontaneous activity of the DH culture (Figure 3.3). Furthermore, the 
GABAA receptor PAM, diazepam, also dose-dependently reduced the spontaneous 
activity (Figure 3.4). Incidentally, the GABAA receptor antagonists bicuculline and 
gabazine increased the spontaneous activity in a dose-dependent manner, 
increasing the rate of peaks in fluorescence and fluorescence intensity (Figure 3.5). 
Additionally baclofen, a GABAB receptor agonist, dose-dependently decreased the 
DH culture activity (Figure 3.6). The GABAB receptor antagonist 2-hydroxysaclofen 
dose-dependently increased the spinal DH culture activity (Figure 3.6).  
 
3.3.3 The Role of the Glycine Receptor in the Dorsal Horn Activity 
Application of each of the glycine receptor agonists, glycine and taurine, both 
produced a decrease in the spontaneous activity of the DH culture in a dose-
dependent manner (Figure 3.7). The potent and selective glycine transporter type 1 
(GlyT1) antagonist CP-802079 also dose-dependently decreased the spontaneous 
activity (Figure 3.8). The two glycine receptor antagonists, strychnine and 
gelsemine, each dose-dependently increased the activity of the DH culture (Figure 
3.9). Conversely, the antagonist of the KCC2 co-transporter, VU 0240551, dose-
dependently increased the spinal DH culture spontaneous activity (Figure 3.10). 
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Figure 3.3 Inhibition of the DH culture spontaneous activity by GABAA receptor agonists. (A) 
A Flexstation relative fluorescence trace against time with the DH cultured cells. GABA (100 
μM) was added to the well at 240 seconds into the recording which completely inhibited the 
spontaneous activity. (B) A Flexstation trace of a recording with muscimol (10 μM) applied at 
240 seconds into the recording, which similarly prevented the spontaneous firing. (C) The 
concentration response curve generated from the Flexstation data with GABA, where the 
EC50 is 43.5 ± 0.1 µM (n=3-5). (D) The concentration response curve for muscimol, where 
the EC50 is 6.7 ± 0.2 µM (n=4-6).  
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Figure 3.4 GABAA receptor PAM, diazepam decreases the spontaneous activity of the spinal 
DH culture. (A) An example Flexstation trace with the cultured DH cells illustrating the effect 
of application of diazepam (10 μM) on the spontaneous activity. (B) The concentration-
response curve generated from the DH culture Flexstation recordings with diazepam 
application. The EC50 for diazepam is 1.0 ± 0.3 μM (n=14-22).  
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Figure 3.5 The effects of GABAA receptor antagonists’ bicuculline and gabazine on the DH 
culture activity. (A) A Flexstation trace to show the effect of bicuculline (10 μM) on the DH 
spontaneous activity. (B) A Flexstation trace to demonstrate the effect of gabazine (30 μM) 
on the DH culture spontaneous activity. Bicuculline was added at 240 s into the experiment. 
(C) The concentration-response curve generated from the bicuculline data obtained from the 
Flexstation, where the IC50 is 39.3 ± 0.04 μM (n=4). (D) The concentration-response curve 
for gabazine, where the IC50 is 18.2 ± 0.8 μM (n=6-9).  
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Figure 3.6 The actions of GABAB receptor agonist and antagonist on the DH cell culture 
spontaneous activity. (A) An example of a Flexstation trace using the DH culture where 
GABAB receptor agonist baclofen (100 μM) was applied at 240 s. (B) An example trace from 
a Flexstation recording with the DH culture where GABAB antagonist 2-hydroxysaclofen was 
applied at 240 s. (C) The concentration-response curve for baclofen generated from the 
FLexstation data, where the EC50 is 118.2 ± 0.9 μM (n=3-6). (D) The concentration-response 
curve for 2-hydroxysaclofen, with an IC50 of 17.3 ± 0.11 μM (D) (n=3-6).  
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Figure 3.7 Glycine receptor agonist effects on the DH cultured cells. (A) A graph of the 
relative fluorescence over time from a single well of DH cells cultured to day 12. The 
baseline spontaneous activity was measured for 240s, at which point 1 mM glycine was 
added to the well. This resulted in a loss of firing. (B) An example of the effects of 2 mM 
taurine on the DH cultured cells. Taurine was added at 240s, which similarly removed all 
spontaneous firing. (C) and (D) show the concentration-response curves for glycine (n=3-8) 
and taurine (n=4-6), respectively. The EC50 for glycine is 74.34 ± 0.64 μM and the EC50 for 
taurine is 1.4 ± 0.55 mM. 
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Figure 3.8 The effect of the GlyT1 antagonist CP-802079 addition on the DH culture 
spontaneous activity. (A) A trace from a Flexstation recording with CP-802079 (100 μM) 
added at 240 seconds. (B) The concentration-response curve generated for CP-802079 
from the Flexstation data with the DH cultured cells, with an IC50 value of 18.0 ± 0.6 μM 
(n=4-12).  
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Figure 3.9 The effect of strychnine and gelsemine on the spontaneous activity of the spinal 
DH culture. (A) An example trace from the Flexstation with strychnine (3 µM) added to the 
DH cells at 240 seconds. (B) An example trace with gelsemine (30 µM) added to the culture 
at 240 seconds. Concentration-response curves were generated for both strychnine (C) 
(n=4-5) and gelsemine (D) (n=3-7) from the Flexstation data with these glycine receptor 
antagonists. The IC50 value for strychnine was 2.9 ± 0.07 μM, and for gelsemine 18.4 ± 0.8 
μM. 
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Figure 3.10 The effect of blocking the KCC2 co-transporter in the spinal DH culture. (A) An 
example recording from the DH cultured cells on the Flexstation, with KCC2 antagonist VU 
0240551 applied at 240 s. (B) The concentration-response curve of the VU 0240551 data 
from the DH culture Flexstation recordings, with an IC50 of 23.3 ± 0.6 μM (n=4-6). 
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3.4 Discussion 
The embryonic spinal DH culture developed in Chapter 2 was used to investigate 
calcium responses, an indicator of the DH culture network activity. A series of well-
characterised pharmacological tools of the GABAA and glycine receptors were 
applied to the DH culture to investigate the role of these receptors in the 
spontaneous, rhythmic network activity. Consequently, the validity and potential 
utility of this in vitro model with the Flexstation calcium imaging assay to screen 
novel compounds can be evaluated. In Chapter 2 the rhythmic activity of the 
cultured spinal DH was shown to have a frequency of 0.082 ± 0.02 Hz. The results 
obtained with the calcium imaging assay illustrate that the rhythmic activity of the 
DH culture can be modulated by GABAA, GABAB and glycine receptor signalling. 
Furthermore, KCC2 was also shown to be critical for the generation of the rhythmic 
activity.  
Spontaneous activity has been previously reported in cortical and spinal cord 
cultures, as well as organotypic spinal cord slices (Legendre et al., 1985, Streit et 
al., 2001, Czarnecki et al., 2008, Hendrich et al., 2012a). Spinal spontaneous 
activity in vitro is believed to originate at least in part in the spinal cord itself. 
Pacemaker neurons within the superficial DH exist and synapse with both other 
interneurons within the DH and with projection neurons, as observed in ex vivo 
preparations of neonatal spinal cords (Li et al., 2014). Evidence that these 
pacemaker neurons project to the nociceptive processing supraspinal regions, 
including the periaqueductal grey and parabrachial nucleus, suggests a role for this 
spontaneous activity in modulating nociceptive signals (Li et al., 2014). The 
proposed ING and PING circuitry mechanisms for the generation of rhythmic 
oscillations in brain networks could apply to the spinal DH network.  
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3.4.1 GABAA and Glycine Receptor Agonists and Antagonists Modulate the 
Spinal Dorsal Horn Culture Activity 
GABAA, GABAB and glycine receptor agonists both dose-dependently decreased 
the spontaneous activity. Antagonists of the GABAA, GABAB and glycine receptors 
both dose-dependently increased the spontaneous activity of the DH culture. These 
results indicate that GABAA, GABAB and glycine receptor signalling is inhibitory in 
this DH culture. During embryonic development GABA has an excitatory action 
which is essential for the development and maturation of the CNS (Owens et al., 
1996, Cancedda et al., 2007). The excitatory action of GABA has also been linked 
to the generation of oscillations in the cortex (Ben-Ari et al., 2007). It is possible that 
during the 12-14 DIV, the DH culture has matured to a state in which GABAA and 
glycine receptor signalling is inhibitory. This is supported by the expression of KCC2 
detected in the IF study in Chapter 2, since the expression of KCC2 is believed to 
be low in early postnatal life (from P10), dramatically increases at P17, and then 
increases gradually peaking at the onset of adulthood (Zhang et al., 2006). This is 
thought to correspond with the switch in GABA from being excitatory to inhibitory 
around P17. This suggests that if both GABA and glycine are inhibitory in the DH 
cell culture model, then the expression of KCC2 in this culture has increased to the 
stage at which the ECl is similar to that of adult spinal DH cells. This could be linked 
to the onset of the spontaneous activity that occurs within the culture, indicating that 
the inhibitory signalling in the DH network is required for the spontaneous rhythmic 
activity. This is further supported by the data with the KCC2 blocker, VU0240551, 
dose-dependently increasing calcium response in the DH culture.  
The results presented in this chapter clearly identify the vital role of GABAA and 
glycine receptors in the modulation of the rhythmic activity in DH culture. GABAergic 
PV-expressing interneurons in the brain regulate cortical oscillations (Lodge et al., 
2009, Kim et al., 2015, Kuki et al., 2015). In Chapter 2, GABAergic PV-positive cells 
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were detected in the DH culture, therefore these cells are potentially involved in the 
regulation of the rhythmic activity of the DH culture network. Glycine receptor 
signalling in the brain is also important in regulating brain oscillations, where glycine 
receptor agonists suppress epileptiform activity (Chen et al., 2014). In the spinal DH 
there are neurons releasing both GABA and glycine (Todd and Sullivan, 1990). 
Therefore, it is highly probable that glycine receptor signalling is also involved in the 
generation and regulation of the spinal DH network rhythmicity.  
The KCC2 antagonist, VU 0240551, dose-dependently increased the DH culture 
activity. The KCC2 co-transporter exports chloride and potassium ions, therefore 
blocking the export of chloride ions increases the intracellular chloride ion 
concentration (DeFazio et al., 2000). This can cause the equilibrium potential for 
chloride ions to become more positive than the cell resting membrane potential, 
which leads to GABAA and glycine receptor signalling to be excitatory (Rivera et al., 
2002, Watanabe and Fukuda, 2015). In the brain a down-regulation of the KCC2 
transporter increases seizure susceptibility (MacKenzie and Maguire, 2015). 
Therefore, the increase in the activity of the DH culture in the presence of the KCC2 
antagonist is likely to be the result of a shift in the chloride equilibrium potential 
causing GABAA and glycine receptors to have a depolarising effect. Furthermore, in 
the embryonic spinal cord a chronic block of glycine receptors with strychnine down-
regulates KCC2 expression, while glycine up-regulates it through non-synaptic 
mechanisms (Allain et al., 2015). Therefore, in the spinal DH culture the application 
of strychnine could increase the DH activity through two mechanisms. Firstly, 
strychnine blocks the glycine receptors and prevents glycinergic inhibition resulting 
in unregulated excitation. Secondly, the blocking of glycine receptors with strychnine 
could also cause downregulation of KCC2 expression and a shift in the chloride 
equilibrium potential. This could result in the signalling of GABAA and any glycine 
receptors, which are not blocked by strychnine, to produce depolarisation of the 
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network’s interneurons. A downregulation of KCC2 has been identified in in vivo 
models of inflammatory and neuropathic pain (Zhang et al., 2008c, Lu et al., 2009, 
Hasbargen et al., 2010, Kahle et al., 2014). Furthermore, the change in intracellular 
chloride concentration has been linked to a change in expression of GABAA 
receptor subtype, which is believed to influence the tonic and phasic firing patterns 
of GABAergic signalling (Succol et al., 2012). Therefore, to restore the KCC2 
expression and consequently the chloride electrochemical gradient in the spinal DH, 
could restore GABAergic signalling and provide a mechanism for analgesia. KCC2 
has been investigated as a potential target in the development of novel analgesics 
(Kahle et al., 2014). Upregulation of KCC2 in the spinal DH by increasing glycinergic 
signalling suggests the glycine receptor as an ideal target for the development of 
novel analgesics.  
Gelsemine has been shown to have analgesic properties, and be selective for 
glycine receptors containing the α3 subunit (Zhang et al., 2013, Zhang and Wang, 
2015). Interestingly, in this study gelsemine addition increased DH activity similarly 
to the other glycine receptor antagonist strychnine. Strychnine and also bicuculline 
exacerbate pain, therefore it is unexpected that gelsemine has anti-nociceptive 
effects in vivo, despite also being a glycine receptor antagonist and increasing the 
DH culture activity like strychnine (Yamamoto and Yaksh, 1993). This could be due 
to differences in the spinal DH network of the culture compared to in vivo conditions, 
which could result in differing effects of gelsemine. However, gelsemine is an 
antagonist of the glycine receptor, like strychnine, therefore the response of the DH 
culture to gelsemine is consistent in the effects of a glycine receptor antagonist. 
Therefore, gelsemine could have alternative actions to strychnine other than simply 
inhibition of glycine receptors which produce an anti-nociceptive response. 
Gelsemine has been linked with upregulating allopregnanolone synthesis in the 
spinal cord (Venard et al., 2011). In the spinal cord, allogregnanolone has an 
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analgesic effect (Candeletti et al., 2006), therefore its upregulation by gelsemine 
could provide the mechanism underlying the analgesic effect of gelsemine.  
 
3.4.2 Conclusions 
In conclusion, the Flexstation calcium imaging assay with the in vitro spinal DH cell 
culture model provides a platform in which the culture can be utilized for drug 
screening. Through the application of well characterised GABAA, GABAB and 
glycine receptor compounds it has been demonstrated that this assay can 
effectively detect calcium responses to compound addition. Therefore, this platform 
can be used to provide an indication of the effect of a compound on the DH network 
activity. The higher-throughput of this platform is also advantageous for fast 
screening of multiple compounds.  
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4 siRNA Knockdown of Glycine Receptor α Subunits in the 
Dorsal Horn Cell Culture Model 
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4.1 Introduction 
4.1.1 RNA Interference Mechanism 
RNA interference (RNAi) is the mechanism by which siRNA or short hairpin RNA 
(shRNA) target and cleave their complementary mRNA in eukaryotic cells. shRNA 
and siRNA have emerged as powerful tools in the study of gene function in 
mammalian cells since the discovery of their ability to achieve knockdown of a 
specific target gene in mammalian cell lines and in vivo (Elbashir et al., 2001a, 
McCaffrey et al., 2002). These molecules are typically 19-23 nucleotides long, 
double-stranded RNAs with one strand being the anti-sense active strand that is 
complementary to a specific target mRNA sequence (Elbashir et al., 2001b). One of 
the principal problems with RNAi technology is to achieve high transfection 
efficiency (Whitehead et al., 2009). Incomplete transfection is unlikely to completely 
silence the target gene, therefore not causing a significant change in the 
downstream effects. The delivery of siRNA into the cytoplasm has proved 
problematic in many cell types, where additional delivery systems are required to 
facilitate the transfection (Kim and Eberwine, 2010). This is because RNA 
molecules are relatively large and they have a negative charge which prevents them 
from easily crossing the cell membrane. Furthermore, RNA molecules are quickly 
degraded by endogenous enzymes, therefore ineffective delivery of siRNA has 
prevented its utilisation in scientific experimentation and its therapeutic potential 
(Whitehead et al., 2009).  
This study has utilised two delivery systems, lentivirus delivery of shRNA and Accell 
siRNA (GE Healthcare Dharmacon Inc., USA). The lentivirus delivery of shRNA has 
been well documented and utilised both experimentally and clinically. Viruses are 
able to inject their RNA directly into a cell where it is converted to DNA and 
transported to the nucleus where it is integrated into the cell’s own DNA (Matrai et 
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al., 2010). The viral DNA is then transcribed into the shRNA along with the cell’s 
own DNA and is then exported to the cytosol (Figure 4.1). Accell siRNA (GE 
Healthcare Dharmacon Inc., USA) is delivered directly to the cytosol of a cell as it is 
able to cross the cell membrane unaided, however, the exact mechanism has not 
yet been disclosed. Accell siRNA needs to be lipophilic to cross the cell membrane, 
this is possible if the Accell siRNA is cholesterol-conjugated siRNA (Wolfrum et al., 
2007).  
Once the shRNA or siRNA are in the cytosol of the cell it uses the cell’s enzymatic 
pathway to degrade the complementary endogenous mRNA (Elbashir et al., 2001b, 
Maniataki and Mourelatos, 2005). The double stranded molecule is loaded into the 
endogenous RNA-induced silencing complex (RISC), where the two strands are 
separated and the sense-strand, or passenger strand, is cleaved by the argonaute 2 
protein contained within the RISC complex (Rand et al., 2004, Matranga et al., 
2005). The anti-sense strand of the siRNA remains attached to the activated RISC, 
which then locates and degrades the complementary target mRNA (Ameres et al., 
2007). The cleaved mRNA is further degraded by other nucleases within the 
cytoplasm, and the activated RISC complex can then go on to find other target 
mRNA molecules and repeat the process thereby silencing the gene’s expression 
(Hutvagner and Zamore, 2002).  
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4.1.2 Glycine Receptor Subunit Gene Silencing 
There are a limited number of drugs known to selectively bind the glycine receptor. 
This has prevented the clinical utility of this receptor and the progress in further 
investigating its physiology (Lynch and Callister, 2006). As an alternative to 
pharmacological assays, the present study has utilised RNAi technology to 
investigate the effects of silencing the glycine receptor α subunits on the activity of 
the cultured DH cells. Only the α subunits were silenced in this study as functional 
Figure 4.1 Gene silencing by transfection of shRNA using a lentiviral vector. The viral RNA 
is injected into the cell’s cytosol using a lentiviral vector which is then reverse transcribed 
into DNA that is then transported into the nucleus and integrated into the cell’s own DNA. 
The DNA is then transcribed, generating the shRNA. The shRNA is transported into the 
cytosol and loaded into the RISC complex which separates the strands of the shRNA and 
degrades the sense strand (red) and uses the anti-sense strand (blue) to locate the 
complementary target gene’s mRNA (green). The argonaute 2 protein within the RISC 
complex then cleaves the target gene’s mRNA silencing the gene. 
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homomeric glycine receptors form only from α subunits (Griffon et al., 1999), while β 
subunits cannot form functional glycine receptors alone (Bormann et al., 1993, 
Kuhse et al., 1993). Furthermore, the α subunits form at least part of the ligand 
binding domain of the glycine receptors, therefore they influence the pharmacology 
of the glycine receptor (Schmieden et al., 1993, Meier et al., 2005). The β subunit 
requires α subunits to form functional heteromeric glycine receptors, with 2α:3β 
subunit stoichiometry being the most prevalent in vivo (Grudzinska et al., 2005). 
Homopentamers have been found extrasynaptically and in early development 
(Malosio et al., 1991b, Harvey et al., 2004). The primary role of the β subunit is to 
anchor the glycine receptor at synapses as it interacts with gephyrin, a 
cytoskeleton-associated protein, which is known for synaptic clustering of receptors 
(Meyer et al., 1995a, Kneussel and Betz, 2000).  
In humans deficiencies in glycinergic inhibition causes hyperekplexia, which is 
characterised by an exaggerated startle reflex and muscular rigidity (hypertonia) 
(Bakker et al., 2006). It is predominantly point mutations in the glycine receptor α1 
gene (Glra1) which result in hyperekplexia in humans (Bakker et al., 2006). A small 
population of people with hyperekplexia can alternatively have mutations in the 
glycine receptor β subunit (Rees et al., 2002). Interestingly, mouse models with 
mutations in the glycine receptor α1 gene have much more severe phenotype than 
humans, with many of the mutations being lethal in mice (Buckwalter et al., 1994, 
Kling et al., 1997). This suggests that there could be different compensatory 
mechanisms in mice compared to humans (Becker et al., 1986). This has been 
shown pharmacologically where administration of the benzodiazepine clonazepam, 
which increases GABAergic neurotransmission and decreases startle attacks in 
humans but is ineffective in mouse models (Buckwalter et al., 1994, Bakker et al., 
2006). Glycine receptor α2 knockout mice do not display any significant 
morphological or molecular alterations in the nervous system; furthermore, brain 
112 
 
development as not affected (Young-Pearse et al., 2006). This could be the result of 
other glycine receptor subunits compensating for the loss of the α2 subunit. The 
glycine receptor α3 knockout mice do not display a typical overt behavioural 
phenotype but do have a reduced pain sensitisation following application of 
prostaglandin E2 (PGE2) or peripheral inflammation (Harvey et al., 2004, Harvey et 
al., 2009). This is in line with the findings that the glycine receptor α3 subunit is 
predominantly expressed in the superficial spinal DH (Harvey et al., 2004). 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
4.1.3 Aims 
The aims of this study using siRNA gene silencing technique in the DH cell culture 
model were:  
1. To investigate the effect of glycine receptor α subunit siRNA gene silencing 
on the DH culture calcium response. 
2. To determine if glycine receptor α subunit gene silencing affects the 
response of the DH culture activity to glycine receptor antagonist strychnine 
and agonist glycine.  
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4.2 Methods 
4.2.1 Lentiviral shRNA Preparation  
SMARTvector 2.0 Lentiviral shRNAs (GE Healthcare Dharmacon Inc., USA) were 
used in this study to silence the expression of three rat glycine receptor α subunits: 
Glra1, Glra2 and Glra3. Each of the glycine receptor α subunits were silenced in the 
spinal DH culture separately to decipher if any of these subunits has a significant 
role in the spinal DH network activity. Three different SMARTvector shRNAs were 
obtained for each of these three genes to test their efficacy in knocking down at 
least one of the sequences below. The sequences of the shRNAs of the Glra1 
lentivirus were 5’-GTCCGTGGTGATCTCGTGG-3’, 5’-
GATGTCAATAGCTTTCACG-3’ and 5’-TATAACCAAAGCTTTCCAG-3’. The three 
Glra2 lentivirus shRNA sequences were 5’-ACGAGTAACATCTTCTTCC -3’, 5’-
AAAATGTTCACTCGGTAGT-3’ and 5’-CGAGATATGGTGTCGATTC-3’. The three 
Glra3 lentivirus shRNA sequences were 5’-TTCTTAGCCCTGTCGATGA-3’, 5’-
GAAACGGTAAAACTTCTCC-3’ and 5’-GATACCCAACGCTACCCGA-3’. These 
shRNAs all had a TurboGFP fluorescent reporter within the sequence to enable 
visualisation of cells which had been transfected with the lentivirus allowing 
determination of the percentage of cells within the culture that had been transfected 
with the lentivirus. A control lentivirus with scrambled shRNA, also containing a 
green fluorescent protein (GFP) reporter tag was used to illustrate that the effects 
on the culture was the result of the shRNA knockdown of the subunits and not solely 
due to the presence of the lentivirus.  All lentivirus work was done in a Class 2 
safety cabinet to minimise the risk of direct contact with lentiviruses which can have 
harmful properties. The lentiviruses exist as viral particles, stored at -80oC, which 
were freeze-thawed on ice when ready to use. Following a quick-spin in a table-top 
centrifuge each of the lentiviruses were suspended in serum-free culture media 2, 
pre-heated to 37oC. The culture media 2 was the same as used in the cell culture 
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described in the methods section of Chapter 2. The media is required to be serum-
free as the transduction of the lentivirus into the cells is affected by serum.  The 
culture media 2 has a B-27 supplement replacement for serum and therefore could 
still be used to culture the DH cells transfected with lentivirus. By using the same 
media in which the cells are cultured prevents an additional variable on changing 
the health and activity of the cultured network. Three different multiplicity of infection 
concentrations (MOIs) of 10, 5 and 2.5 were tested for each of the lentiviruses. The 
MOI is the number of viral particles per cell and testing three different MOIs allows 
determination of the optimal MOI. The volume of viral particle required for the 
highest MOI was determined from the following calculation: 
𝑀𝑂𝐼 =
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑉𝑖𝑟𝑢𝑠 × 𝑉𝑖𝑟𝑎𝑙 𝑇𝑖𝑡𝑒𝑟
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑒𝑙𝑙𝑠
 
The viral titer for each of the lentiviruses was provided by Dharmacon (USA). The 
cells were plated with a density of 1.7 x 106 cells/well and the volume of the 
lentivirus particles required could be calculated for a MOI of 10. The suspended 
lentiviruses were then further diluted in the culture media to obtain solutions with an 
MOI of 5 and 2.5. 
 
4.2.2 Lentiviral Transfection 
The embryonic rat DH cells were extracted and cultured as described previously in 
Chapter 2. After 7-8 DIV the media was removed from the cells and replaced with 
50 µl of the culture media 2 containing lentivirus. A minimum of six wells were 
transfected for each of the different lentiviruses and for each MOI. These six repeats 
were done in wells from minimum of 2 different culture preparations. All tips used for 
pipetting the lentiviruses were changed for each transfer and deactivated in Virkon 
solution (DuPont, USA) before disposal. The plates of cells were then incubated at 
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37oC overnight. After this incubation period an additional 100 µl of pre-heated 
culture media 2 was added to each well of cells with the lentivirus. The cells were 
incubated at 37oC for a further 24 hours with the lentivirus. The lentivirus-containing 
media was then removed and replaced with the culture media 2, and placed back in 
the incubator. This was repeated the following day, and from this point the cells 
were considered safe to be removed from the class 2 safety laboratory and could be 
used for experimentation. At this point the cells have been in culture for 11-12 days, 
which is the same time point at which the DH culture was previous identified to 
display spontaneous activity. 
Images of the cultured cells previously incubated with the lentivirus were taken 
using the EVOS digital inverted microscope (AMG, Fisher Scientific, UK) using the 
GFP filter. The overlay feature of this microscope was used to determine the 
proportion of GFP-positive cells that had been infected by the lentivirus in the whole 
population (Figure 4.2). This feature overlays the GFP fluorescent image with the 
transmitted light image. The number of GFP-positive cells and the total number of 
cells could then be counted and the percentage transfected cells determined from at 
least 3 wells per glycine receptor α subunit lentivirus knockdown.   
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Figure 4.2 Image of the DH culture infected with the glycine receptor α3 lentivirus shRNA 
with TurboGFP tag. The image is an overlay of the images taken with transmitted light and 
with GFP fluorescence using an EVOS digital inverted microscope (AMG, Fisher Scientific, 
UK). The number of GFP positive cells and the number of cells which are not GFP-labelled 
were counted manually allowing the proportion of transfected cells to be determined. Scale 
bar is 200 µm. 
 
4.2.3 Accell siRNA Preparation and Transfection 
The embryonic primary cell culture was performed as previously described in 
section 2.2 of Chapter 2, with the cells plated at a density of 1.7 x 106 cells/well. At 9 
or 10 days in culture the media was removed from the wells and replaced with the 
culture media 2 containing Accell siRNA (GE Healthcare Dharmacon Inc., USA). 
Three target-specific SMARTpool siRNA’s for the three glycine receptor α subunits 
were used to silence their expression in the DH culture. Each of the SMARTpool 
siRNAs contains a mixture of siRNAs with four different sequences to improve gene 
silencing potency. The Accell rat Glra1 (glycine receptor α 1 gene) target sequences 
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were 5’-GUCUCGCCUACAAUGAAUA-3’, 5’-CUGGAAAGCUUUGGUUAUA-3’, 5’-
GGAUCAGACCCAACUUUAA-3’ and 5’-CCAGGGUGUUACAAUAUCC-3’. The four 
Accell rat Glra2 target sequences were 5’-GAAUCAGGCCAAAUUUUAA-3’, 5’-
CUACUAGUCCUAAUGUUGA-3’, 5’-GUGUAUUGCGUAAUUGAUU-3’ and 5’-
GCUACAUGUUUUAAGUAAG-3’. The target sequences for the Accell rat Glra3 
were 5’-CCAAUGGAUCUCAAGAAUU-3’, 5’-GCUUAAGCAAUCAUGUUUA-3’, 5’-
CGAUGAAGUAACAAGAUCA-3’ and 5’-CUACAAUACAGGAAAGUUU-3’. A 
negative control, non-targeting siRNA, was utilised to discriminate any off-target 
effects of the Accell siRNA from that of the sequence-specific gene silencing. 
Cyclophilin B siRNA and Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) 
siRNA were utilised as a positive control for the gene silencing. Additionally a red 
fluorescent protein (RFP) non-targeting siRNA was used to assess the uptake of the 
siRNA by the cells when used in conjunction with fluorescent microscopy. As an 
additional control, 3 wells per plate of cells used in the siRNA experiments were 
cultured without siRNA in the normal culture media 2. All the siRNAs were initially 
re-suspended in 1x siRNA buffer, made by mixing one volume of 5x siRNA buffer 
(GE Healthcare Dharmacon Inc., USA) in 4 volumes of RNase-free water. The 
buffer has been developed by Dharmacon for the re-suspension and long-term 
storage of short double- or single-stranded synthetic RNA molecules (GE 
Healthcare Dharmacon Inc., USA). A 100 µM solution of each of the siRNAs was 
made using the 1X siRNA buffer, which was mixed the solution by pipetting the 
solution 3-5 times avoiding the introduction of bubbles and then placing in an orbital 
mixer for 30 minutes at room temperature. Each of the siRNAs was added to the 
culture media 2 to obtain a final siRNA concentration of 1 µM. 100 µM of siRNA-
containing media was added per well of the cultured DH cells. As described for the 
lentivirus transfection, 6 wells from at least two different culture preparations were 
transfected per siRNA. The cells were incubated at 37oC for 72 hours, with 100 μl of 
culture media 2 added after 36 hours to maintain the health of the culture. The 
118 
 
Dharmacon protocol for using their siRNAs suggests using their Accell Delivery 
Media (GE Healthcare Dharmacon Inc., USA) as it is enriched for culturing in 
serum-free conditions. This Accell Delivery Media with added B-27 supplement (2%) 
and Glutamax (1%), as are included in the culture media 2, was tested on 12 wells 
of the DH culture used in the normal DH cell culture. After 24 hours in this media all 
the cells in the culture had died, therefore the siRNAs were all suspended in the 
normal culture media 2, as it is also serum-free. After the 72 hours incubation of the 
culture with the siRNAs the cells could then be assayed. An AMG EVOS digital 
microscope was used to assess the uptake of the siRNA by the culture by viewing 
the RFP control siRNA wells, as done with the lentivirus experiments.  
 
4.2.4 Calcium Imaging Assay of the Dorsal Horn Culture Transduced with 
Lentivirus or Accell siRNA  
Once the cultures transduced with the lentivirus or Accell siRNA were ready for 
assaying, the media was removed and replaced with 80 µl FLIPR Calcium 5 dye 
(Molecular Devices, USA). As outlined in Chapter 3, after 30 minutes of incubation 
at 37oC with the calcium dye the DH cell culture plates were transferred to the 
Flexstation calcium imaging system (Molecular Devices, USA). The baseline relative 
fluorescence units (RFU) were recorded for 4 minutes, followed by addition of 
strychnine (10 µM). The activity in the presence of strychnine was measured for a 
following 4 minutes, then glycine (2 mM) was added and the activity recorded for a 
final 4 minutes.  
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4.1.1.1 Flexstation Data Analysis 
A graph of the RFU against time was generated during the experiments for each 
well of the plate with the cultured DH cells using the Softmax Pro software. The area 
under the curve was determined for each of the three sections of the recordings 
using the Softmax Pro software. There did not appear to be any difference between 
the three different shRNAs sequences for each of the glycine receptor α subunit 
lentiviruses. Therefore, for the analysis for the three shRNAs for Glar1 were 
combined, similarly for Glra2 and Glra3 shRNA data. The first section was the 
baseline activity, followed by activity in the presence of strychnine and thirdly with 
the addition of glycine. A one-way ANOVA test was used to compare the mean area 
under the curve of the baseline data for each of the cultures transduced with the 
different lentiviruses, and also from the control group of cultures with no lentivirus. 
Similarly the baseline data of the cultures transduced with each of the Accell 
siRNAs were also compared with a one-way ANOVA. To determine if the cultures 
transduced with the various lentiviruses or Accell siRNAs responded differently to 
strychnine and glycine, repeated measures one-way ANOVA was performed 
comparing baseline area data to strychnine and strychnine area data with the 
glycine data. The same process was repeated for the spike frequency data for all 
the lentivirus and Accell siRNA data. GraphPad Prism 6 (GraphPad Software, La 
Jolla California USA; version 6.00) was used to perform the statistical tests and 
draw the graphs. In the results where P≤0.05 this is indicated by *, a P≤0.01 value is 
indicated by **, P≤0.001 by *** and P≤0.0001 indicated by ****, with S.E.M error 
bars.  
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4.2.5 Real-Time PCR with Accell siRNA Transfected Dorsal Horn Cells 
Immediately following the experiments on the Flexstation with the DH cell culture 
the dye was removed and the cells washed twice with PBS (0.1 M). RNA extraction 
and purification from the cultures transfected with each of the glycine receptor α 
subunit siRNAs and the untreated DH cultures was completed as described in 
Chapter 2 (section 2.2.5). Relative quantitative TaqMan RT-PCR was also similarly 
performed as previously described in Chapter 2, section 2.2.5. Three mastermixes 
were made, one for each of the glycine receptor α subunit assays. The 
housekeeping gene ACTB was used as a positive control (Thermo Fisher 
Scientific). The RT-PCR reactions for each glycine receptor α subunit were done in 
triplicate, as were each of the RT negative cDNA samples as negative controls. 
RNase-free water was also used as a negative control to confirm there was no 
contamination of the water used in the reactions. The TaqMan RT-PCR 
amplification reaction and detection was done using the LightCycler 480 II (Roche 
Diagnostics, Switzerland) with the LightCycler 480 II Software (version 1.5.1) as 
previously described in section 2.2.5.  
 
4.2.6  Real-Time PCR Analysis 
The RT-PCR data with the Accell siRNA transfected cultures was analysed using 
the same method described in Chapter 2, section 2.2.6, where the copy numbers 
were scaled relative to the untreated culture expression. GraphPad Prism 6 
(GraphPad Software, La Jolla California USA; version 6.00) was used to perform 
one-way ANOVA with Tukey’s multiple comparisons statistical tests and to generate 
the graphs, which are plotted with S.E.M error bars.  
121 
 
4.3 Results 
4.3.1 Lentivirus Transfection 
Initially transfection with the lentiviruses resulted in extensive cell death (Figure 4.3).  
Optimisation of a number of steps in the transfection process improved the health of 
the culture. The incubation time of the cells with the lentivirus was reduced from 72 
hours to 48 hours, which greatly improved the health of the cells without changing 
the transfection efficiency. Adding the lentiviruses earlier in the culturing process, at 
7-8 DIV compared to 9-10 DIV, and allowing an extra 24 hours before 
experimentation also enhanced the health of the culture and enhanced transfection. 
However, even with the optimised conditions the transfection of the control 
scrambled shRNA lentivirus was very low, on average transfecting 22.1 ± 6.4% of 
the cells in the cultures (Figure 4.4). The Glra1 shRNA lentiviruses had a higher 
transfection rate and were counted in an average of 53.2 ± 5.2% of the DH culture 
cells (Figure 4.5), while the Glra2 lentiviruses were taken up by 50.2 ± 5.8% of the 
total number of cells (Figure 4.6). Finally the Glra3 lentiviruses were counted in an 
average of 68.6 ± 4.1% of the DH cells (Figure 4.7).  
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Figure 4.3 Images taken of a DH culture at 13 DIV. (A) An image of an untreated DH culture 
at 13 DIV which has not been transfected with lentivirus, illustrating the network of neuronal 
DH cells. (B) A DH culture from the same cohort of cells as shown in (A) also at 13 DIV 
which was transfected with the control lentivirus of scrambled shRNA. The lentivirus was 
added to the culture at 10 DIV and incubated for 72 hours, which has resulted in cell death 
and the loss of the network. Scale bars are 200 µm.  
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Figure 4.4 Images of a DH culture transfected with the control lentivirus with scrambled 
shRNA. (A) Image of GFP- positive cells showing successful transfection with scrambled 
lentivirus. (B) An overlay image of the same culture showing both transmitted light image 
and the GFP fluorescence image combined. This overlay image shows that the transfection 
efficiency of this control lentivirus is low, on average this control lentivirus only transfected 
22.1% of the cells in the culture. Scale bars are 400 µm. 
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Figure 4.5 Images of a DH culture transfected with the lentivirus with Glra1 shRNA. (A) The 
DH culture imaged under GFP fluorescence, where those cells containing the virus are 
visible. (B) An overlay image of the same culture showing both transmitted light image and 
the GFP fluorescence image combined. On average 53.2% of the cells in the culture were 
transfected with the Glra1 lentiviruses. Scale bars are 400 µm. 
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Figure 4.6 Images of a DH culture transfected with the lentivirus with Glra2 shRNA. (A) The 
DH culture imaged under GFP fluorescence to determine if this lentivirus can transfected 
any of the cells in the culture. (B) An overlay of the GFP fluorescence image and a 
transmitted light image of the same region of the culture to determine the proportion of cells 
transfected by this virus. The Glra2 lentiviruses transfected 50.2% cells on average. Scale 
bars are 400 µm. 
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Figure 4.7 Images of a DH culture transfected with the Glra3 lentivirus shRNA. (A) The DH 
culture imaged under GFP fluorescence to determine if this lentivirus can transfected any of 
the cells in the culture. (B) An overlay of the GFP fluorescence image and a transmitted light 
image of the same region of the culture to determine the proportion of cells transfected by 
this virus. The Glra3 lentiviruses had the highest transfection efficiency of all the lentiviruses, 
transfecting 68.6% of cells. Scale bars are 400 µm. 
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4.3.2 Activity of the Dorsal Horn Cultures Transfected with Lentivirus 
Despite the relatively low transfection efficiency of these lentiviruses in the DH 
culture, the effect on the spontaneous activity was dramatic when compared to 
untreated DH cultures which were from the same DH preparation. Comparing the 
baseline spontaneous activity of the DH cultures, all those cultures treated with 
lentivirus significantly reduced the area under the curve and the frequency of 
spontaneous spikes (P<0.0001) (Figure 4.8). However, the effect of the scrambled 
control lentivirus was the same, implying that the changes in the baseline activity in 
the cultures transfected with the lentiviruses was not exclusively or at all the result 
of gene silencing of the glycine receptor α subunits.  
The baseline activity of the untreated DH culture had a mean area under the curve 
of 2.281x106 ± 121761 RFU.s, and a mean spike frequency of 0.074 ± 0.007 Hz. On 
average, strychnine (10 µM) doubled the area under the curve to 4.543x106 ± 
181524 RFU.s compared to baseline (P<0.0001). The subsequent addition of 
glycine almost halved the area under the curve compared to that with strychnine, to 
an average of 2.925x106 ± 539550 RFU.s, similar to the baseline level (P<0.05) 
(Figure 4.9B). Likewise the spike frequency was increased with the addition of 
strychnine to 0.107 ± 0.004 Hz (P<0.05) compared to baseline, and the following 
addition of glycine reduced the spike frequency to 0.072 ± 0.010 Hz (P<0.05) 
compared to in the presence of strychnine. The spike frequency in the presence of 
glycine is comparable to the baseline frequency (Figure 4.9C). The scramble control 
lentivirus had a mean baseline area under the curve of 682418 ± 78049 RFU.s. 
Strychnine addition increased this to 1.522x106 ± 212066 RFU.s (P<0.001), which 
was decreased to 803461 ± 331830 RFU.s by glycine (P<0.05). The spike 
frequency of the DH cultures transfected with the scrambled control lentivirus was 
not affected by the application of strychnine. The baseline spike frequency was 
0.003 ± 0.0008 Hz, in the presence of strychnine the frequency was 0.004 ± 0.001 
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Hz (P>0.05). However, glycine significantly decreased the spike frequency to 
0.0009 ± 0.0003 Hz (P<0.0001) (Figure 4.10).  
The DH cells transfected with the Glra1 lentiviruses had a baseline area under the 
curve mean value of 664150 ± 76315 RFU.s. Neither the addition of strychnine or 
glycine had any effect on the area under the curve (P>0.05). However, the spike 
frequency of the Glra1 lentivirus transfected cultures was increased with strychnine 
and decreased with the addition of glycine. The baseline spike frequency was 
0.0043 ± 0.0014 Hz, in the presence of strychnine the frequency was increased to 
0.0071 ± 0.0017 Hz (P<0.001) compared to baseline. Glycine then decreased the 
frequency to 0.0051 ± 0.0018 Hz (P<0.05) compared to in the presence of 
strychnine (Figure 4.11). 
The Glra2 lentivirus transfected DH cultures were also not influenced by strychnine 
or glycine application, with no effect to either the area under the curve or the spike 
frequency (P>0.05) (Figure 4.12). The baseline area under the curve was 749541 ± 
116496 RFU.s, with strychnine added the area was 944714 ± 138984 RFU.s and in 
the presence of glycine the mean area under the curve was 778313 ± 173143 
RFU.s. The spike frequencies were 0.11 ± 0.002, 0.014 ± 0.003 and 0.011 ± 0.002 
Hz for baseline, with strychnine and with glycine respectively. The activity of the 
Glra3 lentivirus transfected DH cells was increased with the addition of strychnine, 
however the addition of glycine had no effect. The baseline area under the curve 
was 816633 ± 68419 RFU.s, which increased to 1.78x106 ± 165957 RFU.s following 
strychnine addition. In the presence of glycine the mean area under the curve was 
1.68x106 ± 233882. The same pattern was observed in the spike frequency data, 
the baseline spike frequency was 0.0081 ± 0.0013 Hz, which increased to 0.017 ± 
0.0021 Hz with strychnine (P<0.0001). However, again glycine had no significant 
effect, as the spike frequency remained similar with a mean of 0.014 ± 0.002 Hz 
129 
 
(Figure 4.13). A summary of the lentivirus area data is shown in Table 4.1 and the 
spike frequency data in Table 4.2. 
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Figure 4.8 Comparison of the baseline activity of the cultures transfected with each of the 
lentiviruses to the untreated DH culture. The activity was measured using calcium 
fluorometry with the Flexstation microplate reader. (A) The area under the curve of relative 
fluorescence against time for the baseline section of the recordings from the DH cultures 
transfected with each of the lentiviruses. (B) The spike frequency during the baseline section 
of the recordings for each of the same cultures. The number of wells with the spinal DH 
culture utilised to generate these graphs for each group are as follows: untreated culture 
n=7, control lentivirus n=40, Glra1 n=68, Glra2 n=25 and Glra3 n=91.  
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Figure 4.9 The activity of the DH culture not transfected with lentivirus, analysing both the 
area under the curve and the spike frequency of the baseline activity, the activity in presence 
of strychnine and glycine. (A) An example recording from an untreated DH culture, 
illustrating the normal baseline activity and responses to strychnine and glycine. The vertical 
red dashed lines separate the different sections of the recording. (B) The average area 
under the curve for the baseline 4 minutes of the recordings, the 4 minutes with strychnine 
(10 µM) present and the 4 minutes with glycine (2 mM) present. (C) The spike frequencies 
for each of these same sections of the recordings with the standard non-transfected DH 
cultured cells (N=3, n=7). 
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Figure 4.10 The activity of the DH cultures transfected with the control scrambled lentivirus 
at baseline and in the presence of strychnine (10 µM) and glycine (2 mM). Two parameters 
of the activity analysed were the area under the curve of the RFU against time recordings for 
each section of the recordings shown in (A), and the spike frequency for each of those 
sections (B) (N=6, n=40).  
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Figure 4.11 The activity of the DH cultures transfected with the Glra1 lentivirus, and their 
responses to strychnine (10 µM) and glycine (2 mM). (A) The area under the curve for each 
section of the recordings, the baseline, with strychnine and with glycine. (B) The spike 
frequencies for each of the same sections of the recordings as in (A) (N=9, n=53). 
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Figure 4.12 The activity of Glra2 lentivirus transfected DH cultures and their responses to 
strychnine (10 µM) and glycine (2 mM). (A) The area under the curve for the three sections 
of the recordings: baseline, with strychnine and with glycine. (B) The spike frequencies for 
each of the same three sections of these recordings. No significant difference was detected 
with the addition of strychnine or glycine in these Glra2 lentivirus transfected cells (N=8, 
n=38) 
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Figure 4.13 The activity of Glra3 lentivirus transfected DH cultures and their responses to 
addition of strychnine (10 µM) and glycine (2 mM). (A) An example trace of the relative 
fluorescence units against time, illustrating the baseline activity and effects of the addition of 
strychnine and glycine. The vertical red lines separate the sections of the recordings based 
on the addition of the compounds. (B) The mean area under the curve for each four minute 
section as indicated in (A). (C) The spike frequency of the cultures for each of the three 
sections. (N=12, n=74) 
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Lentivirus Strychnine Glycine 
Untreated ↑ ↓ 
Control Lentivirus ↑ ↓ 
Glra1 n.s. n.s. 
Glra2 n.s. n.s. 
Glra3 ↑ n.s. 
 
Table 4.1 A summary of the effects on the area under the curve following application of 
strychnine (10 μM) and glycine (2 mM) on each of the DH cultures transfected with lentivirus 
and the untreated DH culture. n.s. indicates no significant effect, ↑ indicates a significant 
increase and ↓ indicates a significant decrease. 
 
Lentivirus Strychnine Glycine 
Untreated ↑ ↓ 
Control Lentivirus  n.s. ↓ 
Glra1 ↑ ↓ 
Glra2 n.s. n.s. 
Glra3 ↑ n.s. 
 
Table 4.2 A summary of the effects on the spike frequency with the addition of strychnine 
(10 μM) and glycine (2 mM) on each of the DH cultures transfected with lentivirus and the 
untreated DH culture. n.s. indicates no significant effect, ↑ indicates a significant increase and ↓ 
indicates a significant decrease. 
  
137 
 
4.3.3 Accell siRNA Transfection 
As the control lentivirus also produced an effect on the DH cell culture an alternative 
gene silencing technique was investigated. Accell siRNA does not require a virus for 
delivery of the siRNA molecules into cells. Therefore glycine receptor α subunit 
Accell siRNAs were employed in this study to determine if silencing of these genes 
can affect the DH culture activity. Two negative control siRNAs and two positive 
control siRNAs were utilized to validate if any changes in the activity profile of the 
DH cultures transfected with the siRNAs are the result of the knockdown of the 
glycine receptor α subunits. The imaging of RFP Accell siRNA transfected DH 
cultures show that the transfection efficiency was much higher than the lentiviruses, 
with on average 97 ± 4.8% of the cells infected with the siRNA (Figure 4.14).  
 
Figure 4.14 The primary DH culture transfected with the control Accell siRNA with encoded 
RFP at 12 DIV. This is an overlay of two images, one taken with RFP fluorescence and 
another with transmitted light using an AMG EVOS digital microscope. This image shows the 
Accell siRNA was taken up by almost 100% of the cells in the DH culture. Scale bar is 100 
µm. 
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4.3.3.1 Real Time-PCR of Dorsal Horn Cultures Transfected with Accell siRNA 
TaqMan quantitative RT-PCR was used to determine the extent of the silencing of 
the glycine receptor α subunits by their Accell siRNAs in the DH cultures. The 
mRNA expression of each of the glycine receptor α subunits was determined in 
each of the cDNA samples from the cultures transfected with each of the Accell 
siRNAs encoding the three subunits, and also for the untreated culture with no 
siRNA transfection. Firstly, analysing the Glra1 TaqMan assay in each of the 
samples revealed that the DH cultures transfected with the Glra1 Accell siRNA had 
a reduced expression of Glra1 compared to the untreated DH culture and compared 
to the cultures transfected with the Accell siRNAs encoding the other glycine 
receptor α subunits (P<0.05) (Figure 4.15). Similarly investigating the expression of 
Glra2 gene in each of the samples it was found that the DH cultures transfected with 
the Glra2 Accell siRNA also had reduced expression of this mRNA compared to the 
other DH cultures (P<0.05) (Figure 4.16). The levels of expression of the Glra3 
mRNA were significantly reduced in each of the transfected cultures compared to 
the untreated culture (P<0.001) (Figure 4.17). 
 
139 
 
R
e
la
ti
v
e
 E
x
p
r
e
s
s
io
n
U
n
tr
e
a
te
d
G
lr
a
1
 s
iR
N
A
G
lr
a
2
 s
iR
N
A
G
lr
a
3
 s
iR
N
A
0
2 0 0 0
4 0 0 0
6 0 0 0
*
 
Figure 4.15 The expression of Glra1 mRNA in each of the four DH cultures relative to the 
untreated DH culture (n=3). The expression of the Glra1 mRNA was significantly less in the 
Glra1 siRNA transfected DH culture compared to the untreated DH culture. The other two 
cultures transfected with Glra2 and Glra3 siRNA displayed equivalent expression of the 
Glra1 mRNA to the untreated DH culture.  
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Figure 4.16 The relative expression of Glra2 mRNA in each of the four different DH cultures 
relative to the untreated DH culture (n=3). The Glra2 mRNA expression was significantly 
reduced in the DH culture transfected with the Glra2 Accell siRNA compared to the 
untreated DH culture. The Glra1 and Glra3 siRNA transfected cultures had equivalent 
expression of Glra2 mRNA as the untreated DH culture. 
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Figure 4.17 The relative expression of the Glra3 mRNA in each of the DH cultures relative 
to the untreated DH culture (n=3). The Glra3 mRNA expression was significantly reduced in 
all three of the DH cultures transfected with the Accell siRNAs encoding each of the glycine 
receptor α subunits compared to the untreated culture.  
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4.3.4 Activity of the Dorsal Horn Cultures Transfected with Accell siRNA 
The baseline activity of the DH cultures transfected with the Accell siRNAs was 
analysed in terms of the area under the curve of the RFU against time graph of the 
calcium imaging recordings and the spike frequency. Comparing the area under the 
curve of the baseline data for the siRNA transfected cultures with that of the cultures 
without siRNA transfection the activity was significantly reduced by all the Accell 
siRNAs (Figure 4.18A). The baseline spike frequency of the cultures with the Accell 
siRNAs were also significantly reduced, except the two negative controls (Figure 
4.18B). 
As done previously with the lentivirus transfected cultures, the activity of the cultures 
transfected with the Accell siRNAs were also recorded following the addition of 
strychnine and glycine. The cultures not transfected with Accell siRNAs, displayed 
the characteristic spontaneous firing at the 12-14 DIV, the area under the curve 
increased from the baseline level of 1.46x106 ± 245151 RFU.s to 4.18x106 ± 417376 
RFU.s in the presence of strychnine (10 µM) (P<0.0001). The subsequent addition 
of glycine (2 mM) significantly reduced the activity to 2.92x106 ± 247494 RFU.s 
(P<0.001) compared to that in the presence of strychnine (Figure 4.19). The same 
effect was observed with the spike frequency of these cultures. The baseline spike 
frequency was 0.018 ± 0.0029 Hz, which significantly increased to 0.050 ± 0.0054 
Hz with addition of strychnine. The spike frequency then significantly decreased with 
application of glycine to 0.040 ± 0.0057 Hz (P<0.001) compared to the frequency in 
the presence of strychnine (Figure 4.19).  
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Figure 4.18 The baseline activity of the DH cultures transfected with the Accell siRNAs, 
each compared to the baseline activity of the untreated cultures (N=6, n=18). The negative 
controls are the non-targeting siRNA and RFP siRNA. The positive controls are cyclophilin B 
and GAPD siRNAs. (A) The baseline activity determined by measuring the area under the 
curve of the baseline section of the calcium imaging recordings. (B) The mean baseline 
spike frequency for each of the DH cultures determined from the same calcium imaging 
recordings as for (A). Asterisks show statistical significance when compared to untreated. 
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Figure 4.19 The activity of the DH cultures without siRNA to illustrate the normal activity of 
the cultures and their responses to the addition of strychnine (10 µM) and glycine (2 mM). 
These cultures were on the same plates as those transfected with the Accell siRNAs, from 
the same DH cell dissections (N=5, n=21). (A) The activity of the cultures as measured from 
the area under the curve for each of the three sections of the recordings: baseline, 
strychnine (10 µM) and glycine (2 mM). The compounds could not be washed out therefore 
glycine was applied following strychnine addition and therefore is also in the presence of 
strychnine. (B) The baseline spike frequency of these cultures, and the spike frequency in 
the presence of strychnine then glycine for the same cultures as in (A).  
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4.3.4.1 Negative Control Accell siRNAs  
The non-targeting negative control Accell siRNA transfected DH cultures had the 
same responses to strychnine and glycine as the non-transfected cultures (Figure 
4.20). The baseline mean area under the curve increased with application of 
strychnine, from 852624 ± 158693 RFU.s to 2.22x106 ± 306007 RFU.s (P<0.0001). 
Glycine subsequently decreased this to 1.58x106 ± 195324 RFU.s (P<0.05). The 
mean spike frequency of the baseline activity was 0.014 ± 0.003 Hz which was 
increased to 0.024 ± 0.004 Hz by strychnine (P<0.05) and then decreased by 
application of glycine to 0.017 ± 0.004 Hz (P<0.05). The responses of the DH 
cultures transfected with the other negative control Accell siRNA with the added 
RFP tag were the same as the first negative control siRNA (Figure 4.21). The area 
under the curve increased from the baseline of 423987 ± 40751 RFU.s to 1.22x106 ± 
113747 RFU.s with strychnine added to the culture (P<0.0001). Glycine decreased 
this activity to 980754 ± 155046 RFU.s (P<0.05). The spike frequency of the 
baseline data from these DH cultures was 0.012 ± 0.0029 Hz, strychnine increased 
this to 0.027 ± 0.0073 Hz (P<0.05) and glycine decreased it to 0.013 ± 0.0045 Hz 
(P<0.05).  
 
4.3.4.2 Positive Control Accell siRNAs 
The cultures transfected with the two positive control Accell siRNAs both responded 
to the addition of strychnine which increased the area under the curve from 483189 
± 30070 RFU.s to 1.21x106 ± 137240 RFU.s in the cyclophilin siRNA transfected 
cells (P<0.001). Glycine did not significantly decrease the area under the curve 
(P>0.05) (Figure 4.22). The GAPD positive control siRNA had a baseline area under 
the curve of 394732 ± 42636 RFU.s which increased to 1.08x106 ± 150909 RFU.s 
following the addition of strychnine (P<0.0001). The application of glycine had no 
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significant effect on the area under the curve which was 1.06x106 ± 195143 RFU.s 
in presence of glycine (P>0.05) (Figure 4.23). 
 
 
Figure 4.20 The activity of the DH cultures transfected with the non-targeting negative 
control siRNA, and their responses to the application of strychnine (10 µM) and glycine (2 
mM) (N=7, n=21). (A) The area under the curve of the recording during the baseline section, 
with strychnine and with glycine. (B) The spike frequency of the cultured DH cells for the 
same recordings as analysed for (A) during each of the sections of the recordings. 
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Figure 4.21 The activity of the DH cultures transfected with the non-targeting negative 
control Accell siRNA with an RFP tag, and their responses to the application of strychnine 
(10 µM) and glycine (2 mM) (N=7, n=21). (A) The area under the curve of the calcium 
imaging recordings for the baseline section, with strychnine and with glycine. (B) The spike 
frequency for each of the same sections of the recordings.  
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Figure 4.22 The activity of the cultured DH cells transfected with the positive control Accell 
siRNA encoding cyclophilin B, and their responses to the application of strychnine (10 µM) 
and glycine (2 mM) (N=7, n=21). (A) The area under the curve of the baseline sections of 
the recordings from these cultures and the area under the curves following addition of 
strychnine and glycine. (B) The spike frequency during each of the same sections of the 
recordings with these DH cultures.  
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Figure 4.23 The activity of the cultured DH cells transfected with the positive control Accell 
siRNA encoding GAPD, and their responses to the application of strychnine (10 µM) and 
glycine (2 mM) (N=8, n=24). (A) The area under the curve of the baseline sections of the 
recordings from these cultures and the area under the curves following addition of strychnine 
and glycine. (B) The spike frequency during each of the same sections of the recording as 
shown in (A). 
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4.3.4.3 Accell siRNA Knockdown of the Glycine Receptor Α Subunits 
The DH cultures transfected with the Glra1 Accell siRNA responded normally to the 
addition of strychnine and glycine (Figure 4.24). The baseline area under the curve 
of these cultures was 381082 ± 35980 RFU.s, which increased to 1.51x106 ± 
245161 RFU.s following the addition of strychnine (P<0.01). Glycine significantly 
decreased this to 1.16x106 ± 144549 RFU.s (P<0.05). The spike frequency of these 
same cultures had a baseline frequency of 0.008 ± 0.002 Hz, which in the presence 
of strychnine increased to 0.017 ± 0.004 Hz (P<0.01). Following glycine addition the 
spike frequency decreased to 0.001 ± 0.003 Hz (P<0.05). 
The transfection of the DH cultures with the Glra2 Accell siRNA did affect the 
response of these cultures to glycine (Figure 4.25). The mean baseline area of 
these DH cultures was 485864 ± 53852 RFU.s, which did significantly increase with 
the addition of strychnine to 1.04x106 ± 139600 RFU.s (P<0.001). Glycine did not 
decrease this activity, the area under the curve following the addition of glycine was 
1.22x106 ± 205798 RFU.s (P>0.05). The baseline spike frequency of the DH 
cultures transfected with the Glra2 Accell siRNA was 0.008 ± 0.003 Hz, which 
increased to 0.015 ± 0.006 Hz following the addition of strychnine. Glycine did 
significantly decrease the spike frequency to 0.012 ± 0.005 Hz (P<0.05).  
In the Glra3 Accell siRNA transfected cultures the addition of glycine had no effect 
on the area or the spike frequency of the cultures (Figure 4.26). The baseline area 
was 202582 ± 29431 RFU.s, which was increased by addition of strychnine to 
996683 ± 81664 RFU.s (P<0.0001). The addition of glycine did not significantly 
change the area which was 1.10x106 ± 155150 RFU.s (P>0.05). The baseline spike 
frequency was 0.002 ± 0.001 Hz. In the presence of strychnine the frequency was 
increased to 0.008 ± 0.002 Hz (P<0.05). In the presence of glycine the spike 
frequency was 0.007 ± 0.002 Hz, which is not significantly different to the frequency 
with strychnine present (P>0.05).  
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Figure 4.24 The activity of the DH cultures transfected with the Accell siRNA encoding the 
Glra1 gene for the knockdown of the glycine receptor α 1 subunit (N=7, n=21). The effects of 
the addition of strychnine (10 µM) and glycine (2 mM) to these DH cultures is also illustrated. 
(A) The area under the curve of the recordings with these cultures for the baseline section, 
the section with the addition of strychnine and the section with glycine added. (B) The spike 
frequency of these DH cultures for each of the same sections described for (A).   
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Figure 4.25 The activity of the DH cultures transfected with the Accell siRNA encoding the 
Glra2 gene for the knockdown of the glycine receptor α2 subunit (N=7, n=21). The effects of 
the addition of strychnine (10 µM) and glycine (2 mM) to these DH cultures is also illustrated. 
(A) The area under the curve of the recordings with these cultures for the baseline section, 
the section with the addition of strychnine and the section with glycine added. (B) The spike 
frequency of these DH cultures for each of the same sections described for (A).   
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Figure 4.26 The activity of the DH cultures transfected with the Accell siRNA encoding the 
Glra3 gene for the knockdown of the glycine receptor α3 subunit (N=7, n=21). The effects of 
the addition of strychnine (10 µM) and glycine (2 mM) to these DH cultures is also illustrated. 
(A) The area under the curve of the recordings with these cultures for the baseline section, 
the section with the addition of strychnine and the section with glycine added. (B) The spike 
frequency of these DH cultures for each of the same sections described for (A).   
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Table 4.3 A summary of the area under the curve data illustrating the effects of each of the 
Accell siRNAs on the DH culture baseline activity compared to the untreated DH culture and 
the responses of the cultures to strychnine and glycine. The n.s. indicates no significant 
difference, ↑ indicates an increase in activity and ↓ indicates a decrease in activity. The 
symbols in black are where the comparison was made to the untreated culture. The blue 
symbols are comparing the effect of strychnine on the baseline activity of the culture. The 
symbols in red are comparing the effect of glycine on the strychnine activity.   
Table 4.4 A summary of the spike frequency data illustrating the effects of each of the Accell 
siRNAs on the DH culture activity and its responses to strychnine and glycine compared to 
the untreated DH culture. The n.s. indicates no significant difference, ↑ indicates an increase 
in activity and ↓ indicates a decrease in activity. The symbols in black are where the 
comparison was made to the untreated culture. The blue symbols are comparing the effect of 
strychnine on the baseline activity of the culture. The symbols in red are comparing the effect 
of glycine to the strychnine activity of that culture.   
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4.4 Discussion 
The experiments of this study set out to determine how glycine receptor α subunit 
gene silencing affects primary spinal DH cell culture calcium activity. Consequently, 
the role of the glycine receptor in controlling the spinal DH network activity can be 
assessed, and it can be determined whether any of the glycine receptor subtypes 
are more or less influential. Thus, the results of this chapter can help to focus the 
development of novel analgesics to a selective glycine receptor subtype, which 
would likely aid in reducing adverse side-effects of the drug. It is not possible to 
assess the extent of individual glycine receptor subtypes pharmacologically as 
compounds which selectively target each subtype are lacking. This is not necessary 
for GABAA receptors, as there are numerous compounds which selectively target 
GABAA receptor subtypes.  
Lentivirus transfection of the DH culture produced a significant loss of the DH 
culture characteristic spontaneous firing at 12-14 DIV. However, the control 
lentivirus produced similar effects in the DH culture calcium activity, suggesting an 
effect of the virus itself. Lentiviruses are toxic at high titres for some neuronal cell 
types (Yee et al., 1994, Chen et al., 1996). All the DH cultures transfected with 
lentivirus did display noticeable cell death in this study, even following optimisation. 
Therefore, it is likely that the lentiviruses utilized in this study were toxic to the 
cultured DH cells. Furthermore, the lentivirus transfection efficiency varied from 22 
to 68%, which implies insufficient gene silencing and consequently definitive 
conclusions cannot be made from the calcium imaging data with these cultures. For 
these reasons an alternative technology for glycine receptor α subunit gene 
silencing was subsequently assayed.  
Accell siRNA had improved transfection efficiency within the primary DH cell culture 
that reached almost 100%. The siRNA transduction did not have the complications 
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of toxicity that occurred with lentivirus transduction of the DH cultures, therefore 
there was a low incidence of cell death following the Accell siRNA transduction. 
Performing the RT-PCR with the transfected cultures demonstrated significant 
decreases in gene expression of each of the glycine receptor α subunits compared 
to the untreated DH cultures for each of the siRNAs. However, the Glra1 and Glra2 
siRNAs also caused a significant knockdown in the expression of Glra3. Therefore, 
the effects observed in the cultures transfected by Glra1 can be considered to 
include silencing of both Glra1 and Glra3. Similarly the effects recorded in the Glra2 
siRNA transfected cultures can be considered to be the effect of Glra2 and Glra3 
silencing. Furthermore, from the RT-PCR results there was no compensatory 
increase in the expression of the other α subunits when any one of the Accell 
siRNAs was transfected. This implies that in the Accell siRNA transfected cultures 
there were fewer glycine receptors compared to the untreated culture.  
 
4.4.1 Glycine Receptor α Subunit Gene Silencing Reduces Dorsal Horn 
Network Activity 
All three of the Accell siRNAs encoding for the three glycine receptor α subunits 
significantly decreased the baseline spontaneous activity compared to the untreated 
DH cultures. However, since the RT-PCR results show that only the Glra3 Accell 
siRNA selectively silences the expression of this subunit, with the other two siRNAs 
silencing the Glra3 gene as well as their own target gene, the reduction in the 
baseline activity in all the cultures could primarily be the result of a loss of the 
glycine receptor α3 subunit. This is consistent with a previous in vivo study that 
used siRNA to silence Glra1 and Glra3 showing that silencing only Glra3 prevented 
the analgesic action of gelsemine (Zhang et al., 2013). Furthermore, findings from 
the present study are also in agreement with previous reports of glycine α3 
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knockout mice displaying reduced behavioural manifestations of pain in response to 
PGE2 injection, peripheral inflammation and acetic acid-induced visceral pain 
(Harvey et al., 2004, Racz et al., 2005). Thus, these published findings indicate that 
the α3-containing glycine receptors have a more significant role in the processing of 
nociceptive signals in the superficial DH compared to the α1- or α2- containing 
glycine receptors. Interestingly, the RT-PCR data from chapter 2 illustrated a higher 
expression of the α1 subunit in the DH culture, and relatively similar expressions of 
the α2 and α3 subunits. This ratio of expression of the glycine receptor α subunits is 
not the same as that found in the in vivo spinal DH, where there is a higher α3 
expression relative to the α1 subunit expression illustrated in chapter 2 with RT-
PCR with a human adult spinal cord sample and by Harvey et al. (2004) in mice. 
Therefore, despite the less dominant expression of the α3 subunit in the DH culture 
compared to in vivo conditions, the silencing of its expression alone was sufficient to 
prevent the generation of the spontaneous activity in the culture. This is possibly 
because the generation of the rhythmic, synchronous activity of the DH cultured 
cells requires inhibitory interneurons, as discussed previously in describing the 
mechanisms of ING and PING (Tiesinga and Sejnowski, 2009).  
Inhibiting glycine receptors with the antagonist strychnine, as reported in chapter 3, 
caused an increase in firing of the DH cultures, while the agonist glycine decreased 
activity.  Strychnine similarly increased activity in the spinal DH cultures transfected 
with the glycine receptor α subunit siRNA. This is presumably through the action of 
strychnine at the glycine receptors in the DH culture which have formed from the 
subunits that do not include the silenced α subunit. However, the response of the 
DH cultures transfected with the Glra3 siRNA displayed a lack of response to 
glycine addition. The Glra2 siRNA transfected DH cultures also did not display a 
decrease in activity in terms of area under the curve with the addition of glycine, 
however the spike frequency of these cultures was significantly reduced. Since the 
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Glra2 siRNA also silenced the glycine receptor α3 subunit in the culture this loss of 
effect with glycine could be primarily through the loss of the α3 subunit, and the α1 
subunit not being able to compensate for the silencing of the other two α subunits.  
 
4.4.2 Conclusions 
The Accell siRNA results presented in this chapter confirm previous findings that the 
α3-containing glycine receptors are potentially more selective targets for the design 
and development of novel analgesics. Gelsemine has analgesic properties in vivo 
and bind selectively to α3-containing glycine receptors (Zhang et al., 2013, Wu et 
al., 2015b, Zhang and Wang, 2015). Interestingly, in this spinal DH culture the 
application of gelsemine increased firing frequency, similarly to the antagonist 
strychnine. Many previous studies have implicated that inhibition in the spinal DH 
needs to be re-instated in neuropathic and inflammatory pain models following the 
loss of GABAergic and glycinergic inhibition (Ibuki et al., 1996, Meisner et al., 2010, 
Berrocal et al., 2014). However, gelsemine action implies that its mechanism of 
action through α3-containing glycine receptors is contrary to this hypothesis. The 
analgesic action of gelsemine could be to prevent the rhythmic oscillations in the 
spinal DH by inhibiting the inhibition through α3-containing glycine receptors. 
Consequently, development of other compounds which can modulate the spinal DH 
rhythmic activity could prove potentially beneficial analgesics.  
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5 Extracellular Single Electrode Spinal Cord Slice 
Recordings 
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5.1 Introduction 
5.1.1 4-Aminopyridine-Induced Rhythmic Activity in the Central Nervous 
System 
4-aminopyridine (4-AP) is a non-selective potassium channel blocker (Smith et al., 
2009), which causes depolarisation in cells as a result of preventing the re-
polarisation by efflux of potassium ions following an action potential. 4-AP has been 
shown to increase neurotransmitter release from both inhibitory and excitatory 
interneurons (Perreault and Avoli, 1991). Application of 4-AP to brain slices is 
commonly used as a model of epilepsy. Extracellular recordings of 4-AP-induced 
epileptic-like activity in hippocampal slices have shown that the 4-AP-induced 
rhythmic activity can be modulated by GABAA and GABAB receptor compounds 
(Watts and Jefferys, 1993). 4-AP has also been used as a model of pain in spinal 
cord slices, where 4-AP-induced activity in the spinal DH is akin to that observed in 
pain states, including neuropathic pain (Ruscheweyh and Sandkuhler, 2003, Asghar 
et al., 2005, Chapman et al., 2009). Sandkuhler and Eblen-Zajjur (1994) detected 
rhythmic activity with a frequency of 0.5-13 Hz in their in vivo spinal DH recordings. 
In in vitro recordings from the spinal DH the frequency of the 4-AP-induced rhythmic 
activity detected was similar to the in vivo rhythm, between 4 and 12 Hz (Chapman 
et al., 2009, Visockis and King, 2013). Ruscheweyh and Sandkuhler (2003) also 
investigated the effects of anticonvulsants on the 4-AP activity in the spinal DH and 
revealed that the anticonvulsants also caused an attenuation of the 4-AP-induced 
hyperactivity. This concurs with the anti-nociceptive actions of these anticonvulsants 
in vivo (Swerdlow, 1984) and the role of inhibitory signalling in processing 
nociceptive inputs from the periphery. It has therefore been proposed that the spinal 
DH rhythmic activity is involved in regulating the propagation of nociceptive signals 
from the periphery before they are transmitted to the brain (Ruscheweyh and 
Sandkuhler, 2005, Zeilhofer et al., 2012). Developing novel analgesics which target 
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the GABAA and glycine receptors in the spinal DH could produce their actions by 
modulating the rhythmic activity of this network, which may in turn be linked with the 
excitability of the network. The correlation between rhythmic oscillations and 
excitability of a network has previously been identified in the brain (Ploner et al., 
2006) and therefore could be extrapolated to spinal DH network oscillations. In this 
chapter 4-AP has been utilised to induced rhythmic oscillations in the spinal DH of 
acute rat spinal cord slices. The potential utility of this in vitro model system with 4-
AP-induced oscillations will be assessed by recording the effects of classic GABAA 
and glycine receptor compounds.  
 
5.1.2 Aims 
In this chapter 4-AP-induced rhythmic activity has been measured in the spinal DH 
of acute rat spinal cord slices using extracellular recordings. The aim of this chapter 
is to demonstrate whether or not enhancing or blocking GABAA and glycine 
receptors affects the 4-AP-induced rhythmic activity and population spikes in the SG 
region of the spinal DH in the acute rat spinal cord slices. Pharmacologically 
targeting these receptors with well characterised compounds will help elucidate the 
effects these receptors have on the rhythmic activity and population spikes. 
Consequently, the potential of this in vitro model system for screen novel GABAA 
and glycine receptor analgesics can be assessed. In addition GABAB receptors 
were also investigated into their effects on the 4-AP-induced rhythmic activity in the 
SG of acute spinal cord slices. In this chapter the following aims are investigated: 
1. Obtain extracellular recordings of 4-AP-induced hyperexcitability in the SG of 
acute spinal cord slices 
2. Determine the effects of GABAA, GABAB and glycine receptor compounds on 
the 4-AP-induced rhythmic oscillatory activity with power spectral analysis. 
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3. Determine the effects of GABAA, GABAB and glycine receptor compounds on 
the 4-AP-induced population spikes in the SG of the acute spinal cord slices 
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5.2 Methods  
The focus of this study is on the superficial spinal DH where the primary nociceptive 
neurons innervate the spinal cord, are processed and then transmitted to higher 
brain centres. To investigate the activity of this network, extracellular recordings 
were made from the SG laminae of acute transverse spinal cord slices. The SG 
lamina II region of the spinal DH can be easily identified by its more translucent 
appearance compared to the other laminae in a transverse section of a spinal cord 
making it easy to position a recording electrode into this region. The translucent 
appearance of this lamina region exists because of the lower concentration of 
myelinated fibres. Extracellular field recordings have been used in this study to 
investigate the rhythmic oscillations of the superficial spinal DH as well as the 
population spikes generated by this network within the spinal cord slices. This 
method of recording allows for the activity of a small group of synchronously firing 
neurons to be measured simultaneously within a network. The more stable nature of 
extracellular recording compared to intracellular recording, means the activity of a 
network within a slice can be recorded for hours, allowing for the effects of a series 
of perfused compounds to establish and stabilise.  
 
5.2.1 Spinal Cord Slices 
Wistar rats aged 12-16 days (27-35 g) were anaesthetised with an intraperitoneal 
injection of pentobarbital 40-50 mg/kg (Henry Schein Medical). A trans-cardiac 
perfusion was performed with sucrose-containing artificial cerebrospinal fluid 
(aCSF), which was made using distilled water and contained 126 mM sucrose, 2.5 
mM KCl, 1.4 mM NaH2PO4, 1.2 mM MgCl2, 2.4 mM CaCl2, 25 mM NaHCO3 and 11 
mM glucose. The sucrose aCSF was made in advance and kept at 4oC, using 
chilled solutions throughout the preparation slows the deterioration of the tissue and 
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improves the quality of the slices (Lein et al., 2011). Trans-cardiac perfusion with 
sucrose aCSF slows neuronal and metabolic activity to provide more time for the 
dissection and slicing, and consequently improves tissue viability. To perform the 
trans-cardiac perfusion the rat was pinned to a dissection board placed inside a 
plastic container, positioned on its back. The chest cavity was opened to expose the 
heart, and held open using clamping scissors. An incision was made into the right 
atria of the heart using small spring scissors, and then the 23-gauge needle 
containing the sucrose-aCSF was inserted into the base of the left ventricle. 20 ml 
of the sucrose-aCSF was then perfused throughout the body from the left ventricle 
around the body and out of the through the incision that was made in the right atria 
thereby removing the blood from body. Following the trans-cardiac perfusion a 
dorsal laminectomy was performed. The rat was turned over and the neck was cut 
to confirm death. The skin from the back of the animal was removed, and then small 
spring scissors were used to open the spinal column. The vertebrae were cut either 
side of the spinal cord from the incision made at the cervical region down to the 
sacral vertebrae. The dorsal side of the cut vertebrae was held and peeled away 
with forceps as the vertebrae were cut. The spinal cord could then be removed, 
picking it up with forceps and cutting the connecting spinal nerves to separate the 
cord. The spinal cord was placed in oxygenated (95% oxygen, 5% carbon dioxide), 
ice-cold standard aCSF, without sucrose. The standard aCSF contained 126 mM 
NaCl, 2.5 mM KCl, 1.4 mM NaH2PO4, 1.2 mM MgCl2, 2.4 mM CaCl2, 25 mM 
NaHCO3 and 11 mM glucose,. While in the ice cold aCSF, the meninges 
surrounding the spinal cord were removed under a dissection microscope (Nikon, 
Japan). Using two pairs of fine forceps the meninges could be separated from the 
spinal cord which also removed any remaining dorsal and ventral roots that were 
attached to the cord. The meninges were removed prior to slicing as the vibratome 
is unable to cut through them. The spinal cord was cut to separate the lumbar 
region. 3% agar solution (Alfa Aesar, UK) made in distilled water was microwaved 
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for 40-50 seconds, and poured into a small weigh boat surrounded by ice. Once 
cooled slightly the lumbar section of the spinal cord was embedded into the agar. 
When the agar had set around the spinal cord, the spinal cord section encased 
within a rectangular agar block was cut out with a scalpel and super glued onto the 
base plate of the vibratome (Leica VT1000S, Leica Microsystems, Germany). This 
was then placed into the vibratome bath which contained oxygenated, ice-cold, 
standard aCSF. Transverse slices were cut to a thickness of 350 µm with a 
stainless steel blade (Campden Instruments Limited, UK) and transferred to a 
holding chamber (Figure 5.1), where they were submerged in oxygenated aCSF, 
maintained at 32oC using a waterbath. Typically 10-12 slices were obtained from 
one spinal cord preparation. The slices were transferred using a dropper pasture 
pipette with the tip cut off to minimise physical contact with the slice and therefore 
reduce damage to the tissue. All the slices were then incubated for one hour before 
commencing the electrophysiological recordings. This incubation time allows for the 
slice to recover from the cutting of the tissue which causes the release of enzymes 
and ions that can alter the metabolic state of the tissue and will remove some of the 
dead cells from the surface of the slices caused by the slicing (Lein et al., 2011). An 
hour incubation time is widely considered sufficient for the slices to equilibrate to the 
solution and conditions and consequently regain their electrophysiological and 
biochemical activity (Teyler, 1980).  
 
5.2.2 Single-Electrode Extracellular Slice Recordings 
To record from a slice, one spinal cord slice was transferred onto a custom built 
Perspex interface recording chamber, where a humidified atmosphere (95% 
oxygen-5% carbon dioxide) could be maintained (Figure 5.2). The slices were 
bathed in oxygenated aCSF (36oC), which flowed at 2 ml/min using a gravity 
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perfusion system. The slices were positioned on filter paper, which improves the 
flow of solution around the slice.  
Extracellular field recordings were made using borosilicate glass microelectrodes 
(Harvard Apparatus, Kent, UK) (10-15 MΩ) filled with standard aCSF. The 
electrodes were pulled from 1.2 mm OD x 0.94 mm ID glass capillaries using a 
vertical PP830 electrode puller (Narishiges, Japan). The electrode is placed into an 
electrode holder which goes onto a HS-2A headstage (Axon Instruments) that is 
attached to a micromanipulator. Using the manipulator, the electrode was guided 
into place into the SG region of a slice, identifiable due to its translucent appearance 
under the microscope, and inserted to a depth of 150 µm. The headstage connects 
to an Axoclamp 2A system (Molecular Devices, CA, USA) which was used to record 
and amplify (x10) the voltage waveforms. A Neurolog NL106 module (Digitimer, 
Welwyn Garden City, UK) was used for further amplification (x1000).  The low pass 
band filter of the Neurolog NL106 set at 120 Hz was used for initial filtering of the 
voltage signals. An additional low pass band filter setting of 40 Hz (Neurolog NL106, 
Digitimer) was also used for all recordings. To minimise electrical disturbance, a 
Humbug noise eliminator was included in the circuit. The signals recorded were 
translated into digital values using the CED 1401 acquisition interface which in turn 
fed into the computer with Spike 2 software (Cambridge Electronic Design, UK) for 
recording and analysis. Figure 5.3 shows a diagram of this complete circuit.  
Spike 2 software was used to capture the voltage waveforms at a sampling rate of 
10,000 Hz. The sampling rate is required to be at least twice that of the highest 
possible frequency of the analogue signal (5000 Hz determined by the CED 1401) 
to avoid losing any of the recording’s signal information, according to the Nyquist-
Shannon sampling theorem. A 60 second baseline recording was made during 
perfusion of standard aCSF for each spinal cord slice from the SG. The slice was 
then perfused with 25 µM 4-AP (Sigma, UK) in standard aCSF for 45 minutes, to 
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allow for the response to stabilise (Figure 5.4). Previous studies using 4-AP to 
induce epileptiform activity in spinal cord slices have used either 50 or 100 µM 4-AP 
(Ruscheweyh and Sandkuhler, 2003, Chapman et al., 2009). However, while this 
induced highly reliable activity it would be difficult to determine if addition of other 
compounds could enhance this activity further as it appears to be almost maximal 
firing of the SG network. Therefore a lower concentration was used which was able 
to reliably produce activity, but allowed scope for further increases in activity with 
the addition of other compounds (Visockis and King, 2013). The Spike 2 
configuration used for recordings was set to record one minute every 3 minutes as 
usually approximately 30 minutes was required for an effect of the compound 
perfused to materialise and reach a stable level, so not all the data was required for 
analysis. Population spikes and rhythmic oscillations were induced by application of 
4-AP. The effects of GABA and glycine receptor compounds were then tested 
against this 4-AP induced activity. Each GABA and glycine receptor compound was 
co-applied with the 4-AP diluted in standard aCSF for 45 minutes similarly with one 
minute recorded every three minutes. This was then followed by perfusions with 4-
AP-containing aCSF (4-AP wash) to show if the activity could be recovered. An 
aCSF alone wash was then done to show if the 4-AP-induced activity could 
reversed to normal baseline levels.  
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Figure 5.1 Photograph of the spinal cord slice holder. The glass beaker is filled with 
standard aCSF and the slice holder placed inside it. The slice holder is made from a plastic 
beaker with the base removed and replaced with a nylon netting. The nylon net allows the 
oxygenated aCSF to pass through it and is soft so that it does not damage the slices. 
  
169 
 
 
Figure 5.2 Photograph of the interface chamber used for the single electrode slice 
recordings. The flow of heated distilled water into the chamber warms the slice interface. 
The warm air from the chamber passes into the slice interface through holes either side of 
the interface. The slice interface is kept humid by placing glass slides on top of the interface 
to retain the heat and humidity, leaving a gap for the microelectrode to enter the slice. The 
tubing containing the perfusion solution is passed through the chamber so that it is also 
heated before it enters the slice interface.   
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Figure 5.3 A schematic diagram of the circuit used for the single electrode recordings from 
the spinal cord slices.  
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Figure 5.4 An example of a recording from the SG of a spinal cord slice using the single electrode extracellular recording technique. Il lustrated here 
are one minute sections of a recording from left to right with only the first of every three minutes recorded. The first minute section is the baseline 
with standard aCSF perfusion. Following this aCSF containing 4-AP (25 μM) was then perfused from the time point indicated by the arrow. After 15 
minutes (the 5
th
 section) population spikes can be observed, which further increase in amplitude and frequency until after approximately 30 minutes 
of perfusion of 4-AP where the activity stabilises. 
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5.2.3 Spike 2 Data Analysis 
The first minute of baseline and the final minute recorded in the presence of each 
compound were used for analysis. The recordings were analysed in two ways, firstly 
the underlying inter-spike interval oscillatory rhythmic activity of the superficial 
dorsal horn network was studied. Fast Fourier Transform (FFT) Power Spectral 
analysis was performed to quantify any changes in the inter-spike interval oscillatory 
activity. The FFT analysis determines all the different amplitudes, frequencies and 
phases which are the components of the oscillating activity of the slice recordings 
and converts them to cosine waves. The power value is generated from the 
amplitudes of each cosine waves for each frequency, with units of μV2 (10-6V2). The 
output of this analysis is a Power Spectra displaying the power at each frequency. 
Therefore, the strongest frequency and how strong this frequency is can be 
determined for a chosen time period of the recording and compared with different 
sections of the recording where a compound was present. 
The data were initially processed using the DC remove process in Spike 2, with a 
time constant of 0.1 s. A low pass digital FIR (Finite Impulse Response) filter was 
then applied to the recording, which reduces the noise of the recording and 
enhances the remaining frequencies. A script was specially designed by C.E.D. 
which removed the population spikes with amplitudes above a chosen threshold of 
15 µV. The script detects the rising phase of a spike as it crosses the 15 µV  
threshold and removes the data 0.5 s before and after the spike leaving the inter-
spike interval regions of the recording (Figure 5.5). A minimum amplitude of 15 µV   
was chosen because the baseline voltage was typically between ±10 µV, therefore 
to distinguish between the baseline and a spike 15 µV  was selected. Power spectra 
could then be created from the inter-spike interval data for the 60 second epochs. 
The Power Spectra had an FFT size of 8192 with a Hanning window function. From 
the FFT analysis the peak power amplitude, area and frequency were determined 
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within the 4-12 Hz frequency range (Figure 5.6B). This frequency range was 
selected because the power spectra show that this frequency was the most 
dominant frequency range observed to occur with no other strong frequency range 
detected, which has also been demonstrated previously (Chapman et al., 2009, 
Visockis and King, 2013) (Figure 5.6A). In vivo recordings from the spinal SG region 
have also detected similar frequency range, 6-13 Hz (Sandkuhler and Eblen-Zajjur, 
1994). The second aspect of the analysis of the recorded data involved 
characterising the changes in the population spikes. Spike amplitude and frequency 
were characterised for large amplitude population spikes over 15 µV using Spike 2 
for the same 60 second sections of the recordings. 
 
5.2.4 Statistics 
The percent change in each of the parameters from the power spectrum analysis 
and the population spike analysis of the single electrode recordings was calculated 
for each slice as paired data. The mean percent change in power area was then 
determined from all the recordings with 4-AP and GABA, and displayed as a 
histogram with the S.E.M. A minimum of 6 slices were recorded from for each 
compound, with slices from at least 2 different rats. The data was analysed using 
GraphPad Prism software. Two-tailed, paired T-tests or a repeated measure one-
way ANOVA, where values for each parameter were compared with the value of 4-
AP with a Dunnett’s multiple comparisons test.  A P<0.05 significance level was 
used for t-test or one-way ANOVA analysis. On the graphs a P<0.05 is indicted by *, 
P<0.01 by ** and P<0.001 by *** when comparing the values with 4-AP.   
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Figure 5.5 Processing of extracellular recordings from the SG region of a rat spinal cord 
slice for analysis of the rhythmic oscillations. (a) A 60 s section of a single electrode 
extracellular recording from the SG region of a transverse lumbar spinal cord slice during 
perfusion of 4-AP (25 µM). This display shows the large population spikes induced by 4-AP 
of variable amplitudes, and the inter-spike interval regions of variable durations. (b) The 
same section of the recording as shown in (a) following the removal of all population spikes 
over 15 µV. This is the result of running the script written in Spike 2 software used to analyse 
the data. The script was coded to remove the section of recording where the voltage crosses 
the 15 µV threshold and removes 0.5 s either side of the spike. (c) An inter-spike interval 
region of the recording in (b) magnified to illustrate the underlying oscillating activity of the 
network within the superficial DH. 
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Figure 5.6 A Power Spectra generated from FFT Power Spectrum analysis of the rhythmic 
oscillations recorded from the SG region of the spinal cord slices. (A) An example Power 
Spectra showing the frequency range from 0 to 60 Hz. The only dominant frequency range is 
between 4-12 Hz. (B) An example Power Spectra showing the 4-12Hz frequency range and 
illustrating how the three parameters, power amplitude, power area and peak frequency, are 
measured.  
 
A 
B 
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5.2.5 Materials 
A full list of the compounds used in this study is shown in Error! Not a valid 
bookmark self-reference., along with their details of concentrations and suppliers.  
 
Table 5.1 List of compounds used in the single electrode extracellular acute spinal cord slice 
recordings 
Compound Action 
Working 
Concentration 
Supplier References 
4-Aminopyridine 
K
+
 channel 
blocker 
25 µM Sigma 
Chapman et al. 
(2009), Ruscheweyh 
and Sandkuhler 
(2003), Visockis and 
King (2013) 
GABA 
GABAA and 
GABAB agonist 
200 μM Sigma Andersen et al. (1980) 
Muscimol GABAA agonist 10 μM Sigma Neal and Shah (1989) 
THIP GABAA agonist 10 μM Sigma 
Drasbek and Jensen 
(2006) 
L-838,417 GABAA PAM 10 μM Sigma 
(Mirza and Nielsen, 
2006), (Nickolls et al., 
2011) 
Bicuculline 
Methiodide 
GABAA 
antagonist 
50 μM Sigma 
Chapman et al. 
(2009) 
Gabazine 
GABAA 
antagonist 
10 μM Sigma 
Drasbek and Jensen 
(2006) 
Baclofen GABAB agonist 10 μM Sigma 
Ault and Nadler 
(1983), (Neal and 
Shah, 1989) 
2-Hydroxysaclofen 
GABAB 
antagonist 
10 μM 
Alfa 
Aesar 
Chub and O'Donovan 
(1998) 
Glycine Glycine agonist 2 mM Sigma 
(Kullmann et al., 
2002) 
Strychnine 
Glycine 
antagonist 
10 μM Sigma 
Chub and O'Donovan 
(1998), Ruscheweyh 
and Sandkuhler 
(2003) 
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5.3 Results 
5.3.1 GABAA Receptor Agonist and Antagonist Effects on Spinal Dorsal 
Horn Activity 
5.3.1.1 Rhythmic Oscillatory Activity 
GABAA receptor agonist GABA (200 µM) did not significantly affect any of the three 
parameters measured from the power spectral analysis (Figure 5.7). However, 
muscimol (10 µM) decreased power amplitude from 9.24 to 4.2 µV2 (P<0.05) and 
power area from 36.01 to 28.92 µV2.Hz (P<0.05) (Figure 5.8). Although, the power 
spectra peak frequency was unchanged by muscimol (P>0.05). THIP (10 µM) 
significantly decreased power amplitude from 10.76 µV2 with 4-AP to 2.93 µV2 with 
4-AP and THIP perfusion (P<0.05). THIP also significantly reduced power area from 
41.91 to 15.17 µV2.Hz (P<0.05), but had no effect on the peak frequency (P>0.05) 
(Figure 5.9). Furthermore, L-838,417 (10 µM), the positive allosteric modulator 
(PAM) of GABAA receptors, significantly reduced power amplitude by 38.5% from 
8.32 to 5.28 µV2 (P<0.01). Power area was reduced by 34.1% on average from 
39.09 to 27.5 µV2.Hz (P<0.05). Peak frequency was unaffected by this GABAA 
receptor PAM (P>0.05) (Figure 5.10).  
GABAA receptor antagonist bicuculline (50 µM) significantly decreased power 
amplitude and power area and significantly increased the peak frequency of the 
Power Spectra analysis. The mean power amplitude was decreased from 6.74 to 
2.22 µV2 (P<0.001), power amplitude was reduced from 29.1 to 11.95 µV2.Hz 
(P<0.001) and peak frequency was increased from 6.19 to 7.06 Hz (P<0.01) (Figure 
5.11). Gabazine (50 µV), the second GABAA receptor antagonist investigated, 
similarly decreased power amplitude and power area, and increased peak 
frequency of the rhythmic activity in the SG of the spinal cord slices (Figure 5.12). 
The power amplitude mean was decreased from 6.76 µV2 with 4-AP to 4.59 µV2 with 
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4-AP and gabazine (P<0.05). The mean power area was decreased from 29.70 to 
17.09 µV2.Hz by gabazine (P<0.01), while the peak frequency was significantly 
increased from 7.06 to 7.71 Hz (P<0.05). The GABAA receptor antagonists were the 
only compounds to significantly affect the peak frequency of the rhythmic activity in 
the spinal DH recordings. A summary of all the effects of the GABAA receptor 
compounds is listed in Table 5.2.   
 
Table 5.2 A summary of the effects of the GABAA receptor compounds on the 4-AP-induced 
rhythmic activity parameters investigated. The symbols ↑ and ↓ indicated a significant 
increase or decrease respectively in the parameter, n.s. indicates no significant change in 
the parameter. 
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Figure 5.7 The effects of GABA (200 µM) on the 4AP-induced rhythmic activity in the SG 
region of rat spinal DH. (A) Sections from the recording of a slice during perfusion of 
standard aCSF, followed by aCSF containing 25 µM 4-AP and then aCSF with 4-AP and 
GABA. (B) The power spectra generated from the recording in (A) for each condition. (C) 
The mean power amplitude values during perfusion of standard aCSF, aCSF with 4-AP and 
aCSF with 4-AP and GABA. (D) The mean power area values for each condition. (E) The 
mean peak frequency values for each condition. (F) The overall percent change in each of 
the rhythmic activity parameters comparing activity during perfusion of 4-AP to that with 4-
AP and GABA. (N=3, n=6) 
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Figure 5.8 GABAA receptor agonist muscimol effects on the 4-AP-induced activity in the SG 
of rat spinal cord slices. (A) One second sections of a recording during the perfusion of (i) 
aCSF, (ii) aCSF with 4-AP and (iii) aCSF with 4-AP and muscimol. (B) The power spectra of 
the data from the recording in (A) for each of the three conditions. The mean power 
amplitude values (C), power area (D) and peak frequency (E) of the recordings during 
perfusion of aCSF alone and with 4-AP and muscimol as indicated. (F) The percent change 
in power amplitude power area and peak frequency from 4-AP to 4-AP with muscimol. (N=4, 
n=8) 
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Figure 5.9 The effects of GABAA agonist THIP on the 4-AP-induced rhythmic activity in the 
spinal DH SG. (A) One second sections from a slice recording during perfusion of aCSF 
alone (i), aCSF with 4-AP (ii) and aCSF with 4-AP and THIP. (B) The power spectra for the 
recording shown in part (A). The power amplitudes (C), power area values (D) and peak 
frequency values (E) for each section of the recording. (F) The percent change values for 
power amplitude, area and peak frequency, comparing 4-AP induced activity with 4-AP with 
THIP activity. (N=4, n=9) 
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Figure 5.10 The effects of the GABAA receptor positive allosteric modulator L-838,417 on 
the 4-AP-induced rhythmic activity. (A) Three one second sections of a recording to show 
the rhythmic activity during perfusion of aCSF alone, with 4-AP and with 4-AP and L-
838,417. (B) The power spectra for the recording in (A). The mean power amplitudes (C), 
power areas (D) and peak frequencies (E) for the recordings with L-838,417 for each of the 
sections in the recordings as indicated. (F) The percent change in the three parameters to 
describe the rhythmic activity comparing the 4-AP activity to that with 4-AP and L-838,417 
(N=2, n=6). 
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Figure 5.11 GABAA receptor antagonist bicuculline effects on 4AP-induced rhythmic activity 
in the SG laminae of a lumbar spinal cord slice recorded using single electrode extracellular 
recording technique. (A) Inter-spike interval sections of a slice recording during perfusion of 
(i) aCSF, (ii) aCSF with 4-AP and (iii) aCSF with 4-AP and bicuculline (50 µM). (B) The 
power spectra for each section of the recording in part (A). (C) The mean power amplitudes 
of each section of the slice recordings. (D) The power area values for each section of the 
recordings. (E) The peak frequency values for each section of the recordings. (F) The 
percentage change in each of the rhythmic activity parameters comparing 4-AP activity to 
the activity with 4-AP and bicuculline. (N=4, n=11)  
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Figure 5.12 The effects of gabazine on the 4-AP-induced rhythmic activity in the SG of 
spinal cord slices recorded from using single electrode extracellular recording technique. (A) 
Sections of a recording during perfusion of (i) aCSF alone, (ii) aCSF with 4-AP and (iii) aCSF 
with 4-AP and gabazine (50 µM). (B) The power spectra generated for each of the sections 
of the recording described in part (A). (C) The mean power amplitude values for each 
section of these slice recordings as indicated. (D) The power area values for each section of 
the recordings. (E) The peak frequency values for each section of these slice recordings. (F) 
The percent change in each of the rhythmic activity parameters, comparing the 4-AP activity 
to that with 4-AP and gabazine (N=5, n=16). 
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5.3.1.2 Population Spikes 
GABA had a more profound effect on the population spikes, significantly increasing 
spike frequency from 0.67 to 0.97 Hz (P<0.01) and spike amplitude from 22.29 to 
40.06 µV (P<0.05) (Figure 5.13). Muscimol significantly decreased population spike 
frequency from 0.70 Hz to 0.01 Hz (P<0.01). The mean population spike amplitude 
decreased from 123.1 µV with 4-AP to 5.42 µV with the perfusion of 4-AP and 
muscimol (P<0.001) (Figure 5.14). In all but one of the recordings with muscimol the 
population spikes were completely inhibited. THIP similarly decreased spike 
frequency from a mean of 0.76 to 0.36 Hz (P<0.05). However, spike amplitude was 
unaffected, with a mean of 136.4 Hz during 4-AP perfusion to 133.6 Hz during 
perfusion with 4-AP and THIP (P>0.05) (Figure 5.15). The GABAA receptor PAM, L-
838,417, did not affect population spike amplitude or frequency. The 4-AP mean 
population spike frequency was 0.91 Hz, and with the addition of L-838,417 the 
frequency was 1.06 Hz (P>0.05). The mean spike amplitude with 4-AP was 126.0 
µV, and with 4-AP and L-838,417 it was 125.5 µV (P>0.05) (Figure 5.16). 
Both GABAA receptor antagonists significantly decreased 4-AP–induced population 
spike amplitude and frequency. In many of the slices the spikes were completely 
abolished or had very few spikes remaining following perfusion of gabazine or 
bicuculline. Bicuculline (50 µM) decreased spike frequency on average by 97 ± 
0.73%, from a mean of 0.59 to 0.02 Hz (P<0.0001). Spike amplitude was 
significantly decreased by bicuculline on average by 73 ± 5.93% from 115.80 to 
35.58 µV (P<0.0001) (Figure 5.17). Gabazine (10 µM) decreased population spike 
frequency on average by 93 ± 2.51% from a mean of 0.75 to 0.03 Hz (P<0.0001). 
Spike amplitude was reduced by 73 ± 9.26% on average by gabazine, from a mean 
of 113.7 to 23.9 µV (P<0.001) (Figure 5.18). A summary of the effects of the GABAA 
receptor compounds on the 4-AP-induced population spikes in the SG of the spinal 
cord slices are listed in Table 5.3.  
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Figure 5.13 The changes in population spike frequency and amplitude by GABA (200 µM) 
recorded in the SG of the spinal cord slices using single electrode extracellular recordings. 
(A) The mean spike frequencies measured during perfusion of standard aCSF, aCSF with 4-
AP and aCSF with 4-AP and GABA, followed by a wash with 4-AP then a wash with aCSF to 
show recovery of activity. (B) The mean spike amplitudes measured during each of the 
same sections of the recording as indicated. (C) The percent change in spike frequency and 
amplitude from those recorded during 4-AP perfusion and 4-AP with GABA perfusion. (N=3, 
n=10) 
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Figure 5.14 The changes in population spike frequency and amplitude in the SG of spinal 
cord slices by GABAA receptor agonist muscimol (10 µM). (A) The mean spike frequencies 
measured during perfusion of standard aCSF, aCSF with 4-AP and aCSF with 4-AP and 
muscimol, followed by a wash with 4-AP then a wash with aCSF to show recovery of activity. 
(B) The mean spike amplitudes measured during each of the same sections of the recording 
as indicated. (C) The percent change in spike frequency and amplitude from those recorded 
during 4-AP perfusion and 4-AP with muscimol perfusion. (N=4, n=8) 
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Figure 5.15 The changes in population spike frequency and amplitude in the SG of spinal 
cord slices by GABAA receptor agonist THIP (10 µM). (A) The mean spike frequencies 
measured during perfusion of standard aCSF, aCSF with 4-AP and aCSF with 4-AP and 
THIP, followed by a wash with 4-AP then a wash with aCSF to show recovery of activity. (B) 
The mean spike amplitudes measured during each of the same sections of the recording as 
indicated. (C) The percent change in spike frequency and amplitude from those recorded 
during 4-AP perfusion and 4-AP with THIP perfusion. (N=4, n=9) 
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Figure 5.16 The changes in population spike frequency and amplitude in the SG of spinal 
cord slices by GABAA receptor PAM L-838,417 (10 µM). (A) The mean spike frequencies 
measured during perfusion of standard aCSF, aCSF with 4-AP and aCSF with 4-AP and L-
838,417, followed by a wash with 4-AP then a wash with aCSF to show recovery of activity. 
(B) The mean spike amplitudes measured during each of the same sections of the recording 
as indicated. (C) The percent change in spike frequency and amplitude from those recorded 
during 4-AP perfusion and 4-AP with L-838,417 perfusion. (N=2, n=6) 
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Figure 5.17 The changes in 4-AP-induced population spike frequency and amplitude in the 
SG of spinal cord slices by GABAA receptor antagonist bicuculline (50 µM). (A) The mean 
population spike frequencies measured during perfusion of standard aCSF, aCSF with 4-AP 
and aCSF with 4-AP and bicuculline, followed by a wash with 4-AP then a wash with aCSF 
to show recovery of activity. (B) The mean spike amplitudes measured during each of the 
same sections of the recording as indicated. (C) The percent change in spike frequency and 
amplitude from those recorded during 4-AP perfusion and 4-AP with bicuculline. (N=4, n=14) 
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Figure 5.18  The changes in 4-AP-induced population spike frequency and amplitude in the 
SG of spinal cord slices by GABAA receptor antagonist gabazine (10 µM). (A) The mean 
population spike frequencies measured during perfusion of standard aCSF, aCSF with 4-AP 
and aCSF with 4-AP and gabazine, followed by a wash with 4-AP then a wash with aCSF to 
show recovery of activity. (B) The mean spike amplitudes measured during each of the 
same sections of the recording as indicated. (C) The percent change in spike frequency and 
amplitude from those recorded during 4-AP perfusion and 4-AP with gabazine. (N=5, n=16) 
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Table 5.3 A summary of the effects of the GABAA receptor compounds on the 4-AP-induced 
population spikes in the SG of the spinal cord slices recorded using single electrode 
extracellular recordings. The symbols ↑ and ↓ indicated a significant increase or decrease 
respectively in the parameter, and n.s. indicates no significant change. 
 
 
5.3.2 GABAB Receptor Compound Effects on Spinal Dorsal Horn Activity 
5.3.2.1 Effects on the 4-AP-Induced Rhythmic Activity 
The GABAB receptor agonist baclofen (10 µM) significantly decreased power 
amplitude and area by an average of 82 ± 3.7% and 81 ± 3.4% respectively, but had 
no effect on the peak frequency of the rhythmic activity (Figure 5.19). Baclofen 
decreased power amplitude from a mean of 3.80 to 0.73 µV2 (P<0.05), and power 
area from a mean of 17.92 to 3.71 µV2.Hz (P<0.01). GABAB receptor antagonist 2-
hydroxysaclofen (10 µM) increased power amplitude and power area of the rhythmic 
activity, while peak frequency was again unaffected (Figure 5.20). 2-
Hydroxysaclofen increased power amplitude on average by 121 ± 57.7% from a 
mean of 5.87 µV2 to a mean of 10.27 µV2 (P<0.05). Power area was increased on 
average by 127 ± 66%, from a mean of 29.69 to 52.39 µV2.Hz (P<0.05). A summary 
of the effects of GABAB receptor agonist and antagonists on the 4-AP-induced 
rhythmic activity in the spinal SG region is shown in Table 5.4. 
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Figure 5.19 The effects of GABAB receptor agonist baclofen on the 4-AP-induced rhythmic 
activity in the SG of spinal cord slices recorded from using single electrode extracellular 
recording technique. (A) Sections of a recording during perfusion of (i) aCSF alone, (ii) aCSF 
with 4-AP and (iii) aCSF with 4-AP and baclofen (10 µM). (B) The power spectra generated 
for each of the sections of the recording described in part (A). (C) The mean power 
amplitude values for each section of the slice recordings as indicated. (D) The power area 
values for each section of the slice recordings. (E) The peak frequency values for each 
section of these slice recordings. (F) The percent change in each of the rhythmic activity 
parameters, comparing the 4-AP activity to that with 4-AP and baclofen. (N=2, n=6) 
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Figure 5.20 The effects of GABAB receptor antagonist 2-hydroxysaclofen on 4-AP-induced 
activity in the SG of spinal cord slices recorded from using single electrode extracellular 
recording technique. (A) Sections of a recording during perfusion of (i) aCSF alone, (ii) aCSF 
with 4-AP and (iii) aCSF with 4-AP and 2-hydroxysaclofen (2-OH-S) (10 µM). (B) The power 
spectra generated for each of the sections of the recording described in part (A). (C) The 
mean power amplitude values for each section of the slice recordings as indicated. (D) The 
power area values for each section of the slice recordings. (E) The peak frequency values 
for each section of these slice recordings. (F) The percent change in each of the rhythmic 
activity parameters, comparing the 4-AP activity to that with 4-AP and 2-hydroxysaclofen. 
(N=2, n=6) 
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Table 5.4 A summary of the effects of the GABAB receptor agonist baclofen, and antagonist 
2-hydroxysaclofen (2-OH-S) on the 4-AP-induced rhythmic activity. The symbols ↑ and ↓ 
indicated a significant increase or decrease respectively, n.s. indicates no significant change 
in the parameter. 
 
 
5.3.2.2 GABAB Receptor Signalling Effects on 4-AP-Induced Population Spikes 
Baclofen significantly decreased population spike amplitude and frequency, with 
almost all spikes being completely eradicated (Figure 5.21). The population spike 
frequency was reduced by 99 ± 0.21% on average from 0.52 to 0.003 Hz (P<0.05). 
Spike amplitude was reduced from a mean of 120.8 to 9.5 µV, an average of 94 ± 
5.6% (P<0.05). Antagonist 2-hydroxysaclofen significantly increased spike 
frequency but although increases in spike amplitude could be seen the effect was 
not significant due to large variation (Figure 5.22). On average the population spike 
frequency increased by 81 ± 38% from 0.67 to 1.11 Hz (P<0.05). Spike amplitude 
on average increased by 33 ± 27% from a mean of 76.84 µV to 106.80 µV (P>0.05). 
A summary of these effects are displayed in Table 5.5. 
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Figure 5.21 The changes in 4-AP-induced population spike frequency and amplitude in the 
SG of spinal cord slices by GABAB receptor agonist baclofen (10 µM). (A) The mean 
population spike frequencies measured during perfusion of standard aCSF, aCSF with 4-AP 
and aCSF with 4-AP and baclofen, followed by a wash with 4-AP then a wash with aCSF to 
show recovery of activity. (B) The mean spike amplitudes measured during each of the 
same sections of the recording as indicated. (C) The percent change in spike frequency and 
amplitude from those recorded during 4-AP perfusion and 4-AP with baclofen. (N=2, n=6) 
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Figure 5.22 The changes in 4-AP-induced population spike frequency and amplitude in the 
SG of spinal cord slices by GABAB receptor antagonist 2-hydroxysaclofen (10 µM) (n=6). (A) 
The mean population spike frequencies measured during perfusion of standard aCSF, aCSF 
with 4-AP and aCSF with 4-AP and 2-hydroxysaclofen, followed by a wash with 4-AP then a 
wash with aCSF to show recovery of activity. (B) The mean spike amplitudes measured 
during each of the same sections of the recording as indicated. (C) The percent change in 
spike frequency and amplitude from those recorded during 4-AP perfusion and 4-AP with 2-
hydroxysaclofen. 
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Table 5.5 A summary of the effects of the GABAB receptor agonist baclofen, and antagonist 
2-hydroxysaclofen (2-OH-S) on the 4-AP-induced population spikes. The symbols ↑ and ↓ 
indicated a significant increase or decrease respectively. 
 
 
5.3.3 Glycine Receptor Agonist and Antagonist Effects on Spinal Dorsal 
Horn Activity 
5.3.3.1 Rhythmic Activity  
The glycine (2 mM) was perfused on to the spinal cord slices and significantly 
increased the 4-AP-induced power amplitude by 96.2 ± 35.1% (P<0.05) from 0.062 
µV2 with 4-AP perfusion to 0.14 µV2 with 4-AP and glycine perfusion. Power area 
was increased on average by 74.3 ± 28.2% from a mean of 0.23 to 0.320 µV2.Hz 
(P<0.01) (Figure 5.23). The peak frequency of the oscillations was not affected by 
glycine (P>0.05). Strychnine (10 µM), the potent and selective glycine receptor 
antagonist, decreased the power amplitude and power area of the DH rhythm by 
43.2 and 54.6% respectively, but did not affect the peak frequency (P>0.05) (Figure 
5.24). Power amplitudes were decreased from a mean of 8.21 to 2.34 µV2 
(P<0.001), and power area was decreased from 15.67 to 5.41 µV2.Hz (P<0.05). 
Table 5.6 summarises the effects of glycine and strychnine on the 4-AP-induced 
rhythmic activity in the spinal DH.  
 
199 
 
5.3.3.2 Population Spikes 
Glycine did not affect population spike frequency, the mean spike frequency with 4-
AP perfusing the slices was 6.98 Hz, and with glycine the frequency was 6.64 Hz 
(P>0.05). However, the population spike amplitude was significantly increased by 
197.2 ± 52.9% on average, from 70.3 to 139.7 µV (P<0.05) (Figure 5.25). 
Strychnine reduced the population spike frequency by 83 ± 7.4% from a mean of 
0.70 to 0.12 Hz with strychnine (P<0.01). Strychnine’s effects on spike amplitude 
were extremely variable, with an overall decrease of 40 ± 36.2%, consequently no 
significant effect was determined (P>0.05) (Figure 5.26).  
Table 5.7 summarises the effects of glycine and strychnine on the 4-AP-induced 
population spike amplitude and frequency in the DH of the spinal cord slices.  
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Figure 5.23 The effects of glycine on 4-AP-induced activity in the SG of spinal cord slices 
recorded from using single electrode extracellular recording technique. (A) Sections of a 
recording during perfusion of (i) aCSF alone, (ii) aCSF with 4-AP and (iii) aCSF with 4-AP 
and glycine (2 mM). (B) The power spectra generated for each of the sections of the 
recording described in part (A). (C) The mean power amplitude values for each section of 
the slice recordings as indicated. (D) The power area values for each section of the slice 
recordings. (E) The peak frequency values for each section of these slice recordings. (F) 
The percent change in each of the rhythmic activity parameters, comparing the 4-AP activity 
to that with 4-AP and glycine. (N=3, n=7) 
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Figure 5.24 The effects of glycine receptor antagonist strychnine on 4-AP-induced activity in 
the SG of spinal cord slices recorded from using single electrode extracellular recording 
technique. (A) Sections of a recording during perfusion of (i) aCSF alone, (ii) aCSF with 4-
AP and (iii) aCSF with 4-AP and strychnine (10 µM). (B) The power spectra generated for 
each of the sections of the recording described in part (A). (C) The mean power amplitude 
values for each section of the slice recordings as indicated. (D) The power area values for 
each section of the slice recordings. (E) The peak frequency values for each section of these 
slice recordings. (F) The percent change in each of the rhythmic activity parameters, 
comparing the 4-AP activity to that with 4-AP and strychnine. (N=3, n=8) 
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Figure 5.25 The changes in 4-AP-induced population spike frequency and amplitude in the 
SG of spinal cord slices by glycine (2 mM). (A) The mean population spike frequencies 
measured during perfusion of standard aCSF, aCSF with 4-AP and aCSF with 4-AP and 
glycine, followed by a wash with 4-AP then a wash with aCSF to show recovery of activity. 
(B) The mean spike amplitudes measured during each of the same sections of the recording 
as indicated. (C) The percent change in spike frequency and amplitude from those recorded 
during 4-AP perfusion and 4-AP with glycine. (N=3, n=11) 
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Figure 5.26 The changes in 4-AP-induced population spike frequency and amplitude in the 
SG of spinal cord slices by glycine receptor antagonist strychnine (10 µM). (A) The mean 
population spike frequencies measured during perfusion of standard aCSF, aCSF with 4-AP 
and aCSF with 4-AP and strychnine, followed by a wash with 4-AP then a wash with aCSF 
to show recovery of activity. (B) The mean spike amplitudes measured during each of the 
same sections of the recording as indicated. (C) The percent change in spike frequency and 
amplitude from those recorded during 4-AP perfusion and 4-AP with strychnine. (N=3, n=8) 
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Table 5.6 A summary of the effects of the glycine and strychnine on the 4-AP-induced 
rhythmic activity in the SG. The symbols ↑ and ↓ indicated a significant increase or decrease 
respectively, n.s. indicates no significant change. 
 
 
Table 5.7 A summary of the effects of the glycine and strychnine on the 4-AP-induced 
population spike activity in the SG. The symbols ↑ and ↓ indicated a significant increase or 
decrease respectively, n.s. indicates no significant change. 
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Tables 5.8 and 5.9 display a comprehensive list of the effects of all the compounds 
tested on the spinal cord slices against the 4-AP-induced rhythmic activity (Table 
5.8) and population spike activity (Table 5.9) in the SG of the spinal DH.  
 
Table 5.8 Summary of the actions of each compound applied on the 4-AP-induced rhythmic 
activity in the SG of the spinal cord slices. ↑ signifies a significant increase in that parameter 
compared to 4-APalone. ↓ signifies a significant decrease in the parameter compared to 
4AP, and n.s. signifies no significant change in the parameter.  
Receptor Selectivity 
and Action 
Compound 
Effect on 4-AP-Induced Rhythmic Activity 
Power 
Amplitude 
Power Area 
Peak 
Frequency 
GABAA Agonist GABA n.s. n.s. n.s. 
GABAA Agonist Muscimol ↓ n.s. n.s. 
GABAA Agonist THIP ↓ ↓ n.s. 
GABAA PAM L-838,417 ↓ ↓ n.s. 
GABAA Antagonist Bicuculline ↓ ↓ ↑ 
GABAA Antagonist Gabazine ↓ ↓ ↑ 
GABAB Agonist Baclofen ↓ ↓ n.s. 
GABAB Antagonist 2-Hydroxysaclofen ↑ ↑ n.s. 
Glycine Agonist Glycine ↑ ↑ n.s. 
Glycine Antagonist Strychnine ↓ ↓ n.s. 
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Table 5.9 Summary of the actions of each compound applied on the 4-AP-induced 
population spike amplitude and frequency in the SG of the spinal cord slices. ↑ signifies a 
significant increase in that parameter compared to 4-APalone. ↓ signifies a significant 
decrease in the parameter compared to 4AP, and n.s. signifies no significant change in the 
parameter.  
Receptor Selectivity 
and Action 
Compound 
Effect on 4-AP-Induced Population Spikes 
Spike Frequency Spike Amplitude 
GABAA Agonist GABA ↑ ↑ 
GABAA Agonist Muscimol ↓ ↓ 
GABAA Agonist THIP ↓ n.s. 
GABAA PAM L-838,417 n.s. n.s. 
GABAA Antagonist Bicuculline ↓ ↓ 
GABAA Antagonist Gabazine ↓ ↓ 
GABAB Agonist Baclofen ↓ ↓ 
GABAB Antagonist 2-Hydroxysaclofen ↑ ↑ 
Glycine Agonist Glycine n.s. ↑ 
Glycine Antagonist Strychnine ↓ n.s. 
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5.4 Discussion 
The first aim of this chapter was to record hyperexcitability induced by 4-AP in the 
SG of transverse spinal cord slices using extracellular single electrode recordings 
and then perfuse GABAA, GABAB and glycine receptor compounds. There were no 
spikes recorded prior to perfusing the slices with 4-AP, and there was no dominant 
rhythmic activity frequency. 4-AP (25 µM) produced reliable hyperexcitability in the 
SG recordings, but not at maximal activity, therefore allowing for further increases in 
activity with the perfusion of other compounds to be detected, as well as decreases 
in activity. The second aim of this study was to analyse the rhythmic activity of the 
recordings induced by 4-AP, which changed following perfusion of many of the 
compounds investigated. The third aim was to analyse the population spikes that 
occurred in the presence of 4-AP and determine if these were affected by any of the 
compounds investigated. All but one of the compounds applied to the spinal cord 
slices affected the population spikes recorded in the SG.  
 
5.4.1 4-AP Activity and LTP 
Increases in rhythmic activity and population spike parameters could be the result of 
plasticity of the synapses in the network. LTP of synapses has long been known to 
result from an increased frequency or prolonged stimulation at a synapse (Bliss and 
Lomo, 1973). This can arise from an increase in expression of AMPA receptors at 
the synapse as a result of excessive NMDA receptor activation, and/or an increase 
in AMPA receptor conductance and open probability (Manabe et al., 1992, Shi et al., 
1999, Lu et al., 2001, Collingridge et al., 2004). Synaptic strength can occur through 
an increase in the probability of neurotransmitter release or an increase in the 
amount of neurotransmitter released at the synapse (Benke et al., 1998, Banke et 
al., 2000, Tomita et al., 2005). As explained in Chapter 1, rhythmic activity in the 
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spinal DH is thought to be generated though an intrinsically active neuron or by a 
specific network of interneurons. Enhancing depolarisation of the intrinsically active 
neuron or of a network of interneurons in the DH by blocking the potassium 
channels with 4-AP could lead to LTP by alleviating the voltage-dependent block of 
NMDA receptors. This increased NMDA receptor activation would lead to LTP as 
described above. The addition of compounds to the slices could either result in 
further LTP or reverse the process by long-term depression (LTD), which results 
from a reduction in stimulation of a synapse and internalisation of AMPA receptors. 
The two components of the 4-AP-induced activity, population spikes and rhythmic 
activity could occur due to the different components of LTP. For example, an 
increase in rhythmic activity could be the effect of an increase in AMPA receptor 
expression while an increase in population spikes could be due to the increased 
neurotransmitter release. L-838,417, glycine and strychnine only affected the 
rhythmic activity or one of the population spike parameters, which could result from 
their influence in specific components of LTD or LTP. For example, the inhibitory 
effect of stimulating the GABAA or glycine receptors with agonists is likely to reduce 
NMDA receptor activity by repolarisation of the cell membrane. Consequently, this is 
could result in the internalisation of AMPA receptors and therefore LTD of the 
synapses within the network of the spinal DH. The effect may predominantly affect 
the rhythmic activity more than the population spike activity of the network. 
 
5.4.2 GABAA Receptor Agonists Decrease Rhythmic Activity and Population 
Spikes with the Exception of GABA 
Perfusion of GABAA receptor agonists muscimol, THIP and PAM L-838,417 reduced 
either power amplitude or power area parameters, or both of the 4-AP-induced 
rhythmic activity parameters. Only GABA did not significantly change these 
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parameters. The effects of these compounds on the population spikes mostly 
concur with their effects on the rhythmic activity, which suggests that the two 
components of the 4-AP-induced activity are associated. This includes GABA, which 
did not instigate a significant increase the rhythmic activity parameters, but did 
increase population spike amplitude and frequency. However, L-838,417 did not 
have any significant effect on the population spike parameters but did significantly 
decrease both power amplitude and area of the rhythmic activity.  
GABA and agonists of the GABA receptors are typically known for producing an 
inhibitory, hyper-polarising effect in the CNS. However, it is widely accepted that in 
neurons where there is a higher expression of the sodium-potassium-chloride 
cotransporter 1 (NKCC1) and lower KCC2 the effects of GABA are depolarising, 
producing excitation rather than inhibition (Zhang et al., 2006). NKCC1 accumulates 
chloride ions inside the cell, along with sodium and potassium ions to balance the 
electrical charge. KCC2 transporters export a chloride ion along with a potassium 
ion to balance the charge. During early development there is a higher expression of 
NKCC1 and lower expression of KCC2.  It has been shown in rats that from 
postnatal day 14 (P14) the expression of NKCC1 increases until P28, where it starts 
to decline and remains low in adult rats. Whereas in mature neurons there is a 
higher expression of KCC2 and a lower expression of NKCC1, as KCC2 expression 
increases more slowly after birth and remains high in adult rats (Coull et al., 2003, 
Zhang et al., 2006, Asiedu et al., 2012). Changing the expression levels of KCC2 is 
sufficient to switch GABA polarity between inhibitory and excitatory (Lee et al., 
2005, Ben-Ari et al., 2007). In an immature state, when the GABAA receptor 
channels are opened there is an efflux of chloride ions, which depolarises the cell, 
enhancing excitability. In mature, adult rats this is reversed and opening of GABAA 
receptor channels causes inhibition, due to an influx of chloride ions (Figure 5.27). 
The age at which the switch in GABA occurs from being excitatory to inhibitory has 
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not been consistently verified. Furthermore, it has been published that the GABA 
switch is complete at different ages in different regions of the CNS. For example, in 
the rat brainstem the switch in GABA has been reported to occur by P8 
(Balakrishnan et al., 2003). In the rat spinal cord, GABA becomes hyperpolarising 
by P6-7 (Baccei and Fitzgerald, 2004). In the retina there is evidence that the GABA 
switch does not happen until P14-18 (Fischer et al., 1998). In this study the rats 
used were P14, therefore according to previously published data in the spinal cord 
the GABA switch should have occurred and therefore GABA should produce an 
inhibitory effect. This is consistent with the GABAA receptor agonists investigated in 
this study, and the PAM L-838,417, reducing the rhythmic activity and population 
spikes. 
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Figure 5.27 A schematic diagram of the switch in direction of chloride ion flux between immature and mature neurons as a result of a change in the 
expression of the transporters KCC2 and NKCCs. Immature neurons have a higher expression of NKCCs and a lower expression of KCC2s, which 
causes an accumulation of chloride ions inside the neuron. Therefore an opening of GABAA and or glycine receptor channels produces a net efflux 
of chloride ions. The opposite occurs in the mature system where there is a low intracellular chloride ions concentration as a result of an increased 
KCC2 expression and a decreased NKCC expression.  
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The different effect on activity observed with GABA compared to the other GABAA 
receptor agonists could be because it is the endogenous agonist of both the GABAA 
and GABAB receptors. While GABAA receptors tend be located post-synaptically, 
GABAB receptors are located both pre- and post-synaptically (Essrich et al., 1998, 
Yang et al., 2002). Therefore GABAB receptors can either exert their effects by 
inhibiting release of neurotransmitter pre-synaptically or by hyperpolarising the post-
synaptic cell, preventing propagation of action potentials. Therefore, depending on 
the expression of GABAA and GABAB receptors in excitatory and inhibitory neurons 
within the spinal DH network their activation could either produce an overall 
inhibition or excitation of the network. This could explain the different outcome 
observed with perfusion of GABA with the other GABAA receptor agonists which are 
more specific to GABAA than GABAB. The selective GABAA agonists only exert their 
influence on the GABAA receptors while GABA influences the activity of both GABAA 
and GABAB receptors when perfused across the slices. Since GABA perfusion 
increased the population spike frequency and amplitude this could suggest that the 
activation of those GABAA and GABAB receptors located on inhibitory interneurons 
dominated over the actions of GABA at these receptors located on excitatory 
interneurons.  
Alternatively, the perfusion of GABA on the spinal cord slices could result in 
desensitisation of the GABAA and GABAB receptors from excessive stimulation due 
to the high GABA concentration. There is evidence that desensitisation of GABAB 
receptors results in their internalisation (Guetg et al., 2010). A desensitisation of 
GABAB receptors would reduce GABA inhibition as there would be fewer receptors 
for GABA to bind, which could lead to disinhibition in the spinal DH network and 
increase excitability. There is also evidence that excessive GABAA receptor 
activation leads to membrane depolarisation as a result of a collapse in the chloride 
concentration gradient, changing the flux of chloride ions through the GABAA 
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receptors (Staley et al., 1995). This was suggested to result in a depolarisation of 
the membrane and therefore remove the voltage-dependent block of NMDA 
receptors by magnesium. The opening of NMDA receptors would then cause the 
increase in excitability, which was observed with the perfusion of GABA in this 
study. The depolarisation of the membrane by excessive GABAA receptor activation 
has also been shown to be dependent on an efflux of bicarbonate ions, due to the 
increase in intracellular chloride ions from the excessive activation of GABAA 
receptors (Kaila et al., 1997). GABAA receptors are also permeable to bicarbonate 
ions (Kaila and Voipio, 1987).  The efflux of bicarbonate ions through the GABAA 
receptors would lead to the depolarisation of the membrane. 
GABA, muscimol, THIP and L-838,417 also exerts an analgesic effect in in vivo and 
in vitro studies. GABA exerts prolonged analgesia following nerve injury in vivo 
(Eaton et al., 1999). Muscimol also has analgesic effects for both thermal and 
mechanical pain (Miletic et al., 2003). Intrathecal administration of muscimol 
reduces inflammatory pain and allodynia that result from spinal nerve ligation 
(Hwang and Yaksh, 1997, Kaneko and Hammond, 1997). Furthermore, THIP and 
muscimol administration decreases mechanical allodynia following nerve injury 
(Malan et al., 2002, Rode et al., 2005). THIP is selective for extrasynaptic GABAA 
receptors, which typically contain a δ-subunit, particularly receptors composed of 
α4β3δ subunits (Nusser et al., 1998, Brown et al., 2002, Krogsgaard-Larsen et al., 
2004, Shen et al., 2005). In the neocortex and cerebellum THIP increases δ-subunit 
containing GABAA receptor current, producing tonic inhibition (Brickley et al., 1996, 
Drasbek and Jensen, 2006). Since THIP was the only GABAA agonist which did not 
induce any effect on the population spike amplitude in this study, perhaps this is 
related to this compound primarily binding extrasynaptic receptors. Extrasynaptic 
GABAA receptor subtypes have longer decay kinetics, slower desensitisation and a 
higher affinity for GABA which results in a prolonged, tonic inhibition of the neuron 
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(Brickley et al., 1996, Saxena and Macdonald, 1996, Devor et al., 2001, Nusser and 
Mody, 2002). These properties make these extrasynaptic receptors ideal targets for 
novel analgesics, as there is the potential that a lower dose and/or frequency of 
dose could be required reducing treatment-associated side-effects. 
L-838,417 binds to the benzodiazepine site on GABAA receptors. The development 
of this compound was considered a breakthrough in GABA receptor pharmacology 
due to its high subtype-selective efficacy. L-838,417 does not modulate α1-
containing GABAA receptors but enhances GABA response in α2-, α3- and α5-
containing receptors (McKernan et al., 2000). This is highly beneficial for the 
analgesic properties of this compound, as without the efficacy at α1-containing 
GABAA receptors this compound does not display sedative effects like many other 
compounds but retains its properties as an analgesic and anxiolytic. In vivo 
application of L-838,417 has been shown to exert anti-hyperalgesic effects in 
inflammatory and neuropathic pain models (Knabl et al., 2008). Despite the 
numerous advantages of this compound, L-838,417 could not undergo clinical trials 
due to its pharmacokinetic limitations. Since the development of this compound 
others have been designed based on its structure, including CTP-354, which retains 
the advantageous properties of L-838,417 and has improved pharmacokinetics 
(Knabl et al., 2008). CTP-354 is currently undergoing clinical trials for the treatment 
of pain and spasticity resulting from spinal cord injury or multiple sclerosis 
(CoNCERT Pharmaceuticals Inc, 2015). The results presented in this study show 
that L-838,417 application to the spinal cord causes a decrease in the power 
amplitude and area of the rhythmic activity, without affecting the population spikes in 
the spinal DH. Therefore, the analgesic properties of L-838,417 are likely to be the 
result of the change in rhythmic activity of the network. Consequently it could be 
beneficial to design novel analgesics which exert the same effects on these 
rhythmic activity parameters. 
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5.4.3 GABAA Receptor Antagonists Decrease 4-AP-Induced Rhythmic 
Activity and Population Spikes in the SG of the Spinal Cord 
GABAA receptor antagonists bicuculline and gabazine both decreased the power 
amplitude and area, and increased peak frequency of the rhythmic activity. These 
were the only compounds to affect the peak frequency of the rhythmic activity. The 
explanation of the GABAA agonists utilized in this study cannot be extended to the 
antagonist bicuculline and gabazine. These antagonists produced an inhibitory 
effect on the 4-AP-induced hyperexcitability, which is consistent with previously 
published data that have also used this 4-AP model in the spinal DH (Ruscheweyh 
and Sandkuhler, 2003, Chapman et al., 2009). Additionally, bicuculline reduced 4-
AP-induced activity in the neocortex, where similarly almost all spikes were inhibited 
(Aram et al., 1991). The circuitry of the superficial DH network could explain the 
phenomenon of the GABAA agonists and antagonists both producing an inhibitory 
effect on the 4-AP-induced hyperexcitability. There is evidence of synapses 
between two inhibitory interneurons within the spinal DH, as well as synapses 
between excitatory and inhibitory interneurons (Zheng et al., 2010).Figure 5.28 
illustrates two hypothetical series of interneurons in the superficial spinal DH which 
both exist, according to previous reports, on the synapses between interneurons in 
the DH. This explanation relies on GABAA antagonists acting only to inhibit those 
receptors on the second inhibitory interneuron in Figure 5.28B. There is 
considerable evidence for inhibitory interneurons in the spinal cord co-releasing 
GABA and glycine (Bohlhalter et al., 1994). Furthermore, a group of interneurons 
predominantly bicuculline-sensitive (GABA-dominant) and another group primarily 
glycine-dominant have been identified in the superficial spinal DH (Takazawa and 
MacDermott, 2010). If the first inhibitory interneuron in the hypothetical model is 
GABA-dominant and the second is glycine-dominant, this would concur with the 
effects observed with bicuculline and gabazine. The inhibition of the GABAA 
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receptors at the first inhibitory synapse would prevent the second inhibitory 
interneuron being inhibited. However, at the second synapse, inhibition of the 
GABAA receptors would not prevent the inhibition of the postsynaptic excitatory 
interneuron as glycine would be released at this synapse inhibiting the post-synaptic 
interneuron leading to inhibition of the network activity. Inhibitory interneurons in 
laminae I-IIo may be GABA-dominant while those at the lamina II-III boarder are 
mainly glycine-dominant (Inquimbert et al., 2007). The recordings made in this study 
were from lamina II, which is a likely region where there is a crossover, such that 
there are some GABA- and some glycine-dominant interneurons.  
Alternatively the effects of the antagonists could be explained by a depolarising 
block. The blocking of inhibition by the GABAA receptor antagonists could result in 
excessive excitation by the glutamatergic interneurons to the point where the 
glutamatergic receptors reach a depolarising block (Bianchi et al., 2012). However, 
no initial increase in oscillations or population spikes was observed in the recordings 
with these antagonists from the time-point when they were applied to the slices.  
There is evidence that application of 4-AP causes a downregulation of KCC2 
(Rivera et al., 2004). A downregulation of KCC2 in the spinal DH would result in an 
accumulation of chloride ions inside the interneurons, reverting the neurons back to 
a state similar to that of an immature neuron as illustrated in Figure 5.27. 
Consequently this would result in GABAA receptor activation having a depolarising 
effect and therefore blocking this with an antagonist would have an inhibitory effect. 
This would be consistent with the antagonists bicuculline and gabazine exerting an 
inhibitory effect and with the perfusion of GABA having an excitatory effect. 
However, the inhibition of activity seen with the other GABAA receptor agonists does 
not fit with this notion. It is possible that as mentioned previously the actions of 
these compounds could depend on the location of the GABAA receptors at which 
these compounds are effective and the synapses between the interneurons, as 
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proposed in Figure 5.28. If 4-AP does cause a change in the KCC2 expression and 
therefore the intracellular chloride ion concentration switching GABA signalling from 
inhibitory to excitatory, the hypothetical model circuitry proposed in Figure 5.28 
would have to be switched so that the agonists and antagonists actions are 
exchanged compared to those described.  
Bicuculline increases allodynia and produces hypersensitivity, lowering pain 
thresholds (Yaksh, 1989, Sivilotti and Woolf, 1994, Green and Dickenson, 1997, 
Reeve et al., 1998, Sorkin et al., 1998, Malan et al., 2002). In spinal cord slice in 
vitro studies bicuculline has been shown to produce hypersensitivity in DH neurons. 
If bicuculline does produce a decrease in excitability in vivo as has been shown in 
the results presented here then the mechanism by which this effect results in 
enhanced nociception remains to be understood. In understanding this mechanism 
the development of novel analgesics could be revolutionised.  
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Figure 5.28 Hypothetical models to account for the effects observed with the GABAA 
receptor agonists and antagonists. (A) The circuit of two excitatory interneurons intercepted 
by an inhibitory interneuron. In the presence of a GABAA receptor agonist this series of 
interneurons would cause inhibition of the network activity. (B) A circuit where there are two 
inhibitory interneurons in series. Activation of the first inhibitory interneuron would inhibit the 
second preventing the second inhibitory interneuron from inhibiting the post-synaptic 
excitatory interneuron thereby causing an increase in the activity. However, in the presence 
of an antagonist of GABAA receptors, the inhibition of the second interneuron would be 
prevented by the blocking of the GABAA receptors at the synapse. Thereby the second 
inhibitory interneuron can inhibit the postsynaptic excitatory interneuron and thus inhibit 
network excitability. This assumes that the antagonist of the GABAA receptors only works at 
those receptors located on the inhibitory interneuron and not the final postsynaptic excitatory 
interneuron.  
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5.4.4 GABAB Receptor Agonist Inhibits and Antagonist Enhances 4-AP-
Induced Rhythmic Activity and Population Spikes 
The GABAB receptor agonist baclofen produced an inhibitory effect on both the 
rhythmic activity and population spikes. Additionally, the antagonist of the GABAB 
receptor increased the activity. These results correlate with activation of GABAB 
receptor producing hyperpolarisation, by inhibiting calcium channel conductance 
and increasing potassium channel conductance (Chronwall et al., 2001). GABAB 
receptors are located both pre- and post-synaptically, and are predominantly 
expressed in lamina I and II of the spinal DH. Pre-synaptically they inhibit calcium 
channels and therefore prevent the release of neurotransmitters into the synaptic 
cleft while post-synaptically they hyperpolarise the membrane by opening potassium 
channels (Yang et al., 2001). The data of this study imply GABAB receptors are 
involved in modulating the rhythmic activity within the spinal DH as well as the 
population spikes. Baclofen has anti-nociceptive effects in rat models of neuropathic 
pain and has been used clinically as an analgesic and anti-spastic drug (Sokal and 
Chapman, 2003). Baclofen and PAM of GABAB CGP7930 act as analgesics to 
mechanically induced visceral pain (Brusberg et al., 2009). In addition, it is effective 
in the treatment of headache, migraines and trigeminal neuralgia (Hering-Hanit, 
1999, Hering-Hanit and Gadoth, 2000, 2001). Interestingly, the CNS actions of 
baclofen have a more significant role for its analgesic effects than in the periphery 
(Gangadharan et al., 2009). Therefore, the effects of GABAB receptor signalling on 
the spinal DH rhythm and spikes could explain the higher effectiveness of baclofen 
in the CNS as opposed to the periphery.  
The GABAB antagonist 2-hydroxysaclofen can reverse the inhibition and anti-
nociceptive actions of baclofen in vivo (Yajima et al., 2000). There is evidence of 
GABAB receptors controlling the release of transmitter from primary afferents in the 
spinal DH (Marvizon et al., 1999, Ataka et al., 2000). Since GABAB receptors are G-
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protein coupled receptors (GPCRs), they modulate the DH rhythmic activity and 
population spikes by a different mechanism to the ionotropic GABAA receptors. This 
could explain the differences observed between the antagonists of the GABAA 
receptors and the GABAB antagonist 2-hydroxysaclofen. The GABAB receptors 
control the release of GABA from inhibitory interneurons in the spinal DH by 
regulating P/Q-type calcium channels (Yang et al., 2015). Therefore, baclofen 
inhibiting the activity in the DH could act through preventing the inhibition of a 
postsynaptic excitatory interneuron, as illustrated in Figure 5.28A.  
 
5.4.5 Glycine receptor compound effects on spinal dorsal horn activity 
As well as GABA, glycine is known as one of the main inhibitory neurotransmitters 
in the CNS. Similarly to GABA, glycine produced an increase in the 4-AP-induced 
rhythmic activity with the effects being significant for power amplitude and area. 
Glycine also increased population spike amplitude but did not significantly increase 
the frequency. Moreover, the potent glycine receptor antagonist strychnine reduced 
power amplitude and area of the 4AP-induced rhythmic activity. The population 
spike frequency and amplitude were also decreased. This is consistent with the 
GABAA receptor antagonist effects. Therefore, it appears likely that the 
electrochemical gradient of chloride ions is not the same as would be expected in 
an adult. However, glycine is also a co-agonist of the NMDA receptor along with 
glutamate (Papouin et al., 2012). Therefore, application of glycine is likely to 
increase the activity of NMDA receptors which will in turn increase excitation. The 
blocking of the glycine transporters has an analgesic effect in vivo (Haranishi et al., 
2010). By inhibiting glycine transporters the extracellular concentration of glycine 
would increase, creating a similar state to that of applying glycine directly as done in 
this study. This could suggest the mechanism of analgesia in the spinal DH is more 
221 
 
complicated than that proposed in the hypothetical models in Figure 5.28. 
Alternatively the notion that the chloride electrochemical gradient in the slice is 
altered by 4-AP could similarly explain this phenomenon of glycine increasing 
rhythmic activity and population spikes, which concurs with the inhibitory effects of 
strychnine. The study of the role of glycine receptors is difficult due to the lack of 
specific compounds acting at this receptor. Strychnine has long been used to 
separate the effects of GABA from glycine due to its ability to selectively bind the 
glycine receptor. Strychnine causes pain-like behaviour in animals when applied to 
the spinal cord (Yaksh, 1989). Co-release of GABA and glycine from a single 
neuron is known to occur in the superficial spinal DH (Keller et al., 2001). The 
combined release of these neurotransmitters in the DH could be required for their 
optimal effects.  
 
5.4.6 Extracellular Recordings from Spinal Cord Slice Dorsal Horn as a 
Model for Investigating the Network   
This study has illustrated that this model of 4-AP activity in spinal cord slices, 
recorded with extracellular recordings, can be utilised to record rhythmic activity in 
the spinal DH as well as population spikes. The effects of the GABAA, GABAB and 
glycine receptor drugs could also be determined. This recording technique is not 
amenable to fast high-throughput screening, which does hamper its use in the initial 
screening of multiple novel drugs. However, this model does provide a more intact  
DH network platform which is more suited to investigating the physiology of the 
spinal DH, and studying the rhythmic activity. Although the circuitry cannot be 
identified through using extracellular recordings it does provide a mechanism in 
which to study the network as a whole, which is more transferrable to in vivo 
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studies. The spinal DH circuitry is unknown and its complexity limits the predictive 
power of this assay.  
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6 Multi-Electrode Array with Spinal Cord Slices and 
Cultured Dorsal Horn Cells 
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6.1 Introduction 
A MEA typically consists of an arrangement of 60 titanium nitride electrodes 
embedded in a glass base-plate recording area. MEAs come with various 
arrangements of electrodes which can be of different sizes, distances apart and 
arrangements (Multi Channel Systems, Germany). The electrodes on the base 
recording area are surrounded so that there is a chamber in which cells can be 
cultured or slices can be perfused. Each electrode on a MEA detects the 
extracellular field potentials of the surrounding population of cells. Fast voltage 
transients can be detected, which correspond to the combined action potentials of a 
number of neurons in contact with the electrode. This recording technique can be 
done over longer periods of time compared to intracellular recording methods (Spira 
and Hai, 2013). The development of MEA technology is centred on improving our 
understanding of neuronal network connectivity and their physiological function. The 
research of neuronal networks has been limited by the electrophysiological 
techniques available. While extracellular recordings are stable for long duration 
recordings from large populations of cells, intracellular recordings can measure 
subthreshold membrane oscillations and individual cell EPSPs or IPSPs but are less 
stable recordings (Spira and Hai, 2013, Kruskal et al., 2015). Intracellular recording 
from hundreds of individual neurons simultaneously, where individual neurons could 
be stimulated by current injection, would be the ideal technique to facilitate our 
understanding of the involvement of individual neurons in network activity. Currently 
there are a number of approaches which are tackling the development of such a 
technique (Ojovan et al., 2015). Until the development of this technique is finalised, 
MEA technology with slices or cultured cells provides a method by which the activity 
of a neuronal network can be measured simultaneously at multiple sites across the 
slice or cultured cell network (Streit et al., 2001, Xiang et al., 2007, Hill et al., 2010, 
Baltz and Voigt, 2015). The electrodes of an MEA can cover an area of between 
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700 μm2 to 5 mm2 depending on electrode arrangement and electrode size (Multi 
Channel Systems, Germany). Therefore, the firing behaviour across different brain 
regions or multiple spinal laminae of a rodent tissue slice section can be detected 
simultaneously. Furthermore, the synchronicity of activity across a slice or a 
cultured network of cells can also be determined from MEA recordings. The primary 
advantage of this type of extracellular recording over the single electrode recordings 
is that the activity at 60 distinct locations on a tissue slice or culture is recorded 
simultaneously, which enables comparisons to be made between multiple regions.  
As used previously with the single electrode recordings from spinal cord slices, in 
this chapter 4-AP was used to induce activity in the spinal cord slices with the MEA 
recording technique. The 4-AP model of epilepsy has been investigated with MEA 
technology with brain slices (Hill et al., 2010). MEA recordings from hippocampal 
slices have shown that synchronous firing occurs with application of 4-AP (Grosser 
et al., 2014). Grosser et al (2014) also confirmed that GABAergic interneurons 
synchronously fire in these slices. These synchronously firing GABAergic 
interneurons were proposed to be what gave rise to the recorded inhibitory local 
field potentials (LFPs). In this study GABAA, GABAB and glycine receptor agonists 
and antagonists were applied to the acute spinal cord slices and cultured DH cells 
during MEA recordings to explore the roles of these receptors in the spinal DH 
network and provide an indication of the utility of the MEA assay with the two in vitro 
models for screening novel compounds. 
In this chapter MEA spinal cord slice recordings have been compared with the 
single electrode recordings from the DH of spinal cord slices. Consequently, this 
allows for validation of both data sets as well as allowing for a comparison of the 
recordings from the superficial DH with that from the deeper DH laminae and the 
VH. MEA recordings using the cultured DH cells provide a non-invasive 
electrophysiological technique to directly record the electrical activity of the culture 
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network. The MEA recordings from the spinal DH cell culture can be compared with 
that of the spinal cord slices, which will help to determine the potential of this cell 
culture model for investigating the activity of the network of the superficial DH and 
its potential as a screening platform for novel analgesics. Furthermore, the MEA 
recordings performed using the cultured DH cells can also be compared with the 
data obtained from the calcium imaging assays with the culture. The calcium 
imaging experiments provided an indirect method to measure the whole network 
activity and its responses to pharmacological compounds, while the DH culture MEA 
recordings directly measure the electrical activity at multiple sites across the culture.  
 
6.1.1 Aims 
The aims of this investigation using MEA methodology, as applied to both acute 
spinal cord slices and cultured DH cells, were: 
1. To determine whether 4-AP-induced hyperexcitability recorded within SG using 
the single microelectrode method in acute spinal cord slices can be replicated 
under MEA recording conditions.  
2. To use MEA technology to determine more fully the extent and spread of 4-AP-
induced hyperexcitability manifest across superficial and deep DH and VH. 
3. To compare and contrast the effects of glycinergic and GABA-ergic 
pharmacological tools on 4-AP-induced hyperexcitability recorded using either 
the single microelectrode technique or MEA technology  
4. To determine whether inhibition of the potassium chloride cotransporter KCC2 
can modify 4-AP-induced hyperexcitability under MEA conditions 
5. To determine whether spontaneous activity of the cultured DH cells detected 
using the calcium imaging assay additionally manifests as electrical events that 
can be recorded as population field activity using MEA technology. 
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6. To evaluate the effects of glycinergic and GABAergic pharmacological tools on 
spontaneous electrical activity recorded from cultured DH cells using MEA 
technology.  
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6.2 Methods 
6.2.1 Multi-Electrode Extracellular Spinal Cord Slice Recordings 
Traverse lumbar spinal cord slices from Wistar rats (12-16 days old) were cut to a 
thickness of 350 µm and incubated at 32oC in standard, oxygenated aCSF for one 
hour as described previously in Chapter 5. After the incubation period a slice was 
placed into the well of a perforated multi-electrode array (MEA) (Multi Channel 
Systems, Germany). The MEA has 60 3-D microelectrodes arranged on an 8 x 8 
grid, with an internal reference electrode (
 
 
Figure 6.1). The microelectrodes were of low density (electrodes spaced 200 µm 
apart, diameter 40 µm, height 45 µm) and titanium nitrate-coated. Placing the MEA 
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onto the preamplifier headstage platform in the rig the slice could then be seen 
using an inverted CK40 Olympus microscope (Figure 6.2). The slice could be 
moved around the base of the MEA using a pasture pipette with standard aCSF 
solution to push the slice without damaging it and keeping it moist. The slice was 
positioned so that as many electrodes as possible were located on the SG region ( 
Figure 6.3). To prevent the slice moving during the perfusion of the aCSF a harp 
slice grid (ALA Scientific Instruments, USA) was placed on top of the slice using fine 
forceps (Figure 6.3). This improves the contact of the slice with the electrodes 
thereby reducing the noise of the recordings at the electrodes. The MEA was 
clamped to the headstage between a heating element and the MEA1060-Inv-BC-PA 
amplifier. The MEA1060-Inv-BC-PA amplifier was connected to a FA60SBC filter 
amplifier, which in turn was linked to the computer with MC Rack software (Multi 
Channel Systems, Germany) so that the signal can be digitised and the data 
captured for analysis. The temperature of the heating element under the MEA chip 
and that of an inline PH01 perfusion cannula was controlled by a TC02 temperature 
control unit. The temperature of the perfusing solution and the bath solution could 
therefore be maintained at 37oC. A Minipuls 3 peristaltic pump (Gilson, Middleton, 
USA) was used to perfuse the slice at a rate of 1.5-2 ml/min. The perfusion outlet 
was operated by a constant vacuum pump (CVP), with the cannula outlet 
submerged in the bath solution to remove aCSF. Therefore there was a continuous 
flow of fresh, oxygenated aCSF either with or without a compound depending on the 
stage of the experiment in progress. For each slice recording the baseline activity 
was measured for one minute, followed by recording for 25 minutes with aCSF 
containing 4-AP (25 μM). Each compound tested on the slices was perfused for a 
subsequent 25 minutes, made in the aCSF with 4-AP solution. A list of the 
compounds applied and their concentrations can be found in Table 6.1. Each 
compound was typically tested on 6 slices (n) from at least two different rats (N). 
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Table 6.1 List of compounds applied to the spinal cord slices during the MEA recordings, 
with their concentrations, supplier and the solvent utilised to dissolve the substance.  
 
6.2.2 MC Rack MEA Data Analysis 
The MC Rack software was used for the analysis of the MEA recordings. Electrodes 
were selected for analysis based on their location on the slice. Those electrodes 
positioned in the SG region of the superficial spinal DH were used in the analysis 
and compared with the data from electrodes in the deep DH laminae and ventral 
horn (VH) according to the images taken for each recording. The recorded data was 
initially run through a low pass filter with a cut-off frequency of 50 Hz.  A spike sorter 
was used to detect spikes, set at pre-trigger of 100 ms, post-trigger of 200 ms and a 
dead time of 200 ms. The spike threshold level was set at -15 µV, spike analysers 
could then be set up to determine the peak to peak amplitude and rate of firing. 
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Values for these parameters were determined for the data during perfusion of 4-AP 
and during perfusion of 4-AP with the drug of interest added to demonstrate the 
change in activity as a result of the drug applied. Statistical analysis of the data sets 
was performed using Graph Pad Prism 6 (GraphPad Software Inc., California, 
USA). Two-tailed, paired t-tests were used to calculate significance probability 
between the activity with 4-AP application to that with 4-AP and drug. A one-way 
ANOVA with a Tukey post-hoc comparison was utilised to compare data sets of 
each region of the spinal cord, the SG, deep DH and VH. The number of rats 
utilised per compound tested is denoted N, with the number of individual slices 
recorded from for each compound is denoted n. 
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Figure 6.1 (A) A photograph of a perforated MEA probe demonstrating the green plastic 
base plate with a circular glass centre, enclosed within a well. The electrodes are embedded 
within the glass and connected to the gold plates that surround the central well. The pins on 
the headstage of the MEA connect with the gold plates of the array. The photograph was 
taken with an Xperia Z3 camera (Sony, UK). (B) A photograph of the electrodes on the 
central glass base of the MEA, taken with Moticam 100 camera (Motic, Barcelona, Spain). 
(C) An image of the MEA electrodes upon which the slice sits (image is modified from Multi 
Channel Systems, Japan).  
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Figure 6.2 Photographs of the MEA rig setup taken with an Xperia Z3 (Sony, UK). (A) The 
inverted microscope with the preamplifier headstage and Moticam attached. This camera is 
placed in one of the eye pieces of the inverted CK40 Olympus microscope (Olympus, UK) in 
the rig on which the MEA preamplifier is situated. This camera was connected to the 
computer, where Motic Images software was used for image capture. (B) A photograph of 
the preamplifier headstage, consisting of the lower supporting plate and upper amplifier with 
the connecting gold pins which are pressed down on to the MEA probe. The probe is placed 
in the between the supporting plate and the upper preamplifier. The metal plate upon which 
the MEA probe sits is temperature controlled, and set to 37
o
C.  
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Figure 6.3 (A) A photograph of a lumbar spinal cord slice on an 8x8 MEA probe, taken with 
the Moticam 100 camera (Motic, Barcelona, Spain). The SG laminae can be seen as more 
transparent compared to the other laminae and is innervated by three electrodes in each 
hemisphere of the slice which is indicated by arrows. (B) An image of the harp grid used as 
a weight to hold the slice in place over the electrodes on the MEA. The harp weighs 
approximately 0.4 g, consisting of glass-coated steel ring with polyimide-coated silica fibers 
at 1mm spacing. This photograph was taken using an Xperia Z3 camera (Sony, UK).   
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6.2.3 Culturing Embryonic Dorsal Horn Cells on the MED64 Arrays 
The MEA probes used for cell culture were MED64 probes (Alpha MED Scientific 
Incorporated, Japan) (Figure 6.4). These were cleaned, sterilised and coated before 
being used for cell culture. The probes were first treated with 0.1% polyethylenimine 
(Fulka Analytical) diluted in 28 mM Borate Buffer (Fulka Analytical) at pH 8.4 
overnight at room temperature. They were then rinsed with sterile distilled water 3 
times before incubation with PBS (Sigma) containing 10% FBS Gold (PAA) and 
10% horse serum for 1 hour at 37oC. The probes were rinsed with ethanol and left 
to dry in a sterile hood, and then further sterilised by exposure to UV light for one 
hour. Once sterilised the probes were kept in sterile 6 cm petri dishes (Thermo 
Fisher Scientific, UK). As done previously for the plates, the MED64 probes were 
coated with poly-D-lysine (>300,000 MW) for a minimum of 24 hours before use, 
and coated with mouse laminin (0.01 mM) for at least 3 hours before the cells were 
added and kept at 37oC. The tissue dissection from the embryos at E14 and the 
processing for the DH tissue was performed as described previously in Chapter 2. 
Once the cells were added to the MED64 probes with a cell density of 1.5 x 106 
cells/probe, the probes were then pulse spun to 1000 rpm using an eppendorf 
centrifuge (Eppendorf AG, USA). The MED64 probes were kept in the sterile 6 cm 
petri dishes and incubated at 37oC. The same procedure of media changes were 
performed as described for culturing the cells on 96-well plates for up to 14 days.  
  
6.2.4 MED64 Recordings with Cultured Dorsal Horn Cells 
The cultured DH cells on the MED64 probes were recorded at day 12-14 in culture. 
The media was removed and replaced with 1 ml HBSS (-/-) with added calcium 
chloride (1.8 mM) and 1% HEPES, adjusted to pH 7.4 with sodium hydroxide and 
warmed to 37oC. The MED64 array is placed on the MED connector headstage, 
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which has gold contact pins to pick up the signals from the electrodes and transfer 
them to the amplifier (Panasonic SU-MED640). The amplifier is connected to a 
computer with Mobius software (version Win 7 0.3.9) (Alpha MED Scientific Inc., 
Japan) with the Spike Sorter package for data acquisition and analysis. Baseline 
data was recorded for up to 5 minutes at which point a compound was directly 
pipetted into the well of the MEA probe. The signals were then recorded for a further 
5 minutes in the presence of the compound. This time frame was found to be 
sufficiently long enough for all the compounds to exert their effects on the activity of 
the culture and stabilise to allow time of the effects of the compounds on the activity 
of the culture to be recorded. Further compound additions were done in the same 
way, without washing out of the first compound. The compounds utilised in this 
assay were GABA, muscimol, bicuculline, glycine, taurine, strychnine and 
gelsemine. These are the same as those used in the slice MEA recordings as listed 
in Table 6.1, with the addition of taurine which was supplied by Sigma, dissolved in 
dH2O and applied to the cultures at 1 mM. All compounds were diluted in HBSS (-/-) 
to the required concentration so that the final concentration in the well of the MED64 
probe was as stated in the results. The MEA probe DH culture data for each 
compound were obtained from a minimum of two different culture preparations from 
different sets of embryos, except in the case of muscimol where only one of the DH 
cultures on the MEA tested with muscimol displayed spontaneous activity.  
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Figure 6.4 (A) A MED64 probe used to culture the DH cells. It consists of a glass base plate 
with 64 embedded electrodes, which are enclosed in a well. Photograph taken with a Xperia 
Z3 camera (Sony, UK). (B) A photograph of the array of electrodes on the base of the 
MED64 probe, this was taken with an EVOS digital inverted microscope (AMG, Fisher 
Scientific).  
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6.2.5 Analysis of MED64 Recordings with Cultured Dorsal Horn Cells 
All analysis was completed offline with a pre-defined workflow template in the Spike 
Sorter software. Only those electrode channels in which spikes were observed 
either before or after compounds were applied were analysed. Furthermore where 
multiple electrodes were recording from the same cluster of cells, only two of the 
neighbouring electrodes were analysed as they were considered to be identical 
recordings from the same cells. These data were filtered with a 50 Hz filter.  Using 
the analysis template, spikes were detected according to a chosen threshold and 
grouped according to their waveform similarity. For a distinct waveform type to be 
classified as a cluster there had to be a minimum of 5 spikes that meet the same 
waveform criteria determined by the software programme script. The threshold for 
spike detection was between ±10 μV. The spike frequency was determined for the 
baseline data and in the presence of each compound. The effects of the compounds 
on the cells was found to occur within 30 seconds following addition, therefore the 
full 5 minutes of recording in the presence of the compound was used to determine 
the spike frequency. On the MED64 system the compounds could not be washed 
off, therefore the activity of the culture during consecutive compound additions is 
overcoming the effects of the previous compound. The spike frequencies between 
the baseline section and those sections of the recording with compounds were 
compared with a paired one-way ANOVA followed by Tukey’s multiple comparisons 
test using GraphPad Prism 6 (GraphPad Software, Inc.). The graphs are displayed 
with significance stars, where * indicates p<0.05, ** signifies p<0.01 and *** 
indicates p<0.001. All graphs are plotted with the mean ± S.E.M. The number of 
individual preparations is denoted N, with the number of MEA recordings from the 
cultured DH cells is denoted n. The total number of electrodes from all the MEA 
recordings for each experiment included in the analysis is denoted e.  
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6.3 Results  
6.3.1 MEA Recordings Show 4-AP Induces Population Spikes throughout 
the Dorsal Horn and Ventral Horn of Spinal Cord Slices 
The MEA recordings from acute spinal cord slices illustrate that 4-AP induces 
population spikes, similar to those observed in the single electrode extracellular 
recordings. The 4-AP activity across the spinal cord slices was compared by 
combining data from 28 MEA slice recordings. The mean spike amplitudes and 
spike frequencies were determined for the SG, deep DH and VH for the 4-AP-
induced activity (Figure 6.5). The spike amplitude and frequency in the SG region 
were not significantly different to those found in the deep DH. However, the mean 
population spike frequency and amplitude in the VH were significantly lower than 
that recorded in the SG and deep DH. The MEA slice recordings demonstrated that 
the population spikes have a highly synchronised firing pattern across each of the 
hemispheres of the slice. Typically it could be seen that the right and left DH 
hemispheres of the slice had their own synchronous activity but are not 
synchronous with each other (Figure 6.6).  
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Figure 6.5 4-AP-induced activity in the SG, deep DH and VH of spinal cord slices on the 
MEA (N=15, n=28). The mean population spike amplitude (A), and the mean population 
spike frequency (B), calculated for the SG, deep DH and VH. 
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Figure 6.6 The incidence of spikes at each electrode at a single 1 second time point in a 
MEA recording from a spinal cord slice perfused with 4-AP. (A) Each box represents one 
electrode of the MEA array, which is numbered according to the column and row in which it 
is situated. For example electrode 34 is located in column 3, row 4 of the array. The location 
of each electrode on the spinal cord slice from which the recording was made can be seen in 
(B). When a spike is detected at an electrode according to a set threshold, the 
corresponding box becomes coloured according to the pseudo-colour map shown. The 
larger the spike amplitude, the further to the right of the pseudo-colour map the box 
becomes (A). At the 1 second time point of this example, the electrodes recording from the 
SG (12, 22, 32, 52, 62, 72 and 82) and deeper DH laminae (electrodes 13-84) have each 
detected a population spike. Therefore, this illustrates the synchronous firing across the DH 
networks, which are not synchronous with the VH.  
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6.1.1.1 GABAA Receptor Agonists and Antagonists Modulate the 4-AP-Induced 
Activity 
Pharmacological tools were used to probe whether GABAA receptor signalling 
contributes to the 4-AP-induced activity within the SG, seep DH and VH. This was 
investigated using the agonists GABA, muscimol and THIP and the antagonists 
bicuculline and gabazine. Perfusion of GABA (50 μM) significantly increased the 
amplitude and spike frequency induced by 4-AP in the SG, deep DH and VH (Figure 
6.7). Similarly application of THIP (gaboxadol) (50 μM) significantly increased the 4-
AP-induced spike amplitude and frequency in each of the three regions analysed, 
except the spike frequency in the VH (Figure 6.8). The GABAA receptor agonist 
muscimol (10 μM) significantly decreased 4-AP-induced spike amplitude and 
frequency across the spinal cord slices in the DH and VH (Figure 6.9). The GABAA 
receptor antagonist bicuculline (50 μM) significantly decreased the 4-AP-induced 
population spike amplitude and frequency in the SG and deep DH, but had no 
significant effect in the VH (Figure 6.10). Gabazine exerted similar effects to 
bicuculline, significantly decreasing the 4-AP-induced spike frequency and 
amplitude in the SG and deep DH. Additionally, gabazine decreased the spike 
frequency and amplitude in the VH (Figure 6.11).  
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Figure 6.7 The average spike amplitudes and frequencies in the SG, deep DH and VH 
regions of the spinal cord slices determined from MEA recordings during the perfusion of 4-
AP and 4-AP with GABA (50 µM) (N=3, n=6). (A), (C) and (E) illustrate the population spike 
amplitudes in the SG, deep DH and VH respectively during the perfusion of 4-AP and 4-AP 
with GABA. (B), (D) and (F) show the spike frequency data in the SG, deep DH and VH 
respectively during the perfusion of 4-AP and 4-AP with GABA. 
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Figure 6.8 The mean population spike amplitude and frequency in the SG, deep DH and VH 
of the spinal cord slices determined from MEA recordings during the perfusion of 4-AP and 
4-AP with THIP (50 µM) (N=3, n=7). (A), (C) and (E) demonstrate the spike amplitude data 
in the SG, deep DH and VH respectively during the perfusion of 4-AP and subsequent 
perfusion of 4-AP with THIP. (B), (D) and (F) show the population spike frequency data in 
the SG, deep DH and VH respectively during the perfusion of 4-AP and then with 4-AP with 
THIP.  
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Figure 6.9 The average population spike amplitude and frequency during the perfusion of 4-
AP and 4-AP with muscimol (10 µM) in the SG, deep DH and VH of the spinal cord slices 
measured from MEA recordings (N=3, n=6). (A) The mean spike amplitude and (B) the 
mean spike frequency in the SG of the spinal DH during 4-AP perfusion and during the 
subsequent perfusion of 4-AP with muscimol. In the deep DH region of the spinal cord slice 
(C) the mean spike amplitude and (D) spike frequency in the presence of 4-AP and 4-AP 
with muscimol. The 4-AP and 4-AP with muscimol mean population spike amplitude (E) and 
spike frequency (F).  
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Figure 6.10  The average population spike amplitude and frequency in the SG, deep DH 
and VH of spinal cord slices recorded using the MEA during the perfusion of 4-AP and then 
with 4-AP with bicuculline (50 µM) (N=4, n=8). (A), (C) and (E) show the population spike 
amplitudes in the SG, deep DH and VH respectively. (B), (D) and (F) show the population 
spike frequencies in the SG, deep DH and VH respectively.  
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Figure 6.11 The average population spike amplitude and frequency recorded from the SG, 
deep DH and VH of spinal cord slices on the MEA during perfusion of 4-AP and 4-AP with 
gabazine (10 µM) (N=2, n=4). (A), (C) and (E) illustrate the spike amplitude data in the SG, 
deep DH and VH respectively. (B), (D) and (F) demonstrate the spike frequency data in the 
SG, deep DH and VH regions respectively.  
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6.1.1.2 GABAB Receptor Agonist and Antagonist Modulate the 4-AP-Induced 
Activity 
GABAB agonist baclofen and antagonist 2-hydroxysaclofen were applied to the 
slices on the MEA probes to determine if GABAB receptor signalling is involved in 
controlling the hyperexcitability in the spinal DH. Baclofen significantly reduced the 
amplitude and frequency of the population spikes induced by 4-AP in the SG and 
deep DH (Figure 6.12). In the VH, baclofen significantly reduced amplitude but had 
no effect on spike frequency. The antagonist 2-hydroxysaclofen significantly 
increased the spike amplitudes in the SG, deep DH and VH. However, 2-
hydroxysaclofen did not change the frequency in any of these regions (Figure 6.13). 
 
6.1.1.3 Glycine Receptor Agonists and Antagonists Modulate the 4-AP-Induced 
Activity 
Glycine (1 mM) significantly increased the spike amplitude and rate in the superficial 
SG region, deep DH and in the VH (Figure 6.14). The glycine receptor antagonist 
strychnine, highly selective for glycine receptors over GABA receptors, also 
significantly increased population spike amplitude and rate in all these three regions 
of the spinal cord slices (Figure 6.15). Gelsemine produced a significant decrease in 
4-AP-induced population spike amplitude and frequency in the SG region of the 
spinal DH. In the deep DH the frequency was also significantly reduced, however 
the spike amplitude was significantly increased. Furthermore, gelsemine did not 
have any effects on the 4-AP activity in the VH of the spinal cord slices (Figure 
6.16).  
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6.1.1.4 KCC2 Inhibitor VU0240551 Increases 4-AP-Induced Activity 
The application of the KCC2 inhibitor VU0240551 to the spinal cord slices increased 
spike amplitude in the SG, deep DH and VH regions. However this inhibitor had no 
influence on the rate of spike firing in the DH. VU0240551 increased the frequency 
of firing in the VH although the firing frequencies here were very low. There were no 
spikes in the VH with 4-AP perfusion alone in these slices, and the addition of 
VU0240551 only increased firing frequency to between 0.02 and 0.08 Hz in 6 of the 
VH electrodes (Figure 6.17).  
A summary of the effects of all the GABAA and GABAB receptor compounds on the 
4-AP-induced activity recorded from the spinal cord slices on the MEA can be found 
in Table 6.2. A summary of the effects of the glycine receptor agonist and 
antagonist, and the KCC2 inhibitor VU 024551 on the 4-AP-induced activity in the 
spinal cord slices on the MEA can be found in Table 6.3. 
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Figure 6.12  The mean population spike amplitude and frequency in the SG, deep DH and 
VH during perfusion of 4-AP and 4-AP with baclofen (10 μM) recorded with the MEA (N=3, 
n=7). (A) and (B) show the data for the SG during perfusion of 4-AP and then 4-AP with 
baclofen. (C) and (D) illustrate the data for the deep DH and (E) and (F) show the data for 
the VH.  
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Figure 6.13  The mean population spike amplitude and frequency during perfusion of 4-AP 
and 4-AP with 2-hydroxysaclofen (10 µM) in SG, deep DH and VH of the spinal cord slice 
during the MEA recordings (N=2, n=4). (A), (C) and (E) show the mean spike amplitude 
values in the SG, deep DH and VH during the perfusion of 4-AP and 4-AP with 2-
hydroxysaclofen. (B), (D) and (F) demonstrate the spike frequency data in the SG, deep DH 
and VH during perfusion of 4-AP and 4-AP with 2-hydroxysaclofen. 2-hydroxysaclofen only 
influenced the spike amplitude and not the frequency of the 4-AP-induced activity. 
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Figure 6.14  The mean population spike amplitude and frequency in the spinal cord slices 
recorded with the MEA during the perfusion of 4-AP and 4-AP with glycine (1 mM) (N=2, 
n=6). (A), (C) and (E) illustrate the spike amplitude data in the SG, deep DH and VH 
respectively, during perfusion of 4-AP and then 4-AP with glycine. (B), (D) and (F) show the 
mean spike frequency values in the SG, deep DH and VH during the perfusion of 4-AP and 
4-AP with glycine.  
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Figure 6.15  The mean population spike amplitudes and frequencies in the SG, deep DH 
and VH regions of the spinal cord slices during perfusion of 4-AP and 4-AP with strychnine 
(10 µM) recorded using the MEA (N=4, n=10). (A), (C) and (E) illustrate the spike amplitude 
data for the SG, deep DH and VH during the perfusion of 4-AP and then 4-AP with 
strychnine. (B), (D) and (F) shown the spike frequency values in the SG, deep DH and VH 
during perfusion of 4-AP and then with 4-AP and strychnine. Strychnine increased both 
spike frequency and amplitude across the spinal cord slices. 
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Figure 6.16  The mean population spike amplitudes and frequencies recorded from spinal 
cord slices using the MEA during perfusion of 4-AP and 4-AP with gelsemine (30 µM) (N=2, 
n=4). (A) and (B) show the spike amplitude and frequency respectively in the SG region of 
the spinal cord slices. (C) and (D) show the mean spike amplitude and frequency, 
respectively, in the deep DH. (E) and (F) illustrate the mean spike amplitude and frequency, 
respectively, in the VH of the spinal cord slices.  
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Figure 6.17  The mean population spike amplitudes and frequencies from the SG, deep DH 
and VH regions of spinal cord slices recorded from using the MEA during perfusion of 4-AP 
and 4-AP with VU 0240551 (30 µM) (N=2, n=5). (A), (C) and (E) show the population spike 
amplitude data in the SG, deep DH and VH during the perfusion of 4-AP and 4-AP with VU 
0240551. (B), (D) and (F) illustrate the population spike frequency data in the SG, deep DH 
and VH during perfusion of 4-AP and then 4-AP with VU 0240551.  
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 SG Deep DH VH 
 Amplitude Frequency Amplitude Frequency Amplitude Frequency 
GABA ↑ ↑ ↑ ↑ ↑ ↑ 
THIP ↑ ↑ ↑ ↑ ↑ n.s 
Muscimol ↓ ↓ ↓ ↓ ↓ ↓ 
Bicuculline ↓ ↓ ↓ ↓ n.s n.s 
Gabazine ↓ ↓ ↓ ↓ ↓ ↓ 
Baclofen ↓ ↓ ↓ ↓ ↓ n.s 
2-Hydroxysaclofen ↑ n.s ↑ n.s ↑ n.s 
 
Table 6.2 A summary of the effects on the 4-AP induced activity by the GABAA and GABAB 
receptor agonists and antagonists applied to the spinal cord slices on the MEA. ↑ indicates a 
significant increase, ↓ is a significant decrease and n.s stands for no significant change in 
the 4-AP activity. 
 
 SG Deep DH VH 
 Amplitude Frequency Amplitude Frequency Amplitude Frequency 
Glycine ↑ ↑ ↑ ↑ ↑ ↑ 
Strychnine ↑ ↑ ↑ ↑ ↑ ↑ 
Gelsemine ↓ ↓ ↑ ↓ n.s n.s 
VU0240551 ↑ n.s ↑ n.s ↑ ↑ 
 
Table 6.3 A summary of the effect of the glycine receptor agonist and antagonists and the 
KCC2 inhibitor on the 4-AP-induced population spikes in the SG, deep DH and VH of the 
spinal cord slices recorded from using the MEA. ↑ indicates a significant increase, ↓ is a 
significant decrease and n.s stands for no significant change in the 4-AP activity. 
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6.3.2 MEA Recordings with Cultured Dorsal Horn Cells Detect Spontaneous 
Activity 
It was exceptionally challenging to achieve healthy, spontaneously firing cells when 
culturing the DH cells on the MED64 probes. One of the main problems was that a 
large proportion of the cells did not adhere to the surface of the probes. A number of 
factors were optimised to solve this issue. Firstly, centrifugation of the probes after 
plating the cells improved adhesion of the cells to the base of the arrays. Secondly, 
a higher molecular weight poly-D-lysine coating was utilised, which also aided cell 
adhesion. As observed with the spinal DH culture on the 96-well plates, the density 
of cells in the wells has a huge impact on the health of the culture and the 
spontaneous firing. Therefore it was difficult to obtain spontaneous firing of the 
cultures on the MED64 probes, as after 12-14 days in culture there were often 
significantly fewer cells remaining due to poor cell adhesion. Despite these 
complications, there were a number of healthy cultures on the MED64 probes which 
did display spontaneous firing (Figure 6.18). An example of the spontaneous activity 
of the DH cultures recorded with the MED64 MEA is illustrated in Figure 6.19.  
 
6.3.2.1 The Spontaneous Activity of the Spinal Dorsal Horn Culture was Modulated 
by GABAA and Glycine Receptor Agonists and Antagonists 
The spike frequency detected from the baseline spontaneous firing of the culture on 
the MED64 was variable between different cultures. The mean frequency of 
spontaneous firing determined from combining all recordings from the MED64 was 
0.45 ± 0.08 Hz (N=9, n=13). Due to the limited number of MED64 probes with 
successful cultures only a select number of compounds were investigated. GABA 
receptor agonist GABA (50 μM) significantly reduced the spontaneous firing 
frequency by 60.3% from 0.96 ± 0.05 to 0.38 ± 0.05 Hz. Subsequent addition of 
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bicuculline (50 μM) to the culture increased spike frequency by 71 ± 9.82% 
compared to the frequency observed during GABA alone (Figure 6.20). The GABAA 
receptor-specific agonist muscimol (10 µM) was also applied to the culture. This 
abolished almost all spontaneous spikes from 921 spikes in 300 seconds of 
baseline recording, to 5 spikes in the following 300 seconds in the presence of 
muscimol. Bicuculline (100 µM) was applied after the addition of muscimol and 
which restored some of the spike firing (538 spikes) (Figure 6.21). Table 6.4 
summarises the results from the spinal DH cultures on the MED64 and the effects of 
the GABAA receptor compounds. 
To investigate the role of glycine receptor signalling on the DH culture electrical 
activity, agonists glycine and taurine, and antagonists strychnine and gelsemine 
were applied. Glycine (1 mM) significantly reduced spontaneous firing frequency by 
64.6 ± 0.03% (Figure 6.22). Subsequent addition of gelsemine increased spike 
frequency by 56.5 ± 0.06% to a frequency that was not significantly different to the 
baseline firing rate (Figure 6.22). Taurine (1 mM) did not significantly change the 
spike frequency, but did decrease the baseline frequency by 14 ± 0.04%. Strychnine 
(10 μM) significantly increased spike frequency by 52.4 ± 0.11% compared to the 
frequency in the presence of taurine (Figure 6.23). Table 6.5 summarises the results 
of the glycine receptor agonists and antagonists on the spinal DH cultures on the 
MED64 probes.  
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Figure 6.18 An image of the embryonic spinal DH culture on a MED64 probe after 13 DIV. 
Despite the clustering of the cells, spontaneous electrical activity was detected from those 
electrodes in direct contact or located next to the cell clusters. The image was taken with an 
EVOS inverted microscope (AMG, Fisher Scientific).  
260 
 
A 
 
 
B 
 
 
Figure 6.19 (A) A section of a recording from a MED64 probe with the DH culture at day 12, showing the baseline spontaneous activity. The two 
horizontal white lines indicate the threshold level for spike detection (10 μV). The vertical coloured lines are those highlighted spikes that have 
reached the threshold level. The different colours represent each of the different classes of spikes, categorised according to their waveform 
similarity. (B) The spike frequency profile throughout a full recording from the DH cells on the MED64. Each dot represents the number of spikes at 
that time point. The colours correspond to the different classes of spikes as shown in (A). Each section of the recording is indicated by the vertical 
yellow lines at which point the compounds were added, in this case GABA (50 μM) at 300 seconds and bicuculline (50 μM) at 600 seconds.
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Figure 6.20 Embryonic spinal DH culture recording on the MED64, with GABA 
receptor agonist and antagonist application. (A) A trace of spike frequency 
against time from one electrode of a MED64 probe with cultured DH cells at 12 
DIV. The first 300 seconds show the spontaneous firing activity. Each dot 
represents the number of spikes occurring at that time point. The colours 
represent the different classes of spikes, grouped according to their waveform 
similarity. The following 300 seconds demonstrates the reduction of spikes in 
the presence of GABA (50 μM) which was added at the 300 second time point. 
The final 300 seconds shows the activity with addition of bicuculline (50 μM) 
which was applied at the 600 second time point, without washing off the 
previously applied GABA.  (B) The mean spike frequency (±SEM) during each 
of the sections illustrated in (A) (N=2, n=3, e=8). 
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Figure 6.21 A MED64 recording with the spinal DH culture 
where muscimol and bicuculline are applied to the culture. (A) 
The spike frequency profile against time of a recording from the 
DH culture on the MED64. The first section of the recording 
shows the baseline spontaneous activity, which is followed by 
the addition of muscimol (3 μM). Therefore, the second section 
of the recording is the activity of the culture in the presence of 
muscimol. The final section is in the presence of bicuculline (100 
μM), which restores the population spikes. (B) The spike 
frequency of each of the sections of the data shown in (A) (N=1, 
n=1, e=1).  
263 
 
A
 
B 
 
 
Figure 6.22 The effect of glycine and gelsemine on the spinal DH culture 
electrical activity using the MED64. (A) An example from one electrode of the 
MED65 probe of the profile of the spike frequency against time. The first section 
of the recording illustrates the DH culture baseline activity. The second section is 
the DH culture activity in the presence of glycine (1 mM) and the final section is 
the activity in the presence of gelsemine (50 μM). (B) The mean spike frequencies 
recorded for each of the sections of the recordings described in (A) from the DH 
cultures on the MED64. (N=4, n=6, e=35). 
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Figure 6.23 The effect of taurine and strychnine on the DH cultures on 
the MED64. (A) An example profile from one electrode of a recording with 
taurine and strychnine. The spontaneous baseline activity is shown in the 
initial section, followed by the spike frequency of the culture in the 
presence of taurine (1 mM). The final section of the trace is the spinal DH 
culture activity in the presence of strychnine (10 μM). (B) The mean spike 
frequencies of the DH culture recorded at each electrode for the three 
sections of the recordings described in (A) (N=2, n=3, e=8). 
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Table 6.4 A summary table of the effects of the GABAA receptor agonist and antagonists 
applied to the spinal DH cultures on the MED64 probes. ↑ signifies a significant increase in 
spike frequency and ↓ indicates a significant decrease in spike frequency. 
 
 Spike Frequency 
Glycine ↓ 
Taurine n.s 
Strychnine ↑ 
Gelsemine ↑ 
 
Table 6.5 A summary table of the effects of the glycine receptor agonists and antagonists on 
the spinal DH culture activity recorded using the MED64. ↑ signifies a significant increase in 
the DH culture spike frequency, ↓ indicates a significant decrease in spike frequency and n.s 
signifies no significant change in spike frequency.  
  
 Spike Frequency 
GABA ↓ 
Muscimol ↓ 
Bicuculline ↑ 
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6.4 Discussion 
6.4.1 MEA Spinal Cord Slice Recordings Detected 4-AP-Induced Activity 
Throughout all Laminae of the Dorsal and Ventral Horns 
Hyperexcitability 
Utilising MEA technology with the acute spinal cord slices enabled the 
measurement of activity to be made at multiple sites from within a single laminae of 
the slice and across many different lamina simultaneously. Therefore the activity 
from the SG, deep DH and VH of the spinal cord slices could be measured 
simultaneously. Furthermore, obtaining data from multiple recording sites within the 
SG results in greater statistical power of the data compared to the single electrode 
recordings as described in Chapter 5. As shown previously in Chapter 5, there was 
no spontaneous firing in the spinal cord slices recorded during the baseline period 
prior to 4-AP perfusion. This is consistent with previous reports from spinal cord 
slice recordings where there was a very low incidence of spontaneous activity or 
none at all (Ruscheweyh and Sandkuhler, 2003, Taccola and Nistri, 2005). The 
results presented in this chapter illustrate that 4-AP can be used to induce a 
hyperexcitable state comparable to that which occurs in in vivo pain models 
(Takaishi et al., 1996, Chapman et al., 1998b, Ruscheweyh and Sandkuhler, 2003, 
Urch and Dickenson, 2003, Quinn et al., 2010). This hyperexcitability was similarly 
observed in the single electrode recordings from the spinal cord slices as presented 
in Chapter 5. Importantly, the MEA slice recordings completed for this chapter 
demonstrate that the activity induced by 4-AP in the spinal cord slices manifests 
more prominently in the DH than the VH (Figure 6.5). In the VH, 4-AP has been 
previously demonstrated to induce repetitive firing which has been identified to not 
be influenced by the DH 4-AP-induced activity but can be modulated by the 
locomotor central pattern generator network activity (Taccola and Nistri, 2005). 
Furthermore, synchronicity of the 4-AP-induced activity was detected within one DH 
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region but little coherence between the two DH regions. Additionally, there was little 
synchronicity between the DH and VH. These findings are consistent with previous 
reports from hemisected spinal cord slices (Taccola and Nistri, 2005).  
The subsequent increase in release of GABA from inhibitory interneurons activates 
postsynaptic GABAA receptors, and an influx of chloride ions. The increase in 
intracellular chloride ion concentration activates KCC2 co-transporters, which 
causes an efflux of potassium and chloride ions (Viitanen et al., 2010). This 
potassium ion efflux increases the extracellular potassium ion concentration, which 
has been detected following 4-AP application to hippocampal slices (Morris et al., 
1996). Transient increases in extracellular potassium ion concentration have been 
suggested to initiate the depolarisation of neighbouring neurons as well as shifting 
the reversal potential of GABAA receptors to a more positive potential resulting in 
weaker GABAergic inhibition (Avoli and de Curtis, 2011). Therefore, these 
mechanisms increase neuronal excitability, and suggest how 4-AP initiates 
epileptiform activity in CNS networks. By linking this mechanism with the previously 
described ING and PING networks for generating rhythmic oscillations, the increase 
in neuronal excitability by 4-AP could be the drive for these networks which then 
synchronise neuronal firing and generate the oscillations.  
The higher spike frequency and amplitude recorded from the DH compared to the 
VH of the lumbar spinal cord slices could be the result of a lower expression of 
KCC2 in the VH (Javdani et al., 2015). A lower expression of KCC2 in the VH would 
result in less efflux of chloride and potassium ions following application of 4-AP and 
consequently less neighbouring neurons in the network would be depolarised, 
lessening the excitatory drive for the generation of rhythmic activity. Alternatively, 
there is a lower expression of a number of GABAA receptor subunits in the VH 
compared to the DH (Paul et al., 2012). This could similarly be the cause of the 
reduced 4-AP-induced activity in the VH as there would be less influx of chloride 
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ions through the reduced number of GABAA receptors resulting in a diminished 
activation of KCC2 co-transporters. Therefore, there would be a smaller increase in 
extracellular potassium ion concentration and a smaller excitatory drive for the 
generation of rhythmic oscillations in the VH.  
 
6.4.2 4-AP-Induced Activity in Spinal Cord Slices is Modulated by GABAA 
Receptor Agonists and Antagonists 
The GABAA receptor agonist GABA and the partial agonist THIP both enhanced the 
4-AP-induced population spike frequency and amplitude in the SG, deep DH and 
VH. The increase in excitability observed with the application of these GABA 
receptor agonists could be the result of an increase in activity of the KCC2 co-
transporter as a result of a large increase in intracellular chloride ions following 
GABAA receptor stimulation by the applied GABAA receptor agonists. As described 
previously this may result in an increase in extracellular potassium ion concentration 
which subsequently depolarises neighbouring neurons (Avoli and Jefferys, 2015). 
Furthermore, blocking GABAA receptors with antagonists would have the opposite 
effect, as was observed in the bicuculline and gabazine recordings. However, there 
is evidence that 4-AP downregulates KCC2 expression (Rivera et al., 2004). A 
downregulation of KCC2 would result in an accumulation of chloride ions inside the 
neurons, consequently causing the activation of GABAA receptors to produce an 
efflux of chloride ions and therefore depolarisation and an increased excitability. 
This downregulation of KCC2 by 4-AP could similarly explain the decrease in 4-AP-
induced activity observed with GABAA receptor antagonists bicuculline and 
gabazine. In the case of a downregulation of KCC2 and consequently an increase in 
intracellular chloride ions, the blocking of GABAA receptors would prevent the efflux 
of chloride ions and therefore decrease neuronal excitability. Under normal in vivo 
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conditions bicuculline has been shown to cause hypersensitivity and allodynia in 
rats (Yaksh, 1989). Assuming that the effects of the currently investigated GABAA 
compounds are reversed in the in vitro spinal cord slice model due to changes in the 
chloride electrochemical gradient by 4-AP, the results could be considered 
equivalent to the published in vivo data.  
Interestingly the GABAA receptor agonist muscimol significantly decreased 
population spike frequency and amplitude in the SG, deep DH and VH. This is 
opposite to the effects of GABA application, which could be explained through 
GABA also binding to the GABAB receptor. Alternatively, as GABA is the 
endogenous agonist, dramatically increasing the concentration of GABA 
extracellularly could initiate changes intracellularly to prevent further production or 
increase uptake and degradation of GABA which may over compensate and prevent 
any GABA inhibition.  Muscimol and bicuculline have previously been shown to both 
decrease spinal network activity in vitro (Yoon et al., 2010). Furthermore, muscimol 
decreases activity in the spinal cord of rats with a spinal cord injury, which can be 
reversed by bicuculline (Wakai et al., 2005, Miyazato et al., 2008). Therefore, there 
is potentially an alternative mechanism for the activation of GABAA receptors to 
cause a loss of 4-AP-induced activity in the spinal cord networks. For example, a 
decrease in intracellular chloride ion concentration has been linked with the intrinsic 
pathway of apoptosis (Heimlich and Cidlowski, 2006). Therefore, an excessive block 
of GABAA receptors with bicuculline could decrease the intracellular chloride ion 
concentration, which could lead to cell death or possibly a loss of activity of the 
neurons in the spinal cord slice consequently reducing activity.  
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6.4.3 4-AP Activity in Spinal Cord Slices is Modulated by GABAB Receptor 
Agonist Baclofen and Antagonist 2-Hydroxysaclofen 
GABAB receptor agonist baclofen significantly decreased 4-AP induced spike 
amplitude and frequency in the SG and deep DH. In the VH, baclofen significantly 
decreased spike amplitude but not spike frequency. Baclofen is used clinically as an 
anti-spastic agent and muscle relaxant (Capek and Esplin, 1982, Miyazato et al., 
2008, Kuroiwa et al., 2009). There is also evidence that GABAB receptors are 
involved in the pain pathway in both the periphery and in the spinal DH (Allerton et 
al., 1989, Liu et al., 2014, Huang et al., 2015). Baclofen exerts an analgesic effect in 
rodent pain models, including orofacial formalin model and chronic constriction of 
the sciatic nerve (Franek et al., 2004, Nowak et al., 2013). Therefore, the results 
presented here are consistent with previously reported in vivo and in vitro data with 
baclofen reducing neuronal excitability. The GABAB antagonist 2-hydroxysaclofen 
significantly increased spike amplitude in the SG, deep DH and VH, however there 
was no effect recorded on the spike frequency in any of these regions. This 
increase in excitability was reported previously where 2-hydroxysaclofen reversed 
the effects of baclofen (Curtis et al., 1988). Since 2-hydroxysaclofen did not affect 
the spike frequency and only amplitude, it is possible that there are different 
mechanisms that modulate these different components of the population spikes. For 
example, as discussed previously the frequency of the spikes could be determined 
by the network and the gating of activity by GABAergic and glycinergic interneurons. 
The amplitude of the population spikes could be dependent on synaptic strength, 
which has been previously illustrated for GABAA receptor signalling (Chapman et 
al., 1998a).  
 
271 
 
6.4.4 4-AP Activity in Spinal Cord Slices is Modulated by Glycine Receptor 
Agonist and Antagonists 
Application of glycine to the spinal cord slices on the MEA significantly increased 
the 4-AP-induced population spike amplitude and frequency in the SG, deep DH 
and VH. This was also shown with the single electrode recordings from the DH of 
spinal cord slices presented in chapter 5. Furthermore, the same effect was 
observed with the GABAA receptor agonists GABA and THIP. Therefore, the 
increase in activity in the presence of glycine could similarly be explained by a 
change in the electrochemical gradient of chloride ions as a result of a 
downregulation of KCC2 in the presence of 4-AP. Or the increased activation of 
glycine receptors could add to the increased intracellular chloride ion concentration, 
as similarly described for GABA. This could then increase KCC2 activity to produce 
an increase in extracellular potassium ion concentration, which depolarises nearby 
neurons thus increasing network activity. Alternatively, glycine is also a co-agonist 
at the NMDA receptor, in addition to glutamate (Papouin et al., 2012). When 
activated under normal physiological conditions, NMDA receptors produce 
depolarisation of the cell and thus result in an increase in cell excitability (Chen et 
al., 1997). Therefore, the increased extracellular glycine concentration in the spinal 
cord slices could also produce an increase in the probability of NMDA receptor 
channel opening, which would consequently increase excitability which was 
detected with the perfusion of glycine. However, glycine is only a co-agonist of 
extrasynaptic NMDA receptors (Papouin et al., 2012), which could be less involved 
in the generation of synchronous network activity in the spinal DH. Furthermore, 
previous reports using this model have shown that inhibiting NDMA receptors with 
antagonist AP5 had no significant effect on 4-AP activity (Chapman et al., 2009). 
This suggests that the NMDA receptor does not have a major role in the 4-AP-
induced activity within the spinal DH. Therefore, the effects of glycine perfusion 
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observed here may well be through its actions at glycine receptors and not through 
NMDA receptors.  
Glycine receptor antagonist strychnine also produced a significant increase in 4-AP-
induced spike amplitude and frequency in all regions of the spinal cord slices 
investigated. In the single electrode recordings for spinal cord slices strychnine 
application decreased the 4-AP-induced activity. Previous studies have shown that 
in vivo pharmacological activation of glycine receptors exerts an analgesic effect in 
the spinal cord, while blocking glycine receptors increases symptoms of pain, 
including allodynia (Beyer et al., 1985, Yaksh, 1989, Sivilotti and Woolf, 1994, Lynch 
and Callister, 2006, Lu et al., 2013). Furthermore, in vivo patch-clamp recordings 
from the SG have shown that strychnine blocks IPSPs (Narikawa et al., 2000). The 
enhanced activity with application of both glycine receptor agonist and antagonist 
could be explained by the circuitry of the inhibitory and excitatory interneurons. If 
strychnine acts on those glycine receptors located on postsynaptic glutamatergic 
interneurons, strychnine would prevent the inhibition of these excitatory 
interneurons and therefore increase excitability. Additionally, as previously 
explained in Chapter 5, synapses between two inhibitory interneurons have been 
identified in the spinal DH (Zheng et al., 2010). If the application of glycine to the 
spinal cord slices results in glycine predominantly activating the glycine receptors on 
inhibitory interneurons this would enhance the inhibition of these inhibitory 
interneurons. Consequently, these inhibitory interneurons would be prevented from 
inhibiting postsynaptic glutamatergic interneurons and thus result in further 
excitation.  
Gelsemine binds the glycine receptor and exerts an analgesic effect as well as 
muscle relaxation, sedation and anxiolytic effects (Zhang and Wang, 2015). 
Furthermore, it is believed that gelsemine is selective for α3-containing glycine 
receptors (Venard et al., 2008, Zhang and Wang, 2015). The data presented here 
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illustrate that the application of gelsemine on the spinal cord slices produces a 
significant decrease in 4-AP-induced population spike amplitude and frequency in 
the superficial DH. In the deep DH gelsemine increased spike amplitude but 
decreased spike frequency. While in the VH there was no significant change was 
observed. The different effects in the different lamina could be due to the expression 
of the glycine α3-containing receptors being primarily in the superficial DH (Harvey 
et al., 2004). This would explain the lack of effect in the VH due to the absence of 
the α3-containing glycine receptors, while gelsemine did modify the 4-AP activity in 
the DH where the concentration of these receptors is the highest. The decrease in 
activity in the presence of gelsemine is consistent with the analgesic effect of this 
compound in vivo (Wu et al., 2015a, Zhang and Wang, 2015). Gelsemine has not 
been used clinically due to its highly toxic and short-lived effects which limit its 
dosage and therefore its applications as an analgesic (Wu et al., 2015a, Zhang and 
Wang, 2015). 
 
6.4.5 KCC2 Inhibitor VU0240551 Increases 4-AP Spike Amplitude in the 
Spinal Cord 
The KCC2 inhibitor VU0240551 caused an increase in spike amplitude in the SG, 
deep DH and VH. However, it only increased spike frequency in the VH. Blocking 
the KCC2 transporters likely produced an increase in spike amplitude as a result of 
an increase in intracellular chloride ion concentration, as this co-transporter would 
not be able to export chloride ions from the DH neurons. Therefore, the 
electrochemical gradient chloride would be shifted and the opening of GABAA and 
glycine receptor ion channels would lead to an efflux of chloride ions. Consequently 
these neurons depolarise, thus increasing excitability. A shift in the chloride 
electrochemical gradient from KCC2 downregulation similarly produces an increase 
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in the excitability in the hippocampus where it increases seizure susceptibility 
(MacKenzie and Maguire, 2015). Therefore, the results presented here are 
consistent with previous findings. Pharmacologically targeting the KCC2 co-
transporter has been investigated in the spinal DH for the development of novel 
analgesics (Coull et al., 2003, Zhang et al., 2008c, Hasbargen et al., 2010, Ford et 
al., 2015). 
 
6.4.6 Cultured Dorsal Horn Cells on the MEA Detects Synchronous and 
Non-Synchronous Electrical Activity 
Once optimised, the cultured DH cells on the MEA displayed some diverse activity 
compared to that detected with the calcium imaging assay discussed in Chapter 3. 
The calcium imaging experiments demonstrated a highly synchronous, rhythmic 
activity of the culture. On the MEA the DH culture did have comparable 
synchronous spontaneous field potentials across the culture. In addition, there were 
non-synchronous spikes detected sporadically between the synchronous firing. 
These non-synchronous spikes were likely undetected in the calcium imaging assay 
due to these spikes exerting a smaller change in the fluorescence and the lower 
sensitivity of the calcium imaging assay compared to the electrophysiological 
recordings. However, the pharmacology was consistent with the calcium imaging 
data. The results presented in this chapter show that the GABAA and glycine 
receptor agonists GABA, glycine and taurine all decreased spike frequency. The 
antagonists bicuculline, strychnine and gelsemine all increased spike frequency. 
These results are consistent with these receptors exerting an inhibitory effect in this 
network. Furthermore, these data are consistent with previous in vivo and in vitro 
reports of agonists decreasing excitability and producing anti-nociceptive effects 
and the antagonists increasing activity and causing pronociceptive effects (Beyer et 
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al., 1985, Narikawa et al., 2000, Harvey et al., 2004, Racz et al., 2005, Harvey et al., 
2009, Haranishi et al., 2010, Wu et al., 2015a, Zhang and Wang, 2015).  
  
6.4.7 Comparing the Potential of the Spinal Cord Slice and Spinal Dorsal 
Horn Culture Models  
Extracellular recordings from spinal cord slices provide a useful platform in which to 
obtain information regarding the mechanisms of generating and regulating network 
excitability. The development of the spinal cord slice technique has improved the 
health of the slices and therefore the networks and recordings from them (Avoli and 
Jefferys, 2015). The MEA technique provides a more powerful method of 
investigating the slice activity compared to the single electrode recordings through 
being able to obtain more data from a single slice and study the network 
synchronicity. However, compared to the calcium imaging assay the MEA spinal 
cord slice technique is a lower throughput technique. Furthermore, the problem 
remains that the complexity of the spinal cord slice limits our understanding of the 
data obtained from the extracellular recordings. The simplified DH cell culture 
network provides an accessible model in which to gain further insight into network 
synchronicity and rhythmicity. However, the differences in pharmacological 
responses in the culture compared to the slices, which have a more intact network, 
suggests that both models are required for a more complete understanding of 
network activity. The culturing process of the DH cells could have resulted in the 
loss of some vital component in the DH network which has manifested as a 
difference in pharmacology. The DH culture network is likely to be less similar to the 
in vivo DH network compared to the in vitro slice model. However, the data obtained 
with the spinal DH culture in both the calcium imaging assay and the MEA was 
highly consistent, while the spinal cord slice pharmacology with the single electrode 
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recordings was not entirely consistent with the MEA recordings. Therefore, the 
spinal DH culture model is more robust, and consequently potentially more 
attractive for testing novel analgesics.  
The MEA recording with the DH cells is extremely low throughput to test compounds 
and achieving the required culture conditions is challenging. Recent advancement in 
MEA technology has resulted in the development of multi-well plates with MEA 
arrays in each well (mwMEAs) (Axion Biosystems, USA). Cells can be cultured on 
these MEA multi-well plates and recordings from all wells made simultaneously with 
easy access for compound addition (McConnell et al., 2012). However, even with 
this innovative technology the challenge of obtaining the optimal culturing conditions 
for DH cells on the MEA remains. The MEA slice recordings provide a more cost-
effective and reliable recording method to study the network activity. Furthermore, 
being able to compare the activity across the different lamina of spinal cord slices is 
extremely valuable. Utilising both spinal cord slice and DH culture models on the 
MEA also provides the opportunity to investigate the differences in the networks and 
their pharmacology. Consequently the value of the culture as an in vitro model of 
the DH network can be further assessed and used for the development of 
analgesics. 
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7 General Discussion 
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7.1 Outline  
This research aimed to address the development of in vitro models for the screening 
of novel analgesics and investigate the role of GABAA and glycine receptors on the 
spinal DH network activity. Currently available analgesics, including morphine and 
its analogues, do not provide sufficient pain relief in all patients and are well-known 
for their adverse side effects and abuse-liability (Stein, 2013). Therefore there is a 
high demand for novel analgesics with improved efficacy and fewer side effects. 
Over the past 20 years the greatest progress in the development of new analgesics 
has been limited to the reformulation of opioids, production of anticonvulsants, 
cyclooxygenase (COX) inhibitors and amine reuptake inhibitors (Woolf, 2010). The 
limited advancement in novel analgesic development is partly due to a lack of 
robust, reproducible, translational platforms to predict drug efficacy and investigate 
the feasibility of proposed hypotheses (Borsook et al., 2014). Therefore this study 
has utilised two in vitro model systems of the spinal DH, firstly the well-established 
spinal cord slice model and secondly a developed and optimised primary cell culture 
model. In addition to evaluating these two model systems as potential platforms for 
screening novel centrally acting analgesics, the roles and mechanisms of inhibitory 
GABAA and glycine receptors in the generation and modulation of spinal DH activity 
were investigated. A summary of the overall effects of the compounds tested on 
each model with the different techniques is provided in Table 7.1. 
 
7.2 Primary Cell Culture of the Spinal Dorsal Horn 
7.2.1 Characterisation of the Spinal Dorsal Horn Culture 
In this study the development and optimisation of the embryonic spinal DH cell 
culture has been described with the intentions of this model being utilised for 
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screening novel analgesics and to investigate the physiology of the spinal DH 
network. The spinal DH culture was characterised to determine the expression of 
cell types existing in the ex-vivo spinal cord slice, with a focus on the expression of 
GABAA and glycine receptor subunit expression. Immunohistochemistry was used 
to illustrate proportions in the expression of neuronal cells, glia and microglia in the 
DH culture and as well as that of excitatory and inhibitory interneurons. The 
proportion of inhibitory and excitatory interneurons in the DH culture was found to 
be typical of the spinal DH in ex-vivo spinal cord slices, with 30-40% inhibitory and 
60-70% excitatory (Polgar et al., 2003). Each of the GABAA and glycine receptor α 
subunits were expressed in the DH culture, with the expression of the glycine 
receptor β subunit and glycine transporters 1 and 2 detected by RT-PCR. Absolute 
quantification RT-PCR revealed the expression of the glycine receptor α1 subunit 
was only two-fold higher than the α2 subunit, and approximately seventeen-fold 
higher than α3 subunit expression in the DH culture. The reverse was true in the 
adult human spinal cord mRNA, where the expression of the glycine receptor α3 
subunit was approximately twenty-fold higher than the α1 expression when the 
numbers of molecules for each α3 splice variant are combined. The novel finding in 
the adult human spinal cord mRNA was that the K variant of the glycine receptor α3 
subunit is more highly expressed compared to the L variant. The expression of the 
two splice variants of the α3 subunit has been investigated in the hippocampus 
where there is a higher expression of the α3L variant in rodents and humans. 
Furthermore, in humans with temporal lobe epilepsy (TLE) the expression of the 
α3K variant is increased at the expense of the α3L variant expression (Eichler et al., 
2009). This implies that glycine receptors are fundamentally required for the 
regulation of network rhythmic oscillations and α3-containing glycine receptors play 
a key role. The K variant of the α3 subunit is missing 15 amino acids in the 
intracellular loop compared to the L variant, and has faster desensitizing receptor 
kinetics (Nikolic et al., 1998). The frequency of rhythmic oscillations in the brain are 
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also influenced by GABAA receptor kinetics (Wang and Buzsáki, 1996). Therefore, it 
is highly probable that differences in glycine receptor subtype kinetics could also 
influence the frequency of oscillations in the spinal DH network. If this is the case, 
the lower expression of the glycine receptor α3 subunit relative to the α1 subunit in 
the DH culture compared to the human spinal cord suggests a lower relative 
expression of the glycine receptor α3 K variant. Consequently, a smaller proportion 
of glycine receptors will have faster desensitisation kinetics which could decrease 
the generation and frequency of the rhythmic oscillations in the DH culture 
compared to the human spinal cord. These differences in the networks should be 
taken into account when using the DH culture model to screen novel compounds. 
Further classification of the inhibitory interneurons in the spinal DH cell culture was 
performed to show co-localisation of the inhibitory interneurons with nNOS and PV. 
PV-expressing inhibitory interneurons in the brain are required for the generation of 
gamma oscillatory activity (Sohal et al., 2009, Volman et al., 2011). Therefore the 
occurrence of rhythmic activity in the DH culture could be linked to the PV-
expressing inhibitory interneurons. Importantly there was also strong positive 
staining for KCC2 in many of the DH culture’s inhibitory interneurons, implicating 
that these interneurons could have a similar chloride electrochemical gradient as the 
mature spinal DH network (Rivera et al., 1999, Coull et al., 2003). The prevalent 
expression of KCC2 in the DH culture implies that the embryonic neurons have 
matured during the 12 to 14 day period of culturing. Therefore, GABA and glycine 
neurotransmission in the DH culture is likely to be inhibitory.  
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7.2.2 GABAergic and Glycinergic Neurotransmission Regulate Spinal 
Dorsal Horn Culture Rhythmic Oscillations  
Calcium imaging and MEA techniques were used to measure the activity of the 
cultured DH cells. Spontaneous, rhythmic firing of the DH culture network was 
detected with both these techniques. Calcium imaging is an indirect measure of 
neuronal activity, measuring the flux of intracellular calcium (Grienberger and 
Konnerth, 2012), while MEA recordings measure the extracellular electrical activity 
of the network (Spira and Hai, 2013). The calcium imaging with the BD Pathway 
system enabled visualisation of the spontaneous, highly synchronised, rhythmic 
network activity. This technique was invaluable during the optimisation of the 
culture, however, the throughput is extremely low and therefore the remaining 
calcium imaging data was obtained using the Flexstation microplate reader. The 
Flexstation assay provides a higher throughput technique to investigate the effects 
of compounds on the culture, although smaller oscillations in activity go undetected. 
The MEA recordings provide a more detailed account of the culture’s activity, 
detecting some additional smaller spikes and measuring the duration and amplitude 
of population spikes. The electrical activity of the DH culture measured from 64 
electrodes simultaneously across the culture using the MEA also demonstrated 
synchronous firing of the cells. However, culturing the cells on the MEAs was 
particularly problematic and it is a very low throughput assay but the cultured cells 
on the MEA are extremely accessible. The spontaneous activity measured using 
calcium imaging and MEA techniques was lessened with application of GABAA and 
glycine receptor agonists including GABA, muscimol, glycine and taurine. 
Antagonists of these receptors, including bicuculline, gabazine, strychnine and 
gelsemine, all enhanced the spontaneous activity of the spinal DH cultures. This 
suggests the chloride electrochemical gradient is similar to mature neurons, as the 
stimulation of glycine and GABAA receptors had an inhibitory effect. This is 
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supported by the KCC2 expression in the culture illustrated from the IF staining. 
Furthermore, these results illustrate that the rhythmic oscillatory activity of the spinal 
DH culture requires inhibitory neurotransmission. This finding is supported by 
previous reports of the fundamental requirement of inhibitory neurotransmission for 
oscillatory rhythmic activity in the brain and spinal cord in in vitro slice models and 
spinal cord cell cultures (Sandkuhler and Eblen-Zajjur, 1994, Streit et al., 2001, 
Chapman et al., 2009, Kim et al., 2015, Kuki et al., 2015).  
 
7.2.3 Glycine Receptor siRNA Gene Silencing in the Spinal Dorsal Horn 
Culture  
Due to the lack of glycine receptor subtype-selective compounds, I employed an 
siRNA gene silencing technique in the DH culture to further investigate the role of 
the glycine receptor subtypes in the DH network oscillatory activity. Unfortunately, 
the siRNAs used in this study for the glycine receptor α subunits 1-3 were not all 
selective, as indicated by RT-PCR results in the DH cultures transfected with each 
of the siRNAs. Only the glycine receptor α3 siRNA selectively silenced the 
expression of the glycine receptor α3 subunit, the other two siRNAs knocked-down 
the expression of their target subunit and the α3 subunit. Each of the glycine 
receptor siRNAs caused a significant loss of the spontaneous rhythmic oscillations 
in the culture. This emphasises the key role for the glycine receptor in the 
generation of the spontaneous rhythmic activity, and could suggest that the glycine 
receptor α3 subunit is primarily responsible as its expression was knocked down by 
all three siRNAs. The loss of rhythmic activity in the DH culture could be the result 
of the culture not reaching the same mature state as observed with untreated DH 
cultures, since the siRNA was transfected 3-4 days before the culture is considered 
to have fully matured. Glycine receptors have been linked with formation of 
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synapses and the maturation of networks (Ben-Ari, 2001). However, the majority of 
the cultures were still responsive to strychnine and glycine which produced the 
same effects as observed in the untreated cultures. This implicates the existence of 
glycine receptors within the culture and that the culture has matured to a state 
where glycine receptor transmission is inhibitory which occurs in vivo during 
postnatal development (Ben-Ari et al., 2007). Although the cultures transfected with 
each of the glycine receptor siRNAs all responded to strychnine which increased 
activity, the α3 siRNA transfected cultures were the only cultures not to respond to 
glycine addition in terms of the spike frequency or area under the curve. Therefore, 
this further indicates a prominent role for the α3-containing glycine receptors in the 
DH over the other two receptor subtypes. This result is consistent with other reports 
of the α3 glycine receptors in the spinal DH being selectively involved in pain 
conditions, particularly inflammatory pain (Harvey et al., 2004, Racz et al., 2005, 
Harvey et al., 2009). Consequently, designing compounds that are selective for the 
glycine receptor α3 subtype could lead to the production of novel analgesics with 
reduced adverse side effects. Obtaining subunit-selective siRNAs are required to 
more definitively determine if the α3-glycine receptors are truly the primary subtypes 
involved in the spinal DH network activity.  
 
7.3 Spinal Cord Slice Recordings 
7.3.1 GABAA and Glycine Receptors Modulate the 4-AP-Induced Rhythmic 
Activity 
In the spinal cord slice single electrode and MEA recordings the application of 4-AP 
produced hyperexcitability, which could be seen across the slice in the MEA 
recordings. Furthermore, the MEA recordings illustrated that the 4-AP-induced 
activity was highly synchronous across the DH. The 4-AP-induced activity has been 
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previously used as a model of epilepsy in brain slices (Gonzalez-Sulser et al., 2012) 
and in spinal cord slices as a model of neuropathic pain (Ruscheweyh and 
Sandkuhler, 2003, Asghar et al., 2005, Chapman et al., 2009). The data obtained 
from the dorsal and ventral horns of the spinal cord slices using the MEA recordings 
illustrated that the 4-AP-induced activity in the DH had a higher spike frequency and 
amplitude compared to that observed in the VH. An additional benefit of the MEA 
recordings over the single electrode slice recordings was that there are more 
electrodes recording from each of the laminae which produce more statistically 
powerful data. Therefore while the changes in 4-AP-induced activity following 
application of compounds to the slices using each of these techniques were the 
same, the MEA recordings produced the most statistically powerful data.  
Antagonists of the GABAA receptor, bicuculline and gabazine, decreased the 4-AP-
induced spike frequency and amplitude in the single electrode and MEA recordings, 
which is consistent with previously published data in the spinal DH system 
(Ruscheweyh and Sandkuhler, 2003, Chapman et al., 2009). While initially this 
might seem counterintuitive, it is possible that the block of inhibitory 
neurotransmission is required for the generation of the rhythmic oscillations by 
synchronising the excitatory activity. The proposed models of rhythmic oscillatory 
activity, ING and PING described in section 1.5 of chapter 1, require inhibitory 
interneurons to generate the rhythmic activity. There is evidence for these models in 
the hippocampus, where stimulating inhibitory interneurons increased the gamma 
oscillations while hyperpolarising them decreased the oscillations (Cardin et al., 
2009, Sohal et al., 2009). In comparison, the stimulation of excitatory interneurons is 
less effective in increasing the oscillations (Cardin et al., 2009). In the spinal DH 
culture bicuculline increased the activity, this infers potential differences in the 
network circuitry or the mechanisms of generation of the 4-AP activity compared to 
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the spontaneous firing of the culture. If this is the case, caution is required when 
utilizing these models to screen for novel analgesic compounds.  
 Interestingly the glycine receptor antagonist strychnine increased the 4-AP-induced 
population spike frequency and amplitude in the MEA slice recordings. The increase 
in activity following the application of strychnine to the spinal cord slice is consistent 
with the blocking of glycine inhibition resulting in increased excitation. This has been 
indicated in the brain, where a reduction in glycine inhibition can produce 
epileptiform activity (Shen et al., 2015). In agreement with the current data, a more 
pertinent example is that bicuculline and strychnine produce opposite effects in the 
spinal DH following application of 4-AP in the spinal DH (Ruscheweyh and 
Sandkuhler, 2003).  Furthermore, glycine application to the slices also produced an 
increase in the 4-AP-induced spike amplitude and frequency in the recordings 
obtained using both techniques. The action of glycine could be explained from 
glycine also acting as a co-agonist at NMDA receptors (Papouin et al., 2012). 
NMDA receptors are typically excitatory, therefore an increase in glycine 
concentration is likely to increase NMDA receptor activation and consequently 
produce the increase activity in the DH network. The different response to 
application of glycine in the spinal cord slices further suggests that the networks are 
not the same, or that the 4-AP-induced activity involves different mechanisms of 
generation compared to the spontaneous firing of the DH culture. 
 
The GABAA receptor partial agonist L-838,417, which selectively mediates its 
actions through α2, α3 and α5-containing GABAA receptors reduced 4-AP-induced 
rhythmic activity in the spinal DH as observed using the single electrode recordings. 
This result demonstrates that activation of these subtypes of GABAA receptors is 
sufficient to modulate the excitatory activity in the spinal DH. Therefore developing 
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novel compounds which selectively target these GABAA receptor subtypes could be 
advantageous in minimising adverse side effects (Knabl et al., 2008). THIP and 
muscimol similarly decreased the rhythmic oscillatory activity in the spinal DH, as 
observed using single electrode recordings. THIP is an agonist of GABAA receptors 
but an antagonist of GABAA-ρ receptors. Therefore, despite the antagonism of 
GABAA-ρ receptors, the 4-AP-induced activity was still reduced by THIP, which could 
have occurred because GABAA-ρ receptors are not significantly involved in 
modulation of the spinal DH network activity.  
In MEA recordings the blocking of KCC2 with VU0240551 increased the 4-AP-
induced spike amplitude in the DH and VH. In theory the blocking of KCC2 would be 
predicted to prevent the transportation of chloride ions out of the cells to maintain a 
low intracellular chloride ion concentration. Therefore, the opening of the GABAA 
and glycine receptor ion channels would have an efflux of chloride ions, rather than 
the normal influx of chloride ions which causes hyperpolarisation of the cell. The 
same effect was found with VU0240551 in the DH culture, which further confirms 
that the culture has matured to a state where GABAA and glycine receptor 
neurotransmission is inhibitory. The modulation of the rhythmic activity in both the in 
vitro models investigated in this study clearly depends on the chloride ion 
electrochemical gradient and the signalling through GABAA and glycine receptors.  
GABAB receptors also modulated the 4-AP-induced rhythmic activity, with the 
agonist baclofen decreasing the rhythmic activity and population spikes in the single 
electrode and MEA recordings. In contrast GABAB receptor antagonist 2-
hydroxysaclofen enhanced the 4-AP-induced activity, in the spinal cord slice 
recordings by single electrode and MEA techniques. Baclofen and 2-
hydroxysaclofen similarly decreased and increased the DH culture activity 
respectively. Evidence suggests that there is no downregulation of GABAB receptors 
in the spinal DH in models of neuropathic pain (Engle et al., 2006). The reduction in 
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the GABAA receptor signalling in the spinal DH in pain conditions could prevent the 
effectiveness of analgesics targeting the GABAA receptor. Therefore, the sustained 
GABAB receptor expression in the spinal DH in pain conditions is advantageous for 
targeting these receptors in the design of novel analgesics. However, the limited 
subtypes of the GABAB receptor family could imply a potentially large array of side 
effects following administration of GABAB receptor-targeting compounds (Bowery, 
2006).  
 
7.4 Conclusions 
The two in vitro model systems investigated in this study have been utilised to 
illustrate that GABAA, GABAB and glycine receptor signalling is able to modulate the 
rhythmic oscillatory activity of the spinal DH network. Furthermore, the α3-
containing glycine receptors play a key role in this mechanism of modulating the 
network activity, which has also been indicated in human spinal cord. Additionally, 
the spinal DH network activity is also dependent on KCC2 activity, which maintains 
the chloride electrochemical gradient and consequently the effects of GABA and 
glycine neurotransmission within the network. Consequently, designing novel 
analgesics that target these receptors could be efficacious.  
The newly developed and characterised spinal DH culture model platform had many 
similarities with the spinal cord slice physiology in terms of the cell types present 
and the proportions of excitatory and inhibitory interneurons. The culture was easily 
transferable to be utilised in multiple techniques. However, discrepancies between 
the responses to a number of compounds in the spinal DH culture network and the 
spinal cord slice recordings indicate there are differences in the two models. This 
could relate to the 4-AP inducing activity that is different to the inherent, 
spontaneous activity of the DH culture. Alternatively the culturing of dissociated 
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embryonic DH cells could result in the formation of a network which is fundamentally 
different to the in vivo spinal DH, and thus also differ from the in vitro spinal cord 
slice model. The reliance of cell culture models to investigate novel analgesics could 
be the reason why many pharmaceutical companies have not been able to progress 
many of their compounds through clinical trials. However, the complexity of the 
spinal cord slice model prevents a complete interpretation of the data obtained from 
this model. Further characterisation of both these models is necessary to advance 
our understanding of how the spinal DH rhythmic activity is generated and 
modulated. These models provide initial screening platforms for analgesics, which 
could be utilised to indicate which compounds have the potential to be advanced to 
pre-clinical studies with in vivo animal models. Therefore, these in vitro models 
reduce the number of in vivo animal experiments by enabling an initial selection of 
the most promising compounds.  
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Table 7.1 A summary of the overall effect of each of the compounds tested on the spinal DH 
cell culture model and the acute spinal cord slice model for each technique. S.E. stands for 
the single electrode recording technique, ↑ indicates a significant increase in activity, ↓ 
indicates a significant decrease in activity, NA = not applicable or not tested and ND = not 
defined. 
  
290 
 
References 
Ahmad AH, Ismail Z (2002) c-fos and its Consequences in Pain. The Malaysian 
journal of medical sciences : MJMS 9:3-8. 
Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU (2002) PGE2 selectively blocks 
inhibitory glycinergic neurotransmission onto rat superficial dorsal horn 
neurons. Nature neuroscience 5:34-40. 
Akagi H, Hirai K, Hishinuma F (1991) Cloning of a glycine receptor subtype 
expressed in rat brain and spinal cord during a specific period of neuronal 
development. FEBS letters 281:160-166. 
Al Ghamdi KS, Polgar E, Todd AJ (2009) Soma size distinguishes projection 
neurons from neurokinin 1 receptor-expressing interneurons in lamina I of 
the rat lumbar spinal dorsal horn. Neuroscience 164:1794-1804. 
Albantakis L, Lohmann C (2009) A simple method for quantitative calcium imaging 
in unperturbed developing neurons. Journal of neuroscience methods 
184:206-212. 
Albéri L, Lintas A, Kretz R, Schwaller B, Villa AEP (2013) The calcium-binding 
protein parvalbumin modulates the firing 1 properties of the reticular thalamic 
nucleus bursting neurons. Journal of neurophysiology 109:2827-2841. 
Allain A-E, Cazenave W, Delpy A, Exertier P, Barthe C, Meyrand P, Cattaert D, 
Branchereau P (2015) Nonsynaptic glycine release is involved in the early 
KCC2 expression. Developmental Neurobiology n/a-n/a. 
Allerton CA, Boden PR, Hill RG (1989) Actions of the GABAB agonist, (-)-baclofen, 
on neurones in deep dorsal horn of the rat spinal cord in vitro. British journal 
of pharmacology 96:29-38. 
Ameres SL, Martinez J, Schroeder R (2007) Molecular basis for target RNA 
recognition and cleavage by human RISC. Cell 130:101-112. 
Amin J, Brooks-Kayal A, Weiss DS (1997) Two Tyrosine Residues on the α Subunit 
Are Crucial for Benzodiazepine Binding and Allosteric Modulation of γ-
Aminobutyric AcidA Receptors. Molecular pharmacology 51:833-841. 
Andersen P, Dingledine R, Gjerstad L, Langmoen IA, Laursen AM (1980) Two 
different responses of hippocampal pyramidal cells to application of gamma-
amino butyric acid. The Journal of physiology 305:279-296. 
Antal M, Petko M, Polgar E, Heizmann CW, Storm-Mathisen J (1996) Direct 
evidence of an extensive GABAergic innervation of the spinal dorsal horn by 
fibres descending from the rostral ventromedial medulla. Neuroscience 
73:509-518. 
Aram JA, Michelson HB, Wong RK (1991) Synchronized GABAergic IPSPs 
recorded in the neocortex after blockade of synaptic transmission mediated 
by excitatory amino acids. Journal of neurophysiology 65:1034-1041. 
Asghar AU, Cilia La Corte PF, LeBeau FE, Al Dawoud M, Reilly SC, Buhl EH, 
Whittington MA, King AE (2005) Oscillatory activity within rat substantia 
gelatinosa in vitro: a role for chemical and electrical neurotransmission. The 
Journal of physiology 562:183-198. 
Asiedu MN, Mejia G, Ossipov MK, Malan TP, Kaila K, Price TJ (2012) Modulation of 
spinal GABAergic analgesia by inhibition of chloride extrusion capacity in 
mice. The journal of pain : official journal of the American Pain Society 
13:546-554. 
Ataka T, Kumamoto E, Shimoji K, Yoshimura M (2000) Baclofen inhibits more 
effectively C-afferent than Adelta-afferent glutamatergic transmission in 
substantia gelatinosa neurons of adult rat spinal cord slices. Pain 86:273-
282. 
291 
 
Augustine GJ (2001) How does calcium trigger neurotransmitter release? Current 
Opinion in Neurobiology 11:320-326. 
Ault B, Nadler JV (1983) Anticonvulsant-like actions of baclofen in the rat 
hippocampal slice. British journal of pharmacology 78:701-708. 
Avoli M, de Curtis M (2011) GABAergic synchronization in the limbic system and its 
role in the generation of epileptiform activity. Progress in neurobiology 
95:104-132. 
Avoli M, Jefferys JGR (2015) Models of drug-induced epileptiform synchronization in 
vitro. Journal of neuroscience methods. 
Baba H, Ji R-R, Kohno T, Moore KA, Ataka T, Wakai A, Okamoto M, Woolf CJ 
(2003) Removal of GABAergic inhibition facilitates polysynaptic A fiber-
mediated excitatory transmission to the superficial spinal dorsal horn. 
Molecular and Cellular Neuroscience 24:818-830. 
Baccei ML, Fitzgerald M (2004) Development of GABAergic and glycinergic 
transmission in the neonatal rat dorsal horn. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 24:4749-4757. 
Baimbridge KG, Celio MR, Rogers JH (1992) Calcium-binding proteins in the 
nervous system. Trends in Neurosciences 15:303-308. 
Bakker MJ, van Dijk JG, van den Maagdenberg AM, Tijssen MA (2006) Startle 
syndromes. The Lancet Neurology 5:513-524. 
Balakrishnan V, Becker M, Lohrke S, Nothwang HG, Guresir E, Friauf E (2003) 
Expression and function of chloride transporters during development of 
inhibitory neurotransmission in the auditory brainstem. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 23:4134-
4145. 
Baltz T, Voigt T (2015) Interaction of electrically evoked activity with intrinsic 
dynamics of cultured cortical networks with and without functional fast 
GABAergic synaptic transmission. Frontiers in cellular neuroscience 9:272. 
Banke TG, Bowie D, Lee H, Huganir RL, Schousboe A, Traynelis SF (2000) Control 
of GluR1 AMPA receptor function by cAMP-dependent protein kinase. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
20:89-102. 
Barker JL, McBurney RN, Mathers DA (1983) Convulsant-induced depression of 
amino acid responses in cultured mouse spinal neurones studied under 
voltage clamp. British journal of pharmacology 80:619-629. 
Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, 
Bateson AN, Langer SZ (1998) International Union of Pharmacology. XV. 
Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of 
Subunit Structure and Receptor Function. Pharmacological reviews 50:291-
314. 
Baron R (2006) Mechanisms of disease: neuropathic pain--a clinical perspective. 
Nature clinical practice Neurology 2:95-106. 
Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and Molecular 
Mechanisms of Pain. Cell 139:267-284. 
Becker CM, Hermans-Borgmeyer I, Schmitt B, Betz H (1986) The glycine receptor 
deficiency of the mutant mouse spastic: evidence for normal glycine receptor 
structure and localization. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 6:1358-1364. 
Belelli D, Lambert JJ (2005) Neurosteroids: endogenous regulators of the GABAA 
receptor. Nature reviews Neuroscience 6:565-575. 
Ben-Ari Y (2001) Developing networks play a similar melody. Trends in 
Neurosciences 24:353-360. 
Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R (2007) GABA: a pioneer transmitter that 
excites immature neurons and generates primitive oscillations. Physiological 
reviews 87:1215-1284. 
292 
 
Benke TA, Luthi A, Isaac JT, Collingridge GL (1998) Modulation of AMPA receptor 
unitary conductance by synaptic activity. Nature 393:793-797. 
Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium 
signalling. Nat Rev Mol Cell Biol 1:11-21. 
Berrocal YA, Almeida VW, Puentes R, Knott EP, Hechtman JF, Garland M, Pearse 
DD (2014) Loss of central inhibition: implications for behavioral 
hypersensitivity after contusive spinal cord injury in rats. Pain research and 
treatment 2014:178278. 
Beyer C, Roberts LA, Komisaruk BR (1985) Hyperalgesia induced by altered 
glycinergic activity at the spinal cord. Life sciences 37:875-882. 
Bianchi D, Marasco A, Limongiello A, Marchetti C, Marie H, Tirozzi B, Migliore M 
(2012) On the mechanisms underlying the depolarization block in the spiking 
dynamics of CA1 pyramidal neurons. Journal of computational neuroscience 
33:207-225. 
Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the 
dentate area of the anaesthetized rabbit following stimulation of the perforant 
path. The Journal of physiology 232:331-356. 
Bohlhalter S, Mohler H, Fritschy JM (1994) Inhibitory neurotransmission in rat spinal 
cord: co-localization of glycine- and GABAA-receptors at GABAergic 
synaptic contacts demonstrated by triple immunofluorescence staining. Brain 
research 642:59-69. 
Bohlhalter S, Weinmann O, Mohler H, Fritschy JM (1996) Laminar 
compartmentalization of GABAA-receptor subtypes in the spinal cord: an 
immunohistochemical study. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 16:283-297. 
Boileau AJ, Evers AR, Davis AF, Czajkowski C (1999) Mapping the Agonist Binding 
Site of the GABAAReceptor: Evidence for a β-Strand. The Journal of 
Neuroscience 19:4847-4854. 
Bormann J (2000) The ‘ABC’ of GABA receptors. Trends in Pharmacological 
Sciences 21:16-19. 
Bormann J, Rundstrom N, Betz H, Langosch D (1993) Residues within 
transmembrane segment M2 determine chloride conductance of glycine 
receptor homo- and hetero-oligomers. The EMBO journal 12:3729-3737. 
Borsook D, Hargreaves R, Bountra C, Porreca F (2014) Lost but making progress—
Where will new analgesic drugs come from? Science Translational Medicine 
6:249sr243-249sr243. 
Bowery NG (2006) GABAB receptor: a site of therapeutic benefit. Current opinion in 
pharmacology 6:37-43. 
Bragin A, Jando G, Nadasdy Z, Hetke J, Wise K, Buzsaki G (1995) Gamma (40-100 
Hz) oscillation in the hippocampus of the behaving rat. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 15:47-60. 
Brejc K, van Dijk WJ, Smit AB, Sixma TK (2002) The 2.7 A structure of AChBP, 
homologue of the ligand-binding domain of the nicotinic acetylcholine 
receptor. Novartis Foundation symposium 245:22-29; discussion 29-32, 165-
168. 
Bremner L, Fitzgerald M, Baccei M (2006) Functional GABAA-Receptor–Mediated 
Inhibition in the Neonatal Dorsal Horn. Journal of neurophysiology 95:3893-
3897. 
Brickley SG, Cull-Candy SG, Farrant M (1996) Development of a tonic form of 
synaptic inhibition in rat cerebellar granule cells resulting from persistent 
activation of GABAA receptors. The Journal of physiology 497 ( Pt 3):753-
759. 
Brickley SG, Cull-Candy SG, Farrant M (1999) Single-Channel Properties of 
Synaptic and Extrasynaptic GABAA Receptors Suggest Differential 
293 
 
Targeting of Receptor Subtypes. The Journal of Neuroscience 19:2960-
2973. 
Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA (2002) Pharmacological 
characterization of a novel cell line expressing human alpha(4)beta(3)delta 
GABA(A) receptors. British journal of pharmacology 136:965-974. 
Brusberg M, Ravnefjord A, Martinsson R, Larsson H, Martinez V, Lindstrom E 
(2009) The GABA(B) receptor agonist, baclofen, and the positive allosteric 
modulator, CGP7930, inhibit visceral pain-related responses to colorectal 
distension in rats. Neuropharmacology 56:362-367. 
Buckwalter MS, Cook SA, Davisson MT, White WF, Camper SA (1994) A frameshift 
mutation in the mouse alpha 1 glycine receptor gene (Glra1) results in 
progressive neurological symptoms and juvenile death. Human molecular 
genetics 3:2025-2030. 
Buskila Y, Breen PP, Tapson J, van Schaik A, Barton M, Morley JW (2014) 
Extending the viability of acute brain slices. Scientific Reports 4:5309. 
Butt SJB, Harris-Warrick RM, Kiehn O (2002) Firing Properties of Identified 
Interneuron Populations in the Mammalian Hindlimb Central Pattern 
Generator. The Journal of Neuroscience 22:9961-9971. 
Buzsáki G, Anastassiou CA, Koch C (2012) The origin of extracellular fields and 
currents — EEG, ECoG, LFP and spikes. Nature reviews Neuroscience 
13:407-420. 
Buzsaki G, Buhl DL, Harris KD, Csicsvari J, Czeh B, Morozov A (2003) 
Hippocampal network patterns of activity in the mouse. Neuroscience 
116:201-211. 
Buzsaki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 
304:1926-1929. 
Caillard O, Moreno H, Schwaller B, Llano I, Celio MR, Marty A (2000) Role of the 
calcium-binding protein parvalbumin in short-term synaptic plasticity. 
Proceedings of the National Academy of Sciences 97:13372-13377. 
Cancedda L, Fiumelli H, Chen K, Poo M-m (2007) Excitatory GABA Action Is 
Essential for Morphological Maturation of Cortical Neurons In Vivo. The 
Journal of Neuroscience 27:5224-5235. 
Candeletti S, Lopetuso G, Cannarsa R, Cavina C, Romualdi P (2006) Effects of 
prolonged treatment with the opiate tramadol on prodynorphin gene 
expression in rat CNS. J Mol Neurosci 30:341-347. 
Capek R, Esplin B (1982) Baclofen-induced decrease of excitability of primary 
afferents and depression of monosynaptic transmission in cat spinal cord. 
Canadian journal of physiology and pharmacology 60:160-166. 
Cardin JA, Carlen M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai L-H, 
Moore CI (2009) Driving fast-spiking cells induces gamma rhythm and 
controls sensory responses. Nature 459:663-667. 
Castro-Lopes JM, Tavares I, Coimbra A (1993) GABA decreases in the spinal cord 
dorsal horn after peripheral neurectomy. Brain research 620:287-291. 
Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system. 
Neuroscience 35:375-475. 
Celio MR, Heizmann CW (1982) Calcium-binding protein parvalbumin is associated 
with fast contracting muscle fibres. Nature 297:504-506. 
Chang Y, Wang R, Barot S, Weiss DS (1996) Stoichiometry of a Recombinant 
GABAA Receptor. The Journal of Neuroscience 16:5415-5424. 
Chapman CA, Perez Y, Lacaille JC (1998a) Effects of GABA(A) inhibition on the 
expression of long-term potentiation in CA1 pyramidal cells are dependent 
on tetanization parameters. Hippocampus 8:289-298. 
Chapman RJ, Cilia La Corte PF, Asghar AU, King AE (2009) Network-based activity 
induced by 4-aminopyridine in rat dorsal horn in vitro is mediated by both 
chemical and electrical synapses. The Journal of physiology 587:2499-2510. 
294 
 
Chapman V, Suzuki R, Dickenson AH (1998b) Electrophysiological characterization 
of spinal neuronal response properties in anaesthetized rats after ligation of 
spinal nerves L5-L6. The Journal of physiology 507:881-894. 
Chen QX, Perkins KL, Choi DW, Wong RKS (1997) Secondary Activation of a 
Cation Conductance Is Responsible for NMDA Toxicity in Acutely Isolated 
Hippocampal Neurons. The Journal of Neuroscience 17:4032-4036. 
Chen R, Okabe A, Sun H, Sharopov S, Hanganu-Opatz IL, Kolbaev SN, Fukuda A, 
Luhmann HJ, Kilb W (2014) Activation of glycine receptors modulates 
spontaneous epileptiform activity in the immature rat hippocampus. The 
Journal of physiology 592:2153-2168. 
Chen ST, Iida A, Guo L, Friedmann T, Yee JK (1996) Generation of packaging cell 
lines for pseudotyped retroviral vectors of the G protein of vesicular 
stomatitis virus by using a modified tetracycline inducible system. 
Proceedings of the National Academy of Sciences of the United States of 
America 93:10057-10062. 
Chen X, Johnston D (2005) Constitutively active G-protein-gated inwardly rectifying 
K+ channels in dendrites of hippocampal CA1 pyramidal neurons. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
25:3787-3792. 
Chéry N, De Koninck Y (2000) GABAB Receptors Are the First Target of Released 
GABA at Lamina I Inhibitory Synapses in the Adult Rat Spinal Cord. Journal 
of neurophysiology 84:1006-1011. 
Chiara DC, Jayakar SS, Zhou X, Zhang X, Savechenkov PY, Bruzik KS, Miller KW, 
Cohen JB (2013) Specificity of Intersubunit General Anesthetic-binding Sites 
in the Transmembrane Domain of the Human α1β3γ2 γ-Aminobutyric Acid 
Type A (GABA(A)) Receptor. The Journal of biological chemistry 288:19343-
19357. 
Choi I-S, Cho J-H, Jeong S-G, Hong J-S, Kim S-J, Kim J, Lee M-G, Choi B-J, Jang 
I-S (2008) GABAB receptor‐mediated presynaptic inhibition of glycinergic 
transmission onto substantia gelatinosa neurons in the rat spinal cord. Pain 
138:330-342. 
Christensen BN, Perl ER (1970) Spinal neurons specifically excited by noxious or 
thermal stimuli: marginal zone of the dorsal horn. Journal of neurophysiology 
33:293-307. 
Chronwall BM, Davis TD, Severidt MW, Wolfe SE, McCarson KE, Beatty DM, Low 
MJ, Morris SJ, Enna SJ (2001) Constitutive expression of functional 
GABA(B) receptors in mIL-tsA58 cells requires both GABA(B(1)) and 
GABA(B(2)) genes. Journal of neurochemistry 77:1237-1247. 
Chu Y-C, Guan Y, Skinner J, Raja SN, Johns RA, Tao Y-X (2005) Effect of genetic 
knockout or pharmacologic inhibition of neuronal nitric oxide synthase on 
complete Freund's adjuvant-induced persistent pain. Pain 119:113-123. 
Chub N, O'Donovan MJ (1998) Blockade and recovery of spontaneous rhythmic 
activity after application of neurotransmitter antagonists to spinal networks of 
the chick embryo. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 18:294-306. 
Clavier N, Lombard MC, Besson JM (1992) Benzodiazepines and pain: effects of 
midazolam on the activities of nociceptive non-specific dorsal horn neurons 
in the rat spinal cord. Pain 48:61-71. 
Collingridge GL (1995) The brain slice preparation: a tribute to the pioneer Henry 
McIlwain. Journal of neuroscience methods 59:5-9. 
Collingridge GL, Isaac JT, Wang YT (2004) Receptor trafficking and synaptic 
plasticity. Nature reviews Neuroscience 5:952-962. 
Collingridge GL, Olsen RW, Peters J, Spedding M (2009) A nomenclature for 
ligand-gated ion channels. Neuropharmacology 56:2-5. 
295 
 
Coltman BW, Earley EM, Shahar A, Dudek FE, Ide CF (1995) Factors influencing 
mossy fiber collateral sprouting in organotypic slice cultures of neonatal 
mouse hippocampus. The Journal of comparative neurology 362:209-222. 
Contini M, Raviola E (2003) GABAergic synapses made by a retinal dopaminergic 
neuron. Proceedings of the National Academy of Sciences of the United 
States of America 100:1358-1363. 
Cooper EJ, Johnston GAR, Edwards FA (1999) Effects of a naturally occurring 
neurosteroid on GABA(A) IPSCs during development in rat hippocampal or 
cerebellar slices. The Journal of physiology 521:437-449. 
Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, 
De Koninck Y (2005) BDNF from microglia causes the shift in neuronal anion 
gradient underlying neuropathic pain. Nature 438:1017-1021. 
Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, De 
Koninck Y (2003) Trans-synaptic shift in anion gradient in spinal lamina I 
neurons as a mechanism of neuropathic pain. Nature 424:938-942. 
Cox PJ, Pitcher T, Trim SA, Bell CH, Qin W, Kinloch RA (2008) The effect of 
deletion of the orphan G - protein coupled receptor (GPCR) gene MrgE on 
pain-like behaviours in mice. Molecular pain 4:2. 
Cuellar JM, Antognini JF, Carstens E (2004) An in vivo method for recording single 
unit activity in lumbar spinal cord in mice anesthetized with a volatile 
anesthetic. Brain Research Protocols 13:126-134. 
Cunningham MO, Whittington MA, Bibbig A, Roopun A, LeBeau FEN, Vogt A, 
Monyer H, Buhl EH, Traub RD (2004) A role for fast rhythmic bursting 
neurons in cortical gamma oscillations in vitro. Proceedings of the National 
Academy of Sciences of the United States of America 101:7152-7157. 
Curtis DR, Duggan AW, Felix D, Johnston GAR (1970) Bicuculline and Central 
GABA Receptors. Nature 228:676-677. 
Curtis DR, Gynther BD, Beattie DT, Kerr DIB, Prager RH (1988) Baclofen 
antagonism by 2-hydroxy-saclofen in the cat spinal cord. Neuroscience 
letters 92:97-101. 
Cutting GR, Lu L, O'Hara BF, Kasch LM, Montrose-Rafizadeh C, Donovan DM, 
Shimada S, Antonarakis SE, Guggino WB, Uhl GR (1991) Cloning of the 
gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit 
highly expressed in the retina. Proceedings of the National Academy of 
Sciences 88:2673-2677. 
Czarnecki A, Magloire V, Streit J (2008) Local oscillations of spiking activity in 
organotypic spinal cord slice cultures. The European journal of neuroscience 
27:2076-2088. 
Das P, Bell-Horner CL, Machu TK, Dillon GH (2003) The GABA(A) receptor 
antagonist picrotoxin inhibits 5-hydroxytryptamine type 3A receptors. 
Neuropharmacology 44:431-438. 
De Simoni A, Yu LM (2006) Preparation of organotypic hippocampal slice cultures: 
interface method. Nature protocols 1:1439-1445. 
DeFazio RA, Keros S, Quick MW, Hablitz JJ (2000) Potassium-Coupled Chloride 
Cotransport Controls Intracellular Chloride in Rat Neocortical Pyramidal 
Neurons. The Journal of Neuroscience 20:8069-8076. 
Devor A, Fritschy JM, Yarom Y (2001) Spatial distribution and subunit composition 
of GABA(A) receptors in the inferior olivary nucleus. Journal of 
neurophysiology 85:1686-1696. 
Diaz A, Dickenson AH (1997) Blockade of spinal N- and P-type, but not L-type, 
calcium channels inhibits the excitability of rat dorsal horn neurones 
produced by subcutaneous formalin inflammation. Pain 69:93-100. 
Dixon C, Sah P, Lynch JW, Keramidas A (2014) GABA(A) Receptor α and γ 
Subunits Shape Synaptic Currents via Different Mechanisms. The Journal of 
biological chemistry 289:5399-5411. 
296 
 
Drasbek KR, Jensen K (2006) THIP, a hypnotic and antinociceptive drug, enhances 
an extrasynaptic GABAA receptor-mediated conductance in mouse 
neocortex. Cereb Cortex 16:1134-1141. 
Duncalfe LL, Carpenter MR, Smillie LB, Martin IL, Dunn SM (1996) The major site of 
photoaffinity labeling of the gamma-aminobutyric acid type A receptor by 
[3H]flunitrazepam is histidine 102 of the alpha subunit. The Journal of 
biological chemistry 271:9209-9214. 
Eaton MJ, Martinez MA, Karmally S (1999) A single intrathecal injection of GABA 
permanently reverses neuropathic pain after nerve injury. Brain research 
835:334-339. 
Eaton MJ, Plunkett JA, Karmally S, Martinez MA, Montanez K (1998) Changes in 
GAD- and GABA- immunoreactivity in the spinal dorsal horn after peripheral 
nerve injury and promotion of recovery by lumbar transplant of immortalized 
serotonergic precursors. Journal of Chemical Neuroanatomy 16:57-72. 
Ebert B, i Storustovu S, Mortensen M, Frølund B (2002) Characterization of 
GABA(A) receptor ligands in the rat cortical wedge preparation: evidence for 
action at extrasynaptic receptors? British journal of pharmacology 137:1-8. 
Eblen-Zajjur AA, Sandkuhler J (1997) Synchronicity of nociceptive and non-
nociceptive adjacent neurons in the spinal dorsal horn of the rat: stimulus-
induced plasticity. Neuroscience 76:39-54. 
Eglen R, Reisine T (2010) Primary Cells and Stem Cells in Drug Discovery: 
Emerging Tools for High-Throughput Screening. ASSAY and Drug 
Development Technologies 9:108-124. 
Eichler SA, Förstera B, Smolinsky B, Jüttner R, Lehmann T-N, Fähling M, Schwarz 
G, Legendre P, Meier JC (2009) Splice-specific roles of glycine receptor α3 
in the hippocampus. European Journal of Neuroscience 30:1077-1091. 
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001a) 
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured 
mammalian cells. Nature 411:494-498. 
Elbashir SM, Lendeckel W, Tuschl T (2001b) RNA interference is mediated by 21- 
and 22-nucleotide RNAs. Genes & development 15:188-200. 
Emamghoreishi M, Keshavarz M, Nekooeian AA (2015) Acute and chronic effects of 
lithium on BDNF and GDNF mRNA and protein levels in rat primary 
neuronal, astroglial and neuroastroglia cultures. Iranian Journal of Basic 
Medical Sciences 18:240-246. 
Engle MP, Gassman M, Sykes KT, Bettler B, Hammond DL (2006) Spinal Nerve 
Ligation Does Not Alter the Expression or Function of GABA(B) Receptors in 
Spinal Cord and Dorsal Root Ganglia of the Rat. Neuroscience 138:1277-
1287. 
Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B (1998) Postsynaptic 
clustering of major GABAA receptor subtypes requires the gamma 2 subunit 
and gephyrin. Nature neuroscience 1:563-571. 
Farrar SJ, Whiting PJ, Bonnert TP, McKernan RM (1999) Stoichiometry of a Ligand-
gated Ion Channel Determined by Fluorescence Energy Transfer. Journal of 
Biological Chemistry 274:10100-10104. 
Fee MS (2000) Active Stabilization of Electrodes for Intracellular Recording in 
Awake Behaving Animals. Neuron 27:461-468. 
Fischer KF, Lukasiewicz PD, Wong RO (1998) Age-dependent and cell class-
specific modulation of retinal ganglion cell bursting activity by GABA. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
18:3767-3778. 
Fisher RS, Webber WR, Lesser RP, Arroyo S, Uematsu S (1992) High-frequency 
EEG activity at the start of seizures. Journal of clinical neurophysiology : 
official publication of the American Electroencephalographic Society 9:441-
448. 
297 
 
Ford A, Castonguay A, Cottet M, Little JW, Chen Z, Symons-Liguori AM, Doyle T, 
Egan TM, Vanderah TW, De Konnick Y, Tosh DK, Jacobson KA, Salvemini 
D (2015) Engagement of the GABA to KCC2 Signaling Pathway Contributes 
to the Analgesic Effects of A(3)AR Agonists in Neuropathic Pain. The 
Journal of Neuroscience 35:6057-6067. 
Franek M, Vaculin S, Rokyta R (2004) GABA(B) receptor agonist baclofen has non-
specific antinociceptive effect in the model of peripheral neuropathy in the 
rat. Physiological research / Academia Scientiarum Bohemoslovaca 53:351-
355. 
Fritschy JM, Mohler H (1995) GABAA-receptor heterogeneity in the adult rat brain: 
differential regional and cellular distribution of seven major subunits. The 
Journal of comparative neurology 359:154-194. 
Fucile S (2004) Ca2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 
35:1-8. 
Fujita M, Sato K, Sato M, Inoue T, Kozuka T, Tohyama M (1991) Regional 
distribution of the cells expressing glycine receptor beta subunit mRNA in 
the rat brain. Brain research 560:23-37. 
Galimberti I, Gogolla N, Alberi S, Santos AF, Muller D, Caroni P (2006) Long-term 
rearrangements of hippocampal mossy fiber terminal connectivity in the 
adult regulated by experience. Neuron 50:749-763. 
Galzi J-L, Changeux J-P (1994) Neurotransmitter-gated ion channels as 
unconventional allosteric proteins. Current Opinion in Structural Biology 
4:554-565. 
Gangadharan V, Agarwal N, Brugger S, Tegeder I, Bettler B, Kuner R, Kurejova M 
(2009) Conditional gene deletion reveals functional redundancy of GABAB 
receptors in peripheral nociceptors in vivo. Molecular pain 5:68. 
Gao YJ, Ji RR (2009) c-Fos and pERK, which is a better marker for neuronal 
activation and central sensitization after noxious stimulation and tissue 
injury? The open pain journal 2:11-17. 
Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. 
European Journal of Neuroscience 27:2783-2802. 
Ge LH, Lee SC, Liu J, Yang XL (2007) Glycine receptors are functionally expressed 
on bullfrog retinal cone photoreceptors. Neuroscience 146:427-434. 
Gingrich KJ, Roberts WA, Kass RS (1995) Dependence of the GABAA receptor 
gating kinetics on the alpha-subunit isoform: implications for structure-
function relations and synaptic transmission. The Journal of physiology 489 ( 
Pt 2):529-543. 
Gonzalez-Sulser A, Wang J, Queenan BN, Avoli M, Vicini S, Dzakpasu R (2012) 
Hippocampal neuron firing and local field potentials in the in vitro 4-
aminopyridine epilepsy model. Journal of neurophysiology 108:2568-2580. 
Gordon J, Amini S, White MK (2013) General overview of neuronal cell culture. 
Methods in molecular biology (Clifton, NJ) 1078:1-8. 
Graham BA, Brichta AM, Callister RJ (2007) Moving From an Averaged to Specific 
View of Spinal Cord Pain Processing Circuits. Journal of neurophysiology 
98:1057-1063. 
Green GM, Dickenson A (1997) GABA-receptor control of the amplitude and 
duration of the neuronal responses to formalin in the rat spinal cord. Eur J 
Pain 1:95-104. 
Grenier F, Timofeev I, Steriade M (2003) Neocortical very fast oscillations (ripples, 
80-200 Hz) during seizures: intracellular correlates. Journal of 
neurophysiology 89:841-852. 
Grenningloh G, Pribilla I, Prior P, Multhaup G, Beyreuther K, Taleb O, Betz H (1990) 
Cloning and expression of the 58 kd β subunit of the inhibitory glycine 
receptor. Neuron 4:963-970. 
298 
 
Grienberger C, Konnerth A (2012) Imaging Calcium in Neurons. Neuron 73:862-
885. 
Griffon N, Büttner C, Nicke A, Kuhse J, Schmalzing G, Betz H (1999) Molecular 
determinants of glycine receptor subunit assembly. The EMBO journal 
18:4711-4721. 
Grognet A, Hertz F, DeFeudis FV (1983) Comparison of the analgesic actions of 
THIP and morphine. General pharmacology 14:585-589. 
Grosser S, Queenan BN, Lalchandani RR, Vicini S (2014) Hilar somatostatin 
interneurons contribute to synchronized GABA activity in an in vitro epilepsy 
model. PloS one 9:e86250. 
Grudt TJ, Perl ER (2002) Correlations between neuronal morphology and 
electrophysiological features in the rodent superficial dorsal horn. The 
Journal of physiology 540:189-207. 
Grudzinska J, Schemm R, Haeger S, Nicke A, Schmalzing G, Betz H, Laube B 
(2005) The beta subunit determines the ligand binding properties of synaptic 
glycine receptors. Neuron 45:727-739. 
Guan Y, Yaster M, Raja S, Tao Y-X (2007) Genetic knockout and pharmacologic 
inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced 
mechanical hypersensitivity in mice. Molecular pain 3:29. 
Guertin PA (2012) Central Pattern Generator for Locomotion: Anatomical, 
Physiological, and Pathophysiological Considerations. Frontiers in 
Neurology 3:183. 
Guetg N, Abdel Aziz S, Holbro N, Turecek R, Rose T, Seddik R, Gassmann M, 
Moes S, Jenoe P, Oertner TG, Casanova E, Bettler B (2010) NMDA 
receptor-dependent GABAB receptor internalization via CaMKII 
phosphorylation of serine 867 in GABAB1. Proceedings of the National 
Academy of Sciences of the United States of America 107:13924-13929. 
Gurley D, Amin J, Ross PC, Weiss DS, White G (1995) Point mutations in the M2 
region of the alpha, beta, or gamma subunit of the GABAA channel that 
abolish block by picrotoxin. Receptors & channels 3:13-20. 
Han L, Talwar S, Wang Q, Shan Q, Lynch JW (2013) Phosphorylation of α3 Glycine 
Receptors Induces a Conformational Change in the Glycine-Binding Site. 
ACS Chemical Neuroscience 4:1361-1370. 
Hantman AW, van den Pol AN, Perl ER (2004) Morphological and Physiological 
Features of a Set of Spinal Substantia Gelatinosa Neurons Defined by 
Green Fluorescent Protein Expression. The Journal of Neuroscience 24:836-
842. 
Haranishi Y, Hara K, Terada T, Nakamura S, Sata T (2010) The antinociceptive 
effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 
in a rat acute pain model. Anesthesia and analgesia 110:615-621. 
Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG, 
Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H, 
Wolfer DP, Betz H, Zeilhofer HU, Muller U (2004) GlyR alpha3: an essential 
target for spinal PGE2-mediated inflammatory pain sensitization. Science 
304:884-887. 
Harvey RJ, Schmieden V, Von Holst A, Laube B, Rohrer H, Betz H (2000) Glycine 
receptors containing the α4 subunit in the embryonic sympathetic nervous 
system, spinal cord and male genital ridge. European Journal of 
Neuroscience 12:994-1001. 
Harvey VL, Caley A, Muller UC, Harvey RJ, Dickenson AH (2009) A Selective Role 
for alpha3 Subunit Glycine Receptors in Inflammatory Pain. Frontiers in 
molecular neuroscience 2:14. 
Hasbargen T, Ahmed MM, Miranpuri G, Li L, Kahle KT, Resnick D, Sun D (2010) 
Role of NKCC1 and KCC2 in the development of chronic neuropathic pain 
299 
 
following spinal cord injury. Annals of the New York Academy of Sciences 
1198:168-172. 
Heaulme M, Chambon J-P, Leyris R, Molimard J-C, Wermuth CG, Biziere K (1986) 
Biochemical characterization of the interaction of three pyridazinyl-GABA 
derivatives with the GABAA receptor site. Brain research 384:224-231. 
Heimlich G, Cidlowski JA (2006) Selective Role of Intracellular Chloride in the 
Regulation of the Intrinsic but Not Extrinsic Pathway of Apoptosis in Jurkat 
T-cells. Journal of Biological Chemistry 281:2232-2241. 
Heinke B, Ruscheweyh R, Forsthuber L, Wunderbaldinger G, Sandkuhler J (2004) 
Physiological, neurochemical and morphological properties of a subgroup of 
GABAergic spinal lamina II neurones identified by expression of green 
fluorescent protein in mice. The Journal of physiology 560:249-266. 
Hendrich J, Bauer CS, Dolphin AC (2012a) Chronic pregabalin inhibits synaptic 
transmission between rat dorsal root ganglion and dorsal horn neurons in 
culture. Channels (Austin) 6:124-132. 
Hendrich J, Bauer CS, Dolphin AC (2012b) Chronic pregabalin inhibits synaptic 
transmission between rat dorsal root ganglion and dorsal horn neurons in 
culture. Channels 6:124-132. 
Hering-Hanit R (1999) Baclofen for prevention of migraine. Cephalalgia : an 
international journal of headache 19:589-591. 
Hering-Hanit R, Gadoth N (2000) Baclofen in cluster headache. Headache 40:48-
51. 
Hering-Hanit R, Gadoth N (2001) The use of baclofen in cluster headache. Current 
pain and headache reports 5:79-82. 
Hill AJ, Jones NA, Williams CM, Stephens GJ, Whalley BJ (2010) Development of 
multi-electrode array screening for anticonvulsants in acute rat brain slices. 
Journal of neuroscience methods 185:246-256. 
Hinckley C, Seebach B, Ziskind-Conhaim L (2005) Distinct roles of glycinergic and 
GABAergic inhibition in coordinating locomotor-like rhythms in the neonatal 
mouse spinal cord. Neuroscience 131:745-758. 
Hoehn-Saric R (1983) Effects of THIP on chronic anxiety. Psychopharmacology 
80:338-341. 
Hsieh MT, Donaldson LF, Lumb BM (2015) Differential contributions of A- and C-
nociceptors to primary and secondary inflammatory hypersensitivity in the 
rat. Pain 156:1074-1083. 
Huang D, Huang S, Peers C, Du X, Zhang H, Gamper N (2015) GABAB receptors 
inhibit low-voltage activated and high-voltage activated Ca2+ channels in 
sensory neurons via distinct mechanisms. Biochemical and Biophysical 
Research Communications 465:188-193. 
Hubner CA, Holthoff K (2013) Anion transport and GABA signaling. Frontiers in 
cellular neuroscience 7:177. 
Hughes DI, Sikander S, Kinnon CM, Boyle KA, Watanabe M, Callister RJ, Graham 
BA (2012) Morphological, neurochemical and electrophysiological features 
of parvalbumin-expressing cells: a likely source of axo-axonic inputs in the 
mouse spinal dorsal horn. The Journal of physiology 590:3927-3951. 
Humpel C (2015) Organotypic brain slice cultures: A review. Neuroscience 305:86-
98. 
Hutvagner G, Zamore PD (2002) A microRNA in a multiple-turnover RNAi enzyme 
complex. Science 297:2056-2060. 
Hwang JH, Yaksh TL (1997) The effect of spinal GABA receptor agonists on tactile 
allodynia in a surgically-induced neuropathic pain model in the rat. Pain 
70:15-22. 
Ibuki T, Hama AT, Wang XT, Pappas GD, Sagen J (1996) Loss of GABA-
immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury 
300 
 
and promotion of recovery by adrenal medullary grafts. Neuroscience 
76:845-858. 
Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, Sandkuhler J (2006) 
Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 
312:1659-1662. 
Infante C, Diaz M, Hernandez A, Constandil L, Pelissier T (2007) Expression of 
nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: effects 
of competitive and uncompetitive N-methyl-D-aspartate antagonists. Arthritis 
Research & Therapy 9:R53. 
Inquimbert P, Rodeau JL, Schlichter R (2007) Differential contribution of GABAergic 
and glycinergic components to inhibitory synaptic transmission in lamina II 
and laminae III-IV of the young rat spinal cord. The European journal of 
neuroscience 26:2940-2949. 
Ito S, Yeh F-C, Hiolski E, Rydygier P, Gunning DE, Hottowy P, Timme N, Litke AM, 
Beggs JM (2014) Large-Scale, High-Resolution Multielectrode-Array 
Recording Depicts Functional Network Differences of Cortical and 
Hippocampal Cultures. PloS one 9:e105324. 
Javdani F, Holló K, Hegedűs K, Kis G, Hegyi Z, Dócs K, Kasugai Y, Fukazawa Y, 
Shigemoto R, Antal M (2015) Differential expression patterns of K+/Cl− 
cotransporter 2 in neurons within the superficial spinal dorsal horn of rats. 
Journal of Comparative Neurology 523:1967-1983. 
Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A, Andreasen A, 
Viner A, Trudell JR, Harrison NL (2001) Evidence for a common binding 
cavity for three general anesthetics within the GABAA receptor. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 
21:RC136. 
Jia F, Pignataro L, Harrison NL (2007) GABAA receptors in the thalamus: α4 
subunit expression and alcohol sensitivity. Alcohol 41:177-185. 
Jin N, Narasaraju T, Kolliputi N, Chen J, Liu L (2005) Differential expression of 
GABAA receptor π subunit in cultured rat alveolar epithelial cells. Cell and 
tissue research 321:173-183. 
Jonsson S, Morud J, Pickering C, Adermark L, Ericson M, Söderpalm B (2012) 
Changes in glycine receptor subunit expression in forebrain regions of the 
Wistar rat over development. Brain research 1446:12-21. 
Kahle KT, Khanna A, Clapham DE, Woolf CJ (2014) Therapeutic restoration of 
spinal inhibition via druggable enhancement of potassium-chloride 
cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic 
pain. JAMA neurology 71:640-645. 
Kaila K, Lamsa K, Smirnov S, Taira T, Voipio J (1997) Long-lasting GABA-mediated 
depolarization evoked by high-frequency stimulation in pyramidal neurons of 
rat hippocampal slice is attributable to a network-driven, bicarbonate-
dependent K+ transient. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 17:7662-7672. 
Kaila K, Voipio J (1987) Postsynaptic fall in intracellular pH induced by GABA-
activated   bicarbonate conductance. Nature 330:163-165. 
Kaneko M, Hammond DL (1997) Role of spinal gamma-aminobutyric acidA 
receptors in formalin-induced nociception in the rat. The Journal of 
pharmacology and experimental therapeutics 282:928-938. 
Kato G, Kawasaki Y, Ji RR, Strassman AM (2007) Differential wiring of local 
excitatory and inhibitory synaptic inputs to islet cells in rat spinal lamina II 
demonstrated by laser scanning photostimulation. The Journal of physiology 
580:815-833. 
Keefer EW, Gramowski A, Gross GW (2001) NMDA Receptor-Dependent Periodic 
Oscillations in Cultured Spinal Cord Networks. Journal of neurophysiology 
86:3030-3042. 
301 
 
Keller AF, Breton J-D, Schlichter R, Poisbeau P (2004) Production of 5α-Reduced 
Neurosteroids Is Developmentally Regulated and Shapes GABAA Miniature 
IPSCs in Lamina II of the Spinal Cord. The Journal of Neuroscience 24:907-
915. 
Keller AF, Coull JA, Chery N, Poisbeau P, De Koninck Y (2001) Region-specific 
developmental specialization of GABA-glycine cosynapses in laminas I-II of 
the rat spinal dorsal horn. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 21:7871-7880. 
Kern DS, Maclean KN, Jiang H, Synder EY, Sladek JJR, Bjugstad KB (2011) Neural 
Stem Cells Reduce Hippocampal Tau and Reelin Accumulation in Aged 
Ts65Dn Down Syndrome Mice. Cell Transplantation 20:371-379. 
Kibaly C, Meyer L, Patte-Mensah C, Mensah-Nyagan AG (2008) Biochemical and 
functional evidence for the control of pain mechanisms by 
dehydroepiandrosterone endogenously synthesized in the spinal cord. The 
FASEB Journal 22:93-104. 
Kilic G, Moran O, Cherubini E (1991) N-methyl-D-aspartate receptor-mediated 
spontaneous activity in cerebellar granule cells in culture. Neuroscience 
Letters 130:263-266. 
Kim T, Thankachan S, McKenna JT, McNally JM, Yang C, Choi JH, Chen L, Kocsis 
B, Deisseroth K, Strecker RE, Basheer R, Brown RE, McCarley RW (2015) 
Cortically projecting basal forebrain parvalbumin neurons regulate cortical 
gamma band oscillations. Proceedings of the National Academy of Sciences 
of the United States of America 112:3535-3540. 
Kim TK, Eberwine JH (2010) Mammalian cell transfection: the present and the 
future. Analytical and Bioanalytical Chemistry 397:3173-3178. 
Kling C, Koch M, Saul B, Becker CM (1997) The frameshift mutation oscillator 
(Glra1(spd-ot)) produces a complete loss of glycine receptor alpha1-
polypeptide in mouse central nervous system. Neuroscience 78:411-417. 
Knabl J, Witschi R, Hosl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J, 
Sergejeva M, Hess A, Brune K, Fritschy JM, Rudolph U, Mohler H, Zeilhofer 
HU (2008) Reversal of pathological pain through specific spinal GABAA 
receptor subtypes. Nature 451:330-334. 
Kneussel M, Betz H (2000) Receptors, gephyrin and gephyrin-associated proteins: 
novel insights into the assembly of inhibitory postsynaptic membrane 
specializations. The Journal of physiology 525 Pt 1:1-9. 
Korpi ER, Koikkalainen P, Vekovischeva OY, Mäkelä R, Kleinz R, Uusi-Oukari M, 
Wisden W (1999) Cerebellar granule-cell-specific GABAA receptors 
attenuate benzodiazepine-induced ataxia: evidence from α6-subunit-
deficient mice. European Journal of Neuroscience 11:233-240. 
Koutsikou S, Parry DM, MacMillan FM, Lumb BM (2007) Laminar organization of 
spinal dorsal horn neurones activated by C- vs. A-heat nociceptors and their 
descending control from the periaqueductal grey in the rat. The European 
journal of neuroscience 26:943-952. 
Kovalchuk Y, Eilers J, Lisman J, Konnerth A (2000) NMDA Receptor-Mediated 
Subthreshold Ca2+ Signals in Spines of Hippocampal Neurons. The Journal 
of Neuroscience 20:1791-1799. 
Krogsgaard-Larsen P, Frolund B, Liljefors T, Ebert B (2004) GABA(A) agonists and 
partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel 
type of hypnotic. Biochemical pharmacology 68:1573-1580. 
Krosnowski K, Ashby S, Sathyanesan A, Luo W, Ogura T, Lin W (2012) Diverse 
populations of intrinsic cholinergic interneurons in the mouse olfactory bulb. 
Neuroscience 213:161-178. 
Kruskal Peter B, Jiang Z, Gao T, Lieber Charles M (2015) Beyond the Patch Clamp: 
Nanotechnologies for Intracellular Recording. Neuron 86:21-24. 
302 
 
Kuhse J, Laube B, Magalei D, Betz H (1993) Assembly of the inhibitory glycine 
receptor: identification of amino acid sequence motifs governing subunit 
stoichiometry. Neuron 11:1049-1056. 
Kuhse J, Schmieden V, Betz H (1990) A single amino acid exchange alters the 
pharmacology of neonatal rat glycine receptor subunit. Neuron 5:867-873. 
Kuki T, Fujihara K, Miwa H, Tamamaki N, Yanagawa Y, Mushiake H (2015) 
Contribution of parvalbumin and somatostatin-expressing GABAergic 
neurons to slow oscillations and the balance in beta-gamma oscillations 
across cortical layers. Frontiers in Neural Circuits 9:6. 
Kullmann PH, Ene FA, Kandler K (2002) Glycinergic and GABAergic calcium 
responses in the developing lateral superior olive. The European journal of 
neuroscience 15:1093-1104. 
Kumazawa T, Perl ER (1978) Excitation of marginal and substantia gelatinosa 
neurons in the primate spinal cord: indications of their place in dorsal horn 
functional organization. The Journal of comparative neurology 177:417-434. 
Kuroiwa M, Kitano Y, Takasuna K, Manabe S, Saito T (2009) Muscle relaxant and 
neurotoxic activities of intrathecal baclofen in rats. Pharmacological 
Research 60:392-396. 
Labrakakis C, Lorenzo LE, Bories C, Ribeiro-da-Silva A, De Koninck Y (2009) 
Inhibitory coupling between inhibitory interneurons in the spinal cord dorsal 
horn. Molecular pain 5:24. 
Labrakakis C, Rudolph U, De Koninck Y (2014) The heterogeneity in GABAA 
receptor-mediated IPSC kinetics reflects heterogeneity of subunit 
composition among inhibitory and excitatory interneurons in spinal lamina II. 
Frontiers in cellular neuroscience 8:424. 
Lange MD, Doengi M, Lesting J, Pape HC, Jungling K (2012) Heterosynaptic long-
term potentiation at interneuron-principal neuron synapses in the amygdala 
requires nitric oxide signalling. The Journal of physiology 590:131-143. 
Lau BK, Vaughan CW (2014) Descending modulation of pain: the GABA 
disinhibition hypothesis of analgesia. Curr Opin Neurobiol 29:159-164. 
Le Blon D, Hoornaert C, Daans J, Santermans E, Hens N, Goossens H, Berneman 
Z, Ponsaerts P (2014) Distinct spatial distribution of microglia and 
macrophages following mesenchymal stem cell implantation in mouse brain. 
Immunol Cell Biol 92:650-658. 
Lee H, Chen CX, Liu YJ, Aizenman E, Kandler K (2005) KCC2 expression in 
immature rat cortical neurons is sufficient to switch the polarity of GABA 
responses. The European journal of neuroscience 21:2593-2599. 
Legendre P, McKenzie JS, Dupouy B, Vincent JD (1985) Evidence for bursting 
pacemaker neurones in cultured spinal cord cells. Neuroscience 16:753-767. 
Lein PJ, Barnhart CD, Pessah IN (2011) Acute hippocampal slice preparation and 
hippocampal slice cultures. Methods Mol Biol 758:115-134. 
Lewis TM, Schofield PR, McClellan AML (2003) Kinetic determinants of agonist 
action at the recombinant human glycine receptor. The Journal of physiology 
549:361-374. 
Li CL, Mc IH (1957) Maintenance of resting membrane potentials in slices of 
mammalian cerebral cortex and other tissues in vitro. The Journal of 
physiology 139:178-190. 
Li J, Baccei ML (2011) Pacemaker neurons within newborn spinal pain circuits. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
31:9010-9022. 
Li J, Blankenship ML, Baccei ML (2013) Inward-rectifying potassium (Kir) channels 
regulate pacemaker activity in spinal nociceptive circuits during early life. 
The Journal of neuroscience : the official journal of the Society for 
Neuroscience 33:3352-3362. 
303 
 
Li J, Kritzer E, Ford NC, Arbabi S, Baccei ML (2014) Connectivity of pacemaker 
neurons in the neonatal rat superficial dorsal horn. The Journal of 
comparative neurology. 
Light AR, Perl ER (1979) Reexamination of the dorsal root projection to the spinal 
dorsal horn including observations on the differential termination of coarse 
and fine fibers. The Journal of comparative neurology 186:117-131. 
Lindstrom SH, Azizi N, Weller C, Wilson M (2010) Retinal input to efferent target 
amacrine cells in the avian retina. Visual neuroscience 27:103-118. 
Liu P, Guo W-Y, Zhao X-N, Bai H-P, Wang Q, Wang X-L, Zhang Y-Z (2014) 
Intrathecal baclofen, a GABAB receptor agonist, inhibits the expression of p-
CREB and NR2B in the spinal dorsal horn in rats with diabetic neuropathic 
pain. Canadian journal of physiology and pharmacology 92:655-660. 
Lodge DJ, Behrens MM, Grace AA (2009) A loss of parvalbumin-containing 
interneurons is associated with diminished oscillatory activity in an animal 
model of schizophrenia. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 29:2344-2354. 
Loeser JD, Ward AA, Jr. (1967) Some effects of deafferentation on neurons of the 
cat spinal cord. Archives of neurology 17:629-636. 
Lombard MC, Nashold BS, Jr., Albe-Fessard D, Salman N, Sakr C (1979) 
Deafferentation hypersensitivity in the rat after dorsal rhizotomy: a possible 
animal model of chronic pain. Pain 6:163-174. 
Lossi L, Alasia S, Salio C, Merighi A (2009) Cell death and proliferation in acute 
slices and organotypic cultures of mammalian CNS. Progress in 
neurobiology 88:221-245. 
Lovitt CJ, Shelper TB, Avery VM (2014) Advanced Cell Culture Techniques for 
Cancer Drug Discovery. Biology 3:345-367. 
Lu VB, Biggs JE, Stebbing MJ, Balasubramanyan S, Todd KG, Lai AY, Colmers 
WF, Dawbarn D, Ballanyi K, Smith PA (2009) Brain-derived neurotrophic 
factor drives the changes in excitatory synaptic transmission in the rat 
superficial dorsal horn that follow sciatic nerve injury. The Journal of 
physiology 587:1013-1032. 
Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT (2001) Activation of 
synaptic NMDA receptors induces membrane insertion of new AMPA 
receptors and LTP in cultured hippocampal neurons. Neuron 29:243-254. 
Lu Y, Dong H, Gao Y, Gong Y, Ren Y, Gu N, Zhou S, Xia N, Sun Y-Y, Ji R-R, Xiong 
L (2013) A feed-forward spinal cord glycinergic neural circuit gates 
mechanical allodynia. The Journal of clinical investigation 123:4050-4062. 
Lu Y, Perl ER (2005) Modular organization of excitatory circuits between neurons of 
the spinal superficial dorsal horn (laminae I and II). The Journal of 
neuroscience : the official journal of the Society for Neuroscience 25:3900-
3907. 
Lynch JW (2004) Molecular Structure and Function of the Glycine Receptor 
Chloride Channel. Physiological reviews 84:1051-1095. 
Lynch JW, Callister RJ (2006) Glycine receptors: a new therapeutic target in pain 
pathways. Curr Opin Investig Drugs 7:48-53. 
MacKenzie G, Maguire J (2015) Chronic stress shifts the GABA reversal potential in 
the hippocampus and increases seizure susceptibility. Epilepsy research 
109:13-27. 
Magnuson DSK, Johnson R, Peet MJ, Curry K, McLennan H (1987) A novel spinal 
cord slice preparation from the rat. Journal of neuroscience methods 19:141-
145. 
Majumdar S, Wässle H, Jusuf PR, Haverkamp S (2008) Mirror-symmetrical 
populations of wide-field amacrine cells of the macaque monkey retina. The 
Journal of comparative neurology 508:13-27. 
304 
 
Maksay G, Laube B, Betz H (2001) Subunit-specific modulation of glycine receptors 
by neurosteroids. Neuropharmacology 41:369-376. 
Malan TP, Mata HP, Porreca F (2002) Spinal GABA(A) and GABA(B) receptor 
pharmacology in a rat model of neuropathic pain. Anesthesiology 96:1161-
1167. 
Malet M, Vieytes CA, Lundgren KH, Seal RP, Tomasella E, Seroogy KB, Hokfelt T, 
Gebhart GF, Brumovsky PR (2013) Transcript expression of vesicular 
glutamate transporters in lumbar dorsal root ganglia and the spinal cord of 
mice - effects of peripheral axotomy or hindpaw inflammation. Neuroscience 
248:95-111. 
Malin SA, Davis BM, Molliver DC (2007) Production of dissociated sensory neuron 
cultures and considerations for their use in studying neuronal function and 
plasticity. Nat Protocols 2:152-160. 
Malosio ML, Grenningloh G, Kuhse J, Schmieden V, Schmitt B, Prior P, Betz H 
(1991a) Alternative splicing generates two variants of the alpha 1 subunit of 
the inhibitory glycine receptor. Journal of Biological Chemistry 266:2048-
2053. 
Malosio ML, Marqueze-Pouey B, Kuhse J, Betz H (1991b) Widespread expression 
of glycine receptor subunit mRNAs in the adult and developing rat brain. The 
EMBO journal 10:2401-2409. 
Manabe T, Renner P, Nicoll RA (1992) Postsynaptic contribution to long-term 
potentiation revealed by the analysis of miniature synaptic currents. Nature 
355:50-55. 
Mangan PS, Sun C, Carpenter M, Goodkin HP, Sieghart W, Kapur J (2005) 
Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA 
Receptors. Molecular pharmacology 67:775-788. 
Maniataki E, Mourelatos Z (2005) A human, ATP-independent, RISC assembly 
machine fueled by pre-miRNA. Genes & development 19:2979-2990. 
Maric H-M, Mukherjee J, Tretter V, Moss SJ, Schindelin H (2011) Gephyrin-
mediated γ-Aminobutyric Acid Type A and Glycine Receptor Clustering 
Relies on a Common Binding Site. Journal of Biological Chemistry 
286:42105-42114. 
Marksteiner J, Humpel C (2007) Beta-amyloid expression, release and extracellular 
deposition in aged rat brain slices. Mol Psychiatry 13:939-952. 
Marvizon JC, Grady EF, Stefani E, Bunnett NW, Mayer EA (1999) Substance P 
release in the dorsal horn assessed by receptor internalization: NMDA 
receptors counteract a tonic inhibition by GABA(B) receptors. The European 
journal of neuroscience 11:417-426. 
Marvizon JC, Martinez V, Grady EF, Bunnett NW, Mayer EA (1997) Neurokinin 1 
receptor internalization in spinal cord slices induced by dorsal root 
stimulation is mediated by NMDA receptors. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 17:8129-8136. 
Massobrio P, Tessadori J, Chiappalone M, Ghirardi M (2015) In Vitro Studies of 
Neuronal Networks and Synaptic Plasticity in Invertebrates and in Mammals 
Using Multielectrode Arrays. Neural Plasticity 2015:196195. 
Matrai J, Chuah MKL, VandenDriessche T (2010) Recent Advances in Lentiviral 
Vector Development and Applications. Mol Ther 18:477-490. 
Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD (2005) Passenger-strand 
cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme 
complexes. Cell 123:607-620. 
Matthews EA, Dickenson AH (2001a) Effects of ethosuximide, a T-type Ca2+ 
channel blocker, on dorsal horn neuronal responses in rats. European 
journal of pharmacology 415:141-149. 
305 
 
Matthews EA, Dickenson AH (2001b) Effects of spinally delivered N- and P-type 
voltage-dependent calcium channel antagonists on dorsal horn neuronal 
responses in a rat model of neuropathy. Pain 92:235-246. 
Matzenbach B, Maulet Y, Sefton L, Courtier B, Avner P, Guénet JL, Betz H (1994) 
Structural analysis of mouse glycine receptor alpha subunit genes. 
Identification and chromosomal localization of a novel variant. Journal of 
Biological Chemistry 269:2607-2612. 
Maxwell DJ, Belle MD, Cheunsuang O, Stewart A, Morris R (2007) Morphology of 
inhibitory and excitatory interneurons in superficial laminae of the rat dorsal 
horn. The Journal of physiology 584:521-533. 
McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA (2002) RNA 
interference in adult mice. Nature 418:38-39. 
McConnell ER, McClain MA, Ross J, LeFew WR, Shafer TJ (2012) Evaluation of 
multi-well microelectrode arrays for neurotoxicity screening using a chemical 
training set. Neurotoxicology 33:1048-1057. 
McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, 
Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, 
Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, 
Dawson GR, Whiting PJ (2000) Sedative but not anxiolytic properties of 
benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. 
Nature neuroscience 3:587-592. 
Meier JC, Henneberger C, Melnick I, Racca C, Harvey RJ, Heinemann U, 
Schmieden V, Grantyn R (2005) RNA editing produces glycine receptor 
[alpha]3P185L, resulting in high agonist potency. Nature neuroscience 
8:736-744. 
Meisner JG, Marsh AD, Marsh DR (2010) Loss of GABAergic interneurons in 
laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic 
tone and neuropathic pain after spinal cord injury. Journal of neurotrauma 
27:729-737. 
Melzack R, Wall PD (1965) Pain mechanisms: a new theory. Science 150:971-979. 
Mergenthaler P, Wendland K, Meisel A (2014) A versatile tool for the analysis of 
neuronal survival. Methods 66:325-329. 
Meyer G, Kirsch J, Betz H, Langosch D (1995a) Identification of a gephyrin binding 
motif on the glycine receptor beta subunit. Neuron 15:563-572. 
Meyer G, Kirsch J, Betz H, Langosch D (1995b) Identification of a gephyrin binding 
motif on the glycine receptor β subunit. Neuron 15:563-572. 
Miletic G, Draganic P, Pankratz MT, Miletic V (2003) Muscimol prevents long-lasting 
potentiation of dorsal horn field potentials in rats with chronic constriction 
injury exhibiting decreased levels of the GABA transporter GAT-1. Pain 
105:347-353. 
Miletic V, Randic M (1981) Neonatal rat spinal cord slice preparation: postsynaptic 
effects of neuropeptides on dorsal horn neurons. Brain research 254:432-
438. 
Milligan CJ, Buckley NJ, Garret M, Deuchars J, Deuchars SA (2004) Evidence for 
Inhibition Mediated by Coassembly of GABAA and GABAC Receptor 
Subunits in Native Central Neurons. The Journal of Neuroscience 24:7241-
7250. 
Mirza NR, Nielsen EO (2006) Do subtype-selective gamma-aminobutyric acid A 
receptor modulators have a reduced propensity to induce physical 
dependence in mice? The Journal of pharmacology and experimental 
therapeutics 316:1378-1385. 
Mitchell SJ, Silver RA (2003) Shunting Inhibition Modulates Neuronal Gain during 
Synaptic Excitation. Neuron 38:433-445. 
Miyazato M, Sasatomi K, Hiragata S, Sugaya K, Chancellor MB, de Groat WC, 
Yoshimura N (2008) GABA-RECEPTOR ACTIVATION IN THE 
306 
 
LUMBOSACRAL SPINAL CORD REDUCES DETRUSOR OVERACTIVITY 
IN SPINAL CORD INJURED RATS. The Journal of urology 179:1178-1183. 
Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ (2002) Partial 
peripheral nerve injury promotes a selective loss of GABAergic inhibition in 
the superficial dorsal horn of the spinal cord. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 22:6724-6731. 
Morris ME, Obrocea GV, Avoli M (1996) Extracellular K+ accumulations and 
synchronous GABA-mediated potentials evoked by 4-aminopyridine in the 
adult rat hippocampus. Exp Brain Res 109:71-82. 
Mortensen M, Smart TG (2006) Extrasynaptic αβ subunit GABA(A) receptors on rat 
hippocampal pyramidal neurons. The Journal of physiology 577:841-856. 
Murase K, Nedeljkov V, Randic M (1982) The actions of neuropeptides on dorsal 
horn neurons in the rat spinal cord slice preparation: an intracellular study. 
Brain research 234:170-176. 
Narikawa K, Furue H, Kumamoto E, Yoshimura M (2000) In Vivo Patch-Clamp 
Analysis of IPSCs Evoked in Rat Substantia Gelatinosa Neurons by 
Cutaneous Mechanical Stimulation. Journal of neurophysiology 84:2171-
2174. 
Nayeem N, Green TP, Martin IL, Barnard EA (1994) Quaternary Structure of the 
Native GABAA Receptor Determined by Electron Microscopic Image 
Analysis. Journal of neurochemistry 62:815-818. 
Neal MJ, Shah MA (1989) Baclofen and phaclofen modulate GABA release from 
slices of rat cerebral cortex and spinal cord but not from retina. British 
journal of pharmacology 98:105-112. 
Neher E, Sakaba T (2008) Multiple Roles of Calcium Ions in the Regulation of 
Neurotransmitter Release. Neuron 59:861-872. 
Nickolls S, Mace H, Fish R, Edye M, Gurrell R, Ivarsson M, Pitcher T, Tanimoto-
Mori S, Richardson D, Sweatman C, Nicholson J, Ward C, Jinks J, Bell C, 
Young K, Rees H, Moss A, Kinloch R, McMurray G (2011) A Comparison of 
the alpha2/3/5 Selective Positive Allosteric Modulators L-838,417 and 
TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain. 
Advances in pharmacological sciences 2011:608912. 
Nikolic Z, Laube B, Weber RG, Lichter P, Kioschis P, Poustka A, Mülhardt C, 
Becker C-M (1998) The Human Glycine Receptor Subunit α3: GLRA3 GENE 
STRUCTURE, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL 
CHARACTERIZATION OF ALTERNATIVE TRANSCRIPTS. Journal of 
Biological Chemistry 273:19708-19714. 
Nowak P, Kowalińska-Kania M, Nowak D, Kostrzewa RM, Malinowska-Borowska J 
(2013) Antinociceptive Effects of H(3) (R-Methylhistamine) and GABA(B) 
(Baclofen)-Receptor Ligands in an Orofacial Model of Pain in Rats. 
Neurotoxicity Research 24:258-264. 
Nusser Z, Mody I (2002) Selective modulation of tonic and phasic inhibitions in 
dentate gyrus granule cells. Journal of neurophysiology 87:2624-2628. 
Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABAA receptors 
to synaptic and extrasynaptic membranes of cerebellar granule cells. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
18:1693-1703. 
Obien MEJ, Deligkaris K, Bullmann T, Bakkum DJ, Frey U (2015) Revealing 
Neuronal Function through Microelectrode Array Recordings. Frontiers in 
Neuroscience 8. 
Ojovan SM, Rabieh N, Shmoel N, Erez H, Maydan E, Cohen A, Spira ME (2015) A 
feasibility study of multi-site,intracellular recordings from mammalian 
neurons by extracellular gold mushroom-shaped microelectrodes. Scientific 
Reports 5:14100. 
307 
 
Oliveira AL, Hydling F, Olsson E, Shi T, Edwards RH, Fujiyama F, Kaneko T, 
Hokfelt T, Cullheim S, Meister B (2003) Cellular localization of three 
vesicular glutamate transporter mRNAs and proteins in rat spinal cord and 
dorsal root ganglia. Synapse 50:117-129. 
Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes 
of γ-Aminobutyric Acid(A) Receptors: Classification on the Basis of Subunit 
Composition, Pharmacology, and Function. Update. Pharmacological 
reviews 60:243-260. 
Olsen RW, Sieghart W (2009) GABAA receptors: Subtypes provide diversity of 
function and pharmacology. Neuropharmacology 56:141-148. 
Owens DF, Boyce LH, Davis MBE, Kriegstein AR (1996) Excitatory GABA 
Responses in Embryonic and Neonatal Cortical Slices Demonstrated by 
Gramicidin Perforated-Patch Recordings and Calcium Imaging. The Journal 
of Neuroscience 16:6414-6423. 
Pan Z-H, Zhang D, Zhang X, Lipton SA (2000) Evidence for coassembly of mutant 
GABACρ1 with GABAAγ2S, glycine α1 and glycine α2 receptor subunits in 
vitro. European Journal of Neuroscience 12:3137-3145. 
Pandamooz S, Nabiuni M, Miyan J, Ahmadiani A, Dargahi L (2015) Organotypic 
Spinal Cord Culture: a Proper Platform for the Functional Screening. Mol 
Neurobiol 1-16. 
Papouin T, Ladepeche L, Ruel J, Sacchi S, Labasque M, Hanini M, Groc L, 
Pollegioni L, Mothet JP, Oliet SH (2012) Synaptic and extrasynaptic NMDA 
receptors are gated by different endogenous coagonists. Cell 150:633-646. 
Paul J, Zeilhofer HU, Fritschy J-M (2012) Selective distribution of GABAA receptor 
subtypes in mouse spinal dorsal horn neurons and primary afferents. Journal 
of Comparative Neurology 520:3895-3911. 
Perreault P, Avoli M (1991) Physiology and pharmacology of epileptiform activity 
induced by 4-aminopyridine in rat hippocampal slices. Journal of 
neurophysiology 65:771-785. 
Ploner M, Gross J, Timmermann L, Pollok B, Schnitzler A (2006) Oscillatory activity 
reflects the excitability of the human somatosensory system. NeuroImage 
32:1231-1236. 
Poisbeau P, Patte-Mensah C, Keller AF, Barrot M, Breton J-D, Luis-Delgado OE, 
Freund-Mercier MJ, Mensah-Nyagan AG, Schlichter R (2005) Inflammatory 
Pain Upregulates Spinal Inhibition via Endogenous Neurosteroid Production. 
The Journal of Neuroscience 25:11768-11776. 
Polgar E, Durrieux C, Hughes DI, Todd AJ (2013) A quantitative study of inhibitory 
interneurons in laminae I-III of the mouse spinal dorsal horn. PloS one 
8:e78309. 
Polgar E, Hughes DI, Arham AZ, Todd AJ (2005) Loss of neurons from laminas I-III 
of the spinal dorsal horn is not required for development of tactile allodynia 
in the spared nerve injury model of neuropathic pain. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 25:6658-
6666. 
Polgar E, Hughes DI, Riddell JS, Maxwell DJ, Puskar Z, Todd AJ (2003) Selective 
loss of spinal GABAergic or glycinergic neurons is not necessary for 
development of thermal hyperalgesia in the chronic constriction injury model 
of neuropathic pain. Pain 104:229-239. 
Polgár E, Sardella TCP, Tiong SYX, Locke S, Watanabe M, Todd AJ (2013) 
Functional differences between neurochemically defined populations of 
inhibitory interneurons in the rat spinal dorsal horn. PAIN® 154:2606-2615. 
Poulter M, Barker J, O'Carroll A, Lolait S, Mahan L (1992) Differential and transient 
expression of GABAA receptor alpha-subunit mRNAs in the developing rat 
CNS. The Journal of Neuroscience 12:2888-2900. 
308 
 
Pratten M, Ahir BK, Smith-Hurst H, Memon S, Mutch P, Cumberland P (2012) 
Primary cell and micromass culture in assessing developmental toxicity. 
Methods Mol Biol 889:115-146. 
Prescott SA, Sejnowski TJ, De Koninck Y (2006) Reduction of anion reversal 
potential subverts the inhibitory control of firing rate in spinal lamina I 
neurons: towards a biophysical basis for neuropathic pain. Molecular pain 
2:32-32. 
Pribilla I, Takagi T, Langosch D, Bormann J, Betz H (1992) The atypical M2 
segment of the beta subunit confers picrotoxinin resistance to inhibitory 
glycine receptor channels. The EMBO journal 11:4305-4311. 
Punnakkal P, von Schoultz C, Haenraets K, Wildner H, Zeilhofer HU (2014) 
Morphological, biophysical and synaptic properties of glutamatergic neurons 
of the mouse spinal dorsal horn. The Journal of physiology 592:759-776. 
Quadrato G, Elnaggar MY, Duman C, Sabino A, Forsberg K, Di Giovanni S (2014) 
Modulation of GABAA receptor signaling increases neurogenesis and 
suppresses anxiety through NFATc4. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 34:8630-8645. 
Quinn KP, Dong L, Golder FJ, Winkelstein BA (2010) Neuronal hyperexcitability in 
the dorsal horn after painful facet joint injury. Pain 151:414-421. 
Racz I, Schutz B, Abo-Salem OM, Zimmer A (2005) Visceral, inflammatory and 
neuropathic pain in glycine receptor alpha 3-deficient mice. Neuroreport 
16:2025-2028. 
Rand TA, Ginalski K, Grishin NV, Wang X (2004) Biochemical identification of 
Argonaute 2 as the sole protein required for RNA-induced silencing complex 
activity. Proceedings of the National Academy of Sciences of the United 
States of America 101:14385-14389. 
Ransom BR, Neale E, Henkart M, Bullock PN, Nelson PG (1977) Mouse spinal cord 
in cell culture. I. Morphology and intrinsic neuronal electrophysiologic 
properties. Journal of neurophysiology 40:1132-1150. 
Ravikumar M, Jain S, Miller RH, Capadona JR, Selkirk SM (2012) An organotypic 
spinal cord slice culture model to quantify neurodegeneration. Journal of 
neuroscience methods 211:280-288. 
Rees MI, Lewis TM, Kwok JB, Mortier GR, Govaert P, Snell RG, Schofield PR, 
Owen MJ (2002) Hyperekplexia associated with compound heterozygote 
mutations in the beta-subunit of the human inhibitory glycine receptor 
(GLRB). Human molecular genetics 11:853-860. 
Reeve AJ, Dickenson AH, Kerr NC (1998) Spinal effects of bicuculline: modulation 
of an allodynia-like state by an A1-receptor agonist, morphine, and an 
NMDA-receptor antagonist. Journal of neurophysiology 79:1494-1507. 
Rexed B (1952) The cytoarchitectonic organization of the spinal cord in the cat. The 
Journal of comparative neurology 96:414-495. 
Richardson JE, Garcia PS, O'Toole KK, Derry JM, Bell SV, Jenkins A (2007) A 
conserved tyrosine in the beta2 subunit M4 segment is a determinant of 
gamma-aminobutyric acid type A receptor sensitivity to propofol. 
Anesthesiology 107:412-418. 
Rivera C, Li H, Thomas-Crusells J, Lahtinen H, Viitanen T, Nanobashvili A, Kokaia 
Z, Airaksinen MS, Voipio J, Kaila K, Saarma M (2002) BDNF-induced TrkB 
activation down-regulates the K+-Cl- cotransporter KCC2 and impairs 
neuronal Cl- extrusion. The Journal of cell biology 159:747-752. 
Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, Pirvola U, 
Saarma M, Kaila K (1999) The K+/Cl- co-transporter KCC2 renders GABA 
hyperpolarizing during neuronal maturation. Nature 397:251-255. 
Rivera C, Voipio J, Thomas-Crusells J, Li H, Emri Z, Sipila S, Payne JA, Minichiello 
L, Saarma M, Kaila K (2004) Mechanism of activity-dependent 
downregulation of the neuron-specific K-Cl cotransporter KCC2. The Journal 
309 
 
of neuroscience : the official journal of the Society for Neuroscience 
24:4683-4691. 
Rode F, Jensen DG, Blackburn-Munro G, Bjerrum OJ (2005) Centrally-mediated 
antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve 
injury model of neuropathic pain. European journal of pharmacology 
516:131-138. 
Rossi DJ, Hamann M (1998) Spillover-Mediated Transmission at Inhibitory 
Synapses Promoted by High Affinity α6 Subunit GABAA Receptors and 
Glomerular Geometry. Neuron 20:783-795. 
Ruscheweyh R, Sandkuhler J (2003) Epileptiform activity in rat spinal dorsal horn in 
vitro has common features with neuropathic pain. Pain 105:327-338. 
Ruscheweyh R, Sandkuhler J (2005) Long-range oscillatory Ca2+ waves in rat 
spinal dorsal horn. The European journal of neuroscience 22:1967-1976. 
Ruscheweyh R, Wilder-Smith O, Drdla R, Liu XG, Sandkuhler J (2011) Long-term 
potentiation in spinal nociceptive pathways as a novel target for pain 
therapy. Molecular pain 7:20. 
Russo D, Clavenzani P, Sorteni C, Bo Minelli L, Botti M, Gazza F, Panu R, 
Ragionieri L, Chiocchetti R (2013) Neurochemical features of boar 
lumbosacral dorsal root ganglion neurons and characterization of sensory 
neurons innervating the urinary bladder trigone. The Journal of comparative 
neurology 521:342-366. 
Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, 
Woolf CJ (2001) Interleukin-1[beta]-mediated induction of Cox-2 in the CNS 
contributes to inflammatory pain hypersensitivity. Nature 410:471-475. 
Sandkühler J (2009) Models and Mechanisms of Hyperalgesia and Allodynia. 
Physiological reviews 89:707-758. 
Sandkuhler J, Eblen-Zajjur AA (1994) Identification and characterization of rhythmic 
nociceptive and non-nociceptive spinal dorsal horn neurons in the rat. 
Neuroscience 61:991-1006. 
Sardella TCP, Polgár E, Watanabe M, Todd AJ (2011) A quantitative study of 
neuronal nitric oxide synthase expression in laminae I–III of the rat spinal 
dorsal horn. Neuroscience 192:708-720. 
Sarnthein J, Stern J, Aufenberg C, Rousson V, Jeanmonod D (2006) Increased 
EEG power and slowed dominant frequency in patients with neurogenic 
pain. Brain : a journal of neurology 129:55-64. 
Sato K, Zhang JH, Saika T, Sato M, Tada K, Tohyama M (1991) Localization of 
glycine receptor α1 subunit mRNA-containing neurons in the rat brain: An 
analysis using in situ hybridization histochemistry. Neuroscience 43:381-
395. 
Saxena NC, Macdonald RL (1996) Properties of putative cerebellar gamma-
aminobutyric acid A receptor isoforms. Molecular pharmacology 49:567-579. 
Schmidtko A, Tegeder I, Geisslinger G (2009) No NO, no pain? The role of nitric 
oxide and cGMP in spinal pain processing. Trends in Neurosciences 32:339-
346. 
Schmieden V, Betz H (1995) Pharmacology of the inhibitory glycine receptor: 
agonist and antagonist actions of amino acids and piperidine carboxylic acid 
compounds. Molecular pharmacology 48:919-927. 
Schmieden V, Grenningloh G, Schofield PR, Betz H (1989) Functional expression in 
Xenopus oocytes of the strychnine binding 48 kd subunit of the glycine 
receptor. The EMBO journal 8:695-700. 
Schmieden V, Kuhse J, Betz H (1993) Mutation of glycine receptor subunit creates 
beta-alanine receptor responsive to GABA. Science 262:256-258. 
Schoenen J (1982) The dendritic organization of the human spinal cord: the dorsal 
horn. Neuroscience 7:2057-2087. 
310 
 
Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee 
LM, Ramachandran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA 
(1987) Sequence and functional expression of the GABAA receptor shows a 
ligand-gated receptor super-family. Nature 328:221-227. 
Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA, Decosterd 
I, Coggeshall RE, Woolf CJ (2005) Blocking caspase activity prevents 
transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the 
dorsal horn after peripheral nerve injury. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 25:7317-7323. 
Seelke AMH, Dooley JC, Krubitzer LA (2013) Differential changes in the cellular 
composition of the developing marsupial brain. Journal of Comparative 
Neurology 521:2602-2620. 
Sejnowski TJ, Destexhe A (2000) Why do we sleep? Brain research 886:208-223. 
Shen H-Y, van Vliet Erwin A, Bright K-A, Hanthorn M, Lytle NK, Gorter J, Aronica E, 
Boison D (2015) Glycine transporter 1 is a target for the treatment of 
epilepsy. Neuropharmacology 99:554-565. 
Shen H, Gong QH, Yuan M, Smith SS (2005) Short-term steroid treatment 
increases delta GABAA receptor subunit expression in rat CA1 
hippocampus: pharmacological and behavioral effects. Neuropharmacology 
49:573-586. 
Sherman SE, Loomis CW (1994) Morphine insensitive allodynia is produced by 
intrathecal strychnine in the lightly anesthetized rat. Pain 56:17-29. 
Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Malinow R 
(1999) Rapid spine delivery and redistribution of AMPA receptors after 
synaptic NMDA receptor activation. Science 284:1811-1816. 
Sieghart W, Sperk G (2002) Subunit composition, distribution and function of 
GABA(A) receptor subtypes. Current topics in medicinal chemistry 2:795-
816. 
Silva LR, Amitai Y, Connors BW (1991) Intrinsic oscillations of neocortex generated 
by layer 5 pyramidal neurons. Science 251:432-435. 
Simon J, Wakimoto H, Fujita N, Lalande M, Barnard EA (2004) Analysis of the Set 
of GABAA Receptor Genes in the Human Genome. Journal of Biological 
Chemistry 279:41422-41435. 
Sivilotti L, Woolf CJ (1994) The contribution of GABAA and glycine receptors to 
central sensitization: disinhibition and touch-evoked allodynia in the spinal 
cord. Journal of neurophysiology 72:169-179. 
Smith C, Kongsamut S, Wang H, Ji J, Kang J, Rampe D (2009) In Vitro 
electrophysiological activity of nerispirdine, a novel 4-aminopyridine 
derivative. Clinical and Experimental Pharmacology and Physiology 
36:1104-1109. 
Smith DAS, Connick JH, Stone TW (1989) Effect of changing extracellular levels of 
magnesium on spontaneous activity and glutamate release in the mouse 
neocortical slice. British Journal of Pharmacology 97:475-482. 
Smith GB, Olsen RW (1995) Functional domains of GABAA receptors. Trends in 
Pharmacological Sciences 16:162-168. 
Smith KM, Boyle KA, Madden JF, Dickinson SA, Jobling P, Callister RJ, Hughes DI, 
Graham BA (2015) Functional heterogeneity of calretinin-expressing 
neurons in the mouse superficial dorsal horn: implications for spinal pain 
processing. The Journal of physiology 593:4319-4339. 
Sohal VS, Keist R, Rudolph U, Huguenard JR (2003) Dynamic GABA(A) receptor 
subtype-specific modulation of the synchrony and duration of thalamic 
oscillations. The Journal of neuroscience : the official journal of the Society 
for Neuroscience 23:3649-3657. 
Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and 
gamma rhythms enhance cortical circuit performance. Nature 459:698-702. 
311 
 
Sokal D, Chapman V (2003) Inhibitory effects of spinal baclofen on spinal dorsal 
horn neurones in inflamed and neuropathic rats in vivo. Brain research 
987:67-75. 
Soltesz I, Deschenes M (1993) Low- and high-frequency membrane potential 
oscillations during theta activity in CA1 and CA3 pyramidal neurons of the rat 
hippocampus under ketamine-xylazine anesthesia. Journal of 
neurophysiology 70:97-116. 
Somers DL, Clemente FR (2002) Dorsal horn synaptosomal content of aspartate, 
glutamate, glycine and GABA are differentially altered following chronic 
constriction injury to the rat sciatic nerve. Neuroscience letters 323:171-174. 
Sorkin LS, Puig S, Jones DL (1998) Spinal bicuculline produces hypersensitivity of 
dorsal horn neurons: effects of excitatory amino acid antagonists. Pain 
77:181-190. 
Spencer SS, Lee SA (2000) Invasive EEG in neocortical epilepsy: seizure onset. 
Advances in neurology 84:275-285. 
Spira ME, Hai A (2013) Multi-electrode array technologies for neuroscience and 
cardiology. Nature nanotechnology 8:83-94. 
Staley KJ, Soldo BL, Proctor WR (1995) Ionic mechanisms of neuronal excitation by 
inhibitory GABAA receptors. Science 269:977-981. 
Stein C (2013) Opioids, sensory systems and chronic pain. European journal of 
pharmacology 716:179-187. 
Stórustovu Sı, Ebert B (2003) Gaboxadol: in vitro interaction studies with 
benzodiazepines and ethanol suggest functional selectivity. European 
journal of pharmacology 467:49-56. 
Streit J (1993) Regular oscillations of synaptic activity in spinal networks in vitro. 
Journal of neurophysiology 70:871-878. 
Streit J, Tscherter A, Heuschkel MO, Renaud P (2001) The generation of rhythmic 
activity in dissociated cultures of rat spinal cord. The European journal of 
neuroscience 14:191-202. 
Succol F, Fiumelli H, Benfenati F, Cancedda L, Barberis A (2012) Intracellular 
chloride concentration influences the GABAA receptor subunit composition. 
Nature communications 3:738. 
Swerdlow M (1984) Anticonvulsant drugs and chronic pain. Clinical 
neuropharmacology 7:51-82. 
Taccola G, Nistri A (2005) Characteristics of the electrical oscillations evoked by 4-
aminopyridine on dorsal root fibers and their relation to fictive locomotor 
patterns in the rat spinal cord in vitro. Neuroscience 132:1187-1197. 
Taccola G, Nistri A (2006) Oscillatory circuits underlying locomotor networks in the 
rat spinal cord. Critical reviews in neurobiology 18:25-36. 
Takaishi K, Eisele JH, Jr., Carstens E (1996) Behavioral and electrophysiological 
assessment of hyperalgesia and changes in dorsal horn responses following 
partial sciatic nerve ligation in rats. Pain 66:297-306. 
Takazawa T, MacDermott AB (2010) Glycinergic and GABAergic tonic inhibition fine 
tune inhibitory control in regionally distinct subpopulations of dorsal horn 
neurons. The Journal of physiology 588:2571-2587. 
Takehara A, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, 
Nakagawa H (2007) γ-Aminobutyric Acid (GABA) Stimulates Pancreatic 
Cancer Growth through Overexpressing GABAA Receptor π Subunit. 
Cancer Research 67:9704-9712. 
Tao YX, Hassan A, Haddad E, Johns RA (1999) Expression and action of cyclic 
GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal 
cord. Neuroscience 95:525-533. 
Teyler TJ (1980) Brain slice preparation: hippocampus. Brain research bulletin 
5:391-403. 
312 
 
Tibau E, Valencia M, Soriano J (2013) Identification of neuronal network properties 
from the spectral analysis of calcium imaging signals in neuronal cultures. 
Frontiers in Neural Circuits 7:199. 
Tiesinga P, Sejnowski TJ (2009) Cortical enlightenment: are attentional gamma 
oscillations driven by ING or PING? Neuron 63:727-732. 
Todd AJ (2010) Neuronal circuitry for pain processing in the dorsal horn. Nature 
reviews Neuroscience 11:823-836. 
Todd AJ, Hughes DI, Polgar E, Nagy GG, Mackie M, Ottersen OP, Maxwell DJ 
(2003) The expression of vesicular glutamate transporters VGLUT1 and 
VGLUT2 in neurochemically defined axonal populations in the rat spinal cord 
with emphasis on the dorsal horn. The European journal of neuroscience 
17:13-27. 
Todd AJ, McKenzie J (1989) GABA-immunoreactive neurons in the dorsal horn of 
the rat spinal cord. Neuroscience 31:799-806. 
Todd AJ, Spike RC (1993) The localization of classical transmitters and 
neuropeptides within neurons in laminae I-III of the mammalian spinal dorsal 
horn. Progress in neurobiology 41:609-645. 
Todd AJ, Sullivan AC (1990) Light microscope study of the coexistence of GABA-
like and glycine-like immunoreactivities in the spinal cord of the rat. The 
Journal of comparative neurology 296:496-505. 
Tohidi V, Nadim F (2009) Membrane resonance in bursting pacemaker neurons of 
an oscillatory network is correlated with network frequency. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 29:6427-
6435. 
Tomita S, Stein V, Stocker TJ, Nicoll RA, Bredt DS (2005) Bidirectional synaptic 
plasticity regulated by phosphorylation of stargazin-like TARPs. Neuron 
45:269-277. 
Tong CK, MacDermott AB (2014) Synaptic GluN2A and GluN2B containing NMDA 
receptors within the superficial dorsal horn activated following primary 
afferent stimulation. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 34:10808-10820. 
Treede RD, Kenshalo DR, Gracely RH, Jones AK (1999) The cortical representation 
of pain. Pain 79:105-111. 
Tretter V, Ehya N, Fuchs K, Sieghart W (1997) Stoichiometry and Assembly of a 
Recombinant GABAA Receptor Subtype. The Journal of Neuroscience 
17:2728-2737. 
Urch CE, Dickenson AH (2003) In vivo single unit extracellular recordings from 
spinal cord neurones of rats. Brain Research Protocols 12:26-34. 
Valtschanoff JG, Weinberg RJ, Rustioni A, Schmidt HH (1992) Nitric oxide synthase 
and GABA colocalize in lamina II of rat spinal cord. Neuroscience letters 
148:6-10. 
Venard C, Boujedaini N, Belon P, Mensah-Nyagan AG, Patte-Mensah C (2008) 
Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal 
cord by glycine and the alkaloidal analogs strychnine and gelsemine. 
Neuroscience 153:154-161. 
Venard C, Boujedaini N, Mensah-Nyagan AG, Patte-Mensah C (2011) Comparative 
Analysis of Gelsemine and Gelsemium sempervirens Activity on 
Neurosteroid Allopregnanolone Formation in the Spinal Cord and Limbic 
System. Evidence-Based Complementary and Alternative Medicine 2011. 
Viitanen T, Ruusuvuori E, Kaila K, Voipio J (2010) The K+–Cl− cotransporter KCC2 
promotes GABAergic excitation in the mature rat hippocampus. The Journal 
of physiology 588:1527-1540. 
Vikman KS, Hill RH, Backstrom E, Robertson B, Kristensson K (2003) Interferon-
gamma induces characteristics of central sensitization in spinal dorsal horn 
neurons in vitro. Pain 106:241-251. 
313 
 
Vikman KS, Kristensson K, Hill RH (2001) Sensitization of dorsal horn neurons in a 
two-compartment cell culture model: wind-up and long-term potentiation-like 
responses. The Journal of neuroscience : the official journal of the Society 
for Neuroscience 21:RC169. 
Visockis V, King AE (2013) M-channels modulate network excitatory activity induced 
by 4-aminopyridine in immature rat substantia gelatinosa in vitro. Brain 
research 1513:9-16. 
Volman V, Behrens MM, Sejnowski TJ (2011) Downregulation of Parvalbumin at 
Cortical GABA Synapses Reduces Network Gamma Oscillatory Activity. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 
31:18137-18148. 
Voss J, Sanchez C, Michelsen S, Ebert B (2003) Rotarod studies in the rat of the 
GABAA receptor agonist gaboxadol: lack of ethanol potentiation and 
benzodiazepine cross-tolerance. European journal of pharmacology 
482:215-222. 
Wafford KA, Ebert B (2006) Gaboxadol--a new awakening in sleep. Current opinion 
in pharmacology 6:30-36. 
Wakai A, Kohno T, Yamakura T, Okamoto M, Ataka T, Baba H (2005) Action of 
isoflurane on the substantia gelatinosa neurons of the adult rat spinal cord. 
Anesthesiology 102:379-386. 
Waldvogel HJ, Baer K, Snell RG, During MJ, Faull RLM, Rees MI (2003) 
Distribution of gephyrin in the human brain: an immunohistochemical 
analysis. Neuroscience 116:145-156. 
Wang X-J, Buzsáki G (1996) Gamma Oscillation by Synaptic Inhibition in a 
Hippocampal Interneuronal Network Model. The Journal of Neuroscience 
16:6402-6413. 
Wang X, Sun Q-Q (2012) Characterization of axo-axonic synapses in the piriform 
cortex of Mus musculus. The Journal of comparative neurology 520:832-
847. 
Watanabe E, Akagi H (1995) Distribution patterns of mRNAs encoding glycine 
receptor channels in the developing rat spinal cord. Neuroscience Research 
23:377-382. 
Watanabe M, Fukuda A (2015) Development and regulation of chloride homeostasis 
in the central nervous system. Frontiers in cellular neuroscience 9:371. 
Watts AE, Jefferys JG (1993) Effects of carbamazepine and baclofen on 4-
aminopyridine-induced epileptic activity in rat hippocampal slices. British 
journal of pharmacology 108:819-823. 
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers: advances 
in siRNA delivery. Nature reviews Drug discovery 8:129-138. 
Whittington MA, Traub RD, Kopell N, Ermentrout B, Buhl EH (2000) Inhibition-based 
rhythms: experimental and mathematical observations on network dynamics. 
International Journal of Psychophysiology 38:315-336. 
Wisden W, Cope D, Klausberger T, Hauer B, Sinkkonen ST, Tretter V, Lujan R, 
Jones A, Korpi ER, Mody I, Sieghart W, Somogyi P (2002) Ectopic 
expression of the GABAA receptor α6 subunit in hippocampal pyramidal 
neurons produces extrasynaptic receptors and an increased tonic inhibition. 
Neuropharmacology 43:530-549. 
Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, Pandey RK, Rajeev 
KG, Nakayama T, Charrise K, Ndungo EM, Zimmermann T, Koteliansky V, 
Manoharan M, Stoffel M (2007) Mechanisms and optimization of in vivo 
delivery of lipophilic siRNAs. Nature biotechnology 25:1149-1157. 
Woolf CJ (2010) Overcoming obstacles to developing new analgesics. Nat Med 
16:1241-1247. 
Wu Y-e, Li Y-d, Luo Y-j, Wang T-x, Wang H-j, Chen S-n, Qu W-m, Huang Z-l 
(2015a) Gelsemine alleviates both neuropathic pain and sleep disturbance in 
314 
 
partial sciatic nerve ligation mice. Acta pharmacologica Sinica 36:1308-
1317. 
Wu YE, Li YD, Luo YJ, Wang TX, Wang HJ, Chen SN, Qu WM, Huang ZL (2015b) 
Gelsemine alleviates both neuropathic pain and sleep disturbance in partial 
sciatic nerve ligation mice. Acta pharmacologica Sinica. 
Wu Z, Guo Z, Gearing M, Chen G (2014) Tonic inhibition in dentate gyrus impairs 
long-term potentiation and memory in an Alzheimer's [corrected] disease 
model. Nature communications 5:4159. 
Xia J, Pan R, Gao X, Meucci O, Hu H (2014) Native store-operated calcium 
channels are functionally expressed in mouse spinal cord dorsal horn 
neurons and regulate resting calcium homeostasis. The Journal of 
physiology 592:3443-3461. 
Xiang G, Pan L, Huang L, Yu Z, Song X, Cheng J, Xing W, Zhou Y (2007) 
Microelectrode array-based system for neuropharmacological applications 
with cortical neurons cultured in vitro. Biosensors and Bioelectronics 
22:2478-2484. 
Yajima Y, Narita M, Tsuda M, Imai S, Kamei J, Nagase H, Suzuki T (2000) 
Modulation of NMDA- and (+)TAN-67-induced nociception by GABA(B) 
receptors in the mouse spinal cord. Life sciences 68:719-725. 
Yaksh TL (1989) Behavioral and autonomic correlates of the tactile evoked 
allodynia produced by spinal glycine inhibition: effects of modulatory 
receptor systems and excitatory amino acid antagonists. Pain 37:111-123. 
Yamamoto C, McIlwain H (1966) Electrical activities in thin sections from the 
mammalian brain maintained in chemically-defined media in vitro. Journal of 
neurochemistry 13:1333-1343. 
Yamamoto T, Yaksh TL (1993) Effects of intrathecal strychnine and bicuculline on 
nerve compression-induced thermal hyperalgesia and selective antagonism 
by MK-801. Pain 54:79-84. 
Yang K, Ma R, Wang Q, Jiang P, Li YQ (2015) Optoactivation of parvalbumin 
neurons in the spinal dorsal horn evokes GABA release that is regulated by 
presynaptic GABAB receptors. Neuroscience letters 594:55-59. 
Yang K, Ma WL, Feng YP, Dong YX, Li YQ (2002) Origins of GABA(B) receptor-like 
immunoreactive terminals in the rat spinal dorsal horn. Brain research 
bulletin 58:499-507. 
Yang K, Wang D, Li YQ (2001) Distribution and depression of the GABA(B) receptor 
in the spinal dorsal horn of adult rat. Brain research bulletin 55:479-485. 
Yang Z, Cromer BA, Harvey RJ, Parker MW, Lynch JW (2007) A proposed 
structural basis for picrotoxinin and picrotin binding in the glycine receptor 
pore. Journal of neurochemistry 103:580-589. 
Yasaka T, Tiong SY, Hughes DI, Riddell JS, Todd AJ (2010) Populations of 
inhibitory and excitatory interneurons in lamina II of the adult rat spinal 
dorsal horn revealed by a combined electrophysiological and anatomical 
approach. Pain 151:475-488. 
Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T (1994) A 
general method for the generation of high-titer, pantropic retroviral vectors: 
highly efficient infection of primary hepatocytes. Proceedings of the National 
Academy of Sciences of the United States of America 91:9564-9568. 
Yoon YJ, Gokin AP, Martin-Caraballo M (2010) Pharmacological manipulation of 
GABA-driven activity in ovo disrupts the development of dendritic 
morphology but not the maturation of spinal cord network activity. Neural 
Development 5:11-11. 
Youn D-h, Gerber G, Sather WA (2013) Ionotropic Glutamate Receptors and 
Voltage-Gated Ca(2+) Channels in Long-Term Potentiation of Spinal Dorsal 
Horn Synapses and Pain Hypersensitivity. Neural Plasticity 2013:654257. 
315 
 
Young-Pearse TL, Ivic L, Kriegstein AR, Cepko CL (2006) Characterization of mice 
with targeted deletion of glycine receptor alpha 2. Molecular and cellular 
biology 26:5728-5734. 
Young AB, Snyder SH (1973) Strychnine Binding Associated with Glycine 
Receptors of the Central Nervous System. Proceedings of the National 
Academy of Sciences of the United States of America 70:2832-2836. 
Zafrakas M, Chorovicer M, Klaman I, Kristiansen G, Wild P-J, Heindrichs U, 
Knüchel R, Dahl E (2006) Systematic characterisation of GABRP expression 
in sporadic breast cancer and normal breast tissue. International Journal of 
Cancer 118:1453-1459. 
Zeilhofer HU, Möhler H, Di Lio A (2009) GABAergic analgesia: new insights from 
mutant mice and subtype-selective agonists. Trends in Pharmacological 
Sciences 30:397-402. 
Zeilhofer HU, Wildner H, Yevenes GE (2012) Fast synaptic inhibition in spinal 
sensory processing and pain control. Physiological reviews 92:193-235. 
Zelano J, Berg A, Thams S, Hailer NP, Cullheim S (2009) SynCAM1 expression 
correlates with restoration of central synapses on spinal motoneurons after 
two different models of peripheral nerve injury. The Journal of comparative 
neurology 517:670-682. 
Zhang J, Xue F, Chang Y (2008a) Structural Determinants for Antagonist 
Pharmacology That Distinguish the ρ1 GABAC Receptor from GABAA 
Receptors. Molecular pharmacology 74:941-951. 
Zhang JY, Gong N, Huang JL, Guo LC, Wang YX (2013) Gelsemine, a principal 
alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific 
antinociception in chronic pain by acting at spinal alpha3 glycine receptors. 
Pain 154:2452-2462. 
Zhang JY, Wang YX (2015) Gelsemium analgesia and the spinal glycine 
receptor/allopregnanolone pathway. Fitoterapia 100:35-43. 
Zhang LL, Fina ME, Vardi N (2006) Regulation of KCC2 and NKCC during 
development: membrane insertion and differences between cell types. The 
Journal of comparative neurology 499:132-143. 
Zhang M, Møller M, Broman J, Sukiasyan N, Wienecke J, Hultborn H (2008b) 
Expression of calcium channel CaV1.3 in cat spinal cord: Light and electron 
microscopic immunohistochemical study. The Journal of comparative 
neurology 507:1109-1127. 
Zhang W, Liu LY, Xu TL (2008c) Reduced potassium-chloride co-transporter 
expression in spinal cord dorsal horn neurons contributes to inflammatory 
pain hypersensitivity in rats. Neuroscience 152:502-510. 
Zhang XC, Zhang YQ, Zhao ZQ (2005) Involvement of nitric oxide in long-term 
potentiation of spinal nociceptive responses in rats. Neuroreport 16:1197-
1201. 
Zheng J, Lu Y, Perl ER (2010) Inhibitory neurones of the spinal substantia 
gelatinosa mediate interaction of signals from primary afferents. Journal of 
Physiology 588:2065-2075. 
Zhou C, Huang Z, Ding L, Deel ME, Arain FM, Murray CR, Patel RS, Flanagan CD, 
Gallagher MJ (2013) Altered cortical GABAA receptor composition, 
physiology, and endocytosis in a mouse model of a human genetic absence 
epilepsy syndrome. The Journal of biological chemistry 288:21458-21472. 
 
 
